*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 22 HIS~? 21.70 NI NI A 304 A 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 22 HIS~? 21.70 NI NI A 304 A 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 83 HIS~? 17.38 NI NI A 304 A 250 ALA A 82 ALA~? 21.17 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -24.62 16.98 -31.39 -25.35 18.12 -30.70 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 83 HIS~? 17.38 NI NI A 304 A 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 83 HIS~? 17.38 NI NI A 304 A 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 22 HIS~? 22.02 NI NI B 305 A 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 22 HIS~? 22.02 NI NI B 305 A 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 83 HIS~? 17.68 NI NI B 305 A 250 ALA B 82 ALA~? 21.25 NI NI B 305 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 83 HIS~? 17.68 NI NI B 305 A 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 83 HIS~? 17.68 NI NI B 305 A 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 10 hits 2wwt_o00 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 79 SER~? 16.97 CA CA A 301 A 524 ASP A 21 ASP~? 19.27 CA CA A 301 A 556 HIS A 22 HIS~? 21.70 NI NI A 304 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER A 79 SER~? 16.97 CA CA A 301 A 524 ASP A 21 ASP~? 19.27 CA CA A 301 A 556 HIS A 83 HIS~? 17.38 NI NI A 304 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER B 79 SER~? 19.41 NI NI B 305 A 524 ASP B 21 ASP~? 22.52 NI NI B 305 A 556 HIS B 22 HIS~? 22.02 NI NI B 305 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER B 79 SER~? 19.41 NI NI B 305 A 524 ASP B 21 ASP~? 22.52 NI NI B 305 A 556 HIS B 83 HIS~? 17.68 NI NI B 305 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 1 3 # 1 A 98 SER B 79 SER~? 19.41 NI NI B 305 A 123 HIS B 22 HIS~? 22.02 NI NI B 305 A 172 ASP B 21 ASP~? 22.52 NI NI B 305 coo 45.74 29.80 42.79 47.58 31.06 41.64 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 44.17 25.61 37.60 45.21 25.56 35.81 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 39.85 24.35 34.94 41.12 25.58 33.83 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 3qwd_o00 ATP-DEPENDENT CLP PROTEASE PROTEOLYTuser 2 3 # 2 A 98 SER B 79 SER~? 19.41 NI NI B 305 A 123 HIS B 83 HIS~? 17.68 NI NI B 305 A 172 ASP B 21 ASP~? 22.52 NI NI B 305 coo 45.74 29.80 42.79 47.58 31.06 41.64 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 44.17 25.61 37.60 45.21 25.56 35.81 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 39.85 24.35 34.94 41.12 25.58 33.83 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 3qwd_o00 source 3QWD ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT: 2 hits 3qwd_o00 naa= 3 ULMN 4 1a0j_c08 TRYPSIN user 1 4 # 1 A 57 HIS A 22 HIS~? 21.70 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 195 SER A 79 SER~? 16.97 CA CA A 301 A 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 22.33 45.48 59.73 23.35 43.67 60.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 20.90 36.72 61.65 22.18 37.53 63.52 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 20.40 37.63 58.06 19.79 37.28 58.50 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c08 TRYPSIN user 2 4 # 2 A 57 HIS A 83 HIS~? 17.38 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 195 SER A 79 SER~? 16.97 CA CA A 301 A 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 20.90 36.72 61.65 22.18 37.53 63.52 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 20.40 37.63 58.06 19.79 37.28 58.50 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c08 TRYPSIN user 3 4 # 3 A 57 HIS B 22 HIS~? 22.02 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 195 SER B 79 SER~? 19.41 NI NI B 305 A 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 20.90 36.72 61.65 22.18 37.53 63.52 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 20.40 37.63 58.06 19.79 37.28 58.50 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1a0j_c08 TRYPSIN user 4 4 # 4 A 57 HIS B 83 HIS~? 17.68 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 195 SER B 79 SER~? 19.41 NI NI B 305 A 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 25.57 41.22 61.68 24.18 39.98 62.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 20.90 36.72 61.65 22.18 37.53 63.52 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 20.40 37.63 58.06 19.79 37.28 58.50 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1a0j_c08 source 1a0j TRYPSIN : 4 hits 1a0j_c08 naa= 4 ULMN 4 1a0j_c09 TRYPSIN user 1 4 # 1 B 57 HIS A 22 HIS~? 21.70 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 B 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 43.04 44.75 47.18 43.31 45.51 49.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 48.11 50.52 52.24 48.62 48.46 53.13 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 45.44 52.17 50.15 46.23 52.37 50.05 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c09 TRYPSIN user 2 4 # 2 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 B 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 48.11 50.52 52.24 48.62 48.46 53.13 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 45.44 52.17 50.15 46.23 52.37 50.05 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c09 TRYPSIN user 3 4 # 3 B 57 HIS B 22 HIS~? 22.02 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 B 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 48.11 50.52 52.24 48.62 48.46 53.13 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 45.44 52.17 50.15 46.23 52.37 50.05 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1a0j_c09 TRYPSIN user 4 4 # 4 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 B 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 44.08 45.58 52.81 45.86 46.55 52.85 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 48.11 50.52 52.24 48.62 48.46 53.13 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 45.44 52.17 50.15 46.23 52.37 50.05 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1a0j_c09 source 1a0j TRYPSIN : 4 hits 1a0j_c09 naa= 4 ULMN 4 1a0j_c10 TRYPSIN user 1 4 # 1 C 57 HIS A 22 HIS~? 21.70 NI NI A 304 C 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 C 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 34.89 38.34 78.12 35.11 39.59 76.42 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 36.16 46.87 75.66 34.01 46.43 74.59 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 39.34 45.13 76.73 39.04 45.77 77.16 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c10 TRYPSIN user 2 4 # 2 C 57 HIS A 83 HIS~? 17.38 NI NI A 304 C 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 C 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 36.16 46.87 75.66 34.01 46.43 74.59 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 39.34 45.13 76.73 39.04 45.77 77.16 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c10 TRYPSIN user 3 4 # 3 C 57 HIS B 22 HIS~? 22.02 NI NI B 305 C 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 C 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 36.16 46.87 75.66 34.01 46.43 74.59 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 39.34 45.13 76.73 39.04 45.77 77.16 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1a0j_c10 TRYPSIN user 4 4 # 4 C 57 HIS B 83 HIS~? 17.68 NI NI B 305 C 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 C 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 34.37 41.18 73.21 34.04 43.09 73.87 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 36.16 46.87 75.66 34.01 46.43 74.59 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 39.34 45.13 76.73 39.04 45.77 77.16 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1a0j_c10 source 1a0j TRYPSIN : 4 hits 1a0j_c10 naa= 4 ULMN 4 1a0j_c11 TRYPSIN user 1 4 # 1 D 57 HIS A 22 HIS~? 21.70 NI NI A 304 D 102 ASP A 21 ASP~? 19.27 CA CA A 301 D 195 SER A 79 SER~? 16.97 CA CA A 301 D 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 13.53 16.28 93.98 11.45 16.21 94.40 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 6.63 21.03 97.42 6.71 19.20 98.95 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 7.63 22.04 93.90 7.66 22.58 94.52 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c11 TRYPSIN user 2 4 # 2 D 57 HIS A 83 HIS~? 17.38 NI NI A 304 D 102 ASP A 21 ASP~? 19.27 CA CA A 301 D 195 SER A 79 SER~? 16.97 CA CA A 301 D 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 6.63 21.03 97.42 6.71 19.20 98.95 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 7.63 22.04 93.90 7.66 22.58 94.52 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1a0j_c11 TRYPSIN user 3 4 # 3 D 57 HIS B 22 HIS~? 22.02 NI NI B 305 D 102 ASP B 21 ASP~? 22.52 NI NI B 305 D 195 SER B 79 SER~? 19.41 NI NI B 305 D 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 6.63 21.03 97.42 6.71 19.20 98.95 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 7.63 22.04 93.90 7.66 22.58 94.52 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1a0j_c11 TRYPSIN user 4 4 # 4 D 57 HIS B 83 HIS~? 17.68 NI NI B 305 D 102 ASP B 21 ASP~? 22.52 NI NI B 305 D 195 SER B 79 SER~? 19.41 NI NI B 305 D 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 8.19 15.01 95.72 7.78 16.53 97.01 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 6.63 21.03 97.42 6.71 19.20 98.95 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 7.63 22.04 93.90 7.66 22.58 94.52 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1a0j_c11 source 1a0j TRYPSIN : 4 hits 1a0j_c11 naa= 4 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 1 4 # 1 A 142 ALA A 44 ALA~? 19.89 CA CA B 303 A 144 GLY A 45 GLY~? 17.79 NI NI A 304 A 280 TYR B 15 TYR^? 16.36 NI NI B 305 A 414 GLU A 43 GLU~? 22.12 CA CA A 306 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -24.31 -5.26 -5.52 -23.36 -4.37 -3.82 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 2 4 # 2 A 142 ALA A 44 ALA~? 19.89 CA CA B 303 A 144 GLY A 47 GLY~? 21.14 NI NI A 304 A 280 TYR B 15 TYR^? 16.36 NI NI B 305 A 414 GLU A 43 GLU~? 22.12 CA CA A 306 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -24.31 -5.26 -5.52 -23.36 -4.37 -3.82 ULMN 4 1b8f_c00 HISTIDINE AMMONIA-LYASE user 3 4 # 3 A 142 ALA B 44 ALA~? 21.16 NI NI B 305 A 144 GLY B 47 GLY~? 21.31 NI NI B 305 A 280 TYR A 15 TYR^? 16.16 NI NI A 304 A 414 GLU B 43 GLU~? 26.30 NI NI B 305 coo 8.90 -17.98 11.65 7.53 -18.34 11.16 -23.24 2.66 -69.27 -24.25 2.76 -68.14 coo 11.65 -18.01 12.88 11.72 -18.24 12.53 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo -3.84 22.59 11.63 -6.55 23.25 11.72 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 7.29 -23.46 8.78 9.26 -22.73 8.47 -26.02 0.23 -73.88 -25.38 -0.28 -75.86 1b8f_c00 source 1b8f HISTIDINE AMMONIA-LYASE : 3 hits 1b8f_c00 naa= 4 ULMN 4 1c17_c11 ATP SYNTHASE SUBUNIT C user 1 4 # 1 A 61 ASP B 90 ASP~? 18.88 CA CA B 303 M 206 SER B 133 SER^? 18.43 NI NI B 305 M 210 ARG B 198 ARG^? 13.15 NI NI B 305 M 214 ASN B 192 ASN.? 16.32 NI NI B 305 coo 2.15 -17.14 -6.89 2.91 -15.59 -8.10 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo -2.55 -23.32 19.81 -3.48 -21.59 18.38 -10.40 -17.22 -68.30 -9.98 -16.63 -70.62 coo 1.98 -17.11 17.69 1.79 -15.15 15.33 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 8.13 -16.73 20.92 6.75 -15.93 19.51 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 1c17_c11 source 1c17 ATP SYNTHASE SUBUNIT C : 1 hits 1c17_c11 naa= 4 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 B 57 HIS A 22 HIS~? 21.70 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 C 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 9.31 59.87 4.78 10.85 60.06 6.19 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 5.59 57.53 8.57 7.14 58.09 7.29 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 14.55 58.92 8.37 13.10 60.57 7.33 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 13.67 55.27 8.79 14.08 55.70 9.37 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 2 4 # 2 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 C 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 9.31 59.87 4.78 10.85 60.06 6.19 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 5.59 57.53 8.57 7.14 58.09 7.29 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 14.55 58.92 8.37 13.10 60.57 7.33 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 13.67 55.27 8.79 14.08 55.70 9.37 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 3 4 # 3 B 57 HIS B 22 HIS~? 22.02 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 C 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 9.31 59.87 4.78 10.85 60.06 6.19 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 5.59 57.53 8.57 7.14 58.09 7.29 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 14.55 58.92 8.37 13.10 60.57 7.33 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 13.67 55.27 8.79 14.08 55.70 9.37 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1ca0_c02 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 4 4 # 4 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 C 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 9.31 59.87 4.78 10.85 60.06 6.19 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 5.59 57.53 8.57 7.14 58.09 7.29 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 14.55 58.92 8.37 13.10 60.57 7.33 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 13.67 55.27 8.79 14.08 55.70 9.37 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1ca0_c02 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 4 hits 1ca0_c02 naa= 4 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 1 4 # 1 G 57 HIS A 22 HIS~? 21.70 NI NI A 304 G 102 ASP A 21 ASP~? 19.27 CA CA A 301 H 195 SER A 79 SER~? 16.97 CA CA A 301 H 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 55.62 80.38 34.57 53.54 80.49 34.33 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 55.92 77.51 29.55 55.59 78.35 31.47 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 49.36 79.22 35.31 50.95 80.97 34.93 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 49.96 75.54 34.73 49.24 75.92 34.45 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 2 4 # 2 G 57 HIS A 83 HIS~? 17.38 NI NI A 304 G 102 ASP A 21 ASP~? 19.27 CA CA A 301 H 195 SER A 79 SER~? 16.97 CA CA A 301 H 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 55.62 80.38 34.57 53.54 80.49 34.33 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 55.92 77.51 29.55 55.59 78.35 31.47 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 49.36 79.22 35.31 50.95 80.97 34.93 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 49.96 75.54 34.73 49.24 75.92 34.45 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 3 4 # 3 G 57 HIS B 22 HIS~? 22.02 NI NI B 305 G 102 ASP B 21 ASP~? 22.52 NI NI B 305 H 195 SER B 79 SER~? 19.41 NI NI B 305 H 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 55.62 80.38 34.57 53.54 80.49 34.33 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 55.92 77.51 29.55 55.59 78.35 31.47 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 49.36 79.22 35.31 50.95 80.97 34.93 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 49.96 75.54 34.73 49.24 75.92 34.45 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1ca0_c03 PROTEASE INHIBITOR DOMAIN OF ALZHEIMuser 4 4 # 4 G 57 HIS B 83 HIS~? 17.68 NI NI B 305 G 102 ASP B 21 ASP~? 22.52 NI NI B 305 H 195 SER B 79 SER~? 19.41 NI NI B 305 H 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 55.62 80.38 34.57 53.54 80.49 34.33 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 55.92 77.51 29.55 55.59 78.35 31.47 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 49.36 79.22 35.31 50.95 80.97 34.93 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 49.96 75.54 34.73 49.24 75.92 34.45 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1ca0_c03 source 1ca0 PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLO: 4 hits 1ca0_c03 naa= 4 ULMN 4 1dub_c00 2-ENOYL-COA HYDRATASE user 1 4 # 1 A 98 ALA A 44 ALA~? 19.89 CA CA B 303 A 141 GLY A 47 GLY~? 21.14 NI NI A 304 A 144 GLU A 50 GLU~? 22.49 CA CA A 302 A 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 58.27 102.60 178.19 59.43 101.66 178.07 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 59.27 103.88 173.55 59.11 104.69 173.45 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 61.78 103.61 169.93 62.63 102.26 171.29 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 65.46 104.88 175.81 64.47 105.72 174.12 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 1dub_c00 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c00 naa= 4 ULMN 4 1dub_c01 2-ENOYL-COA HYDRATASE user 1 4 # 1 B 98 ALA A 44 ALA~? 19.89 CA CA B 303 B 141 GLY A 47 GLY~? 21.14 NI NI A 304 B 144 GLU A 50 GLU~? 22.49 CA CA A 302 B 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 93.67 115.22 150.99 93.63 113.90 150.22 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 88.87 114.43 152.30 88.45 115.15 152.32 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 85.20 111.99 152.05 86.60 110.89 150.91 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 88.14 113.46 145.73 86.79 113.92 147.30 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 1dub_c01 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c01 naa= 4 ULMN 4 1dub_c02 2-ENOYL-COA HYDRATASE user 1 4 # 1 C 98 ALA A 44 ALA~? 19.89 CA CA B 303 C 141 GLY A 47 GLY~? 21.14 NI NI A 304 C 144 GLU A 50 GLU~? 22.49 CA CA A 302 C 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 53.00 102.79 132.36 53.08 101.42 133.06 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 56.28 104.55 135.84 56.09 105.34 136.05 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 58.46 103.90 139.48 57.57 102.00 139.16 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 51.71 102.03 140.09 53.02 103.62 140.54 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 1dub_c02 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c02 naa= 4 ULMN 4 1dub_c03 2-ENOYL-COA HYDRATASE user 1 4 # 1 D 98 ALA A 44 ALA~? 19.89 CA CA B 303 D 141 GLY A 47 GLY~? 21.14 NI NI A 304 D 144 GLU A 50 GLU~? 22.49 CA CA A 302 D 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 88.91 81.99 128.63 88.96 83.34 129.32 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 86.19 80.64 132.77 86.38 79.85 132.93 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 84.75 81.24 136.88 85.62 83.14 136.43 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 91.47 83.05 136.24 90.35 81.38 136.84 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 1dub_c03 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c03 naa= 4 ULMN 4 1dub_c04 2-ENOYL-COA HYDRATASE user 1 4 # 1 E 98 ALA A 44 ALA~? 19.89 CA CA B 303 E 141 GLY A 47 GLY~? 21.14 NI NI A 304 E 144 GLU A 50 GLU~? 22.49 CA CA A 302 E 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 91.93 82.37 174.92 90.77 83.36 175.00 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 90.07 81.07 170.50 90.23 80.26 170.38 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 87.05 81.30 167.53 86.38 82.74 168.94 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 84.40 80.02 173.80 85.08 79.06 172.03 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 1dub_c04 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c04 naa= 4 ULMN 4 1dub_c05 2-ENOYL-COA HYDRATASE user 1 4 # 1 F 98 ALA A 44 ALA~? 19.89 CA CA B 303 F 141 GLY A 47 GLY~? 21.14 NI NI A 304 F 144 GLU A 50 GLU~? 22.49 CA CA A 302 F 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 52.21 69.79 154.56 52.11 71.07 153.72 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 57.12 70.68 155.10 57.52 69.95 155.02 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 60.62 73.13 154.21 59.05 74.26 153.35 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 56.75 71.71 148.46 58.44 71.01 149.54 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 1dub_c05 source 1dub 2-ENOYL-COA HYDRATASE : 1 hits 1dub_c05 naa= 4 ULMN 4 1ecl_c00 MOLECULE: ESCHERICHIA COLI TOPOISOMEuser 1 4 # 1 9 GLU A 89 GLU~? 25.01 NI NI A 304 111 ASP A 90 ASP~? 20.31 NI NI A 304 319 TYR A 15 TYR^? 16.16 NI NI A 304 365 HIS A 16 HIS^? 15.61 NI NI A 304 coo 40.90 33.12 50.07 39.32 31.72 50.03 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 38.20 29.86 46.47 38.01 31.94 46.26 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 35.52 29.82 41.60 37.98 29.12 42.65 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 32.44 22.36 39.83 33.57 21.39 41.30 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 4 1ecl_c00 MOLECULE: ESCHERICHIA COLI TOPOISOMEuser 2 4 # 2 9 GLU A 103 GLU^? 14.47 CA CA B 303 111 ASP A 104 ASP^? 11.20 NI NI A 304 319 TYR A 60 TYR.? 8.44 NI NI A 304 365 HIS A 119 HIS^? -3.69 NI NI A 304s coo 40.90 33.12 50.07 39.32 31.72 50.03 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 38.20 29.86 46.47 38.01 31.94 46.26 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 35.52 29.82 41.60 37.98 29.12 42.65 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 coo 32.44 22.36 39.83 33.57 21.39 41.30 -7.63 0.70 -25.42 -8.53 2.19 -24.26 ULMN 4 1ecl_c00 MOLECULE: ESCHERICHIA COLI TOPOISOMEuser 3 4 # 3 9 GLU B 89 GLU~? 11.52 CA CA B 303 111 ASP B 90 ASP~? 18.88 CA CA B 303 319 TYR B 15 TYR^? 16.36 NI NI B 305 365 HIS B 16 HIS^? 15.81 NI NI B 305 coo 40.90 33.12 50.07 39.32 31.72 50.03 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 38.20 29.86 46.47 38.01 31.94 46.26 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 35.52 29.82 41.60 37.98 29.12 42.65 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 32.44 22.36 39.83 33.57 21.39 41.30 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 1ecl_c00 source 1ecl MOLECULE: ESCHERICHIA COLI TOPOISOMERASE I : 3 hits 1ecl_c00 naa= 4 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 1 4 # 1 B 57 HIS A 22 HIS~? 21.70 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 C 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 2 4 # 2 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 C 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 3 4 # 3 B 57 HIS B 22 HIS~? 22.02 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 C 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1n8o_c01 CHYMOTRYPSIN A, B CHAIN user 4 4 # 4 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 C 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo 31.98 -6.99 19.44 30.75 -5.55 18.68 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 36.93 -4.10 19.45 35.15 -5.13 19.05 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 28.33 -3.35 15.58 28.24 -4.45 17.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 31.25 -3.44 13.14 30.79 -2.74 13.19 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1n8o_c01 source 1n8o CHYMOTRYPSIN A, B CHAIN : 4 hits 1n8o_c01 naa= 4 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 1 4 # 1 B 363 HIS A 116 HIS^? 7.23 NI NI A 304 B 432 SER A 115 SER.? 13.22 NI NI A 304 B 457 HIS A 119 HIS^? -3.69 NI NI A 304s B 465 ARG A 198 ARG^? 13.22 CA CA A 306 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 -7.58 10.63 -14.31 -5.28 12.67 -14.13 ULMN 4 1nkk_c01 PEPTIDOMIMETIC INHIBITOR user 2 4 # 2 B 363 HIS B 116 HIS^? 6.69 NI NI B 305 B 432 SER B 115 SER.? 13.16 NI NI B 305 B 457 HIS B 119 HIS^? -3.53 NI NI B 305s B 465 ARG B 198 ARG^? 13.15 NI NI B 305 coo 35.32 43.47 -12.43 34.69 42.14 -13.92 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 32.38 38.39 -14.73 32.14 40.79 -14.95 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 40.41 40.81 -13.07 39.42 42.66 -13.07 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 27.37 44.86 -17.95 29.55 46.21 -19.65 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 1nkk_c01 source 1nkk PEPTIDOMIMETIC INHIBITOR : 2 hits 1nkk_c01 naa= 4 ULMN 4 1o04_c00 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 A 192 LYS B 78 LYS~? 25.94 CA CA B 303 A 268 GLU B 103 GLU^? 12.89 NI NI B 305 A 302 SER B 183 SER.? 9.15 NI NI B 305 A 399 GLU B 182 GLU^? 15.43 NI NI B 305 coo 85.01 60.31 56.44 83.15 64.89 56.44 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 coo 71.86 54.60 60.61 70.38 53.71 61.84 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 68.68 62.06 66.08 69.52 59.75 65.97 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 66.34 67.16 63.84 67.47 65.57 63.06 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1o04_c00 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c00 naa= 4 ULMN 4 1o04_c02 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 C 192 LYS B 78 LYS~? 25.94 CA CA B 303 C 268 GLU B 103 GLU^? 12.89 NI NI B 305 C 302 SER B 183 SER.? 9.15 NI NI B 305 C 399 GLU B 182 GLU^? 15.43 NI NI B 305 coo 83.30 16.28 88.61 85.25 11.75 88.79 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 coo 79.88 15.02 74.11 80.06 15.36 72.02 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 87.46 9.36 71.39 86.33 11.53 71.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 87.65 3.44 72.32 86.49 4.99 73.13 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1o04_c02 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c02 naa= 4 ULMN 4 1o04_c03 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 D 192 LYS B 78 LYS~? 25.94 CA CA B 303 D 268 GLU B 103 GLU^? 12.89 NI NI B 305 D 302 SER B 183 SER.? 9.15 NI NI B 305 D 399 GLU B 182 GLU^? 15.43 NI NI B 305 coo 51.91 3.68 69.52 49.61 2.30 73.71 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 coo 55.94 16.93 75.09 55.86 19.04 75.37 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 48.09 18.43 80.84 49.40 18.94 78.77 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 47.32 15.81 86.19 48.62 15.41 84.58 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1o04_c03 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c03 naa= 4 ULMN 4 1o04_c06 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAuser 1 4 # 1 G 192 LYS B 78 LYS~? 25.94 CA CA B 303 G 268 GLU B 103 GLU^? 12.89 NI NI B 305 G 302 SER B 183 SER.? 9.15 NI NI B 305 G 399 GLU B 182 GLU^? 15.43 NI NI B 305 coo 56.79 103.91 140.42 58.85 102.76 144.77 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 coo 69.06 110.82 135.59 70.39 112.47 135.16 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 72.18 114.35 144.24 71.25 114.81 141.99 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 75.14 110.89 148.28 73.91 110.46 146.63 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1o04_c06 source 1o04 ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL PRECURSO: 1 hits 1o04_c06 naa= 4 ULMN 4 1qh9_c01 2-HALOACID DEHALOGENASE user 1 4 # 1 A 10 ASP B 42 ASP~? 18.39 NI NI B 305 A 41 ARG B 69 ARG~? 22.61 NI NI B 305 A 118 SER B 59 SER.? 12.75 NI NI B 305 A 180 ASP B 41 ASP.? 25.32 NI NI B 305 coo 20.70 13.03 9.13 22.27 11.81 9.81 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 23.00 19.17 17.85 22.49 17.70 15.19 -29.41 -6.49 -63.38 -29.52 -5.70 -66.36 coo 17.70 9.25 13.10 16.68 11.30 13.99 -19.36 -3.57 -64.12 -19.85 -5.79 -63.23 coo 26.47 11.43 10.70 25.16 9.82 11.06 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 1qh9_c01 source 1qh9 2-HALOACID DEHALOGENASE : 1 hits 1qh9_c01 naa= 4 ULMN 4 1qrz_c04 PLASMINOGEN user 1 4 # 1 A 603 HIS B 121 HIS.? -3.60 NI NI B 305s A 646 ASP B 104 ASP^? 11.37 NI NI B 305 A 741 SER B 127 SER^? 6.61 NI NI B 305 A 742 GLY B 128 GLY^? 7.45 NI NI B 305 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -13.41 0.94 31.30 -13.38 0.16 31.09 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1qrz_c04 source 1qrz PLASMINOGEN : 1 hits 1qrz_c04 naa= 4 ULMN 4 1qrz_c05 PLASMINOGEN user 1 4 # 1 B 603 HIS A 121 HIS.? -3.63 NI NI A 304s B 646 ASP A 104 ASP^? 11.20 NI NI A 304 B 741 SER A 127 SER^? 6.45 NI NI A 304 B 742 GLY A 128 GLY^? 7.35 NI NI A 304 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 4 1qrz_c05 PLASMINOGEN user 2 4 # 2 B 603 HIS B 121 HIS.? -3.60 NI NI B 305s B 646 ASP B 104 ASP^? 11.37 NI NI B 305 B 741 SER B 127 SER^? 6.61 NI NI B 305 B 742 GLY B 128 GLY^? 7.45 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -41.03 0.89 -7.12 -41.01 0.10 -7.37 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1qrz_c05 source 1qrz PLASMINOGEN : 2 hits 1qrz_c05 naa= 4 ULMN 4 1qrz_c06 PLASMINOGEN user 1 4 # 1 C 603 HIS A 121 HIS.? -3.63 NI NI A 304s C 646 ASP A 104 ASP^? 11.20 NI NI A 304 C 741 SER A 127 SER^? 6.45 NI NI A 304 C 742 GLY A 128 GLY^? 7.35 NI NI A 304 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 4 1qrz_c06 PLASMINOGEN user 2 4 # 2 C 603 HIS B 121 HIS.? -3.60 NI NI B 305s C 646 ASP B 104 ASP^? 11.37 NI NI B 305 C 741 SER B 127 SER^? 6.61 NI NI B 305 C 742 GLY B 128 GLY^? 7.45 NI NI B 305 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 6.69 -6.98 2.53 6.88 -6.20 2.57 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1qrz_c06 source 1qrz PLASMINOGEN : 2 hits 1qrz_c06 naa= 4 ULMN 4 1qrz_c07 PLASMINOGEN user 1 4 # 1 D 603 HIS A 121 HIS.? -3.63 NI NI A 304s D 646 ASP A 104 ASP^? 11.20 NI NI A 304 D 741 SER A 127 SER^? 6.45 NI NI A 304 D 742 GLY A 128 GLY^? 7.35 NI NI A 304 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 4 1qrz_c07 PLASMINOGEN user 2 4 # 2 D 603 HIS B 121 HIS.? -3.60 NI NI B 305s D 646 ASP B 104 ASP^? 11.37 NI NI B 305 D 741 SER B 127 SER^? 6.61 NI NI B 305 D 742 GLY B 128 GLY^? 7.45 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -47.33 -7.05 40.93 -47.11 -6.27 40.97 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1qrz_c07 source 1qrz PLASMINOGEN : 2 hits 1qrz_c07 naa= 4 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 4 # 1 B 57 HIS A 22 HIS~? 21.70 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 B 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 0.64 25.09 37.94 0.51 25.31 37.16 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 4 # 2 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 B 196 GLY A 23 GLY.? 17.48 CA CA A 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 0.64 25.09 37.94 0.51 25.31 37.16 -27.33 19.65 -25.69 -27.09 20.39 -25.46 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 4 # 3 B 57 HIS B 22 HIS~? 22.02 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 B 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 0.64 25.09 37.94 0.51 25.31 37.16 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 ULMN 4 1rtf_c04 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 4 # 4 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 B 196 GLY B 23 GLY.? 23.03 NI NI B 305 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 0.64 25.09 37.94 0.51 25.31 37.16 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 1rtf_c04 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c04 naa= 4 ULMN 4 1vr7_c01 S-ADENOSYLMETHIONINE DECARBOXYLASE Puser 1 4 # 1 B 55 SER B 118 SER^? 9.81 NI NI B 305 B 63 SER B 200 SER^? 8.90 NI NI B 305 B 68 HIS B 119 HIS^? -3.53 NI NI B 305s B 83 CYH B 35 CYH~? 15.94 NI NI B 305 coo 46.97 18.77 24.19 48.48 17.02 24.84 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo 36.25 19.46 37.21 33.98 18.93 36.54 -12.57 -12.65 -63.59 -11.16 -10.79 -62.91 coo 45.78 14.70 26.03 45.81 15.82 27.78 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 29.47 18.23 38.01 31.86 17.60 39.34 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 ULMN 4 1vr7_c01 S-ADENOSYLMETHIONINE DECARBOXYLASE Puser 2 4 # 2 B 55 SER B 183 SER.? 9.15 NI NI B 305 B 63 SER B 200 SER^? 8.90 NI NI B 305 B 68 HIS B 121 HIS.? -3.60 NI NI B 305s B 83 CYH B 35 CYH~? 15.94 NI NI B 305 coo 46.97 18.77 24.19 48.48 17.02 24.84 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 36.25 19.46 37.21 33.98 18.93 36.54 -12.57 -12.65 -63.59 -11.16 -10.79 -62.91 coo 45.78 14.70 26.03 45.81 15.82 27.78 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 29.47 18.23 38.01 31.86 17.60 39.34 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 1vr7_c01 source 1vr7 S-ADENOSYLMETHIONINE DECARBOXYLASE PROENZYME : 2 hits 1vr7_c01 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP B 163 ASP.? 22.00 NI NI B 305 A 100 ARG B 166 ARG.? 22.37 NI NI B 305 A 116 GLN B 167 GLN.? 21.49 NI NI B 305 coo 32.24 20.09 5.34 30.38 19.04 5.27 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 26.40 25.34 6.28 26.15 22.33 7.25 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 26.74 21.94 13.78 27.57 20.97 12.08 8.59 -8.80 -47.03 9.88 -7.15 -46.70 12as_c00 source 12as ASPARAGINE SYNTHETASE : 1 hits 12as_c00 naa= 3 ULMN 3 1a0j_c00 TRYPSIN user 1 3 # 1 A 57 HIS A 22 HIS~? 21.70 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 195 SER A 79 SER~? 16.97 CA CA A 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 22.33 45.48 59.73 23.35 43.67 60.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 20.90 36.72 61.65 22.18 37.53 63.52 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c00 TRYPSIN user 2 3 # 2 A 57 HIS A 83 HIS~? 17.38 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 195 SER A 79 SER~? 16.97 CA CA A 301 coo 25.57 41.22 61.68 24.18 39.98 62.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 20.90 36.72 61.65 22.18 37.53 63.52 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c00 TRYPSIN user 3 3 # 3 A 57 HIS B 22 HIS~? 22.02 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 195 SER B 79 SER~? 19.41 NI NI B 305 coo 25.57 41.22 61.68 24.18 39.98 62.50 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 20.90 36.72 61.65 22.18 37.53 63.52 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 1a0j_c00 TRYPSIN user 4 3 # 4 A 57 HIS B 83 HIS~? 17.68 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 195 SER B 79 SER~? 19.41 NI NI B 305 coo 25.57 41.22 61.68 24.18 39.98 62.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 20.90 36.72 61.65 22.18 37.53 63.52 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 1a0j_c00 source 1a0j TRYPSIN : 4 hits 1a0j_c00 naa= 3 ULMN 3 1a0j_c01 TRYPSIN user 1 3 # 1 B 57 HIS A 22 HIS~? 21.70 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 43.04 44.75 47.18 43.31 45.51 49.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 48.11 50.52 52.24 48.62 48.46 53.13 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c01 TRYPSIN user 2 3 # 2 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 coo 44.08 45.58 52.81 45.86 46.55 52.85 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 48.11 50.52 52.24 48.62 48.46 53.13 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c01 TRYPSIN user 3 3 # 3 B 57 HIS B 22 HIS~? 22.02 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 coo 44.08 45.58 52.81 45.86 46.55 52.85 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 48.11 50.52 52.24 48.62 48.46 53.13 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 1a0j_c01 TRYPSIN user 4 3 # 4 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 coo 44.08 45.58 52.81 45.86 46.55 52.85 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 48.11 50.52 52.24 48.62 48.46 53.13 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 1a0j_c01 source 1a0j TRYPSIN : 4 hits 1a0j_c01 naa= 3 ULMN 3 1a0j_c02 TRYPSIN user 1 3 # 1 C 57 HIS A 22 HIS~? 21.70 NI NI A 304 C 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 34.89 38.34 78.12 35.11 39.59 76.42 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 36.16 46.87 75.66 34.01 46.43 74.59 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c02 TRYPSIN user 2 3 # 2 C 57 HIS A 83 HIS~? 17.38 NI NI A 304 C 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 195 SER A 79 SER~? 16.97 CA CA A 301 coo 34.37 41.18 73.21 34.04 43.09 73.87 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 36.16 46.87 75.66 34.01 46.43 74.59 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c02 TRYPSIN user 3 3 # 3 C 57 HIS B 22 HIS~? 22.02 NI NI B 305 C 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 coo 34.37 41.18 73.21 34.04 43.09 73.87 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 36.16 46.87 75.66 34.01 46.43 74.59 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 1a0j_c02 TRYPSIN user 4 3 # 4 C 57 HIS B 83 HIS~? 17.68 NI NI B 305 C 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 195 SER B 79 SER~? 19.41 NI NI B 305 coo 34.37 41.18 73.21 34.04 43.09 73.87 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 36.16 46.87 75.66 34.01 46.43 74.59 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 1a0j_c02 source 1a0j TRYPSIN : 4 hits 1a0j_c02 naa= 3 ULMN 3 1a0j_c03 TRYPSIN user 1 3 # 1 D 57 HIS A 22 HIS~? 21.70 NI NI A 304 D 102 ASP A 21 ASP~? 19.27 CA CA A 301 D 195 SER A 79 SER~? 16.97 CA CA A 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 13.53 16.28 93.98 11.45 16.21 94.40 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 6.63 21.03 97.42 6.71 19.20 98.95 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c03 TRYPSIN user 2 3 # 2 D 57 HIS A 83 HIS~? 17.38 NI NI A 304 D 102 ASP A 21 ASP~? 19.27 CA CA A 301 D 195 SER A 79 SER~? 16.97 CA CA A 301 coo 8.19 15.01 95.72 7.78 16.53 97.01 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 6.63 21.03 97.42 6.71 19.20 98.95 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1a0j_c03 TRYPSIN user 3 3 # 3 D 57 HIS B 22 HIS~? 22.02 NI NI B 305 D 102 ASP B 21 ASP~? 22.52 NI NI B 305 D 195 SER B 79 SER~? 19.41 NI NI B 305 coo 8.19 15.01 95.72 7.78 16.53 97.01 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 6.63 21.03 97.42 6.71 19.20 98.95 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 1a0j_c03 TRYPSIN user 4 3 # 4 D 57 HIS B 83 HIS~? 17.68 NI NI B 305 D 102 ASP B 21 ASP~? 22.52 NI NI B 305 D 195 SER B 79 SER~? 19.41 NI NI B 305 coo 8.19 15.01 95.72 7.78 16.53 97.01 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 6.63 21.03 97.42 6.71 19.20 98.95 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 1a0j_c03 source 1a0j TRYPSIN : 4 hits 1a0j_c03 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 83 HIS~? 17.38 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 25.57 41.22 61.68 24.18 39.98 62.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 22.33 45.48 59.73 23.35 43.67 60.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 22.57 32.23 64.13 21.98 32.82 64.22 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 83 HIS~? 17.68 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 25.57 41.22 61.68 24.18 39.98 62.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 22.33 45.48 59.73 23.35 43.67 60.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 22.57 32.23 64.13 21.98 32.82 64.22 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1a0j_c12 source 1a0j TRYPSIN : 2 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 44.08 45.58 52.81 45.86 46.55 52.85 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 43.04 44.75 47.18 43.31 45.51 49.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 50.46 51.91 56.90 50.65 51.62 56.14 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 44.08 45.58 52.81 45.86 46.55 52.85 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 43.04 44.75 47.18 43.31 45.51 49.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 50.46 51.91 56.90 50.65 51.62 56.14 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1a0j_c13 source 1a0j TRYPSIN : 2 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 83 HIS~? 17.38 NI NI A 304 C 102 ASP A 21 ASP~? 19.27 CA CA A 301 C 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 34.37 41.18 73.21 34.04 43.09 73.87 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 34.89 38.34 78.12 35.11 39.59 76.42 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 35.43 51.03 72.12 35.20 50.72 72.87 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 83 HIS~? 17.68 NI NI B 305 C 102 ASP B 21 ASP~? 22.52 NI NI B 305 C 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 34.37 41.18 73.21 34.04 43.09 73.87 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 34.89 38.34 78.12 35.11 39.59 76.42 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 35.43 51.03 72.12 35.20 50.72 72.87 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1a0j_c14 source 1a0j TRYPSIN : 2 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 83 HIS~? 17.38 NI NI A 304 D 102 ASP A 21 ASP~? 19.27 CA CA A 301 D 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 8.19 15.01 95.72 7.78 16.53 97.01 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 13.53 16.28 93.98 11.45 16.21 94.40 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 1.80 21.25 100.04 2.61 21.42 100.18 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 83 HIS~? 17.68 NI NI B 305 D 102 ASP B 21 ASP~? 22.52 NI NI B 305 D 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 8.19 15.01 95.72 7.78 16.53 97.01 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 13.53 16.28 93.98 11.45 16.21 94.40 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 1.80 21.25 100.04 2.61 21.42 100.18 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1a0j_c15 source 1a0j TRYPSIN : 2 hits 1a0j_c15 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 101 GLU^? 20.45 NI NI A 304 A 60 ASP A 65 ASP~? 19.57 CA CA B 303 A 175 TYR A 205 TYR^? 13.62 NI NI A 304 coo 46.10 28.27 19.27 45.48 26.99 20.84 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 56.42 28.06 12.93 55.01 27.92 14.50 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 45.02 22.04 15.38 46.16 24.00 13.76 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 32 GLU~? 21.76 NI NI B 305 A 60 ASP B 27 ASP~? 26.12 NI NI B 305 A 175 TYR B 36 TYR~? 20.19 NI NI B 305 coo 46.10 28.27 19.27 45.48 26.99 20.84 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 56.42 28.06 12.93 55.01 27.92 14.50 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 45.02 22.04 15.38 46.16 24.00 13.76 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU B 103 GLU^? 12.89 NI NI B 305 A 60 ASP B 65 ASP~? 20.64 NI NI B 305 A 175 TYR B 205 TYR^? 13.71 NI NI B 305 coo 46.10 28.27 19.27 45.48 26.99 20.84 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 56.42 28.06 12.93 55.01 27.92 14.50 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 45.02 22.04 15.38 46.16 24.00 13.76 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 3 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 205 TYR^? 13.62 NI NI A 304 A 125 HIS A 83 HIS~? 17.38 NI NI A 304 A 156 LYS A 78 LYS~? 23.27 CA CA A 301 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR B 205 TYR^? 13.71 NI NI B 305 A 125 HIS B 83 HIS~? 17.68 NI NI B 305 A 156 LYS B 78 LYS~? 25.94 CA CA B 303 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c00 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 205 TYR^? 13.62 NI NI A 304 C 125 HIS A 83 HIS~? 17.38 NI NI A 304 C 156 LYS A 78 LYS~? 23.27 CA CA A 301 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR B 205 TYR^? 13.71 NI NI B 305 C 125 HIS B 83 HIS~? 17.68 NI NI B 305 C 156 LYS B 78 LYS~? 25.94 CA CA B 303 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 205 TYR^? 13.62 NI NI A 304 D 125 HIS A 83 HIS~? 17.38 NI NI A 304 D 156 LYS A 78 LYS~? 23.27 CA CA A 301 coo 54.10 1.42 85.16 54.14 4.17 85.62 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 61.27 5.43 85.32 62.73 6.38 86.49 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 60.28 4.62 76.00 58.35 6.41 80.65 -28.42 14.17 -26.53 -31.51 16.17 -30.16 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c03 naa= 3 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 1 3 # 1 A 98 SER A 79 SER~? 16.97 CA CA A 301 A 228 ASP A 21 ASP~? 19.27 CA CA A 301 A 257 HIS A 22 HIS~? 21.70 NI NI A 304 coo 9.47 41.64 34.15 9.10 39.28 33.93 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 2.03 38.95 28.44 3.60 38.60 29.83 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 6.85 37.62 29.99 7.50 38.47 31.78 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 2 3 # 2 A 98 SER A 79 SER~? 16.97 CA CA A 301 A 228 ASP A 21 ASP~? 19.27 CA CA A 301 A 257 HIS A 83 HIS~? 17.38 NI NI A 304 coo 9.47 41.64 34.15 9.10 39.28 33.93 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 2.03 38.95 28.44 3.60 38.60 29.83 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 6.85 37.62 29.99 7.50 38.47 31.78 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 3 3 # 3 A 98 SER B 79 SER~? 19.41 NI NI B 305 A 228 ASP B 21 ASP~? 22.52 NI NI B 305 A 257 HIS B 22 HIS~? 22.02 NI NI B 305 coo 9.47 41.64 34.15 9.10 39.28 33.93 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 2.03 38.95 28.44 3.60 38.60 29.83 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 6.85 37.62 29.99 7.50 38.47 31.78 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a7u_c02 CHLOROPEROXIDASE T user 4 3 # 4 A 98 SER B 79 SER~? 19.41 NI NI B 305 A 228 ASP B 21 ASP~? 22.52 NI NI B 305 A 257 HIS B 83 HIS~? 17.68 NI NI B 305 coo 9.47 41.64 34.15 9.10 39.28 33.93 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 2.03 38.95 28.44 3.60 38.60 29.83 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 6.85 37.62 29.99 7.50 38.47 31.78 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1a7u_c02 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c02 naa= 3 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 1 3 # 1 B 98 SER A 79 SER~? 16.97 CA CA A 301 B 228 ASP A 21 ASP~? 19.27 CA CA A 301 B 257 HIS A 22 HIS~? 21.70 NI NI A 304 coo 28.35 71.07 3.94 30.08 69.46 4.49 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 32.76 68.02 0.70 31.21 68.44 2.05 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 2 3 # 2 B 98 SER A 79 SER~? 16.97 CA CA A 301 B 228 ASP A 21 ASP~? 19.27 CA CA A 301 B 257 HIS A 83 HIS~? 17.38 NI NI A 304 coo 28.35 71.07 3.94 30.08 69.46 4.49 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 32.76 68.02 0.70 31.21 68.44 2.05 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 3 3 # 3 B 98 SER B 79 SER~? 19.41 NI NI B 305 B 228 ASP B 21 ASP~? 22.52 NI NI B 305 B 257 HIS B 22 HIS~? 22.02 NI NI B 305 coo 28.35 71.07 3.94 30.08 69.46 4.49 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 32.76 68.02 0.70 31.21 68.44 2.05 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a7u_c03 CHLOROPEROXIDASE T user 4 3 # 4 B 98 SER B 79 SER~? 19.41 NI NI B 305 B 228 ASP B 21 ASP~? 22.52 NI NI B 305 B 257 HIS B 83 HIS~? 17.68 NI NI B 305 coo 28.35 71.07 3.94 30.08 69.46 4.49 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 31.11 65.98 -3.92 31.07 66.41 -1.82 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 32.76 68.02 0.70 31.21 68.44 2.05 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1a7u_c03 source 1a7u CHLOROPEROXIDASE T : 4 hits 1a7u_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 17 ALA^? 18.31 NI NI A 304 19 HIS A 22 HIS~? 21.70 NI NI A 304 22 HIS A 83 HIS~? 17.38 NI NI A 304 coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.68 21.22 -26.29 -15.64 21.37 -27.47 coo 46.88 33.59 48.26 46.24 34.32 46.40 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 48.05 31.12 44.60 48.20 33.05 43.77 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 17 ALA^? 18.31 NI NI A 304 19 HIS A 83 HIS~? 17.38 NI NI A 304 22 HIS A 22 HIS~? 21.70 NI NI A 304 coo 53.27 36.51 45.29 51.98 36.45 44.47 -14.68 21.22 -26.29 -15.64 21.37 -27.47 coo 46.88 33.59 48.26 46.24 34.32 46.40 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 48.05 31.12 44.60 48.20 33.05 43.77 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA A 85 ALA~? 20.35 NI NI A 304 19 HIS A 22 HIS~? 21.70 NI NI A 304 22 HIS A 83 HIS~? 17.38 NI NI A 304 coo 53.27 36.51 45.29 51.98 36.45 44.47 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo 46.88 33.59 48.26 46.24 34.32 46.40 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 48.05 31.12 44.60 48.20 33.05 43.77 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA A 85 ALA~? 20.35 NI NI A 304 19 HIS A 83 HIS~? 17.38 NI NI A 304 22 HIS A 22 HIS~? 21.70 NI NI A 304 coo 53.27 36.51 45.29 51.98 36.45 44.47 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo 46.88 33.59 48.26 46.24 34.32 46.40 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 48.05 31.12 44.60 48.20 33.05 43.77 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA A 86 ALA~? 20.62 NI NI A 304 19 HIS A 22 HIS~? 21.70 NI NI A 304 22 HIS A 83 HIS~? 17.38 NI NI A 304 coo 53.27 36.51 45.29 51.98 36.45 44.47 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 46.88 33.59 48.26 46.24 34.32 46.40 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 48.05 31.12 44.60 48.20 33.05 43.77 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA A 86 ALA~? 20.62 NI NI A 304 19 HIS A 83 HIS~? 17.38 NI NI A 304 22 HIS A 22 HIS~? 21.70 NI NI A 304 coo 53.27 36.51 45.29 51.98 36.45 44.47 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 46.88 33.59 48.26 46.24 34.32 46.40 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 48.05 31.12 44.60 48.20 33.05 43.77 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 7 3 # 7 16 ALA A 117 ALA^? 9.93 NI NI A 304 19 HIS A 119 HIS^? -3.69 NI NI A 304s 22 HIS A 187 HIS^? -3.59 NI NI A 304s coo 53.27 36.51 45.29 51.98 36.45 44.47 -3.31 -0.27 -21.61 -3.23 -1.78 -21.83 coo 46.88 33.59 48.26 46.24 34.32 46.40 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 48.05 31.12 44.60 48.20 33.05 43.77 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 8 3 # 8 16 ALA A 117 ALA^? 9.93 NI NI A 304 19 HIS A 187 HIS^? -3.59 NI NI A 304s 22 HIS A 119 HIS^? -3.69 NI NI A 304s coo 53.27 36.51 45.29 51.98 36.45 44.47 -3.31 -0.27 -21.61 -3.23 -1.78 -21.83 coo 46.88 33.59 48.26 46.24 34.32 46.40 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 48.05 31.12 44.60 48.20 33.05 43.77 -7.63 0.70 -25.42 -8.53 2.19 -24.26 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 9 3 # 9 16 ALA B 17 ALA^? 18.38 NI NI B 305 19 HIS B 22 HIS~? 22.02 NI NI B 305 22 HIS B 83 HIS~? 17.68 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -9.66 -23.82 -53.96 -10.57 -24.14 -52.79 coo 46.88 33.59 48.26 46.24 34.32 46.40 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 48.05 31.12 44.60 48.20 33.05 43.77 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 10 3 # 10 16 ALA B 17 ALA^? 18.38 NI NI B 305 19 HIS B 83 HIS~? 17.68 NI NI B 305 22 HIS B 22 HIS~? 22.02 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -9.66 -23.82 -53.96 -10.57 -24.14 -52.79 coo 46.88 33.59 48.26 46.24 34.32 46.40 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 11 3 # 11 16 ALA B 85 ALA~? 16.03 CA CA B 303 19 HIS B 22 HIS~? 22.02 NI NI B 305 22 HIS B 83 HIS~? 17.68 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo 46.88 33.59 48.26 46.24 34.32 46.40 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 48.05 31.12 44.60 48.20 33.05 43.77 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 12 3 # 12 16 ALA B 85 ALA~? 16.03 CA CA B 303 19 HIS B 83 HIS~? 17.68 NI NI B 305 22 HIS B 22 HIS~? 22.02 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo 46.88 33.59 48.26 46.24 34.32 46.40 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 13 3 # 13 16 ALA B 86 ALA~? 18.65 CA CA B 303 19 HIS B 22 HIS~? 22.02 NI NI B 305 22 HIS B 83 HIS~? 17.68 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 46.88 33.59 48.26 46.24 34.32 46.40 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 48.05 31.12 44.60 48.20 33.05 43.77 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 14 3 # 14 16 ALA B 86 ALA~? 18.65 CA CA B 303 19 HIS B 83 HIS~? 17.68 NI NI B 305 22 HIS B 22 HIS~? 22.02 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 46.88 33.59 48.26 46.24 34.32 46.40 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 15 3 # 15 16 ALA B 117 ALA^? 9.69 NI NI B 305 19 HIS B 116 HIS^? 6.69 NI NI B 305 22 HIS B 119 HIS^? -3.53 NI NI B 305s coo 53.27 36.51 45.29 51.98 36.45 44.47 -3.41 -0.56 -58.89 -3.69 0.94 -58.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 48.05 31.12 44.60 48.20 33.05 43.77 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 16 3 # 16 16 ALA B 117 ALA^? 9.69 NI NI B 305 19 HIS B 119 HIS^? -3.53 NI NI B 305s 22 HIS B 116 HIS^? 6.69 NI NI B 305 coo 53.27 36.51 45.29 51.98 36.45 44.47 -3.41 -0.56 -58.89 -3.69 0.94 -58.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 17 3 # 17 16 ALA B 117 ALA^? 9.69 NI NI B 305 19 HIS B 119 HIS^? -3.53 NI NI B 305s 22 HIS B 187 HIS^? -3.54 NI NI B 305s coo 53.27 36.51 45.29 51.98 36.45 44.47 -3.41 -0.56 -58.89 -3.69 0.94 -58.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 18 3 # 18 16 ALA B 117 ALA^? 9.69 NI NI B 305 19 HIS B 187 HIS^? -3.54 NI NI B 305s 22 HIS B 119 HIS^? -3.53 NI NI B 305s coo 53.27 36.51 45.29 51.98 36.45 44.47 -3.41 -0.56 -58.89 -3.69 0.94 -58.77 coo 46.88 33.59 48.26 46.24 34.32 46.40 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 48.05 31.12 44.60 48.20 33.05 43.77 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 18 hits 1a8h_c02 naa= 3 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 1 3 # 1 94 SER A 79 SER~? 16.97 CA CA A 301 223 ASP A 21 ASP~? 19.27 CA CA A 301 252 HIS A 22 HIS~? 21.70 NI NI A 304 coo 40.95 0.07 3.20 39.54 1.39 4.66 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 41.54 1.64 9.09 40.82 1.05 7.19 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 2 3 # 2 94 SER A 79 SER~? 16.97 CA CA A 301 223 ASP A 21 ASP~? 19.27 CA CA A 301 252 HIS A 83 HIS~? 17.38 NI NI A 304 coo 40.95 0.07 3.20 39.54 1.39 4.66 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 41.54 1.64 9.09 40.82 1.05 7.19 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 3 3 # 3 94 SER B 79 SER~? 19.41 NI NI B 305 223 ASP B 21 ASP~? 22.52 NI NI B 305 252 HIS B 22 HIS~? 22.02 NI NI B 305 coo 40.95 0.07 3.20 39.54 1.39 4.66 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 41.54 1.64 9.09 40.82 1.05 7.19 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a8q_c00 BROMOPEROXIDASE A1 user 4 3 # 4 94 SER B 79 SER~? 19.41 NI NI B 305 223 ASP B 21 ASP~? 22.52 NI NI B 305 252 HIS B 83 HIS~? 17.68 NI NI B 305 coo 40.95 0.07 3.20 39.54 1.39 4.66 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 42.66 -2.61 12.07 41.85 -1.47 10.53 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 41.54 1.64 9.09 40.82 1.05 7.19 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1a8q_c00 source 1a8q BROMOPEROXIDASE A1 : 4 hits 1a8q_c00 naa= 3 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 1 3 # 1 94 SER A 79 SER~? 16.97 CA CA A 301 224 ASP A 21 ASP~? 19.27 CA CA A 301 253 HIS A 22 HIS~? 21.70 NI NI A 304 coo 16.00 80.13 58.60 16.16 82.12 59.96 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 8.47 84.84 62.27 10.52 84.40 62.08 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 13.14 83.03 63.68 14.37 82.62 62.02 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 2 3 # 2 94 SER A 79 SER~? 16.97 CA CA A 301 224 ASP A 21 ASP~? 19.27 CA CA A 301 253 HIS A 83 HIS~? 17.38 NI NI A 304 coo 16.00 80.13 58.60 16.16 82.12 59.96 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 8.47 84.84 62.27 10.52 84.40 62.08 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 13.14 83.03 63.68 14.37 82.62 62.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 3 3 # 3 94 SER B 79 SER~? 19.41 NI NI B 305 224 ASP B 21 ASP~? 22.52 NI NI B 305 253 HIS B 22 HIS~? 22.02 NI NI B 305 coo 16.00 80.13 58.60 16.16 82.12 59.96 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 8.47 84.84 62.27 10.52 84.40 62.08 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 13.14 83.03 63.68 14.37 82.62 62.02 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1a8s_c00 CHLOROPEROXIDASE F user 4 3 # 4 94 SER B 79 SER~? 19.41 NI NI B 305 224 ASP B 21 ASP~? 22.52 NI NI B 305 253 HIS B 83 HIS~? 17.68 NI NI B 305 coo 16.00 80.13 58.60 16.16 82.12 59.96 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 8.47 84.84 62.27 10.52 84.40 62.08 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 13.14 83.03 63.68 14.37 82.62 62.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1a8s_c00 source 1a8s CHLOROPEROXIDASE F : 4 hits 1a8s_c00 naa= 3 ULMN 3 1ab4_c00 GYRASE A user 1 3 # 1 32 ARG A 186 ARG^? 12.05 NI NI A 304 78 HIS A 119 HIS^? -3.69 NI NI A 304s 122 TYR A 36 TYR~? 7.82 CA CA A 306 coo 48.32 72.26 30.89 48.69 69.28 31.53 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 coo 53.63 68.24 34.99 53.08 69.10 33.16 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 75.01 61.87 32.93 75.34 59.26 31.96 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1ab4_c00 GYRASE A user 2 3 # 2 32 ARG A 186 ARG^? 12.05 NI NI A 304 78 HIS A 187 HIS^? -3.59 NI NI A 304s 122 TYR A 36 TYR~? 7.82 CA CA A 306 coo 48.32 72.26 30.89 48.69 69.28 31.53 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 coo 53.63 68.24 34.99 53.08 69.10 33.16 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 75.01 61.87 32.93 75.34 59.26 31.96 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1ab4_c00 GYRASE A user 3 3 # 3 32 ARG A 206 ARG^? 17.65 CA CA B 303 78 HIS A 123 HIS.? 13.29 CA CA B 303 122 TYR B 15 TYR^? 16.36 NI NI B 305 coo 48.32 72.26 30.89 48.69 69.28 31.53 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 53.63 68.24 34.99 53.08 69.10 33.16 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 75.01 61.87 32.93 75.34 59.26 31.96 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 ULMN 3 1ab4_c00 GYRASE A user 4 3 # 4 32 ARG B 157 ARG.? 25.43 NI NI B 305 78 HIS B 148 HIS.? 18.38 NI NI B 305 122 TYR B 131 TYR^? 10.67 NI NI B 305 coo 48.32 72.26 30.89 48.69 69.28 31.53 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 53.63 68.24 34.99 53.08 69.10 33.16 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 75.01 61.87 32.93 75.34 59.26 31.96 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ab4_c00 GYRASE A user 5 3 # 5 32 ARG B 186 ARG^? 11.32 NI NI B 305 78 HIS B 119 HIS^? -3.53 NI NI B 305s 122 TYR B 36 TYR~? 20.19 NI NI B 305 coo 48.32 72.26 30.89 48.69 69.28 31.53 -0.49 -2.47 -50.17 -2.28 -0.14 -49.29 coo 53.63 68.24 34.99 53.08 69.10 33.16 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 75.01 61.87 32.93 75.34 59.26 31.96 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1ab4_c00 GYRASE A user 6 3 # 6 32 ARG B 186 ARG^? 11.32 NI NI B 305 78 HIS B 187 HIS^? -3.54 NI NI B 305s 122 TYR B 36 TYR~? 20.19 NI NI B 305 coo 48.32 72.26 30.89 48.69 69.28 31.53 -0.49 -2.47 -50.17 -2.28 -0.14 -49.29 coo 53.63 68.24 34.99 53.08 69.10 33.16 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 75.01 61.87 32.93 75.34 59.26 31.96 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1ab4_c00 GYRASE A user 7 3 # 7 32 ARG B 206 ARG^? 17.11 NI NI B 305 78 HIS B 123 HIS.? 14.82 NI NI B 305 122 TYR A 15 TYR^? 16.16 NI NI A 304 coo 48.32 72.26 30.89 48.69 69.28 31.53 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 53.63 68.24 34.99 53.08 69.10 33.16 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 75.01 61.87 32.93 75.34 59.26 31.96 -14.58 17.46 -30.91 -16.88 18.89 -30.21 1ab4_c00 source 1ab4 GYRASE A : 7 hits 1ab4_c00 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 121 HIS.? -3.63 NI NI A 304s A 262 HIS A 123 HIS.? 13.29 CA CA B 303 A 312 ASP A 104 ASP^? 11.20 NI NI A 304 coo 29.33 36.13 69.70 30.07 34.20 70.11 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 38.54 36.60 66.38 37.88 34.77 67.15 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 30.62 37.23 61.07 30.08 35.73 62.49 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 123 HIS.? 13.29 CA CA B 303 A 262 HIS A 121 HIS.? -3.63 NI NI A 304s A 312 ASP A 104 ASP^? 11.20 NI NI A 304 coo 29.33 36.13 69.70 30.07 34.20 70.11 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 38.54 36.60 66.38 37.88 34.77 67.15 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 30.62 37.23 61.07 30.08 35.73 62.49 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS B 121 HIS.? -3.60 NI NI B 305s A 262 HIS B 123 HIS.? 14.82 NI NI B 305 A 312 ASP B 104 ASP^? 11.37 NI NI B 305 coo 29.33 36.13 69.70 30.07 34.20 70.11 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 38.54 36.60 66.38 37.88 34.77 67.15 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 30.62 37.23 61.07 30.08 35.73 62.49 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS B 123 HIS.? 14.82 NI NI B 305 A 262 HIS B 121 HIS.? -3.60 NI NI B 305s A 312 ASP B 104 ASP^? 11.37 NI NI B 305 coo 29.33 36.13 69.70 30.07 34.20 70.11 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 38.54 36.60 66.38 37.88 34.77 67.15 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 30.62 37.23 61.07 30.08 35.73 62.49 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 4 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 121 HIS.? -3.63 NI NI A 304s B 262 HIS A 123 HIS.? 13.29 CA CA B 303 B 312 ASP A 104 ASP^? 11.20 NI NI A 304 coo 23.86 29.50 91.20 24.12 31.58 91.00 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 29.35 31.42 99.15 28.72 33.09 98.04 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 20.42 28.25 99.26 20.25 29.62 97.63 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 123 HIS.? 13.29 CA CA B 303 B 262 HIS A 121 HIS.? -3.63 NI NI A 304s B 312 ASP A 104 ASP^? 11.20 NI NI A 304 coo 23.86 29.50 91.20 24.12 31.58 91.00 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 29.35 31.42 99.15 28.72 33.09 98.04 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 20.42 28.25 99.26 20.25 29.62 97.63 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS B 121 HIS.? -3.60 NI NI B 305s B 262 HIS B 123 HIS.? 14.82 NI NI B 305 B 312 ASP B 104 ASP^? 11.37 NI NI B 305 coo 23.86 29.50 91.20 24.12 31.58 91.00 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 29.35 31.42 99.15 28.72 33.09 98.04 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 20.42 28.25 99.26 20.25 29.62 97.63 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS B 123 HIS.? 14.82 NI NI B 305 B 262 HIS B 121 HIS.? -3.60 NI NI B 305s B 312 ASP B 104 ASP^? 11.37 NI NI B 305 coo 23.86 29.50 91.20 24.12 31.58 91.00 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 29.35 31.42 99.15 28.72 33.09 98.04 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 20.42 28.25 99.26 20.25 29.62 97.63 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 4 hits 1aj8_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 121 HIS.? -3.63 NI NI A 304s 320 HIS A 123 HIS.? 13.29 CA CA B 303 375 ASP A 104 ASP^? 11.20 NI NI A 304 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 123 HIS.? 13.29 CA CA B 303 320 HIS A 121 HIS.? -3.63 NI NI A 304s 375 ASP A 104 ASP^? 11.20 NI NI A 304 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS B 121 HIS.? -3.60 NI NI B 305s 320 HIS B 123 HIS.? 14.82 NI NI B 305 375 ASP B 104 ASP^? 11.37 NI NI B 305 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS B 123 HIS.? 14.82 NI NI B 305 320 HIS B 121 HIS.? -3.60 NI NI B 305s 375 ASP B 104 ASP^? 11.37 NI NI B 305 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 1al6_c00 source 1al6 CITRATE SYNTHASE : 4 hits 1al6_c00 naa= 3 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 21 ASP~? 19.27 CA CA A 301 214 ASP A 41 ASP.? 21.30 CA CA A 306 289 ASP A 177 ASP^? 15.76 CA CA A 306 coo -0.62 65.95 29.97 0.31 67.47 31.05 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 26.86 59.76 46.36 25.42 58.23 45.92 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 9.42 68.07 30.27 7.35 68.27 30.10 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 65 ASP~? 19.57 CA CA B 303 214 ASP A 145 ASP.? 18.22 NI NI A 304 289 ASP A 104 ASP^? 11.20 NI NI A 304 coo -0.62 65.95 29.97 0.31 67.47 31.05 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 26.86 59.76 46.36 25.42 58.23 45.92 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 177 ASP^? 15.76 CA CA A 306 214 ASP A 96 ASP.? 21.09 NI NI B 305 289 ASP A 21 ASP~? 19.27 CA CA A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 21 ASP~? 22.52 NI NI B 305 214 ASP B 41 ASP.? 25.32 NI NI B 305 289 ASP B 177 ASP^? 17.56 NI NI B 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 9.42 68.07 30.27 7.35 68.27 30.10 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 75 ASP~? 24.42 NI NI B 305 214 ASP A 96 ASP.? 21.09 NI NI B 305 289 ASP B 81 ASP~? 18.56 NI NI B 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 26.86 59.76 46.36 25.42 58.23 45.92 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 9.42 68.07 30.27 7.35 68.27 30.10 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1amy_c01 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 177 ASP^? 17.56 NI NI B 305 214 ASP B 96 ASP.? 4.50 CA CA B 303 289 ASP B 21 ASP~? 22.52 NI NI B 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 26.86 59.76 46.36 25.42 58.23 45.92 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 9.42 68.07 30.27 7.35 68.27 30.10 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1amy_c01 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c01 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 27 ASP~? -2.92 CA CA A 301s 204 GLU A 30 GLU~? 7.55 CA CA A 301 289 ASP A 75 ASP~? 14.34 CA CA A 301 coo -0.62 65.95 29.97 0.31 67.47 31.05 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 4.34 62.44 32.05 4.22 64.48 32.53 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 104 ASP^? 11.20 NI NI A 304 204 GLU A 103 GLU^? 14.47 CA CA B 303 289 ASP A 65 ASP~? 19.57 CA CA B 303 coo -0.62 65.95 29.97 0.31 67.47 31.05 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 4.34 62.44 32.05 4.22 64.48 32.53 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 9.42 68.07 30.27 7.35 68.27 30.10 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 2 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP B 177 ASP^? 17.56 NI NI B 305 227 GLU B 182 GLU^? 15.43 NI NI B 305 289 ASP B 21 ASP~? 22.52 NI NI B 305 coo -0.62 65.95 29.97 0.31 67.47 31.05 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 3.96 55.76 41.24 4.83 57.69 41.17 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 9.42 68.07 30.27 7.35 68.27 30.10 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 1 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 187 HIS^? -3.59 NI NI A 304s 254 LYS A 142 LYS^? 14.03 NI NI A 304 333 ARG A 198 ARG^? 13.22 CA CA A 306 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 26.09 4.87 14.60 27.89 3.33 10.26 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 37.35 7.47 11.84 34.90 6.11 10.60 -7.58 10.63 -14.31 -5.28 12.67 -14.13 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 187 HIS^? -3.54 NI NI B 305s 254 LYS B 142 LYS^? 13.37 NI NI B 305 333 ARG B 198 ARG^? 13.15 NI NI B 305 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 26.09 4.87 14.60 27.89 3.33 10.26 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 37.35 7.47 11.84 34.90 6.11 10.60 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 2 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 124 SER.? 9.62 NI NI A 304 A 292 ASP B 104 ASP^? 11.37 NI NI B 305 A 322 HIS A 83 HIS~? 17.38 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo 19.73 19.18 41.39 21.50 18.65 40.34 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 127 SER^? 6.45 NI NI A 304 A 292 ASP A 42 ASP~? 18.65 NI NI A 304 A 322 HIS B 123 HIS.? 14.82 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 41.69 45.14 46.60 41.78 47.19 46.18 -17.13 0.41 -45.08 -16.63 2.43 -44.85 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER A 127 SER^? 6.45 NI NI A 304 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS A 116 HIS^? 7.23 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER A 127 SER^? 6.45 NI NI A 304 A 292 ASP B 94 ASP.? -2.87 CA CA B 303s A 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 A 194 SER A 127 SER^? 6.45 NI NI A 304 A 292 ASP B 94 ASP.? -2.87 CA CA B 303s A 322 HIS A 22 HIS~? 21.70 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 A 194 SER A 127 SER^? 6.45 NI NI A 304 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 A 194 SER A 127 SER^? 6.45 NI NI A 304 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS A 22 HIS~? 21.70 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP A 65 ASP~? 19.57 CA CA B 303 A 322 HIS A 148 HIS~? 18.59 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 41.69 45.14 46.60 41.78 47.19 46.18 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS A 116 HIS^? 7.23 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS A 148 HIS~? 18.59 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP B 94 ASP.? -2.87 CA CA B 303s A 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP B 94 ASP.? -2.87 CA CA B 303s A 322 HIS A 83 HIS~? 17.38 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 41.69 45.14 46.60 41.78 47.19 46.18 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 A 194 SER A 183 SER.? 9.24 NI NI A 304 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS A 148 HIS~? 18.59 NI NI A 304 coo 36.34 32.23 39.60 36.43 34.62 39.93 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 A 194 SER A 202 SER^? 4.82 NI NI A 304 A 292 ASP A 196 ASP.? 6.39 CA CA A 306 A 322 HIS A 123 HIS.? 13.29 CA CA B 303 coo 36.34 32.23 39.60 36.43 34.62 39.93 -16.35 6.85 -22.26 -13.93 6.63 -22.28 coo 19.73 19.18 41.39 21.50 18.65 40.34 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 41.69 45.14 46.60 41.78 47.19 46.18 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 A 194 SER B 124 SER.? 10.06 NI NI B 305 A 292 ASP A 104 ASP^? 11.20 NI NI A 304 A 322 HIS B 83 HIS~? 17.68 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo 19.73 19.18 41.39 21.50 18.65 40.34 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 41.69 45.14 46.60 41.78 47.19 46.18 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 A 194 SER B 127 SER^? 6.61 NI NI B 305 A 292 ASP A 94 ASP.? 21.52 NI NI B 305 A 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 41.69 45.14 46.60 41.78 47.19 46.18 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 A 194 SER B 127 SER^? 6.61 NI NI B 305 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 A 194 SER B 127 SER^? 6.61 NI NI B 305 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS B 22 HIS~? 22.02 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 A 194 SER B 127 SER^? 6.61 NI NI B 305 A 292 ASP B 42 ASP~? 18.39 NI NI B 305 A 322 HIS A 123 HIS.? 13.29 CA CA B 303 coo 36.34 32.23 39.60 36.43 34.62 39.93 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 41.69 45.14 46.60 41.78 47.19 46.18 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 A 194 SER B 127 SER^? 6.61 NI NI B 305 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS B 116 HIS^? 6.69 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 A 194 SER B 183 SER.? 9.15 NI NI B 305 A 292 ASP A 94 ASP.? 21.52 NI NI B 305 A 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 41.69 45.14 46.60 41.78 47.19 46.18 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 A 194 SER B 183 SER.? 9.15 NI NI B 305 A 292 ASP A 94 ASP.? 21.52 NI NI B 305 A 322 HIS B 83 HIS~? 17.68 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 41.69 45.14 46.60 41.78 47.19 46.18 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 A 194 SER B 183 SER.? 9.15 NI NI B 305 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 25 3 # 25 A 194 SER B 183 SER.? 9.15 NI NI B 305 A 292 ASP A 96 ASP.? 21.09 NI NI B 305 A 322 HIS B 148 HIS.? 18.38 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.24 -3.74 -47.54 7.83 -3.67 -48.90 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 26 3 # 26 A 194 SER B 183 SER.? 9.15 NI NI B 305 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS B 116 HIS^? 6.69 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 27 3 # 27 A 194 SER B 183 SER.? 9.15 NI NI B 305 A 292 ASP B 96 ASP.? 4.50 CA CA B 303 A 322 HIS B 148 HIS.? 18.38 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 19.73 19.18 41.39 21.50 18.65 40.34 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 41.69 45.14 46.60 41.78 47.19 46.18 6.24 -3.74 -47.54 7.83 -3.67 -48.90 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 28 3 # 28 A 194 SER B 202 SER^? 5.31 NI NI B 305 A 292 ASP B 196 ASP.? 23.47 NI NI B 305 A 322 HIS B 123 HIS.? 14.82 NI NI B 305 coo 36.34 32.23 39.60 36.43 34.62 39.93 -14.59 -10.21 -57.96 -12.31 -9.58 -58.46 coo 19.73 19.18 41.39 21.50 18.65 40.34 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 41.69 45.14 46.60 41.78 47.19 46.18 -17.13 0.41 -45.08 -16.63 2.43 -44.85 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 28 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 124 SER.? 9.62 NI NI A 304 B 292 ASP B 104 ASP^? 11.37 NI NI B 305 B 322 HIS A 83 HIS~? 17.38 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo 24.74 78.07 5.59 24.32 79.03 7.46 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 127 SER^? 6.45 NI NI A 304 B 292 ASP A 42 ASP~? 18.65 NI NI A 304 B 322 HIS B 123 HIS.? 14.82 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 48.81 64.16 26.34 49.30 62.16 26.73 -17.13 0.41 -45.08 -16.63 2.43 -44.85 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER A 127 SER^? 6.45 NI NI A 304 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS A 116 HIS^? 7.23 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER A 127 SER^? 6.45 NI NI A 304 B 292 ASP B 94 ASP.? -2.87 CA CA B 303s B 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 5 3 # 5 B 194 SER A 127 SER^? 6.45 NI NI A 304 B 292 ASP B 94 ASP.? -2.87 CA CA B 303s B 322 HIS A 22 HIS~? 21.70 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 6 3 # 6 B 194 SER A 127 SER^? 6.45 NI NI A 304 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 7 3 # 7 B 194 SER A 127 SER^? 6.45 NI NI A 304 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS A 22 HIS~? 21.70 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 8 3 # 8 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP A 65 ASP~? 19.57 CA CA B 303 B 322 HIS A 148 HIS~? 18.59 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 48.81 64.16 26.34 49.30 62.16 26.73 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 9 3 # 9 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS A 116 HIS^? 7.23 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 10 3 # 10 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS A 148 HIS~? 18.59 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 11 3 # 11 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP B 94 ASP.? -2.87 CA CA B 303s B 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 12 3 # 12 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP B 94 ASP.? -2.87 CA CA B 303s B 322 HIS A 83 HIS~? 17.38 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 48.81 64.16 26.34 49.30 62.16 26.73 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 13 3 # 13 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS A 16 HIS^? 15.61 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 14 3 # 14 B 194 SER A 183 SER.? 9.24 NI NI A 304 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS A 148 HIS~? 18.59 NI NI A 304 coo 35.42 71.28 22.94 36.24 69.06 22.37 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 15 3 # 15 B 194 SER B 124 SER.? 10.06 NI NI B 305 B 292 ASP A 104 ASP^? 11.20 NI NI A 304 B 322 HIS B 83 HIS~? 17.68 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo 24.74 78.07 5.59 24.32 79.03 7.46 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 48.81 64.16 26.34 49.30 62.16 26.73 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 16 3 # 16 B 194 SER B 127 SER^? 6.61 NI NI B 305 B 292 ASP A 94 ASP.? 21.52 NI NI B 305 B 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 48.81 64.16 26.34 49.30 62.16 26.73 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 17 3 # 17 B 194 SER B 127 SER^? 6.61 NI NI B 305 B 292 ASP A 94 ASP.? 21.52 NI NI B 305 B 322 HIS B 22 HIS~? 22.02 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 48.81 64.16 26.34 49.30 62.16 26.73 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 18 3 # 18 B 194 SER B 127 SER^? 6.61 NI NI B 305 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 19 3 # 19 B 194 SER B 127 SER^? 6.61 NI NI B 305 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS B 22 HIS~? 22.02 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 20 3 # 20 B 194 SER B 127 SER^? 6.61 NI NI B 305 B 292 ASP B 42 ASP~? 18.39 NI NI B 305 B 322 HIS A 123 HIS.? 13.29 CA CA B 303 coo 35.42 71.28 22.94 36.24 69.06 22.37 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 48.81 64.16 26.34 49.30 62.16 26.73 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 21 3 # 21 B 194 SER B 127 SER^? 6.61 NI NI B 305 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS B 116 HIS^? 6.69 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 22 3 # 22 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP A 94 ASP.? 21.52 NI NI B 305 B 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 48.81 64.16 26.34 49.30 62.16 26.73 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 23 3 # 23 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP A 94 ASP.? 21.52 NI NI B 305 B 322 HIS B 83 HIS~? 17.68 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 48.81 64.16 26.34 49.30 62.16 26.73 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 24 3 # 24 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS B 16 HIS^? 15.81 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 25 3 # 25 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP A 96 ASP.? 21.09 NI NI B 305 B 322 HIS B 148 HIS.? 18.38 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.24 -3.74 -47.54 7.83 -3.67 -48.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 26 3 # 26 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP B 65 ASP~? 20.64 NI NI B 305 B 322 HIS B 148 HIS.? 18.38 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.24 -3.74 -47.54 7.83 -3.67 -48.90 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 27 3 # 27 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS B 116 HIS^? 6.69 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 28 3 # 28 B 194 SER B 183 SER.? 9.15 NI NI B 305 B 292 ASP B 96 ASP.? 4.50 CA CA B 303 B 322 HIS B 148 HIS.? 18.38 NI NI B 305 coo 35.42 71.28 22.94 36.24 69.06 22.37 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 24.74 78.07 5.59 24.32 79.03 7.46 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 48.81 64.16 26.34 49.30 62.16 26.73 6.24 -3.74 -47.54 7.83 -3.67 -48.90 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 28 hits 1aql_c03 naa= 3 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 B 325 ARG A 157 ARG.? 25.34 NI NI A 304 B 342 ASP A 163 ASP~? 21.63 NI NI A 304 B 531 ARG A 147 ARG~? 21.93 NI NI A 304 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 B 325 ARG A 157 ARG.? 25.34 NI NI A 304 B 342 ASP A 163 ASP~? 21.63 NI NI A 304 B 531 ARG A 158 ARG.? 32.75 NI NI A 304 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 B 325 ARG B 98 ARG.? 11.28 CA CA B 303 B 342 ASP B 94 ASP.? -2.87 CA CA B 303s B 531 ARG A 206 ARG^? 17.65 CA CA B 303 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -24.48 -9.95 -37.71 -23.29 -7.54 -36.21 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 B 325 ARG B 157 ARG.? 25.43 NI NI B 305 B 342 ASP B 163 ASP.? 22.00 NI NI B 305 B 531 ARG B 147 ARG.? 21.34 NI NI B 305 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 B 325 ARG B 157 ARG.? 25.43 NI NI B 305 B 342 ASP B 163 ASP.? 22.00 NI NI B 305 B 531 ARG B 158 ARG.? 33.41 NI NI B 305 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1asy_c00 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 B 325 ARG B 206 ARG^? 17.11 NI NI B 305 B 342 ASP B 81 ASP~? 18.56 NI NI B 305 B 531 ARG B 98 ARG.? 11.28 CA CA B 303 coo 68.60 41.07 -12.62 69.17 40.45 -9.67 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 73.51 47.41 -3.97 72.62 46.48 -5.62 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 59.93 41.82 -5.59 61.38 39.13 -5.79 -24.48 -9.95 -37.71 -23.29 -7.54 -36.21 1asy_c00 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 6 hits 1asy_c00 naa= 3 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 1 3 # 1 A 325 ARG A 157 ARG.? 25.34 NI NI A 304 A 342 ASP A 163 ASP~? 21.63 NI NI A 304 A 531 ARG A 147 ARG~? 21.93 NI NI A 304 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 2 3 # 2 A 325 ARG A 206 ARG^? 17.65 CA CA B 303 A 342 ASP A 81 ASP~? 18.70 NI NI A 304 A 531 ARG A 98 ARG.? 20.57 NI NI B 305 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -25.95 5.08 -43.97 -24.52 2.34 -44.05 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 3 3 # 3 A 325 ARG A 206 ARG^? 17.65 CA CA B 303 A 342 ASP B 96 ASP.? 4.50 CA CA B 303 A 531 ARG B 206 ARG^? 17.11 NI NI B 305 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 4 3 # 4 A 325 ARG B 13 ARG.? 21.21 NI NI B 305 A 342 ASP B 163 ASP.? 22.00 NI NI B 305 A 531 ARG B 147 ARG.? 21.34 NI NI B 305 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -4.25 -19.48 -42.40 -4.50 -22.44 -43.20 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 5 3 # 5 A 325 ARG B 157 ARG.? 25.43 NI NI B 305 A 342 ASP B 163 ASP.? 22.00 NI NI B 305 A 531 ARG B 147 ARG.? 21.34 NI NI B 305 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 6 3 # 6 A 325 ARG B 157 ARG.? 25.43 NI NI B 305 A 342 ASP B 163 ASP.? 22.00 NI NI B 305 A 531 ARG B 158 ARG.? 33.41 NI NI B 305 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 7 3 # 7 A 325 ARG B 206 ARG^? 17.11 NI NI B 305 A 342 ASP A 96 ASP.? 21.09 NI NI B 305 A 531 ARG A 206 ARG^? 17.65 CA CA B 303 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1asy_c01 TRANSFER RIBONUCLEIC ACID (TRNAASP) user 8 3 # 8 A 325 ARG B 206 ARG^? 17.11 NI NI B 305 A 342 ASP B 96 ASP.? 4.50 CA CA B 303 A 531 ARG A 206 ARG^? 17.65 CA CA B 303 coo 73.40 61.96 -24.99 72.46 63.92 -22.84 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 66.77 64.93 -14.03 68.02 64.49 -15.66 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 80.46 68.51 -18.35 79.98 68.55 -21.36 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 1asy_c01 source 1asy TRANSFER RIBONUCLEIC ACID (TRNAASP) : 8 hits 1asy_c01 naa= 3 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 110 SER A 79 SER~? 16.97 CA CA A 301 A 266 ASP A 21 ASP~? 19.27 CA CA A 301 A 294 HIS A 22 HIS~? 21.70 NI NI A 304 coo 32.07 25.76 77.83 34.46 26.05 77.46 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 33.07 35.01 79.81 33.39 33.02 79.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 35.53 30.26 79.89 34.62 28.71 78.80 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 110 SER A 79 SER~? 16.97 CA CA A 301 A 266 ASP A 21 ASP~? 19.27 CA CA A 301 A 294 HIS A 83 HIS~? 17.38 NI NI A 304 coo 32.07 25.76 77.83 34.46 26.05 77.46 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 33.07 35.01 79.81 33.39 33.02 79.13 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 35.53 30.26 79.89 34.62 28.71 78.80 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 110 SER B 79 SER~? 19.41 NI NI B 305 A 266 ASP B 21 ASP~? 22.52 NI NI B 305 A 294 HIS B 22 HIS~? 22.02 NI NI B 305 coo 32.07 25.76 77.83 34.46 26.05 77.46 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 33.07 35.01 79.81 33.39 33.02 79.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 35.53 30.26 79.89 34.62 28.71 78.80 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1azw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 110 SER B 79 SER~? 19.41 NI NI B 305 A 266 ASP B 21 ASP~? 22.52 NI NI B 305 A 294 HIS B 83 HIS~? 17.68 NI NI B 305 coo 32.07 25.76 77.83 34.46 26.05 77.46 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 33.07 35.01 79.81 33.39 33.02 79.13 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 35.53 30.26 79.89 34.62 28.71 78.80 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1azw_c00 source 1azw PROLINE IMINOPEPTIDASE : 4 hits 1azw_c00 naa= 3 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 1 3 # 1 B 110 SER A 79 SER~? 16.97 CA CA A 301 B 266 ASP A 21 ASP~? 19.27 CA CA A 301 B 294 HIS A 22 HIS~? 21.70 NI NI A 304 coo 51.18 33.22 36.61 49.29 31.79 37.02 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 44.19 39.32 34.54 45.21 37.66 35.38 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 45.79 34.26 34.63 47.54 33.80 35.70 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 2 3 # 2 B 110 SER A 79 SER~? 16.97 CA CA A 301 B 266 ASP A 21 ASP~? 19.27 CA CA A 301 B 294 HIS A 83 HIS~? 17.38 NI NI A 304 coo 51.18 33.22 36.61 49.29 31.79 37.02 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 44.19 39.32 34.54 45.21 37.66 35.38 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 45.79 34.26 34.63 47.54 33.80 35.70 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 3 3 # 3 B 110 SER B 79 SER~? 19.41 NI NI B 305 B 266 ASP B 21 ASP~? 22.52 NI NI B 305 B 294 HIS B 22 HIS~? 22.02 NI NI B 305 coo 51.18 33.22 36.61 49.29 31.79 37.02 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 44.19 39.32 34.54 45.21 37.66 35.38 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 45.79 34.26 34.63 47.54 33.80 35.70 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1azw_c01 PROLINE IMINOPEPTIDASE user 4 3 # 4 B 110 SER B 79 SER~? 19.41 NI NI B 305 B 266 ASP B 21 ASP~? 22.52 NI NI B 305 B 294 HIS B 83 HIS~? 17.68 NI NI B 305 coo 51.18 33.22 36.61 49.29 31.79 37.02 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 44.19 39.32 34.54 45.21 37.66 35.38 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 45.79 34.26 34.63 47.54 33.80 35.70 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1azw_c01 source 1azw PROLINE IMINOPEPTIDASE : 4 hits 1azw_c01 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 83 HIS~? 17.38 NI NI A 304 A 171 ARG A 206 ARG^? 17.65 CA CA B 303 A 190 LYS A 78 LYS~? 23.27 CA CA A 301 coo 22.59 2.26 43.22 21.17 3.47 42.27 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 13.63 3.81 28.83 14.49 2.91 31.59 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 24.97 7.47 37.69 21.24 10.69 35.89 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 2 3 # 2 A 85 HIS A 187 HIS^? -3.59 NI NI A 304s A 171 ARG A 147 ARG~? 21.93 NI NI A 304 A 190 LYS A 142 LYS^? 14.03 NI NI A 304 coo 22.59 2.26 43.22 21.17 3.47 42.27 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 13.63 3.81 28.83 14.49 2.91 31.59 1.99 9.46 -40.00 3.54 12.00 -39.24 coo 24.97 7.47 37.69 21.24 10.69 35.89 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 3 3 # 3 A 85 HIS B 83 HIS~? 17.68 NI NI B 305 A 171 ARG B 206 ARG^? 17.11 NI NI B 305 A 190 LYS B 78 LYS~? 25.94 CA CA B 303 coo 22.59 2.26 43.22 21.17 3.47 42.27 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 13.63 3.81 28.83 14.49 2.91 31.59 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 24.97 7.47 37.69 21.24 10.69 35.89 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 4 3 # 4 A 85 HIS B 187 HIS^? -3.54 NI NI B 305s A 171 ARG B 147 ARG.? 21.34 NI NI B 305 A 190 LYS B 142 LYS^? 13.37 NI NI B 305 coo 22.59 2.26 43.22 21.17 3.47 42.27 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 13.63 3.81 28.83 14.49 2.91 31.59 3.78 -8.72 -40.00 5.97 -10.16 -41.63 coo 24.97 7.47 37.69 21.24 10.69 35.89 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 4 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 187 HIS^? -3.59 NI NI A 304s B 171 ARG A 147 ARG~? 21.93 NI NI A 304 B 190 LYS A 142 LYS^? 14.03 NI NI A 304 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 2.83 4.83 10.84 1.96 4.32 7.97 1.99 9.46 -40.00 3.54 12.00 -39.24 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 2 3 # 2 B 85 HIS B 83 HIS~? 17.68 NI NI B 305 B 171 ARG B 206 ARG^? 17.11 NI NI B 305 B 190 LYS B 78 LYS~? 25.94 CA CA B 303 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.83 4.83 10.84 1.96 4.32 7.97 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 2 hits 1azy_c01 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 148 HIS~? 18.59 NI NI A 304 A 58 GLU A 144 GLU^? 14.15 NI NI A 304 A 92 HIS A 187 HIS^? -3.59 NI NI A 304s coo 12.70 27.74 1.76 10.77 27.11 1.24 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 11.38 23.30 3.20 9.27 23.34 3.13 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 2.67 19.36 1.56 3.51 21.24 1.94 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS B 148 HIS.? 18.38 NI NI B 305 A 58 GLU B 144 GLU^? 13.93 NI NI B 305 A 92 HIS B 187 HIS^? -3.54 NI NI B 305s coo 12.70 27.74 1.76 10.77 27.11 1.24 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 11.38 23.30 3.20 9.27 23.34 3.13 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 2.67 19.36 1.56 3.51 21.24 1.94 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 148 HIS~? 18.59 NI NI A 304 B 58 GLU A 144 GLU^? 14.15 NI NI A 304 B 92 HIS A 187 HIS^? -3.59 NI NI A 304s coo 10.74 36.24 16.20 9.81 34.52 16.97 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 5.02 36.40 17.74 5.55 34.41 17.37 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 0.68 29.04 20.43 2.46 29.56 19.46 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS B 148 HIS.? 18.38 NI NI B 305 B 58 GLU B 144 GLU^? 13.93 NI NI B 305 B 92 HIS B 187 HIS^? -3.54 NI NI B 305s coo 10.74 36.24 16.20 9.81 34.52 16.97 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 5.02 36.40 17.74 5.55 34.41 17.37 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 0.68 29.04 20.43 2.46 29.56 19.46 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 197 ASP.? 9.27 CA CA A 306 A 182 GLU A 195 GLU.? -3.34 CA CA A 302s A 286 ASN A 192 ASN.? 10.14 CA CA A 302 coo 26.03 44.66 108.90 25.67 42.61 108.82 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 18.06 44.02 105.38 18.08 45.37 107.03 -3.71 10.89 -2.05 -2.53 10.06 -0.48 coo 25.47 38.28 112.06 27.26 39.30 111.54 -4.75 8.04 -11.36 -5.74 9.45 -10.12 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 1 hits 1b57_c00 naa= 3 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 148 CYH A 35 CYH~? 11.73 CA CA A 306 A 179 ASP A 42 ASP~? 18.65 NI NI A 304 A 183 GLN A 46 GLN~? 19.44 CA CA A 306 coo 21.87 3.71 21.27 20.32 3.55 23.64 -21.62 7.57 -11.19 -20.62 8.88 -13.43 coo 17.09 11.24 20.19 17.85 10.05 21.76 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 19.54 13.23 15.90 21.64 12.89 15.61 -18.86 -2.85 -7.06 -20.18 -2.72 -5.38 ULMN 3 1b5d_c00 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 148 CYH B 35 CYH~? 15.94 NI NI B 305 A 179 ASP B 42 ASP~? 18.39 NI NI B 305 A 183 GLN B 46 GLN~? 22.28 NI NI B 305 coo 21.87 3.71 21.27 20.32 3.55 23.64 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 coo 17.09 11.24 20.19 17.85 10.05 21.76 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 19.54 13.23 15.90 21.64 12.89 15.61 -18.81 -1.27 -73.26 -19.28 -1.92 -75.25 1b5d_c00 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c00 naa= 3 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 148 CYH A 35 CYH~? 11.73 CA CA A 306 B 179 ASP A 42 ASP~? 18.65 NI NI A 304 B 183 GLN A 46 GLN~? 19.44 CA CA A 306 coo 30.30 0.93 3.58 31.01 1.18 0.88 -21.62 7.57 -11.19 -20.62 8.88 -13.43 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -18.86 -2.85 -7.06 -20.18 -2.72 -5.38 ULMN 3 1b5d_c01 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 148 CYH B 35 CYH~? 15.94 NI NI B 305 B 179 ASP B 42 ASP~? 18.39 NI NI B 305 B 183 GLN B 46 GLN~? 22.28 NI NI B 305 coo 30.30 0.93 3.58 31.01 1.18 0.88 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 24.68 -8.53 5.16 25.68 -8.09 7.00 -18.81 -1.27 -73.26 -19.28 -1.92 -75.25 1b5d_c01 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 40 GLU~? 12.94 CA CA A 306 A 148 CYH A 49 CYH~? 14.80 NI NI A 304 A 179 ASP A 42 ASP~? 18.65 NI NI A 304 coo 20.47 15.77 27.32 19.04 14.27 26.94 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 21.87 3.71 21.27 20.32 3.55 23.64 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 17.09 11.24 20.19 17.85 10.05 21.76 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU B 40 GLU~? 23.91 NI NI B 305 A 148 CYH B 49 CYH~? 14.83 NI NI B 305 A 179 ASP B 42 ASP~? 18.39 NI NI B 305 coo 20.47 15.77 27.32 19.04 14.27 26.94 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 21.87 3.71 21.27 20.32 3.55 23.64 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 17.09 11.24 20.19 17.85 10.05 21.76 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 40 GLU~? 12.94 CA CA A 306 B 148 CYH A 49 CYH~? 14.80 NI NI A 304 B 179 ASP A 42 ASP~? 18.65 NI NI A 304 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 30.30 0.93 3.58 31.01 1.18 0.88 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU B 40 GLU~? 23.91 NI NI B 305 B 148 CYH B 49 CYH~? 14.83 NI NI B 305 B 179 ASP B 42 ASP~? 18.39 NI NI B 305 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 30.30 0.93 3.58 31.01 1.18 0.88 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 2 hits 1b5d_c05 naa= 3 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 A 18 HIS A 123 HIS.? 13.29 CA CA B 303 A 91 ARG A 206 ARG^? 17.65 CA CA B 303 A 129 SER A 124 SER.? 9.62 NI NI A 304 coo 24.39 47.01 49.70 26.42 47.04 49.21 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 25.98 44.20 42.23 28.53 42.98 43.43 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 30.00 49.76 45.68 28.73 48.72 47.47 -16.69 2.20 -34.43 -16.43 1.36 -32.16 ULMN 3 1b6t_c00 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 2 3 # 2 A 18 HIS B 123 HIS.? 14.82 NI NI B 305 A 91 ARG B 206 ARG^? 17.11 NI NI B 305 A 129 SER B 124 SER.? 10.06 NI NI B 305 coo 24.39 47.01 49.70 26.42 47.04 49.21 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 25.98 44.20 42.23 28.53 42.98 43.43 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 30.00 49.76 45.68 28.73 48.72 47.47 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 1b6t_c00 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 2 hits 1b6t_c00 naa= 3 ULMN 3 1b6t_c01 PHOSPHOPANTETHEINE ADENYLYLTRANSFERAuser 1 3 # 1 B 18 HIS B 123 HIS.? 14.82 NI NI B 305 B 91 ARG B 206 ARG^? 17.11 NI NI B 305 B 129 SER B 124 SER.? 10.06 NI NI B 305 coo 18.19 17.03 40.71 18.55 17.18 38.64 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 25.60 21.10 38.54 23.57 20.93 36.25 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 21.33 14.29 34.62 19.25 14.88 35.71 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 1b6t_c01 source 1b6t PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE : 1 hits 1b6t_c01 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR B 170 TYR^? 15.66 NI NI B 305 A 230 ASP B 163 ASP.? 22.00 NI NI B 305 A 273 LYS B 159 LYS.? 30.31 NI NI B 305 coo 9.23 21.44 106.88 10.18 19.34 105.31 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 1.45 22.80 104.16 2.58 21.02 104.01 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 2.97 11.64 107.87 6.59 15.13 107.03 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_c04 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 73 PHE~? 16.31 CA CA A 301 A 159 ASP A 65 ASP~? 19.57 CA CA B 303 A 188 LYS A 78 LYS~? 23.27 CA CA A 301 coo 13.91 34.58 14.67 12.95 36.00 12.47 -25.83 8.44 -17.90 -23.57 8.20 -16.27 coo 20.97 28.40 16.26 20.19 30.15 15.34 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 22.55 41.65 15.60 18.92 37.20 14.63 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 73 PHE~? 16.83 NI NI B 305 A 159 ASP B 65 ASP~? 20.64 NI NI B 305 A 188 LYS B 78 LYS~? 25.94 CA CA B 303 coo 13.91 34.58 14.67 12.95 36.00 12.47 -23.58 -13.67 -62.51 -21.58 -13.05 -64.36 coo 20.97 28.40 16.26 20.19 30.15 15.34 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 22.55 41.65 15.60 18.92 37.20 14.63 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE B 168 PHE^? 16.16 NI NI B 305 A 159 ASP B 163 ASP.? 22.00 NI NI B 305 A 188 LYS B 159 LYS.? 30.31 NI NI B 305 coo 13.91 34.58 14.67 12.95 36.00 12.47 5.97 -7.92 -52.72 6.39 -5.22 -52.12 coo 20.97 28.40 16.26 20.19 30.15 15.34 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 22.55 41.65 15.60 18.92 37.20 14.63 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 3 hits 1b9h_c02 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 104 ASP^? 11.20 NI NI A 304 16 HIS A 121 HIS.? -3.63 NI NI A 304s 67 GLY A 53 GLY~? 18.18 NI NI A 304 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 104 ASP^? 11.20 NI NI A 304 16 HIS A 121 HIS.? -3.63 NI NI A 304s 67 GLY A 114 GLY.? 12.41 CA CA A 302 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -4.84 2.83 -11.96 -4.27 3.38 -12.10 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 104 ASP^? 11.20 NI NI A 304 16 HIS A 121 HIS.? -3.63 NI NI A 304s 67 GLY A 176 GLY.? 12.58 CA CA A 306 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -16.93 18.91 -18.06 -16.18 18.74 -18.33 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP B 104 ASP^? 11.37 NI NI B 305 16 HIS B 121 HIS.? -3.60 NI NI B 305s 67 GLY B 53 GLY~? 17.62 NI NI B 305 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -9.40 5.82 -68.64 -9.89 5.39 -68.12 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP B 104 ASP^? 11.37 NI NI B 305 16 HIS B 121 HIS.? -3.60 NI NI B 305s 67 GLY B 114 GLY.? 14.04 NI NI B 305 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -4.30 -3.98 -68.39 -3.58 -4.34 -68.25 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP B 104 ASP^? 11.37 NI NI B 305 16 HIS B 121 HIS.? -3.60 NI NI B 305s 67 GLY B 176 GLY.? 17.70 NI NI B 305 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP B 177 ASP^? 17.56 NI NI B 305 16 HIS B 16 HIS^? 15.81 NI NI B 305 67 GLY B 114 GLY.? 14.04 NI NI B 305 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -4.30 -3.98 -68.39 -3.58 -4.34 -68.25 1be1_c02 source 1be1 GLUTAMATE MUTASE : 7 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 27 ASP~? -2.92 CA CA A 301s 435 GLU A 30 GLU~? 7.55 CA CA A 301 510 ASP A 75 ASP~? 14.34 CA CA A 301 coo 88.62 69.90 41.16 89.05 70.67 43.04 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 89.52 76.11 40.17 89.01 75.16 41.97 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 84.89 77.60 46.67 85.63 75.79 46.03 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 104 ASP^? 11.20 NI NI A 304 435 GLU A 103 GLU^? 14.47 CA CA B 303 510 ASP A 65 ASP~? 19.57 CA CA B 303 coo 88.62 69.90 41.16 89.05 70.67 43.04 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 89.52 76.11 40.17 89.01 75.16 41.97 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 84.89 77.60 46.67 85.63 75.79 46.03 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP B 27 ASP~? 26.12 NI NI B 305 435 GLU B 30 GLU~? 25.54 NI NI B 305 510 ASP B 75 ASP~? 24.42 NI NI B 305 coo 88.62 69.90 41.16 89.05 70.67 43.04 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 89.52 76.11 40.17 89.01 75.16 41.97 -23.64 -21.41 -69.78 -24.93 -22.08 -68.23 coo 84.89 77.60 46.67 85.63 75.79 46.03 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 1bf2_c00 source 1bf2 ISOAMYLASE : 3 hits 1bf2_c00 naa= 3 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 1 3 # 1 28 GLU A 144 GLU^? 14.15 NI NI A 304 70 HIS A 148 HIS~? 18.59 NI NI A 304 281 HIS B 16 HIS^? 15.81 NI NI B 305 coo 66.09 46.17 155.81 66.77 48.19 155.70 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 69.05 50.55 157.03 68.00 52.29 156.51 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 100.93 36.73 156.02 100.47 38.42 157.18 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1bfd_c00 BENZOYLFORMATE DECARBOXYLASE user 2 3 # 2 28 GLU B 144 GLU^? 13.93 NI NI B 305 70 HIS B 148 HIS.? 18.38 NI NI B 305 281 HIS A 16 HIS^? 15.61 NI NI A 304 coo 66.09 46.17 155.81 66.77 48.19 155.70 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 69.05 50.55 157.03 68.00 52.29 156.51 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 100.93 36.73 156.02 100.47 38.42 157.18 -10.06 19.38 -25.76 -9.54 19.61 -23.74 1bfd_c00 source 1bfd BENZOYLFORMATE DECARBOXYLASE : 2 hits 1bfd_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 29 GLU~? -4.66 CA CA A 301s A 503 TYR A 36 TYR~? 7.82 CA CA A 306 A 537 GLU A 32 GLU~? -3.00 CA CA A 306s coo 24.06 146.21 11.09 22.89 146.18 9.36 -21.95 18.47 -6.84 -23.04 19.65 -5.43 coo 15.91 140.69 8.32 15.71 143.39 9.13 -19.14 8.29 -6.46 -16.48 9.15 -6.41 coo 16.65 144.44 13.24 18.34 145.22 12.33 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU A 30 GLU~? 7.55 CA CA A 301 A 503 TYR A 36 TYR~? 7.82 CA CA A 306 A 537 GLU A 32 GLU~? -3.00 CA CA A 306s coo 24.06 146.21 11.09 22.89 146.18 9.36 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 15.91 140.69 8.32 15.71 143.39 9.13 -19.14 8.29 -6.46 -16.48 9.15 -6.41 coo 16.65 144.44 13.24 18.34 145.22 12.33 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 3 3 # 3 A 461 GLU A 43 GLU~? 22.12 CA CA A 306 A 503 TYR A 57 TYR^? 15.36 NI NI A 304 A 537 GLU A 40 GLU~? 12.94 CA CA A 306 coo 24.06 146.21 11.09 22.89 146.18 9.36 -24.31 -5.26 -5.52 -23.36 -4.37 -3.82 coo 15.91 140.69 8.32 15.71 143.39 9.13 -16.92 0.76 -11.33 -19.53 0.25 -12.18 coo 16.65 144.44 13.24 18.34 145.22 12.33 -20.35 2.54 -4.22 -20.15 4.43 -3.28 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 4 3 # 4 A 461 GLU A 103 GLU^? 14.47 CA CA B 303 A 503 TYR A 205 TYR^? 13.62 NI NI A 304 A 537 GLU A 101 GLU^? 20.45 NI NI A 304 coo 24.06 146.21 11.09 22.89 146.18 9.36 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 15.91 140.69 8.32 15.71 143.39 9.13 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 16.65 144.44 13.24 18.34 145.22 12.33 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 5 3 # 5 A 461 GLU B 29 GLU~? 27.87 NI NI B 305 A 503 TYR B 36 TYR~? 20.19 NI NI B 305 A 537 GLU B 32 GLU~? 21.76 NI NI B 305 coo 24.06 146.21 11.09 22.89 146.18 9.36 -17.38 -22.83 -73.54 -18.54 -23.97 -74.92 coo 15.91 140.69 8.32 15.71 143.39 9.13 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 coo 16.65 144.44 13.24 18.34 145.22 12.33 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 5 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 29 GLU~? -4.66 CA CA A 301s A 504 TYR A 36 TYR~? 7.82 CA CA A 306 A 540 GLU A 32 GLU~? -3.00 CA CA A 306s coo 81.34 87.29 87.22 82.36 86.09 88.61 -21.95 18.47 -6.84 -23.04 19.65 -5.43 coo 80.85 81.34 94.77 81.70 80.16 92.41 -19.14 8.29 -6.46 -16.48 9.15 -6.41 coo 79.94 80.46 88.84 81.11 81.36 87.27 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU A 43 GLU~? 22.12 CA CA A 306 A 504 TYR A 57 TYR^? 15.36 NI NI A 304 A 540 GLU A 40 GLU~? 12.94 CA CA A 306 coo 81.34 87.29 87.22 82.36 86.09 88.61 -24.31 -5.26 -5.52 -23.36 -4.37 -3.82 coo 80.85 81.34 94.77 81.70 80.16 92.41 -16.92 0.76 -11.33 -19.53 0.25 -12.18 coo 79.94 80.46 88.84 81.11 81.36 87.27 -20.35 2.54 -4.22 -20.15 4.43 -3.28 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 3 3 # 3 A 451 GLU A 103 GLU^? 14.47 CA CA B 303 A 504 TYR A 205 TYR^? 13.62 NI NI A 304 A 540 GLU A 101 GLU^? 20.45 NI NI A 304 coo 81.34 87.29 87.22 82.36 86.09 88.61 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 80.85 81.34 94.77 81.70 80.16 92.41 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 79.94 80.46 88.84 81.11 81.36 87.27 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 4 3 # 4 A 451 GLU B 29 GLU~? 27.87 NI NI B 305 A 504 TYR B 36 TYR~? 20.19 NI NI B 305 A 540 GLU B 32 GLU~? 21.76 NI NI B 305 coo 81.34 87.29 87.22 82.36 86.09 88.61 -17.38 -22.83 -73.54 -18.54 -23.97 -74.92 coo 80.85 81.34 94.77 81.70 80.16 92.41 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 coo 79.94 80.46 88.84 81.11 81.36 87.27 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 5 3 # 5 A 451 GLU B 103 GLU^? 12.89 NI NI B 305 A 504 TYR B 205 TYR^? 13.71 NI NI B 305 A 540 GLU B 101 GLU^? 17.23 CA CA B 303 coo 81.34 87.29 87.22 82.36 86.09 88.61 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 80.85 81.34 94.77 81.70 80.16 92.41 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 79.94 80.46 88.84 81.11 81.36 87.27 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 5 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 101 GLU^? 20.45 NI NI A 304 B 504 TYR A 205 TYR^? 13.62 NI NI A 304 B 540 GLU A 103 GLU^? 14.47 CA CA B 303 coo 86.52 35.28 112.74 87.08 36.38 110.99 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 84.93 40.21 105.31 85.72 41.45 107.72 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 83.38 41.19 112.55 85.47 40.59 112.72 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 103 GLU^? 14.47 CA CA B 303 B 504 TYR A 205 TYR^? 13.62 NI NI A 304 B 540 GLU A 101 GLU^? 20.45 NI NI A 304 coo 86.52 35.28 112.74 87.08 36.38 110.99 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 84.93 40.21 105.31 85.72 41.45 107.72 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 83.38 41.19 112.55 85.47 40.59 112.72 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU B 29 GLU~? 27.87 NI NI B 305 B 504 TYR B 36 TYR~? 20.19 NI NI B 305 B 540 GLU B 32 GLU~? 21.76 NI NI B 305 coo 86.52 35.28 112.74 87.08 36.38 110.99 -17.38 -22.83 -73.54 -18.54 -23.97 -74.92 coo 84.93 40.21 105.31 85.72 41.45 107.72 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 coo 83.38 41.19 112.55 85.47 40.59 112.72 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 3 hits 1bhg_c03 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 162 ARG~? 28.37 NI NI A 304 183 LYS A 159 LYS.? 27.24 CA CA A 302 317 ARG A 186 ARG^? 12.05 NI NI A 304 coo 76.57 109.19 73.41 73.86 110.26 72.16 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 82.09 117.51 66.37 80.60 114.32 71.44 12.17 17.61 -27.47 15.70 15.20 -22.78 coo 65.21 120.62 58.76 63.62 123.14 59.66 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 2 3 # 2 118 ARG B 162 ARG.? 29.21 NI NI B 305 183 LYS B 159 LYS.? 30.31 NI NI B 305 317 ARG B 186 ARG^? 11.32 NI NI B 305 coo 76.57 109.19 73.41 73.86 110.26 72.16 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 82.09 117.51 66.37 80.60 114.32 71.44 15.99 -14.57 -52.82 19.67 -12.66 -51.79 coo 65.21 120.62 58.76 63.62 123.14 59.66 -0.49 -2.47 -50.17 -2.28 -0.14 -49.29 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 2 hits 1bib_c00 naa= 3 ULMN 3 1bmt_c04 METHIONINE SYNTHASE (B12-BINDING DOMuser 1 3 # 1 A 757 ASP A 21 ASP~? 19.27 CA CA A 301 A 759 HIS A 83 HIS~? 17.38 NI NI A 304 A 810 SER A 20 SER~? 13.98 CA CA A 301 coo 30.11 61.02 29.12 29.36 59.77 27.63 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 30.94 56.62 25.28 29.94 54.94 26.14 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 25.05 62.74 29.97 26.88 61.45 29.19 -21.98 22.65 -22.42 -20.53 24.32 -21.40 1bmt_c04 source 1bmt METHIONINE SYNTHASE (B12-BINDING DOMAINS) (E.C: 1 hits 1bmt_c04 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 116 HIS^? 7.23 NI NI A 304 A 105 GLU A 188 GLU^? 11.68 NI NI A 304 A 109 HIS A 187 HIS^? -3.59 NI NI A 304s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 187 HIS^? -3.59 NI NI A 304s A 105 GLU A 188 GLU^? 11.68 NI NI A 304 A 109 HIS A 116 HIS^? 7.23 NI NI A 304 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS B 116 HIS^? 6.69 NI NI B 305 A 105 GLU B 188 GLU^? 11.04 NI NI B 305 A 109 HIS B 187 HIS^? -3.54 NI NI B 305s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS B 187 HIS^? -3.54 NI NI B 305s A 105 GLU B 188 GLU^? 11.04 NI NI B 305 A 109 HIS B 116 HIS^? 6.69 NI NI B 305 coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 1bol_c00 source 1bol RIBONUCLEASE RH : 4 hits 1bol_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 128 GLY^? 7.35 NI NI A 304 48 HIS A 83 HIS~? 17.38 NI NI A 304 99 ASP A 21 ASP~? 19.27 CA CA A 301 coo 12.38 5.55 24.25 13.27 5.59 24.39 -14.74 9.68 -27.07 -14.93 8.99 -26.74 coo 18.80 12.68 24.53 17.69 13.54 26.08 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY A 128 GLY^? 7.35 NI NI A 304 48 HIS A 83 HIS~? 17.38 NI NI A 304 99 ASP A 81 ASP~? 18.70 NI NI A 304 coo 12.38 5.55 24.25 13.27 5.59 24.39 -14.74 9.68 -27.07 -14.93 8.99 -26.74 coo 18.80 12.68 24.53 17.69 13.54 26.08 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 17.07 18.51 26.62 16.67 17.07 28.09 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 3 3 # 3 30 GLY B 128 GLY^? 7.45 NI NI B 305 48 HIS B 83 HIS~? 17.68 NI NI B 305 99 ASP B 21 ASP~? 22.52 NI NI B 305 coo 12.38 5.55 24.25 13.27 5.59 24.39 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 coo 18.80 12.68 24.53 17.69 13.54 26.08 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 17.07 18.51 26.62 16.67 17.07 28.09 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 4 3 # 4 30 GLY B 128 GLY^? 7.45 NI NI B 305 48 HIS B 83 HIS~? 17.68 NI NI B 305 99 ASP B 81 ASP~? 18.56 NI NI B 305 coo 12.38 5.55 24.25 13.27 5.59 24.39 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 coo 18.80 12.68 24.53 17.69 13.54 26.08 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 17.07 18.51 26.62 16.67 17.07 28.09 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 4 hits 1bp2_c00 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 187 HIS^? -3.59 NI NI A 304s A 168 ARG A 166 ARG~? 23.27 NI NI A 304 A 187 LYS A 142 LYS^? 14.03 NI NI A 304 coo 62.47 12.00 59.65 61.76 10.14 60.31 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 55.10 8.37 73.00 55.48 9.59 70.20 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 66.76 10.09 66.23 61.80 8.06 65.82 -1.82 9.73 -24.13 2.97 5.99 -23.26 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 187 HIS^? -3.59 NI NI A 304s B1168 ARG A 198 ARG^? 13.22 CA CA A 306 B1187 LYS A 142 LYS^? 14.03 NI NI A 304 coo 35.03 5.72 103.61 36.82 5.00 102.79 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 41.91 5.48 91.85 40.59 6.81 94.28 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -1.82 9.73 -24.13 2.97 5.99 -23.26 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 1 hits 1brw_c01 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 90 ASP~? 20.31 NI NI A 304 A 354 GLU A 89 GLU~? 25.01 NI NI A 304 A 421 ASP A 94 ASP.? 21.52 NI NI B 305 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 29.07 50.42 58.36 29.02 52.18 59.49 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 30.82 59.76 58.47 31.12 59.02 60.40 -19.72 10.83 -48.01 -21.47 10.84 -49.25 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 90 ASP~? 20.31 NI NI A 304 A 354 GLU A 92 GLU~? 26.61 NI NI A 304 A 421 ASP A 94 ASP.? 21.52 NI NI B 305 coo 31.05 49.37 64.51 31.97 51.11 63.85 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 29.07 50.42 58.36 29.02 52.18 59.49 -15.71 18.15 -44.39 -15.11 19.36 -46.01 coo 30.82 59.76 58.47 31.12 59.02 60.40 -19.72 10.83 -48.01 -21.47 10.84 -49.25 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP B 90 ASP~? 18.88 CA CA B 303 A 354 GLU B 89 GLU~? 11.52 CA CA B 303 A 421 ASP B 94 ASP.? -2.87 CA CA B 303s coo 31.05 49.37 64.51 31.97 51.11 63.85 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 29.07 50.42 58.36 29.02 52.18 59.49 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 30.82 59.76 58.47 31.12 59.02 60.40 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP B 90 ASP~? 18.88 CA CA B 303 A 354 GLU B 92 GLU.? 12.87 CA CA B 303 A 421 ASP B 94 ASP.? -2.87 CA CA B 303s coo 31.05 49.37 64.51 31.97 51.11 63.85 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 29.07 50.42 58.36 29.02 52.18 59.49 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 coo 30.82 59.76 58.47 31.12 59.02 60.40 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 90 ASP~? 20.31 NI NI A 304 B 354 GLU A 89 GLU~? 25.01 NI NI A 304 B 421 ASP A 94 ASP.? 21.52 NI NI B 305 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 27.87 10.66 47.95 27.82 8.60 48.27 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 26.02 1.87 43.38 25.90 1.97 45.49 -19.72 10.83 -48.01 -21.47 10.84 -49.25 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 90 ASP~? 20.31 NI NI A 304 B 354 GLU A 92 GLU~? 26.61 NI NI A 304 B 421 ASP A 94 ASP.? 21.52 NI NI B 305 coo 25.90 8.19 53.87 25.36 6.97 52.29 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 27.87 10.66 47.95 27.82 8.60 48.27 -15.71 18.15 -44.39 -15.11 19.36 -46.01 coo 26.02 1.87 43.38 25.90 1.97 45.49 -19.72 10.83 -48.01 -21.47 10.84 -49.25 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP A 163 ASP~? 21.63 NI NI A 304 B 354 GLU A 164 GLU~? 25.12 NI NI A 304 B 421 ASP A 145 ASP.? 18.22 NI NI A 304 coo 25.90 8.19 53.87 25.36 6.97 52.29 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 27.87 10.66 47.95 27.82 8.60 48.27 2.03 20.18 -36.55 1.23 21.62 -37.90 coo 26.02 1.87 43.38 25.90 1.97 45.49 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 90 ASP~? 18.88 CA CA B 303 B 354 GLU B 89 GLU~? 11.52 CA CA B 303 B 421 ASP B 94 ASP.? -2.87 CA CA B 303s coo 25.90 8.19 53.87 25.36 6.97 52.29 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 27.87 10.66 47.95 27.82 8.60 48.27 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 26.02 1.87 43.38 25.90 1.97 45.49 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 5 3 # 5 B 325 ASP B 90 ASP~? 18.88 CA CA B 303 B 354 GLU B 92 GLU.? 12.87 CA CA B 303 B 421 ASP B 94 ASP.? -2.87 CA CA B 303s coo 25.90 8.19 53.87 25.36 6.97 52.29 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 27.87 10.66 47.95 27.82 8.60 48.27 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 coo 26.02 1.87 43.38 25.90 1.97 45.49 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 6 3 # 6 B 325 ASP B 163 ASP.? 22.00 NI NI B 305 B 354 GLU B 164 GLU.? 26.04 NI NI B 305 B 421 ASP B 145 ASP.? 18.27 NI NI B 305 coo 25.90 8.19 53.87 25.36 6.97 52.29 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.04 -19.25 -44.07 7.68 -20.18 -42.28 coo 26.02 1.87 43.38 25.90 1.97 45.49 4.18 -8.01 -46.36 4.59 -9.01 -44.53 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 6 hits 1bvz_c09 naa= 3 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 1 3 # 1 A 110 SER A 79 SER~? 16.97 CA CA A 301 A 235 ASP A 21 ASP~? 19.27 CA CA A 301 A 263 HIS A 22 HIS~? 21.70 NI NI A 304 coo 30.32 56.27 16.76 31.62 57.99 17.94 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 31.33 62.80 9.68 31.68 62.04 11.62 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 30.23 62.32 14.77 30.86 60.47 15.53 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 2 3 # 2 A 110 SER A 79 SER~? 16.97 CA CA A 301 A 235 ASP A 21 ASP~? 19.27 CA CA A 301 A 263 HIS A 83 HIS~? 17.38 NI NI A 304 coo 30.32 56.27 16.76 31.62 57.99 17.94 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 31.33 62.80 9.68 31.68 62.04 11.62 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 30.23 62.32 14.77 30.86 60.47 15.53 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 3 3 # 3 A 110 SER B 79 SER~? 19.41 NI NI B 305 A 235 ASP B 21 ASP~? 22.52 NI NI B 305 A 263 HIS B 22 HIS~? 22.02 NI NI B 305 coo 30.32 56.27 16.76 31.62 57.99 17.94 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 31.33 62.80 9.68 31.68 62.04 11.62 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 30.23 62.32 14.77 30.86 60.47 15.53 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1c4x_c00 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIEuser 4 3 # 4 A 110 SER B 79 SER~? 19.41 NI NI B 305 A 235 ASP B 21 ASP~? 22.52 NI NI B 305 A 263 HIS B 83 HIS~? 17.68 NI NI B 305 coo 30.32 56.27 16.76 31.62 57.99 17.94 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 31.33 62.80 9.68 31.68 62.04 11.62 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 30.23 62.32 14.77 30.86 60.47 15.53 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1c4x_c00 source 1c4x 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDR: 4 hits 1c4x_c00 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 103 GLU^? 14.47 CA CA B 303 A 65 ARG B 98 ARG.? 11.28 CA CA B 303 A 85 HIS A 123 HIS.? 13.29 CA CA B 303 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -24.48 -9.95 -37.71 -23.29 -7.54 -36.21 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 1c54_c00 source 1c54 RIBONUCLEASE SA : 1 hits 1c54_c00 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN B 108 ASN^? 7.81 NI NI B 305 A 399 HIS B 116 HIS^? 6.69 NI NI B 305 A 408 TYR B 54 TYR.? 11.06 NI NI B 305 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 1c82_c00 source 1c82 HYALURONATE LYASE : 1 hits 1c82_c00 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN B 108 ASN^? 7.81 NI NI B 305 A 225 HIS B 116 HIS^? 6.69 NI NI B 305 A 234 TYR B 54 TYR.? 11.06 NI NI B 305 coo 26.32 35.76 46.63 26.28 33.63 46.67 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 coo 27.04 28.61 41.75 26.86 28.65 43.84 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 21.80 30.48 43.67 23.70 29.06 45.12 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 1cb8_c00 source 1cb8 CHONDROITINASE AC : 1 hits 1cb8_c00 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 157 ARG.? 25.34 NI NI A 304 127 ARG A 166 ARG~? 23.27 NI NI A 304 270 GLU A 144 GLU^? 14.15 NI NI A 304 coo -0.83 25.63 1.57 0.97 28.05 0.90 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 5.93 17.15 -30.01 7.54 17.94 -27.52 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 166 ARG~? 23.27 NI NI A 304 127 ARG A 157 ARG.? 25.34 NI NI A 304 270 GLU A 144 GLU^? 14.15 NI NI A 304 coo -0.83 25.63 1.57 0.97 28.05 0.90 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 9.58 14.02 -35.46 8.24 13.80 -38.23 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG B 157 ARG.? 25.43 NI NI B 305 127 ARG B 166 ARG.? 22.37 NI NI B 305 270 GLU B 144 GLU^? 13.93 NI NI B 305 coo -0.83 25.63 1.57 0.97 28.05 0.90 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 2.78 -5.24 -49.99 3.13 -3.29 -50.74 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG B 166 ARG.? 22.37 NI NI B 305 127 ARG B 157 ARG.? 25.43 NI NI B 305 270 GLU B 144 GLU^? 13.93 NI NI B 305 coo -0.83 25.63 1.57 0.97 28.05 0.90 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 2.78 -5.24 -49.99 3.13 -3.29 -50.74 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 4 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 75 ASP~? 14.34 CA CA A 301 264 GLU A 103 GLU^? 14.47 CA CA B 303 328 ASP A 81 ASP~? 18.70 NI NI A 304 coo 45.62 80.42 43.69 45.65 82.01 45.07 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 59.69 92.71 39.85 58.53 92.03 41.47 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 45.39 90.72 40.63 45.07 89.14 41.90 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 163 ASP~? 21.63 NI NI A 304 264 GLU A 188 GLU^? 11.68 NI NI A 304 328 ASP A 145 ASP.? 18.22 NI NI A 304 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 59.69 92.71 39.85 58.53 92.03 41.47 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 45.39 90.72 40.63 45.07 89.14 41.90 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 177 ASP^? 15.76 CA CA A 306 264 GLU A 89 GLU~? 25.01 NI NI A 304 328 ASP A 21 ASP~? 19.27 CA CA A 301 coo 45.62 80.42 43.69 45.65 82.01 45.07 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 59.69 92.71 39.85 58.53 92.03 41.47 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 75 ASP~? 24.42 NI NI B 305 264 GLU B 103 GLU^? 12.89 NI NI B 305 328 ASP B 81 ASP~? 18.56 NI NI B 305 coo 45.62 80.42 43.69 45.65 82.01 45.07 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 59.69 92.71 39.85 58.53 92.03 41.47 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 45.39 90.72 40.63 45.07 89.14 41.90 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 163 ASP.? 22.00 NI NI B 305 264 GLU B 188 GLU^? 11.04 NI NI B 305 328 ASP B 145 ASP.? 18.27 NI NI B 305 coo 45.62 80.42 43.69 45.65 82.01 45.07 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 59.69 92.71 39.85 58.53 92.03 41.47 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 45.39 90.72 40.63 45.07 89.14 41.90 4.18 -8.01 -46.36 4.59 -9.01 -44.53 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 177 ASP^? 17.56 NI NI B 305 264 GLU B 89 GLU~? 11.52 CA CA B 303 328 ASP B 21 ASP~? 22.52 NI NI B 305 coo 45.62 80.42 43.69 45.65 82.01 45.07 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 59.69 92.71 39.85 58.53 92.03 41.47 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 45.39 90.72 40.63 45.07 89.14 41.90 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c00 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 119 HIS^? -3.69 NI NI A 304s A 262 GLU A 188 GLU^? 11.68 NI NI A 304 A 358 GLU A 144 GLU^? 14.15 NI NI A 304 coo 26.19 60.87 43.98 27.48 59.27 43.30 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 27.13 54.07 50.45 26.96 54.19 48.35 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 27.06 50.43 44.36 27.99 52.27 44.74 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 187 HIS^? -3.59 NI NI A 304s A 262 GLU A 188 GLU^? 11.68 NI NI A 304 A 358 GLU A 144 GLU^? 14.15 NI NI A 304 coo 26.19 60.87 43.98 27.48 59.27 43.30 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 27.13 54.07 50.45 26.96 54.19 48.35 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 27.06 50.43 44.36 27.99 52.27 44.74 1.81 5.70 -30.20 2.38 3.69 -29.88 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 119 HIS^? -3.69 NI NI A 304s B 262 GLU A 188 GLU^? 11.68 NI NI A 304 B 358 GLU A 144 GLU^? 14.15 NI NI A 304 coo 44.98 77.01 48.39 44.42 78.67 47.18 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 41.60 83.57 54.16 42.46 83.24 52.25 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 44.05 87.61 48.73 43.15 85.67 48.52 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 187 HIS^? -3.59 NI NI A 304s B 262 GLU A 188 GLU^? 11.68 NI NI A 304 B 358 GLU A 144 GLU^? 14.15 NI NI A 304 coo 44.98 77.01 48.39 44.42 78.67 47.18 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 41.60 83.57 54.16 42.46 83.24 52.25 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 44.05 87.61 48.73 43.15 85.67 48.52 1.81 5.70 -30.20 2.38 3.69 -29.88 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 2 hits 1chm_c01 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 23 GLY.? 17.48 CA CA A 301 A 228 SER A 20 SER~? 13.98 CA CA A 301 A 549 ASP A 21 ASP~? 19.27 CA CA A 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -27.33 19.65 -25.69 -27.09 20.39 -25.46 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 113 GLY.? 8.86 CA CA A 302 A 228 SER A 194 SER.? 9.10 CA CA A 302 A 549 ASP A 196 ASP.? 6.39 CA CA A 306 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -2.38 4.05 -9.32 -3.10 4.18 -9.66 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -3.34 11.88 -6.70 -5.38 12.98 -7.40 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -9.18 12.61 -5.36 -9.90 13.29 -3.47 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 137 GLY.? 14.81 CA CA A 306 A 228 SER A 194 SER.? 9.10 CA CA A 302 A 549 ASP A 196 ASP.? 6.39 CA CA A 306 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -2.03 18.07 -12.62 -1.94 17.26 -12.43 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -3.34 11.88 -6.70 -5.38 12.98 -7.40 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -9.18 12.61 -5.36 -9.90 13.29 -3.47 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY A 176 GLY.? 12.58 CA CA A 306 A 228 SER A 20 SER~? 13.98 CA CA A 301 A 549 ASP A 21 ASP~? 19.27 CA CA A 301 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -16.93 18.91 -18.06 -16.18 18.74 -18.33 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 23 GLY.? 23.03 NI NI B 305 A 228 SER B 20 SER~? 23.19 NI NI B 305 A 549 ASP B 21 ASP~? 22.52 NI NI B 305 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY B 113 GLY.? 17.53 NI NI B 305 A 228 SER B 194 SER.? 19.35 NI NI B 305 A 549 ASP B 196 ASP.? 23.47 NI NI B 305 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -1.49 -4.12 -70.96 -2.11 -4.52 -70.63 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -0.75 -12.31 -73.01 -2.71 -13.39 -72.05 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY B 137 GLY.? 20.05 NI NI B 305 A 228 SER B 194 SER.? 19.35 NI NI B 305 A 549 ASP B 196 ASP.? 23.47 NI NI B 305 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 0.49 -18.64 -67.37 0.53 -17.81 -67.38 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -0.75 -12.31 -73.01 -2.71 -13.39 -72.05 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 8 3 # 8 A 198 GLY B 176 GLY.? 17.70 NI NI B 305 A 228 SER B 20 SER~? 23.19 NI NI B 305 A 549 ASP B 21 ASP~? 22.52 NI NI B 305 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 8 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 113 GLY.? 8.86 CA CA A 302 B1228 SER A 194 SER.? 9.10 CA CA A 302 B1549 ASP A 196 ASP.? 6.39 CA CA A 306 coo 126.34 72.75 125.66 125.95 73.27 126.11 -2.38 4.05 -9.32 -3.10 4.18 -9.66 coo 131.65 74.68 129.41 130.31 72.73 128.82 -3.34 11.88 -6.70 -5.38 12.98 -7.40 coo 134.72 69.43 130.42 133.03 70.65 130.08 -9.18 12.61 -5.36 -9.90 13.29 -3.47 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 137 GLY.? 14.81 CA CA A 306 B1228 SER A 194 SER.? 9.10 CA CA A 302 B1549 ASP A 196 ASP.? 6.39 CA CA A 306 coo 126.34 72.75 125.66 125.95 73.27 126.11 -2.03 18.07 -12.62 -1.94 17.26 -12.43 coo 131.65 74.68 129.41 130.31 72.73 128.82 -3.34 11.88 -6.70 -5.38 12.98 -7.40 coo 134.72 69.43 130.42 133.03 70.65 130.08 -9.18 12.61 -5.36 -9.90 13.29 -3.47 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 176 GLY.? 12.58 CA CA A 306 B1228 SER A 20 SER~? 13.98 CA CA A 301 B1549 ASP A 21 ASP~? 19.27 CA CA A 301 coo 126.34 72.75 125.66 125.95 73.27 126.11 -16.93 18.91 -18.06 -16.18 18.74 -18.33 coo 131.65 74.68 129.41 130.31 72.73 128.82 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo 134.72 69.43 130.42 133.03 70.65 130.08 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 23 GLY.? 23.03 NI NI B 305 B1228 SER B 20 SER~? 23.19 NI NI B 305 B1549 ASP B 21 ASP~? 22.52 NI NI B 305 coo 126.34 72.75 125.66 125.95 73.27 126.11 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 coo 131.65 74.68 129.41 130.31 72.73 128.82 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo 134.72 69.43 130.42 133.03 70.65 130.08 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 113 GLY.? 17.53 NI NI B 305 B1228 SER B 194 SER.? 19.35 NI NI B 305 B1549 ASP B 196 ASP.? 23.47 NI NI B 305 coo 126.34 72.75 125.66 125.95 73.27 126.11 -1.49 -4.12 -70.96 -2.11 -4.52 -70.63 coo 131.65 74.68 129.41 130.31 72.73 128.82 -0.75 -12.31 -73.01 -2.71 -13.39 -72.05 coo 134.72 69.43 130.42 133.03 70.65 130.08 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY B 137 GLY.? 20.05 NI NI B 305 B1228 SER B 194 SER.? 19.35 NI NI B 305 B1549 ASP B 196 ASP.? 23.47 NI NI B 305 coo 126.34 72.75 125.66 125.95 73.27 126.11 0.49 -18.64 -67.37 0.53 -17.81 -67.38 coo 131.65 74.68 129.41 130.31 72.73 128.82 -0.75 -12.31 -73.01 -2.71 -13.39 -72.05 coo 134.72 69.43 130.42 133.03 70.65 130.08 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 B1198 GLY B 176 GLY.? 17.70 NI NI B 305 B1228 SER B 20 SER~? 23.19 NI NI B 305 B1549 ASP B 21 ASP~? 22.52 NI NI B 305 coo 126.34 72.75 125.66 125.95 73.27 126.11 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 coo 131.65 74.68 129.41 130.31 72.73 128.82 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo 134.72 69.43 130.42 133.03 70.65 130.08 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 7 hits 1cjy_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 40 GLU~? 12.94 CA CA A 306 A 89 GLU A 32 GLU~? -3.00 CA CA A 306s A 120 SER A 34 SER~? 11.27 CA CA A 301 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -24.69 9.63 -10.31 -25.97 11.32 -11.50 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 40 GLU~? 23.91 NI NI B 305 A 89 GLU B 32 GLU~? 21.76 NI NI B 305 A 120 SER B 34 SER~? 21.79 NI NI B 305 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -22.10 -14.67 -70.00 -23.10 -16.65 -69.01 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 101 GLU^? 17.23 CA CA B 303 A 89 GLU B 103 GLU^? 12.89 NI NI B 305 A 120 SER B 124 SER.? 10.06 NI NI B 305 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 1cns_c00 source 1cns CHITINASE : 3 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 40 GLU~? 12.94 CA CA A 306 B 89 GLU A 32 GLU~? -3.00 CA CA A 306s B 120 SER A 34 SER~? 11.27 CA CA A 301 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -24.69 9.63 -10.31 -25.97 11.32 -11.50 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 40 GLU~? 23.91 NI NI B 305 B 89 GLU B 32 GLU~? 21.76 NI NI B 305 B 120 SER B 34 SER~? 21.79 NI NI B 305 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -22.10 -14.67 -70.00 -23.10 -16.65 -69.01 1cns_c01 source 1cns CHITINASE : 2 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 205 TYR^? 13.62 NI NI A 304 A 173 ASP A 81 ASP~? 18.70 NI NI A 304 C 48 ARG A 206 ARG^? 17.65 CA CA B 303 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 24.35 4.55 25.11 25.94 3.23 25.53 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 205 TYR^? 13.71 NI NI B 305 A 173 ASP B 81 ASP~? 18.56 NI NI B 305 C 48 ARG B 206 ARG^? 17.11 NI NI B 305 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 24.35 4.55 25.11 25.94 3.23 25.53 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 206 ARG^? 17.65 CA CA B 303 C 101 TYR A 205 TYR^? 13.62 NI NI A 304 C 173 ASP A 81 ASP~? 18.70 NI NI A 304 coo 32.27 5.62 48.15 31.93 6.48 51.06 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 29.64 3.64 57.39 31.22 5.14 55.65 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 206 ARG^? 17.11 NI NI B 305 C 101 TYR B 205 TYR^? 13.71 NI NI B 305 C 173 ASP B 81 ASP~? 18.56 NI NI B 305 coo 32.27 5.62 48.15 31.93 6.48 51.06 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 29.64 3.64 57.39 31.22 5.14 55.65 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 206 ARG^? 17.65 CA CA B 303 D 101 TYR A 205 TYR^? 13.62 NI NI A 304 D 173 ASP A 81 ASP~? 18.70 NI NI A 304 coo 69.08 8.58 32.60 69.70 10.81 30.58 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 71.77 11.86 24.26 70.23 12.22 26.56 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 71.60 6.14 19.25 70.26 6.87 20.69 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 206 ARG^? 17.11 NI NI B 305 D 101 TYR B 205 TYR^? 13.71 NI NI B 305 D 173 ASP B 81 ASP~? 18.56 NI NI B 305 coo 69.08 8.58 32.60 69.70 10.81 30.58 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 71.77 11.86 24.26 70.23 12.22 26.56 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 71.60 6.14 19.25 70.26 6.87 20.69 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 205 TYR^? 13.62 NI NI A 304 B 173 ASP A 81 ASP~? 18.70 NI NI A 304 D 48 ARG A 206 ARG^? 17.65 CA CA B 303 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 205 TYR^? 13.71 NI NI B 305 B 173 ASP B 81 ASP~? 18.56 NI NI B 305 D 48 ARG B 206 ARG^? 17.11 NI NI B 305 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 41 ASP.? 21.30 CA CA A 306 315 GLU A 43 GLU~? 22.12 CA CA A 306 390 TYR A 57 TYR^? 15.36 NI NI A 304 coo 32.46 99.13 19.34 30.94 100.38 20.07 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 32.04 94.22 18.23 30.57 94.75 16.88 -24.31 -5.26 -5.52 -23.36 -4.37 -3.82 coo 21.10 94.74 18.36 23.09 96.71 18.59 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 145 ASP.? 18.22 NI NI A 304 315 GLU A 144 GLU^? 14.15 NI NI A 304 390 TYR A 170 TYR^? 15.79 NI NI A 304 coo 32.46 99.13 19.34 30.94 100.38 20.07 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 32.04 94.22 18.23 30.57 94.75 16.88 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 21.10 94.74 18.36 23.09 96.71 18.59 1.42 13.38 -22.88 3.34 11.36 -22.90 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 41 ASP.? 25.32 NI NI B 305 315 GLU B 43 GLU~? 26.30 NI NI B 305 390 TYR B 57 TYR^? 15.35 NI NI B 305 coo 32.46 99.13 19.34 30.94 100.38 20.07 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 32.04 94.22 18.23 30.57 94.75 16.88 -26.02 0.23 -73.88 -25.38 -0.28 -75.86 coo 21.10 94.74 18.36 23.09 96.71 18.59 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP B 145 ASP.? 18.27 NI NI B 305 315 GLU B 144 GLU^? 13.93 NI NI B 305 390 TYR B 170 TYR^? 15.66 NI NI B 305 coo 32.46 99.13 19.34 30.94 100.38 20.07 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 32.04 94.22 18.23 30.57 94.75 16.88 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 21.10 94.74 18.36 23.09 96.71 18.59 4.23 -12.71 -57.64 5.48 -10.20 -57.84 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 4 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 27 ASP~? -2.92 CA CA A 301s A 340 GLU A 30 GLU~? 7.55 CA CA A 301 A 395 ASP A 75 ASP~? 14.34 CA CA A 301 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 104 ASP^? 11.20 NI NI A 304 A 340 GLU A 103 GLU^? 14.47 CA CA B 303 A 395 ASP A 65 ASP~? 19.57 CA CA B 303 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP B 27 ASP~? 26.12 NI NI B 305 A 340 GLU B 30 GLU~? 25.54 NI NI B 305 A 395 ASP B 75 ASP~? 24.42 NI NI B 305 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -23.64 -21.41 -69.78 -24.93 -22.08 -68.23 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 1cwy_c00 source 1cwy AMYLOMALTASE : 3 hits 1cwy_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 41 ASP.? 21.30 CA CA A 306 A 56 ILE A 107 ILE^? 13.32 NI NI A 304 A 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -19.31 4.74 -15.42 -20.27 5.32 -14.56 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP A 41 ASP.? 21.30 CA CA A 306 A 56 ILE A 109 ILE^? 11.54 CA CA A 306 A 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 3 3 # 3 A 37 ASP A 41 ASP.? 21.30 CA CA A 306 A 56 ILE A 109 ILE^? 11.54 CA CA A 306 A 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 4 3 # 4 A 37 ASP A 42 ASP~? 18.65 NI NI A 304 A 56 ILE A 109 ILE^? 11.54 CA CA A 306 A 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 5 3 # 5 A 37 ASP A 104 ASP^? 11.20 NI NI A 304 A 56 ILE A 126 ILE^? 12.20 NI NI A 304 A 82 TYR A 205 TYR^? 13.62 NI NI A 304 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -16.78 9.37 -33.46 -16.04 10.52 -34.10 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 6 3 # 6 A 37 ASP A 196 ASP.? 6.39 CA CA A 306 A 56 ILE A 109 ILE^? 11.54 CA CA A 306 A 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 7 3 # 7 A 37 ASP A 197 ASP.? 9.27 CA CA A 306 A 56 ILE A 38 ILE~? 16.45 CA CA A 306 A 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -24.24 3.90 -11.54 -24.65 4.14 -12.83 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 8 3 # 8 A 37 ASP A 197 ASP.? 9.27 CA CA A 306 A 56 ILE A 107 ILE^? 13.32 NI NI A 304 A 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -19.31 4.74 -15.42 -20.27 5.32 -14.56 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 9 3 # 9 A 37 ASP B 41 ASP.? 25.32 NI NI B 305 A 56 ILE B 107 ILE^? 13.43 NI NI B 305 A 82 TYR B 57 TYR^? 15.35 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -18.04 -8.82 -64.77 -18.90 -9.68 -65.56 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 10 3 # 10 A 37 ASP B 41 ASP.? 25.32 NI NI B 305 A 56 ILE B 109 ILE^? 15.30 NI NI B 305 A 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 11 3 # 11 A 37 ASP B 41 ASP.? 25.32 NI NI B 305 A 56 ILE B 109 ILE^? 15.30 NI NI B 305 A 82 TYR B 57 TYR^? 15.35 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 12 3 # 12 A 37 ASP B 42 ASP~? 18.39 NI NI B 305 A 56 ILE B 109 ILE^? 15.30 NI NI B 305 A 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 13 3 # 13 A 37 ASP B 104 ASP^? 11.37 NI NI B 305 A 56 ILE B 126 ILE^? 12.24 NI NI B 305 A 82 TYR B 205 TYR^? 13.71 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -14.34 -12.81 -46.79 -13.20 -13.54 -46.32 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 14 3 # 14 A 37 ASP B 196 ASP.? 23.47 NI NI B 305 A 56 ILE B 109 ILE^? 15.30 NI NI B 305 A 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 15 3 # 15 A 37 ASP B 196 ASP.? 23.47 NI NI B 305 A 56 ILE B 199 ILE^? 15.49 NI NI B 305 A 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -12.96 -13.26 -68.21 -13.86 -13.32 -69.21 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 16 3 # 16 A 37 ASP B 197 ASP.? 18.81 NI NI B 305 A 56 ILE B 107 ILE^? 13.43 NI NI B 305 A 82 TYR B 57 TYR^? 15.35 NI NI B 305 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -18.04 -8.82 -64.77 -18.90 -9.68 -65.56 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 16 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 41 ASP.? 21.30 CA CA A 306 B 56 ILE A 107 ILE^? 13.32 NI NI A 304 B 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -19.31 4.74 -15.42 -20.27 5.32 -14.56 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP A 41 ASP.? 21.30 CA CA A 306 B 56 ILE A 109 ILE^? 11.54 CA CA A 306 B 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 3 3 # 3 B 37 ASP A 41 ASP.? 21.30 CA CA A 306 B 56 ILE A 109 ILE^? 11.54 CA CA A 306 B 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 4 3 # 4 B 37 ASP A 42 ASP~? 18.65 NI NI A 304 B 56 ILE A 109 ILE^? 11.54 CA CA A 306 B 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 5 3 # 5 B 37 ASP A 104 ASP^? 11.20 NI NI A 304 B 56 ILE A 126 ILE^? 12.20 NI NI A 304 B 82 TYR A 205 TYR^? 13.62 NI NI A 304 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -16.78 9.37 -33.46 -16.04 10.52 -34.10 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 6 3 # 6 B 37 ASP A 196 ASP.? 6.39 CA CA A 306 B 56 ILE A 109 ILE^? 11.54 CA CA A 306 B 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.77 5.03 -10.72 -15.72 5.58 -9.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 7 3 # 7 B 37 ASP A 196 ASP.? 6.39 CA CA A 306 B 56 ILE A 199 ILE^? 8.46 CA CA A 306 B 82 TYR A 36 TYR~? 7.82 CA CA A 306 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -15.18 9.94 -12.15 -16.16 9.72 -11.19 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 8 3 # 8 B 37 ASP A 197 ASP.? 9.27 CA CA A 306 B 56 ILE A 107 ILE^? 13.32 NI NI A 304 B 82 TYR A 57 TYR^? 15.36 NI NI A 304 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -19.31 4.74 -15.42 -20.27 5.32 -14.56 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 9 3 # 9 B 37 ASP B 41 ASP.? 25.32 NI NI B 305 B 56 ILE B 107 ILE^? 13.43 NI NI B 305 B 82 TYR B 57 TYR^? 15.35 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -18.04 -8.82 -64.77 -18.90 -9.68 -65.56 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 10 3 # 10 B 37 ASP B 41 ASP.? 25.32 NI NI B 305 B 56 ILE B 109 ILE^? 15.30 NI NI B 305 B 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 11 3 # 11 B 37 ASP B 41 ASP.? 25.32 NI NI B 305 B 56 ILE B 109 ILE^? 15.30 NI NI B 305 B 82 TYR B 57 TYR^? 15.35 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 12 3 # 12 B 37 ASP B 42 ASP~? 18.39 NI NI B 305 B 56 ILE B 109 ILE^? 15.30 NI NI B 305 B 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 13 3 # 13 B 37 ASP B 104 ASP^? 11.37 NI NI B 305 B 56 ILE B 126 ILE^? 12.24 NI NI B 305 B 82 TYR B 205 TYR^? 13.71 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -14.34 -12.81 -46.79 -13.20 -13.54 -46.32 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 14 3 # 14 B 37 ASP B 196 ASP.? 23.47 NI NI B 305 B 56 ILE B 109 ILE^? 15.30 NI NI B 305 B 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -13.20 -8.07 -69.65 -13.98 -8.61 -70.69 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 15 3 # 15 B 37 ASP B 196 ASP.? 23.47 NI NI B 305 B 56 ILE B 199 ILE^? 15.49 NI NI B 305 B 82 TYR B 36 TYR~? 20.19 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -12.96 -13.26 -68.21 -13.86 -13.32 -69.21 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 16 3 # 16 B 37 ASP B 197 ASP.? 18.81 NI NI B 305 B 56 ILE B 107 ILE^? 13.43 NI NI B 305 B 82 TYR B 57 TYR^? 15.35 NI NI B 305 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -18.04 -8.82 -64.77 -18.90 -9.68 -65.56 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 16 hits 1d6o_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 172 THR.? 16.78 CA CA A 306 A 156 TYR A 170 TYR^? 15.79 NI NI A 304 A 160 LYS A 142 LYS^? 14.03 NI NI A 304 coo 10.50 56.87 17.73 11.24 57.93 19.43 -5.06 17.25 -19.53 -3.57 17.68 -18.02 coo 11.64 63.07 23.95 11.76 62.47 21.20 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 5.78 61.30 21.65 8.04 62.89 17.54 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 172 THR.? 17.34 NI NI B 305 A 156 TYR B 170 TYR^? 15.66 NI NI B 305 A 160 LYS B 142 LYS^? 13.37 NI NI B 305 coo 10.50 56.87 17.73 11.24 57.93 19.43 -1.14 -18.21 -60.52 0.58 -18.51 -61.81 coo 11.64 63.07 23.95 11.76 62.47 21.20 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 5.78 61.30 21.65 8.04 62.89 17.54 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 121 HIS.? -3.63 NI NI A 304s A 63 HIS A 119 HIS^? -3.69 NI NI A 304s A 89 ASP A 104 ASP^? 11.20 NI NI A 304 coo 49.66 36.74 42.37 48.88 35.30 43.64 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 49.93 35.76 35.94 51.58 36.96 35.47 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 46.15 35.33 47.12 47.46 33.99 46.29 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 1dco_c00 source 1dco DCOH : 1 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 22 HIS~? 21.70 NI NI A 304 A 646 ASP A 21 ASP~? 19.27 CA CA A 301 A 739 GLY A 128 GLY^? 7.35 NI NI A 304 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 11.37 50.89 2.29 11.05 51.63 2.25 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 16 HIS^? 15.81 NI NI B 305 A 646 ASP B 177 ASP^? 17.56 NI NI B 305 A 739 GLY B 137 GLY.? 20.05 NI NI B 305 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 11.37 50.89 2.29 11.05 51.63 2.25 0.49 -18.64 -67.37 0.53 -17.81 -67.38 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 22 HIS~? 22.02 NI NI B 305 A 646 ASP B 21 ASP~? 22.52 NI NI B 305 A 739 GLY B 128 GLY^? 7.45 NI NI B 305 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 11.37 50.89 2.29 11.05 51.63 2.25 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1ddj_c12 source 1ddj PLASMINOGEN : 3 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS B 16 HIS^? 15.81 NI NI B 305 B 646 ASP B 177 ASP^? 17.56 NI NI B 305 B 739 GLY B 137 GLY.? 20.05 NI NI B 305 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 0.49 -18.64 -67.37 0.53 -17.81 -67.38 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 22 HIS~? 22.02 NI NI B 305 B 646 ASP B 21 ASP~? 22.52 NI NI B 305 B 739 GLY B 128 GLY^? 7.45 NI NI B 305 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1ddj_c13 source 1ddj PLASMINOGEN : 2 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 22 HIS~? 21.70 NI NI A 304 C 646 ASP A 21 ASP~? 19.27 CA CA A 301 C 739 GLY A 128 GLY^? 7.35 NI NI A 304 coo 15.33 59.81 59.60 13.98 60.99 60.69 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 16.06 55.72 54.73 15.97 56.49 56.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 9.38 49.29 65.28 9.01 50.03 65.31 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS B 16 HIS^? 15.81 NI NI B 305 C 646 ASP B 177 ASP^? 17.56 NI NI B 305 C 739 GLY B 137 GLY.? 20.05 NI NI B 305 coo 15.33 59.81 59.60 13.98 60.99 60.69 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 16.06 55.72 54.73 15.97 56.49 56.70 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 9.38 49.29 65.28 9.01 50.03 65.31 0.49 -18.64 -67.37 0.53 -17.81 -67.38 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 22 HIS~? 22.02 NI NI B 305 C 646 ASP B 21 ASP~? 22.52 NI NI B 305 C 739 GLY B 128 GLY^? 7.45 NI NI B 305 coo 15.33 59.81 59.60 13.98 60.99 60.69 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 16.06 55.72 54.73 15.97 56.49 56.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 9.38 49.29 65.28 9.01 50.03 65.31 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1ddj_c14 source 1ddj PLASMINOGEN : 3 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 16 HIS^? 15.61 NI NI A 304 D 646 ASP A 177 ASP^? 15.76 CA CA A 306 D 739 GLY A 137 GLY.? 14.81 CA CA A 306 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -2.03 18.07 -12.62 -1.94 17.26 -12.43 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 22 HIS~? 21.70 NI NI A 304 D 646 ASP A 21 ASP~? 19.27 CA CA A 301 D 739 GLY A 128 GLY^? 7.35 NI NI A 304 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 16 HIS^? 15.81 NI NI B 305 D 646 ASP B 177 ASP^? 17.56 NI NI B 305 D 739 GLY B 137 GLY.? 20.05 NI NI B 305 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -27.66 47.32 40.66 -27.81 47.01 41.41 0.49 -18.64 -67.37 0.53 -17.81 -67.38 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 22 HIS~? 22.02 NI NI B 305 D 646 ASP B 21 ASP~? 22.52 NI NI B 305 D 739 GLY B 128 GLY^? 7.45 NI NI B 305 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1ddj_c15 source 1ddj PLASMINOGEN : 4 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 187 HIS^? -3.59 NI NI A 304s A 200 ASP A 163 ASP~? 21.63 NI NI A 304 A 229 LYS A 159 LYS.? 27.24 CA CA A 302 coo 1.13 77.49 40.64 0.62 75.57 39.98 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 0.84 91.24 49.01 2.91 91.61 49.23 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 10.53 97.56 43.71 9.33 93.71 47.17 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 187 HIS^? -3.54 NI NI B 305s A 200 ASP B 163 ASP.? 22.00 NI NI B 305 A 229 LYS B 159 LYS.? 30.31 NI NI B 305 coo 1.13 77.49 40.64 0.62 75.57 39.98 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 0.84 91.24 49.01 2.91 91.61 49.23 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 10.53 97.56 43.71 9.33 93.71 47.17 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 187 HIS^? -3.59 NI NI A 304s B 200 ASP A 163 ASP~? 21.63 NI NI A 304 B 229 LYS A 159 LYS.? 27.24 CA CA A 302 coo 9.24 94.26 88.22 8.02 94.07 89.92 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 17.54 90.31 75.01 17.17 92.01 73.80 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 22.32 101.61 71.64 17.89 98.63 71.55 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 187 HIS^? -3.54 NI NI B 305s B 200 ASP B 163 ASP.? 22.00 NI NI B 305 B 229 LYS B 159 LYS.? 30.31 NI NI B 305 coo 9.24 94.26 88.22 8.02 94.07 89.92 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 17.54 90.31 75.01 17.17 92.01 73.80 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 22.32 101.61 71.64 17.89 98.63 71.55 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 187 HIS^? -3.59 NI NI A 304s C 200 ASP A 163 ASP~? 21.63 NI NI A 304 C 229 LYS A 159 LYS.? 27.24 CA CA A 302 coo 26.77 65.84 83.49 27.06 67.76 84.27 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 19.52 52.01 79.59 20.28 51.65 77.65 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 28.90 45.91 73.55 25.22 49.72 72.97 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 187 HIS^? -3.54 NI NI B 305s C 200 ASP B 163 ASP.? 22.00 NI NI B 305 C 229 LYS B 159 LYS.? 30.31 NI NI B 305 coo 26.77 65.84 83.49 27.06 67.76 84.27 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 19.52 52.01 79.59 20.28 51.65 77.65 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 28.90 45.91 73.55 25.22 49.72 72.97 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 187 HIS^? -3.59 NI NI A 304s D 200 ASP A 163 ASP~? 21.63 NI NI A 304 D 229 LYS A 159 LYS.? 27.24 CA CA A 302 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 4.60 52.95 52.50 5.57 51.29 53.40 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 10.05 41.79 49.80 7.94 44.71 53.76 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 187 HIS^? -3.54 NI NI B 305s D 200 ASP B 163 ASP.? 22.00 NI NI B 305 D 229 LYS B 159 LYS.? 30.31 NI NI B 305 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 4.60 52.95 52.50 5.57 51.29 53.40 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 10.05 41.79 49.80 7.94 44.71 53.76 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 170 TYR^? 15.79 NI NI A 304 A 138 ARG A 166 ARG~? 23.27 NI NI A 304 A 161 LYS A 142 LYS^? 14.03 NI NI A 304 coo 29.03 88.95 86.80 28.09 90.57 84.75 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 23.31 93.18 82.88 23.00 93.71 79.86 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 33.83 91.15 88.62 31.07 91.06 83.02 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 170 TYR^? 15.66 NI NI B 305 A 138 ARG B 166 ARG.? 22.37 NI NI B 305 A 161 LYS B 142 LYS^? 13.37 NI NI B 305 coo 29.03 88.95 86.80 28.09 90.57 84.75 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 23.31 93.18 82.88 23.00 93.71 79.86 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 170 TYR^? 15.79 NI NI A 304 B 138 ARG A 166 ARG~? 23.27 NI NI A 304 B 161 LYS A 142 LYS^? 14.03 NI NI A 304 coo 4.62 122.69 99.88 5.46 122.82 97.24 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 10.44 122.27 94.08 11.02 123.87 91.53 5.93 17.15 -30.01 7.54 17.94 -27.52 coo -0.17 119.75 99.65 2.51 123.83 95.70 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 170 TYR^? 15.66 NI NI B 305 B 138 ARG B 166 ARG.? 22.37 NI NI B 305 B 161 LYS B 142 LYS^? 13.37 NI NI B 305 coo 4.62 122.69 99.88 5.46 122.82 97.24 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 10.44 122.27 94.08 11.02 123.87 91.53 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 129 THR^? 6.33 NI NI A 304 A 45 THR A 130 THR^? 12.91 NI NI A 304 A 161 LYS A 142 LYS^? 14.03 NI NI A 304 coo 26.16 88.25 79.16 25.22 89.47 80.71 -14.59 10.44 -23.35 -13.12 9.26 -22.29 coo 27.73 89.90 76.08 29.24 91.46 75.95 -16.25 13.13 -21.25 -18.28 13.57 -20.56 coo 33.83 91.15 88.62 31.07 91.06 83.02 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 130 THR^? 12.91 NI NI A 304 A 45 THR A 129 THR^? 6.33 NI NI A 304 A 161 LYS A 78 LYS~? 23.27 CA CA A 301 coo 26.16 88.25 79.16 25.22 89.47 80.71 -16.25 13.13 -21.25 -18.28 13.57 -20.56 coo 27.73 89.90 76.08 29.24 91.46 75.95 -14.59 10.44 -23.35 -13.12 9.26 -22.29 coo 33.83 91.15 88.62 31.07 91.06 83.02 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR B 129 THR^? 6.57 NI NI B 305 A 45 THR B 130 THR^? 13.17 NI NI B 305 A 161 LYS B 142 LYS^? 13.37 NI NI B 305 coo 26.16 88.25 79.16 25.22 89.47 80.71 -12.09 -13.33 -57.01 -10.85 -11.92 -58.13 coo 27.73 89.90 76.08 29.24 91.46 75.95 -13.11 -16.31 -59.13 -14.98 -17.32 -59.67 coo 33.83 91.15 88.62 31.07 91.06 83.02 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR B 130 THR^? 13.17 NI NI B 305 A 45 THR B 129 THR^? 6.57 NI NI B 305 A 161 LYS B 78 LYS~? 25.94 CA CA B 303 coo 26.16 88.25 79.16 25.22 89.47 80.71 -13.11 -16.31 -59.13 -14.98 -17.32 -59.67 coo 27.73 89.90 76.08 29.24 91.46 75.95 -12.09 -13.33 -57.01 -10.85 -11.92 -58.13 coo 33.83 91.15 88.62 31.07 91.06 83.02 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 4 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 129 THR^? 6.33 NI NI A 304 B 45 THR A 130 THR^? 12.91 NI NI A 304 B 161 LYS A 142 LYS^? 14.03 NI NI A 304 coo 7.39 128.28 94.56 8.34 126.36 94.79 -14.59 10.44 -23.35 -13.12 9.26 -22.29 coo 5.75 129.25 91.25 4.29 128.16 90.07 -16.25 13.13 -21.25 -18.28 13.57 -20.56 coo -0.17 119.75 99.65 2.51 123.83 95.70 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 130 THR^? 12.91 NI NI A 304 B 45 THR A 129 THR^? 6.33 NI NI A 304 B 161 LYS A 78 LYS~? 23.27 CA CA A 301 coo 7.39 128.28 94.56 8.34 126.36 94.79 -16.25 13.13 -21.25 -18.28 13.57 -20.56 coo 5.75 129.25 91.25 4.29 128.16 90.07 -14.59 10.44 -23.35 -13.12 9.26 -22.29 coo -0.17 119.75 99.65 2.51 123.83 95.70 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR B 129 THR^? 6.57 NI NI B 305 B 45 THR B 130 THR^? 13.17 NI NI B 305 B 161 LYS B 142 LYS^? 13.37 NI NI B 305 coo 7.39 128.28 94.56 8.34 126.36 94.79 -12.09 -13.33 -57.01 -10.85 -11.92 -58.13 coo 5.75 129.25 91.25 4.29 128.16 90.07 -13.11 -16.31 -59.13 -14.98 -17.32 -59.67 coo -0.17 119.75 99.65 2.51 123.83 95.70 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR B 130 THR^? 13.17 NI NI B 305 B 45 THR B 129 THR^? 6.57 NI NI B 305 B 161 LYS B 78 LYS~? 25.94 CA CA B 303 coo 7.39 128.28 94.56 8.34 126.36 94.79 -13.11 -16.31 -59.13 -14.98 -17.32 -59.67 coo 5.75 129.25 91.25 4.29 128.16 90.07 -12.09 -13.33 -57.01 -10.85 -11.92 -58.13 coo -0.17 119.75 99.65 2.51 123.83 95.70 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 4 hits 1dhp_c03 naa= 3 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 1 3 # 1 A 48 ALA A 17 ALA^? 18.31 NI NI A 304 A 52 HIS A 83 HIS~? 17.38 NI NI A 304 A 191 TRP A 181 TRP^? 6.14 NI NI A 304 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -14.68 21.22 -26.29 -15.64 21.37 -27.47 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -10.21 8.07 -30.50 -11.08 9.23 -26.84 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 2 3 # 2 A 48 ALA A 117 ALA^? 9.93 NI NI A 304 A 52 HIS A 116 HIS^? 7.23 NI NI A 304 A 191 TRP A 181 TRP^? 6.14 NI NI A 304 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -3.31 -0.27 -21.61 -3.23 -1.78 -21.83 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -10.21 8.07 -30.50 -11.08 9.23 -26.84 ULMN 3 1dj1_c00 CYTOCHROME C PEROXIDASE user 3 3 # 3 A 48 ALA B 17 ALA^? 18.38 NI NI B 305 A 52 HIS B 83 HIS~? 17.68 NI NI B 305 A 191 TRP B 181 TRP^? 6.22 NI NI B 305 coo 0.32 19.13 2.10 -0.45 20.12 1.22 -9.66 -23.82 -53.96 -10.57 -24.14 -52.79 coo 0.08 14.87 -2.02 -1.94 15.16 -2.48 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -12.27 21.19 4.26 -8.94 21.66 2.22 -8.35 -10.18 -50.01 -8.71 -11.53 -53.69 1dj1_c00 source 1dj1 CYTOCHROME C PEROXIDASE : 3 hits 1dj1_c00 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 83 HIS~? 17.38 NI NI A 304 E 102 ASP A 21 ASP~? 19.27 CA CA A 301 E 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 11.39 26.86 25.95 9.85 26.64 27.36 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 4.57 20.60 30.29 4.74 21.36 30.66 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS A 83 HIS~? 17.38 NI NI A 304 E 102 ASP A 81 ASP~? 18.70 NI NI A 304 E 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 11.39 26.86 25.95 9.85 26.64 27.36 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 10.90 32.83 25.96 10.83 30.68 25.98 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 4.57 20.60 30.29 4.74 21.36 30.66 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 3 3 # 3 E 57 HIS B 83 HIS~? 17.68 NI NI B 305 E 102 ASP B 21 ASP~? 22.52 NI NI B 305 E 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 11.39 26.86 25.95 9.85 26.64 27.36 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 10.90 32.83 25.96 10.83 30.68 25.98 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 4.57 20.60 30.29 4.74 21.36 30.66 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 3 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 47 GLY~? 21.14 NI NI A 304 B 144 GLU A 50 GLU~? 22.49 CA CA A 302 B 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 88.87 114.43 152.30 88.45 115.15 152.32 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 85.20 111.99 152.05 86.60 110.89 150.91 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 88.14 113.46 145.73 86.79 113.92 147.30 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY A 47 GLY~? 21.14 NI NI A 304 B 144 GLU A 51 GLU~? 19.07 CA CA B 303 B 164 GLU A 50 GLU~? 22.49 CA CA A 302 coo 88.87 114.43 152.30 88.45 115.15 152.32 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 85.20 111.99 152.05 86.60 110.89 150.91 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 88.14 113.46 145.73 86.79 113.92 147.30 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 3 3 # 3 B 141 GLY B 47 GLY~? 21.31 NI NI B 305 B 144 GLU B 51 GLU~? 22.61 NI NI B 305 B 164 GLU B 50 GLU~? 24.18 NI NI B 305 coo 88.87 114.43 152.30 88.45 115.15 152.32 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 85.20 111.99 152.05 86.60 110.89 150.91 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 88.14 113.46 145.73 86.79 113.92 147.30 -13.23 5.78 -74.13 -14.26 6.16 -75.95 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 47 GLY~? 21.14 NI NI A 304 C 144 GLU A 50 GLU~? 22.49 CA CA A 302 C 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 56.28 104.55 135.84 56.09 105.34 136.05 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 58.46 103.90 139.48 57.57 102.00 139.16 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 51.71 102.03 140.09 53.02 103.62 140.54 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY A 47 GLY~? 21.14 NI NI A 304 C 144 GLU A 51 GLU~? 19.07 CA CA B 303 C 164 GLU A 50 GLU~? 22.49 CA CA A 302 coo 56.28 104.55 135.84 56.09 105.34 136.05 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 58.46 103.90 139.48 57.57 102.00 139.16 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 51.71 102.03 140.09 53.02 103.62 140.54 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 3 3 # 3 C 141 GLY B 47 GLY~? 21.31 NI NI B 305 C 144 GLU B 51 GLU~? 22.61 NI NI B 305 C 164 GLU B 50 GLU~? 24.18 NI NI B 305 coo 56.28 104.55 135.84 56.09 105.34 136.05 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 58.46 103.90 139.48 57.57 102.00 139.16 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 51.71 102.03 140.09 53.02 103.62 140.54 -13.23 5.78 -74.13 -14.26 6.16 -75.95 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 47 GLY~? 21.14 NI NI A 304 D 144 GLU A 50 GLU~? 22.49 CA CA A 302 D 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 86.19 80.64 132.77 86.38 79.85 132.93 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 84.75 81.24 136.88 85.62 83.14 136.43 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 91.47 83.05 136.24 90.35 81.38 136.84 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY A 47 GLY~? 21.14 NI NI A 304 D 144 GLU A 51 GLU~? 19.07 CA CA B 303 D 164 GLU A 50 GLU~? 22.49 CA CA A 302 coo 86.19 80.64 132.77 86.38 79.85 132.93 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 84.75 81.24 136.88 85.62 83.14 136.43 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 91.47 83.05 136.24 90.35 81.38 136.84 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 3 3 # 3 D 141 GLY B 47 GLY~? 21.31 NI NI B 305 D 144 GLU B 51 GLU~? 22.61 NI NI B 305 D 164 GLU B 50 GLU~? 24.18 NI NI B 305 coo 86.19 80.64 132.77 86.38 79.85 132.93 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 84.75 81.24 136.88 85.62 83.14 136.43 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 91.47 83.05 136.24 90.35 81.38 136.84 -13.23 5.78 -74.13 -14.26 6.16 -75.95 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 47 GLY~? 21.14 NI NI A 304 E 144 GLU A 50 GLU~? 22.49 CA CA A 302 E 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 90.07 81.07 170.50 90.23 80.26 170.38 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 87.05 81.30 167.53 86.38 82.74 168.94 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 84.40 80.02 173.80 85.08 79.06 172.03 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY A 47 GLY~? 21.14 NI NI A 304 E 144 GLU A 51 GLU~? 19.07 CA CA B 303 E 164 GLU A 50 GLU~? 22.49 CA CA A 302 coo 90.07 81.07 170.50 90.23 80.26 170.38 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 87.05 81.30 167.53 86.38 82.74 168.94 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 84.40 80.02 173.80 85.08 79.06 172.03 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 3 3 # 3 E 141 GLY B 47 GLY~? 21.31 NI NI B 305 E 144 GLU B 51 GLU~? 22.61 NI NI B 305 E 164 GLU B 50 GLU~? 24.18 NI NI B 305 coo 90.07 81.07 170.50 90.23 80.26 170.38 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 87.05 81.30 167.53 86.38 82.74 168.94 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 84.40 80.02 173.80 85.08 79.06 172.03 -13.23 5.78 -74.13 -14.26 6.16 -75.95 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 47 GLY~? 21.14 NI NI A 304 F 144 GLU A 50 GLU~? 22.49 CA CA A 302 F 164 GLU A 51 GLU~? 19.07 CA CA B 303 coo 57.12 70.68 155.10 57.52 69.95 155.02 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 60.62 73.13 154.21 59.05 74.26 153.35 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 56.75 71.71 148.46 58.44 71.01 149.54 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY A 47 GLY~? 21.14 NI NI A 304 F 144 GLU A 51 GLU~? 19.07 CA CA B 303 F 164 GLU A 50 GLU~? 22.49 CA CA A 302 coo 57.12 70.68 155.10 57.52 69.95 155.02 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 60.62 73.13 154.21 59.05 74.26 153.35 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 56.75 71.71 148.46 58.44 71.01 149.54 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 3 3 # 3 F 141 GLY B 47 GLY~? 21.31 NI NI B 305 F 144 GLU B 51 GLU~? 22.61 NI NI B 305 F 164 GLU B 50 GLU~? 24.18 NI NI B 305 coo 57.12 70.68 155.10 57.52 69.95 155.02 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 60.62 73.13 154.21 59.05 74.26 153.35 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 56.75 71.71 148.46 58.44 71.01 149.54 -13.23 5.78 -74.13 -14.26 6.16 -75.95 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 3 hits 1dub_c17 naa= 3 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 79 SER~? 16.97 CA CA A 301 A 208 ASP A 21 ASP~? 19.27 CA CA A 301 A 236 HIS A 22 HIS~? 21.70 NI NI A 304 coo 49.19 42.85 125.39 50.92 43.54 123.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 57.80 42.94 129.59 56.47 43.28 127.93 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 55.54 41.70 125.00 53.71 42.50 124.53 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER A 79 SER~? 16.97 CA CA A 301 A 208 ASP A 21 ASP~? 19.27 CA CA A 301 A 236 HIS A 83 HIS~? 17.38 NI NI A 304 coo 49.19 42.85 125.39 50.92 43.54 123.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 57.80 42.94 129.59 56.47 43.28 127.93 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 55.54 41.70 125.00 53.71 42.50 124.53 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER B 79 SER~? 19.41 NI NI B 305 A 208 ASP B 21 ASP~? 22.52 NI NI B 305 A 236 HIS B 22 HIS~? 22.02 NI NI B 305 coo 49.19 42.85 125.39 50.92 43.54 123.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 57.80 42.94 129.59 56.47 43.28 127.93 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 55.54 41.70 125.00 53.71 42.50 124.53 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1dwo_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER B 79 SER~? 19.41 NI NI B 305 A 208 ASP B 21 ASP~? 22.52 NI NI B 305 A 236 HIS B 83 HIS~? 17.68 NI NI B 305 coo 49.19 42.85 125.39 50.92 43.54 123.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 57.80 42.94 129.59 56.47 43.28 127.93 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 55.54 41.70 125.00 53.71 42.50 124.53 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1dwo_c00 source 1dwo HYDROXYNITRILE LYASE : 4 hits 1dwo_c00 naa= 3 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 1 3 # 1 B 80 SER A 79 SER~? 16.97 CA CA A 301 B 208 ASP A 21 ASP~? 19.27 CA CA A 301 B 236 HIS A 22 HIS~? 21.70 NI NI A 304 coo 55.25 19.46 97.60 53.04 19.32 98.76 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 57.34 11.46 102.30 56.11 13.10 101.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 55.03 16.17 103.08 54.39 17.23 101.45 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 2 3 # 2 B 80 SER A 79 SER~? 16.97 CA CA A 301 B 208 ASP A 21 ASP~? 19.27 CA CA A 301 B 236 HIS A 83 HIS~? 17.38 NI NI A 304 coo 55.25 19.46 97.60 53.04 19.32 98.76 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 57.34 11.46 102.30 56.11 13.10 101.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 55.03 16.17 103.08 54.39 17.23 101.45 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 3 3 # 3 B 80 SER B 79 SER~? 19.41 NI NI B 305 B 208 ASP B 21 ASP~? 22.52 NI NI B 305 B 236 HIS B 22 HIS~? 22.02 NI NI B 305 coo 55.25 19.46 97.60 53.04 19.32 98.76 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 57.34 11.46 102.30 56.11 13.10 101.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 55.03 16.17 103.08 54.39 17.23 101.45 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1dwo_c01 HYDROXYNITRILE LYASE user 4 3 # 4 B 80 SER B 79 SER~? 19.41 NI NI B 305 B 208 ASP B 21 ASP~? 22.52 NI NI B 305 B 236 HIS B 83 HIS~? 17.68 NI NI B 305 coo 55.25 19.46 97.60 53.04 19.32 98.76 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 57.34 11.46 102.30 56.11 13.10 101.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 55.03 16.17 103.08 54.39 17.23 101.45 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1dwo_c01 source 1dwo HYDROXYNITRILE LYASE : 4 hits 1dwo_c01 naa= 3 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 60 TYR.? 8.44 NI NI A 304 A 40 ASP A 65 ASP~? 19.57 CA CA B 303 A 103 ASP A 104 ASP^? 11.20 NI NI A 304 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1e3v_c02 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR B 60 TYR.? 9.06 NI NI B 305 A 40 ASP B 65 ASP~? 20.64 NI NI B 305 A 103 ASP B 104 ASP^? 11.37 NI NI B 305 coo 3.86 -20.80 85.74 4.58 -18.11 85.73 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 coo 8.98 -11.19 82.60 6.87 -11.00 82.49 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 5.15 -17.92 79.35 5.03 -16.26 80.65 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 1e3v_c02 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c02 naa= 3 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 60 TYR.? 8.44 NI NI A 304 B 40 ASP A 65 ASP~? 19.57 CA CA B 303 B 103 ASP A 104 ASP^? 11.20 NI NI A 304 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1e3v_c03 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR B 60 TYR.? 9.06 NI NI B 305 B 40 ASP B 65 ASP~? 20.64 NI NI B 305 B 103 ASP B 104 ASP^? 11.37 NI NI B 305 coo 4.95 -16.38 58.56 5.78 -19.05 58.68 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 coo 9.81 -26.10 62.11 7.73 -26.45 62.06 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 5.71 -19.27 64.99 5.64 -20.90 63.63 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 1e3v_c03 source 1e3v STEROID DELTA-ISOMERASE : 2 hits 1e3v_c03 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 119 HIS^? -3.69 NI NI A 304s B 43 HIS A 187 HIS^? -3.59 NI NI A 304s B 65 GLU A 144 GLU^? 14.15 NI NI A 304 coo 20.15 22.08 34.36 20.84 20.10 34.21 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 19.55 18.91 30.27 18.21 18.65 31.84 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 10.90 21.31 28.81 12.14 22.15 30.31 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS B 119 HIS^? -3.53 NI NI B 305s B 43 HIS B 187 HIS^? -3.54 NI NI B 305s B 65 GLU B 144 GLU^? 13.93 NI NI B 305 coo 20.15 22.08 34.36 20.84 20.10 34.21 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 19.55 18.91 30.27 18.21 18.65 31.84 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 10.90 21.31 28.81 12.14 22.15 30.31 2.78 -5.24 -49.99 3.13 -3.29 -50.74 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS B 121 HIS.? -3.60 NI NI B 305s B 43 HIS B 119 HIS^? -3.53 NI NI B 305s B 65 GLU B 188 GLU^? 11.04 NI NI B 305 coo 20.15 22.08 34.36 20.84 20.10 34.21 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 19.55 18.91 30.27 18.21 18.65 31.84 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 10.90 21.31 28.81 12.14 22.15 30.31 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS B 121 HIS.? -3.60 NI NI B 305s B 43 HIS B 187 HIS^? -3.54 NI NI B 305s B 65 GLU B 188 GLU^? 11.04 NI NI B 305 coo 20.15 22.08 34.36 20.84 20.10 34.21 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 19.55 18.91 30.27 18.21 18.65 31.84 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 10.90 21.31 28.81 12.14 22.15 30.31 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 4 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 140 ALA.? 11.16 NI NI A 304 A 136 TYR A 170 TYR^? 15.79 NI NI A 304 A 140 LYS A 142 LYS^? 14.03 NI NI A 304 coo 55.90 7.49 23.83 56.71 8.23 22.76 -5.86 11.67 -18.64 -7.20 12.33 -18.40 coo 59.38 10.02 17.51 59.95 9.89 20.21 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 59.52 3.69 18.67 62.31 6.19 22.58 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 140 ALA.? 11.62 NI NI B 305 A 136 TYR B 170 TYR^? 15.66 NI NI B 305 A 140 LYS B 142 LYS^? 13.37 NI NI B 305 coo 55.90 7.49 23.83 56.71 8.23 22.76 -3.13 -13.00 -61.85 -4.31 -13.89 -62.21 coo 59.38 10.02 17.51 59.95 9.89 20.21 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 59.52 3.69 18.67 62.31 6.19 22.58 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 2 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 196 ASP.? 6.39 CA CA A 306 A 35 SER A 194 SER.? 9.10 CA CA A 302 A 218 ASP A 197 ASP.? 9.27 CA CA A 306 coo 47.22 22.34 8.57 45.16 22.02 9.13 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 43.58 20.85 5.15 44.62 23.01 5.76 -3.34 11.88 -6.70 -5.38 12.98 -7.40 coo 44.05 16.99 12.67 44.05 18.89 11.74 -12.14 8.73 -7.75 -12.16 7.25 -6.26 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP A 197 ASP.? 9.27 CA CA A 306 A 35 SER A 133 SER.? 4.86 CA CA A 306 A 218 ASP A 196 ASP.? 6.39 CA CA A 306 coo 47.22 22.34 8.57 45.16 22.02 9.13 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 43.58 20.85 5.15 44.62 23.01 5.76 -13.59 14.24 -12.04 -13.08 13.73 -9.72 coo 44.05 16.99 12.67 44.05 18.89 11.74 -9.18 12.61 -5.36 -9.90 13.29 -3.47 1eag_c04 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c04 naa= 3 ULMN 3 1ecf_c00 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 A 1 CYH B 49 CYH~? 14.83 NI NI B 305 A 101 ASN B 52 ASN~? 15.59 NI NI B 305 A 102 GLY B 53 GLY~? 17.62 NI NI B 305 coo 71.16 56.96 42.22 68.62 58.09 42.46 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 72.93 61.40 42.14 73.34 60.57 44.12 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 70.24 64.11 45.02 69.59 63.75 44.65 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1ecf_c00 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 1 hits 1ecf_c00 naa= 3 ULMN 3 1ecf_c01 GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATuser 1 3 # 1 B 1 CYH B 49 CYH~? 14.83 NI NI B 305 B 101 ASN B 52 ASN~? 15.59 NI NI B 305 B 102 GLY B 53 GLY~? 17.62 NI NI B 305 coo 75.18 21.70 37.98 75.10 20.53 35.34 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 75.17 17.26 39.63 77.17 18.02 39.88 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 77.89 14.61 36.82 77.45 14.93 36.19 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1ecf_c01 source 1ecf GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRA: 1 hits 1ecf_c01 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 16 HIS^? 15.61 NI NI A 304 B 177 ASP A 177 ASP^? 15.76 CA CA A 306 B 203 LYS A 142 LYS^? 14.03 NI NI A 304 coo 14.87 88.04 21.51 13.64 87.90 19.81 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 15.87 92.46 27.37 14.46 91.76 25.94 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 3.60 91.42 23.52 8.20 89.55 22.63 -1.82 9.73 -24.13 2.97 5.99 -23.26 1ecx_c03 source 1ecx AMINOTRANSFERASE : 1 hits 1ecx_c03 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 177 ASP^? 15.76 CA CA A 306 B 246 ASP A 90 ASP~? 20.31 NI NI A 304 B 275 HIS A 16 HIS^? 15.61 NI NI A 304 coo 34.84 56.77 81.62 34.95 54.74 82.03 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 43.18 49.30 68.39 44.75 49.87 69.78 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 38.73 55.10 77.62 36.80 55.01 78.46 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP A 177 ASP^? 15.76 CA CA A 306 B 246 ASP A 163 ASP~? 21.63 NI NI A 304 B 275 HIS A 16 HIS^? 15.61 NI NI A 304 coo 34.84 56.77 81.62 34.95 54.74 82.03 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 43.18 49.30 68.39 44.75 49.87 69.78 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 38.73 55.10 77.62 36.80 55.01 78.46 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 B 107 ASP B 177 ASP^? 17.56 NI NI B 305 B 246 ASP B 90 ASP~? 18.88 CA CA B 303 B 275 HIS B 16 HIS^? 15.81 NI NI B 305 coo 34.84 56.77 81.62 34.95 54.74 82.03 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 43.18 49.30 68.39 44.75 49.87 69.78 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 38.73 55.10 77.62 36.80 55.01 78.46 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 B 107 ASP B 177 ASP^? 17.56 NI NI B 305 B 246 ASP B 163 ASP.? 22.00 NI NI B 305 B 275 HIS B 16 HIS^? 15.81 NI NI B 305 coo 34.84 56.77 81.62 34.95 54.74 82.03 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 43.18 49.30 68.39 44.75 49.87 69.78 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 38.73 55.10 77.62 36.80 55.01 78.46 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 4 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 177 ASP^? 15.76 CA CA A 306 C 246 ASP A 90 ASP~? 20.31 NI NI A 304 C 275 HIS A 16 HIS^? 15.61 NI NI A 304 coo 1.90 35.26 72.76 3.20 35.74 71.18 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 12.03 20.33 71.56 10.48 19.25 70.56 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 3.92 29.96 71.75 4.22 31.96 72.31 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP A 177 ASP^? 15.76 CA CA A 306 C 246 ASP A 163 ASP~? 21.63 NI NI A 304 C 275 HIS A 16 HIS^? 15.61 NI NI A 304 coo 1.90 35.26 72.76 3.20 35.74 71.18 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 12.03 20.33 71.56 10.48 19.25 70.56 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 3.92 29.96 71.75 4.22 31.96 72.31 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 C 107 ASP B 177 ASP^? 17.56 NI NI B 305 C 246 ASP B 90 ASP~? 18.88 CA CA B 303 C 275 HIS B 16 HIS^? 15.81 NI NI B 305 coo 1.90 35.26 72.76 3.20 35.74 71.18 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 12.03 20.33 71.56 10.48 19.25 70.56 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 3.92 29.96 71.75 4.22 31.96 72.31 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 C 107 ASP B 177 ASP^? 17.56 NI NI B 305 C 246 ASP B 163 ASP.? 22.00 NI NI B 305 C 275 HIS B 16 HIS^? 15.81 NI NI B 305 coo 1.90 35.26 72.76 3.20 35.74 71.18 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 12.03 20.33 71.56 10.48 19.25 70.56 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 3.92 29.96 71.75 4.22 31.96 72.31 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 4 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 177 ASP^? 15.76 CA CA A 306 D 246 ASP A 90 ASP~? 20.31 NI NI A 304 D 275 HIS A 16 HIS^? 15.61 NI NI A 304 coo 37.41 19.89 81.58 37.64 21.98 81.53 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 23.50 26.43 88.52 24.76 26.47 90.29 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 33.16 21.44 85.29 34.07 21.53 83.40 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP A 177 ASP^? 15.76 CA CA A 306 D 246 ASP A 163 ASP~? 21.63 NI NI A 304 D 275 HIS A 16 HIS^? 15.61 NI NI A 304 coo 37.41 19.89 81.58 37.64 21.98 81.53 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 23.50 26.43 88.52 24.76 26.47 90.29 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 33.16 21.44 85.29 34.07 21.53 83.40 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 3 3 # 3 D 107 ASP B 177 ASP^? 17.56 NI NI B 305 D 246 ASP B 90 ASP~? 18.88 CA CA B 303 D 275 HIS B 16 HIS^? 15.81 NI NI B 305 coo 37.41 19.89 81.58 37.64 21.98 81.53 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 23.50 26.43 88.52 24.76 26.47 90.29 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 33.16 21.44 85.29 34.07 21.53 83.40 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 4 3 # 4 D 107 ASP B 177 ASP^? 17.56 NI NI B 305 D 246 ASP B 163 ASP.? 22.00 NI NI B 305 D 275 HIS B 16 HIS^? 15.81 NI NI B 305 coo 37.41 19.89 81.58 37.64 21.98 81.53 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 23.50 26.43 88.52 24.76 26.47 90.29 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 33.16 21.44 85.29 34.07 21.53 83.40 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 4 hits 1ehy_c03 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 16 HIS^? 15.61 NI NI A 304 A 197 ASP A 177 ASP^? 15.76 CA CA A 306 A 223 LYS A 142 LYS^? 14.03 NI NI A 304 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -1.82 9.73 -24.13 2.97 5.99 -23.26 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 1 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 16 HIS^? 15.61 NI NI A 304 B 197 ASP A 177 ASP^? 15.76 CA CA A 306 B 223 LYS A 142 LYS^? 14.03 NI NI A 304 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -1.82 9.73 -24.13 2.97 5.99 -23.26 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 1 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 145 ASP.? 18.22 NI NI A 304 153 ARG A 147 ARG~? 21.93 NI NI A 304 177 HIS A 148 HIS~? 18.59 NI NI A 304 coo 6.83 2.75 19.17 7.40 0.75 19.11 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 1.78 0.50 17.43 2.55 -2.31 16.44 1.99 9.46 -40.00 3.54 12.00 -39.24 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP B 145 ASP.? 18.27 NI NI B 305 153 ARG B 147 ARG.? 21.34 NI NI B 305 177 HIS B 148 HIS.? 18.38 NI NI B 305 coo 6.83 2.75 19.17 7.40 0.75 19.11 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 1.78 0.50 17.43 2.55 -2.31 16.44 3.78 -8.72 -40.00 5.97 -10.16 -41.63 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 6.24 -3.74 -47.54 7.83 -3.67 -48.90 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 2 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 82 ALA~? 21.17 NI NI A 304 A 257 ALA A 85 ALA~? 20.35 NI NI A 304 A 328 ASP A 90 ASP~? 20.31 NI NI A 304 coo 39.84 24.12 8.44 38.50 24.23 9.11 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.57 18.81 -37.83 -12.52 19.38 -37.82 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 82 ALA~? 21.17 NI NI A 304 A 257 ALA A 86 ALA~? 20.62 NI NI A 304 A 328 ASP A 21 ASP~? 19.27 CA CA A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 38.17 34.10 6.67 37.72 32.06 6.84 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 85 ALA~? 20.35 NI NI A 304 A 257 ALA A 82 ALA~? 21.17 NI NI A 304 A 328 ASP A 21 ASP~? 19.27 CA CA A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 85 ALA~? 20.35 NI NI A 304 A 257 ALA A 86 ALA~? 20.62 NI NI A 304 A 328 ASP A 21 ASP~? 19.27 CA CA A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 38.17 34.10 6.67 37.72 32.06 6.84 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 86 ALA~? 20.62 NI NI A 304 A 257 ALA A 82 ALA~? 21.17 NI NI A 304 A 328 ASP A 21 ASP~? 19.27 CA CA A 301 coo 39.84 24.12 8.44 38.50 24.23 9.11 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 43.22 26.73 5.37 41.81 27.09 5.79 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 88 ALA~? 18.79 NI NI A 304 A 257 ALA A 86 ALA~? 20.62 NI NI A 304 A 328 ASP A 81 ASP~? 18.70 NI NI A 304 coo 39.84 24.12 8.44 38.50 24.23 9.11 -18.23 14.39 -38.25 -19.54 13.62 -38.30 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 38.17 34.10 6.67 37.72 32.06 6.84 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 99 ALA.? 22.23 NI NI A 304 A 257 ALA A 208 ALA.? 21.69 NI NI A 304 A 328 ASP A 96 ASP.? 21.09 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -26.43 9.74 -38.92 -27.39 10.53 -38.03 coo 43.22 26.73 5.37 41.81 27.09 5.79 -25.95 3.08 -39.32 -27.21 3.87 -38.98 coo 38.17 34.10 6.67 37.72 32.06 6.84 -25.65 8.23 -47.38 -24.09 7.78 -48.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 208 ALA.? 21.69 NI NI A 304 A 257 ALA A 99 ALA.? 22.23 NI NI A 304 A 328 ASP A 96 ASP.? 21.09 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -25.95 3.08 -39.32 -27.21 3.87 -38.98 coo 43.22 26.73 5.37 41.81 27.09 5.79 -26.43 9.74 -38.92 -27.39 10.53 -38.03 coo 38.17 34.10 6.67 37.72 32.06 6.84 -25.65 8.23 -47.38 -24.09 7.78 -48.74 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA B 82 ALA~? 21.25 NI NI B 305 A 257 ALA B 85 ALA~? 16.03 CA CA B 303 A 328 ASP B 90 ASP~? 18.88 CA CA B 303 coo 39.84 24.12 8.44 38.50 24.23 9.11 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 43.22 26.73 5.37 41.81 27.09 5.79 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA B 82 ALA~? 21.25 NI NI B 305 A 257 ALA B 86 ALA~? 18.65 CA CA B 303 A 328 ASP B 21 ASP~? 22.52 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA B 85 ALA~? 16.03 CA CA B 303 A 257 ALA B 82 ALA~? 21.25 NI NI B 305 A 328 ASP B 21 ASP~? 22.52 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 85 ALA~? 16.03 CA CA B 303 A 257 ALA B 86 ALA~? 18.65 CA CA B 303 A 328 ASP B 21 ASP~? 22.52 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA B 86 ALA~? 18.65 CA CA B 303 A 257 ALA B 82 ALA~? 21.25 NI NI B 305 A 328 ASP B 21 ASP~? 22.52 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 43.22 26.73 5.37 41.81 27.09 5.79 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 38.17 34.10 6.67 37.72 32.06 6.84 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA B 88 ALA~? 13.21 CA CA B 303 A 257 ALA B 86 ALA~? 18.65 CA CA B 303 A 328 ASP B 81 ASP~? 18.56 NI NI B 305 coo 39.84 24.12 8.44 38.50 24.23 9.11 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 38.17 34.10 6.67 37.72 32.06 6.84 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 14 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 139 SER.? 15.61 NI NI A 304 A 140 TYR A 170 TYR^? 15.79 NI NI A 304 A 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 34.67 35.79 48.83 33.57 37.88 49.47 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 29.60 38.99 53.89 30.10 37.88 51.36 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 32.73 32.94 54.42 29.29 32.83 50.35 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER B 139 SER.? 15.78 NI NI B 305 A 140 TYR B 170 TYR^? 15.66 NI NI B 305 A 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 34.67 35.79 48.83 33.57 37.88 49.47 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 29.60 38.99 53.89 30.10 37.88 51.36 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 32.73 32.94 54.42 29.29 32.83 50.35 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 139 SER.? 15.61 NI NI A 304 B 140 TYR A 170 TYR^? 15.79 NI NI A 304 B 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 30.90 35.65 89.60 29.85 37.72 88.83 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 24.43 38.83 86.53 27.07 38.03 86.12 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 25.13 32.62 89.49 27.74 32.61 84.91 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER B 139 SER.? 15.78 NI NI B 305 B 140 TYR B 170 TYR^? 15.66 NI NI B 305 B 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 30.90 35.65 89.60 29.85 37.72 88.83 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 24.43 38.83 86.53 27.07 38.03 86.12 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 25.13 32.62 89.49 27.74 32.61 84.91 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 139 SER.? 15.61 NI NI A 304 C 140 TYR A 170 TYR^? 15.79 NI NI A 304 C 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo -8.96 33.70 98.81 -8.96 35.77 97.56 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo -8.28 37.01 91.79 -6.99 36.16 94.13 1.42 13.38 -22.88 3.34 11.36 -22.90 coo -10.48 30.66 93.19 -5.27 31.07 94.32 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER B 139 SER.? 15.78 NI NI B 305 C 140 TYR B 170 TYR^? 15.66 NI NI B 305 C 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo -8.96 33.70 98.81 -8.96 35.77 97.56 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo -8.28 37.01 91.79 -6.99 36.16 94.13 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo -10.48 30.66 93.19 -5.27 31.07 94.32 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 139 SER.? 15.61 NI NI A 304 D 140 TYR A 170 TYR^? 15.79 NI NI A 304 D 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo -29.80 31.30 63.54 -28.79 33.52 63.37 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo -23.30 35.33 62.20 -25.10 34.24 64.06 1.42 13.38 -22.88 3.34 11.36 -22.90 coo -24.76 28.82 60.31 -24.27 29.01 65.58 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER B 139 SER.? 15.78 NI NI B 305 D 140 TYR B 170 TYR^? 15.66 NI NI B 305 D 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo -29.80 31.30 63.54 -28.79 33.52 63.37 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo -23.30 35.33 62.20 -25.10 34.24 64.06 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo -24.76 28.82 60.31 -24.27 29.01 65.58 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 139 SER.? 15.61 NI NI A 304 E 140 TYR A 170 TYR^? 15.79 NI NI A 304 E 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo -3.01 32.72 32.71 -2.80 34.91 33.79 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 0.04 36.70 38.68 -2.21 35.46 37.50 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 1.93 30.52 36.31 -2.84 30.18 38.54 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER B 139 SER.? 15.78 NI NI B 305 E 140 TYR B 170 TYR^? 15.66 NI NI B 305 E 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo -3.01 32.72 32.71 -2.80 34.91 33.79 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 0.04 36.70 38.68 -2.21 35.46 37.50 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 1.93 30.52 36.31 -2.84 30.18 38.54 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 139 SER.? 15.61 NI NI A 304 F 140 TYR A 170 TYR^? 15.79 NI NI A 304 F 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 55.30 92.46 56.72 55.15 90.39 55.38 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 54.49 89.31 49.65 53.35 90.16 52.06 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 56.78 95.62 51.15 51.59 95.31 52.37 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER B 139 SER.? 15.78 NI NI B 305 F 140 TYR B 170 TYR^? 15.66 NI NI B 305 F 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 55.30 92.46 56.72 55.15 90.39 55.38 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 54.49 89.31 49.65 53.35 90.16 52.06 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 56.78 95.62 51.15 51.59 95.31 52.37 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 139 SER.? 15.61 NI NI A 304 G 140 TYR A 170 TYR^? 15.79 NI NI A 304 G 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 76.25 95.63 21.56 75.29 93.40 21.36 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 69.78 91.62 20.06 71.51 92.68 22.02 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 71.19 98.21 18.32 70.69 97.75 23.67 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER B 139 SER.? 15.78 NI NI B 305 G 140 TYR B 170 TYR^? 15.66 NI NI B 305 G 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 76.25 95.63 21.56 75.29 93.40 21.36 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 69.78 91.62 20.06 71.51 92.68 22.02 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 71.19 98.21 18.32 70.69 97.75 23.67 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 139 SER.? 15.61 NI NI A 304 H 140 TYR A 170 TYR^? 15.79 NI NI A 304 H 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 15.45 90.62 47.70 16.55 88.57 46.97 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 21.92 87.58 44.67 19.30 88.41 44.23 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 21.26 93.70 47.67 18.47 93.68 43.08 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER B 139 SER.? 15.78 NI NI B 305 H 140 TYR B 170 TYR^? 15.66 NI NI B 305 H 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 15.45 90.62 47.70 16.55 88.57 46.97 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 21.92 87.58 44.67 19.30 88.41 44.23 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 21.26 93.70 47.67 18.47 93.68 43.08 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 139 SER.? 15.61 NI NI A 304 I 140 TYR A 170 TYR^? 15.79 NI NI A 304 I 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 11.78 90.82 7.18 12.84 88.72 7.93 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 16.78 87.76 12.19 16.39 88.69 9.59 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 13.67 93.83 12.65 17.08 93.94 8.58 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER B 139 SER.? 15.78 NI NI B 305 I 140 TYR B 170 TYR^? 15.66 NI NI B 305 I 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 11.78 90.82 7.18 12.84 88.72 7.93 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 16.78 87.76 12.19 16.39 88.69 9.59 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 13.67 93.83 12.65 17.08 93.94 8.58 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 139 SER.? 15.61 NI NI A 304 J 140 TYR A 170 TYR^? 15.79 NI NI A 304 J 144 LYS A 142 LYS^? 14.03 NI NI A 304 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER B 139 SER.? 15.78 NI NI B 305 J 140 TYR B 170 TYR^? 15.66 NI NI B 305 J 144 LYS B 142 LYS^? 13.37 NI NI B 305 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 2 hits 1eq2_c09 naa= 3 ULMN 3 1esc_c00 ESTERASE user 1 3 # 1 14 SER A 115 SER.? 13.22 NI NI A 304 280 TRP A 106 TRP^? 6.26 NI NI A 304 283 HIS A 116 HIS^? 7.23 NI NI A 304 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -16.25 2.34 -20.13 -16.29 2.41 -24.07 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1esc_c00 ESTERASE user 2 3 # 2 14 SER A 118 SER^? 9.86 NI NI A 304 280 TRP A 181 TRP^? 6.14 NI NI A 304 283 HIS A 119 HIS^? -3.69 NI NI A 304s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -10.21 8.07 -30.50 -11.08 9.23 -26.84 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -7.63 0.70 -25.42 -8.53 2.19 -24.26 ULMN 3 1esc_c00 ESTERASE user 3 3 # 3 14 SER A 124 SER.? 9.62 NI NI A 304 280 TRP A 106 TRP^? 6.26 NI NI A 304 283 HIS A 121 HIS.? -3.63 NI NI A 304s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -16.25 2.34 -20.13 -16.29 2.41 -24.07 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -12.61 2.09 -28.60 -12.23 2.44 -26.56 ULMN 3 1esc_c00 ESTERASE user 4 3 # 4 14 SER A 124 SER.? 9.62 NI NI A 304 280 TRP B 207 TRP.? 10.18 CA CA B 303 283 HIS A 123 HIS.? 13.29 CA CA B 303 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -20.87 -11.01 -39.41 -19.26 -9.54 -36.14 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 ULMN 3 1esc_c00 ESTERASE user 5 3 # 5 14 SER A 183 SER.? 9.24 NI NI A 304 280 TRP A 106 TRP^? 6.26 NI NI A 304 283 HIS A 121 HIS.? -3.63 NI NI A 304s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -16.25 2.34 -20.13 -16.29 2.41 -24.07 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -12.61 2.09 -28.60 -12.23 2.44 -26.56 ULMN 3 1esc_c00 ESTERASE user 6 3 # 6 14 SER B 115 SER.? 13.16 NI NI B 305 280 TRP B 106 TRP^? 6.34 NI NI B 305 283 HIS B 116 HIS^? 6.69 NI NI B 305 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -15.45 -5.89 -60.07 -15.49 -5.89 -56.14 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 ULMN 3 1esc_c00 ESTERASE user 7 3 # 7 14 SER B 118 SER^? 9.81 NI NI B 305 280 TRP B 181 TRP^? 6.22 NI NI B 305 283 HIS B 119 HIS^? -3.53 NI NI B 305s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -8.35 -10.18 -50.01 -8.71 -11.53 -53.69 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 ULMN 3 1esc_c00 ESTERASE user 8 3 # 8 14 SER B 124 SER.? 10.06 NI NI B 305 280 TRP A 207 TRP^? 21.27 NI NI A 304 283 HIS B 123 HIS.? 14.82 NI NI B 305 coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -23.03 6.23 -40.88 -21.50 5.17 -44.34 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -17.13 0.41 -45.08 -16.63 2.43 -44.85 ULMN 3 1esc_c00 ESTERASE user 9 3 # 9 14 SER B 124 SER.? 10.06 NI NI B 305 280 TRP B 106 TRP^? 6.34 NI NI B 305 283 HIS B 121 HIS.? -3.60 NI NI B 305s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -15.45 -5.89 -60.07 -15.49 -5.89 -56.14 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 ULMN 3 1esc_c00 ESTERASE user 10 3 # 10 14 SER B 183 SER.? 9.15 NI NI B 305 280 TRP B 106 TRP^? 6.34 NI NI B 305 283 HIS B 121 HIS.? -3.60 NI NI B 305s coo 48.81 15.65 -14.70 47.48 13.77 -15.39 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 36.74 18.46 -19.41 39.06 21.05 -17.69 -15.45 -5.89 -60.07 -15.49 -5.89 -56.14 coo 43.44 15.25 -16.26 44.71 13.88 -17.22 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 1esc_c00 source 1esc ESTERASE : 10 hits 1esc_c00 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 196 ASP.? 6.39 CA CA A 306 260 GLU A 32 GLU~? -3.00 CA CA A 306s 370 TYR A 36 TYR~? 7.82 CA CA A 306 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP A 197 ASP.? 9.27 CA CA A 306 260 GLU A 40 GLU~? 12.94 CA CA A 306 370 TYR A 57 TYR^? 15.36 NI NI A 304 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 196 ASP.? 23.47 NI NI B 305 260 GLU B 32 GLU~? 21.76 NI NI B 305 370 TYR B 36 TYR~? 20.19 NI NI B 305 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1euu_c00 SIALIDASE user 4 3 # 4 92 ASP B 197 ASP.? 18.81 NI NI B 305 260 GLU B 40 GLU~? 23.91 NI NI B 305 370 TYR B 57 TYR^? 15.35 NI NI B 305 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 1euu_c00 source 1euu SIALIDASE : 4 hits 1euu_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 65 ASP~? 19.57 CA CA B 303 A 74 ASP A 104 ASP^? 11.20 NI NI A 304 A 98 GLU A 103 GLU^? 14.47 CA CA B 303 coo 17.19 9.05 25.28 15.77 9.98 26.53 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 15.99 8.54 17.36 14.96 7.80 19.05 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 16.31 12.85 18.11 16.71 11.79 19.90 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP A 75 ASP~? 14.34 CA CA A 301 A 74 ASP A 27 ASP~? -2.92 CA CA A 301s A 98 GLU A 30 GLU~? 7.55 CA CA A 301 coo 17.19 9.05 25.28 15.77 9.98 26.53 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 15.99 8.54 17.36 14.96 7.80 19.05 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 16.31 12.85 18.11 16.71 11.79 19.90 -27.55 15.68 -10.70 -29.15 16.50 -11.85 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 3 3 # 3 A 68 ASP B 75 ASP~? 24.42 NI NI B 305 A 74 ASP B 27 ASP~? 26.12 NI NI B 305 A 98 GLU B 30 GLU~? 25.54 NI NI B 305 coo 17.19 9.05 25.28 15.77 9.98 26.53 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 15.99 8.54 17.36 14.96 7.80 19.05 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 16.31 12.85 18.11 16.71 11.79 19.90 -23.64 -21.41 -69.78 -24.93 -22.08 -68.23 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 3 hits 1eyi_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP B 41 ASP.? 25.32 NI NI B 305 C 117 GLU B 40 GLU~? 23.91 NI NI B 305 C 131 GLU B 43 GLU~? 26.30 NI NI B 305 coo 68.01 56.37 72.57 68.42 56.10 70.51 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 66.59 62.50 67.44 67.57 60.64 67.12 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 69.24 52.27 71.96 69.91 50.26 71.89 -26.02 0.23 -73.88 -25.38 -0.28 -75.86 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 1 hits 1f6d_c02 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS A 78 LYS~? 23.27 CA CA A 301 A 159 HIS A 22 HIS~? 21.70 NI NI A 304 A 162 HIS A 83 HIS~? 17.38 NI NI A 304 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -28.42 14.17 -26.53 -31.51 16.17 -30.16 coo 29.80 39.37 7.24 28.18 38.06 7.48 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 30.26 35.04 5.34 28.61 35.92 4.39 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS A 78 LYS~? 23.27 CA CA A 301 A 159 HIS A 83 HIS~? 17.38 NI NI A 304 A 162 HIS A 22 HIS~? 21.70 NI NI A 304 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -28.42 14.17 -26.53 -31.51 16.17 -30.16 coo 29.80 39.37 7.24 28.18 38.06 7.48 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 30.26 35.04 5.34 28.61 35.92 4.39 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 3 3 # 3 A 156 LYS B 78 LYS~? 25.94 CA CA B 303 A 159 HIS B 22 HIS~? 22.02 NI NI B 305 A 162 HIS B 83 HIS~? 17.68 NI NI B 305 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 coo 29.80 39.37 7.24 28.18 38.06 7.48 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 30.26 35.04 5.34 28.61 35.92 4.39 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 4 3 # 4 A 156 LYS B 78 LYS~? 25.94 CA CA B 303 A 159 HIS B 83 HIS~? 17.68 NI NI B 305 A 162 HIS B 22 HIS~? 22.02 NI NI B 305 coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 coo 29.80 39.37 7.24 28.18 38.06 7.48 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 30.26 35.04 5.34 28.61 35.92 4.39 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 4 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 16 HIS^? 15.61 NI NI A 304 C 62 LYS A 142 LYS^? 14.03 NI NI A 304 F 35 ASP A 177 ASP^? 15.76 CA CA A 306 coo 15.40 22.79 16.66 13.93 24.10 15.98 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 19.95 18.98 4.81 18.82 20.94 10.49 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 16.32 15.30 17.19 17.71 14.73 18.69 -13.19 18.68 -21.15 -12.48 20.64 -20.80 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 1 hits 1f80_c03 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 70 PHE~? 18.84 CA CA A 301 A 210 ASP A 65 ASP~? 19.57 CA CA B 303 A 244 LYS A 78 LYS~? 23.27 CA CA A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -29.55 5.68 -14.32 -29.26 3.28 -12.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo -1.20 42.34 17.67 3.19 45.13 19.06 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 87 PHE~? 14.67 NI NI A 304 A 210 ASP A 21 ASP~? 19.27 CA CA A 301 A 244 LYS A 78 LYS~? 23.27 CA CA A 301 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo 10.51 37.86 19.71 9.07 39.38 20.04 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -1.20 42.34 17.67 3.19 45.13 19.06 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 168 PHE^? 16.43 NI NI A 304 A 210 ASP A 163 ASP~? 21.63 NI NI A 304 A 244 LYS A 159 LYS.? 27.24 CA CA A 302 coo 9.23 46.77 25.11 11.48 48.39 24.76 4.20 9.10 -27.54 5.46 6.65 -28.03 coo 10.51 37.86 19.71 9.07 39.38 20.04 1.30 20.20 -30.86 1.78 20.99 -28.95 coo -1.20 42.34 17.67 3.19 45.13 19.06 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 70 PHE~? 21.57 NI NI B 305 A 210 ASP B 65 ASP~? 20.64 NI NI B 305 A 244 LYS B 78 LYS~? 25.94 CA CA B 303 coo 9.23 46.77 25.11 11.48 48.39 24.76 -27.52 -11.62 -65.85 -27.73 -9.31 -67.41 coo 10.51 37.86 19.71 9.07 39.38 20.04 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 87 PHE~? 14.92 NI NI B 305 A 210 ASP B 21 ASP~? 22.52 NI NI B 305 A 244 LYS B 78 LYS~? 25.94 CA CA B 303 coo 9.23 46.77 25.11 11.48 48.39 24.76 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo 10.51 37.86 19.71 9.07 39.38 20.04 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -1.20 42.34 17.67 3.19 45.13 19.06 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 168 PHE^? 16.16 NI NI B 305 A 210 ASP B 163 ASP.? 22.00 NI NI B 305 A 244 LYS B 159 LYS.? 30.31 NI NI B 305 coo 9.23 46.77 25.11 11.48 48.39 24.76 5.97 -7.92 -52.72 6.39 -5.22 -52.12 coo 10.51 37.86 19.71 9.07 39.38 20.04 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 70 PHE~? 18.84 CA CA A 301 B 210 ASP A 65 ASP~? 19.57 CA CA B 303 B 244 LYS A 78 LYS~? 23.27 CA CA A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -29.55 5.68 -14.32 -29.26 3.28 -12.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo -2.38 51.82 41.62 2.07 49.19 40.42 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 87 PHE~? 14.67 NI NI A 304 B 210 ASP A 21 ASP~? 19.27 CA CA A 301 B 244 LYS A 78 LYS~? 23.27 CA CA A 301 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo 9.06 56.85 40.30 7.71 55.27 39.90 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -2.38 51.82 41.62 2.07 49.19 40.42 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 168 PHE^? 16.43 NI NI A 304 B 210 ASP A 163 ASP~? 21.63 NI NI A 304 B 244 LYS A 159 LYS.? 27.24 CA CA A 302 coo 8.76 47.85 34.91 11.08 46.36 35.41 4.20 9.10 -27.54 5.46 6.65 -28.03 coo 9.06 56.85 40.30 7.71 55.27 39.90 1.30 20.20 -30.86 1.78 20.99 -28.95 coo -2.38 51.82 41.62 2.07 49.19 40.42 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 70 PHE~? 21.57 NI NI B 305 B 210 ASP B 65 ASP~? 20.64 NI NI B 305 B 244 LYS B 78 LYS~? 25.94 CA CA B 303 coo 8.76 47.85 34.91 11.08 46.36 35.41 -27.52 -11.62 -65.85 -27.73 -9.31 -67.41 coo 9.06 56.85 40.30 7.71 55.27 39.90 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 87 PHE~? 14.92 NI NI B 305 B 210 ASP B 21 ASP~? 22.52 NI NI B 305 B 244 LYS B 78 LYS~? 25.94 CA CA B 303 coo 8.76 47.85 34.91 11.08 46.36 35.41 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo 9.06 56.85 40.30 7.71 55.27 39.90 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -2.38 51.82 41.62 2.07 49.19 40.42 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 168 PHE^? 16.16 NI NI B 305 B 210 ASP B 163 ASP.? 22.00 NI NI B 305 B 244 LYS B 159 LYS.? 30.31 NI NI B 305 coo 8.76 47.85 34.91 11.08 46.36 35.41 5.97 -7.92 -52.72 6.39 -5.22 -52.12 coo 9.06 56.85 40.30 7.71 55.27 39.90 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 148 HIS~? 18.59 NI NI A 304 A 210 ASP A 145 ASP.? 18.22 NI NI A 304 A 244 LYS A 142 LYS^? 14.03 NI NI A 304 coo 11.28 44.53 18.60 9.91 46.00 19.20 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 10.51 37.86 19.71 9.07 39.38 20.04 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -1.20 42.34 17.67 3.19 45.13 19.06 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS B 148 HIS.? 18.38 NI NI B 305 A 210 ASP B 145 ASP.? 18.27 NI NI B 305 A 244 LYS B 142 LYS^? 13.37 NI NI B 305 coo 11.28 44.53 18.60 9.91 46.00 19.20 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 10.51 37.86 19.71 9.07 39.38 20.04 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo -1.20 42.34 17.67 3.19 45.13 19.06 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 148 HIS~? 18.59 NI NI A 304 B 210 ASP A 145 ASP.? 18.22 NI NI A 304 B 244 LYS A 142 LYS^? 14.03 NI NI A 304 coo 10.08 50.18 41.78 8.91 48.61 41.04 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 9.06 56.85 40.30 7.71 55.27 39.90 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -2.38 51.82 41.62 2.07 49.19 40.42 -1.82 9.73 -24.13 2.97 5.99 -23.26 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 1 hits 1fc4_c05 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP A 177 ASP^? 15.76 CA CA A 306 B 268 HIS A 16 HIS^? 15.61 NI NI A 304 B 334 TYR A 131 TYR^? 10.29 NI NI A 304 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 2 3 # 2 B 267 ASP B 177 ASP^? 17.56 NI NI B 305 B 268 HIS B 16 HIS^? 15.81 NI NI B 305 B 334 TYR B 131 TYR^? 10.67 NI NI B 305 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 2 hits 1fgj_c01 naa= 3 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 1 3 # 1 96 SER A 133 SER.? 4.86 CA CA A 306 272 CYH A 35 CYH~? 11.73 CA CA A 306 312 GLU A 32 GLU~? -3.00 CA CA A 306s coo 27.57 5.78 14.13 25.30 6.31 13.99 -13.59 14.24 -12.04 -13.08 13.73 -9.72 coo 18.48 7.50 15.98 21.17 6.92 15.38 -21.62 7.57 -11.19 -20.62 8.88 -13.43 coo 22.30 10.15 12.52 24.07 9.52 13.47 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1fnb_c00 FERREDOXIN:NADP+ OXIDOREDUCTASE (FERuser 2 3 # 2 96 SER B 133 SER^? 18.43 NI NI B 305 272 CYH B 35 CYH~? 15.94 NI NI B 305 312 GLU B 32 GLU~? 21.76 NI NI B 305 coo 27.57 5.78 14.13 25.30 6.31 13.99 -10.40 -17.22 -68.30 -9.98 -16.63 -70.62 coo 18.48 7.50 15.98 21.17 6.92 15.38 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 coo 22.30 10.15 12.52 24.07 9.52 13.47 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 1fnb_c00 source 1fnb FERREDOXIN:NADP+ OXIDOREDUCTASE (FERREDOXIN RE: 2 hits 1fnb_c00 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP A 163 ASP~? 21.63 NI NI A 304 A 281 ARG A 166 ARG~? 23.27 NI NI A 304 A 289 TYR A 170 TYR^? 15.79 NI NI A 304 coo 54.86 40.00 47.23 55.57 38.60 48.67 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 52.08 40.18 50.14 50.83 38.93 47.73 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 57.82 31.70 50.73 57.94 34.00 49.17 1.42 13.38 -22.88 3.34 11.36 -22.90 1foh_c00 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP A 163 ASP~? 21.63 NI NI A 304 B 281 ARG A 166 ARG~? 23.27 NI NI A 304 B 289 TYR A 170 TYR^? 15.79 NI NI A 304 coo 90.56 80.24 98.04 90.36 81.53 96.34 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 86.62 80.67 97.51 87.37 82.00 100.10 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 91.83 88.28 92.88 92.60 85.93 94.14 1.42 13.38 -22.88 3.34 11.36 -22.90 1foh_c01 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP A 163 ASP~? 21.63 NI NI A 304 C 281 ARG A 166 ARG~? 23.27 NI NI A 304 C 289 TYR A 170 TYR^? 15.79 NI NI A 304 coo 42.34 76.83 49.10 43.06 78.59 50.01 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 46.12 77.15 48.13 44.44 77.61 45.70 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 42.69 86.18 51.69 41.59 83.63 51.54 1.42 13.38 -22.88 3.34 11.36 -22.90 1foh_c02 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c02 naa= 3 ULMN 3 1foh_c03 PHENOL HYDROXYLASE user 1 3 # 1 D 54 ASP A 163 ASP~? 21.63 NI NI A 304 D 281 ARG A 166 ARG~? 23.27 NI NI A 304 D 289 TYR A 170 TYR^? 15.79 NI NI A 304 coo 75.05 45.80 106.18 74.73 43.88 105.51 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 78.52 44.93 104.78 78.72 44.49 107.76 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 72.35 36.51 104.82 72.00 39.20 105.46 1.42 13.38 -22.88 3.34 11.36 -22.90 1foh_c03 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c03 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 89 GLU~? 25.01 NI NI A 304 A 319 ASP A 90 ASP~? 20.31 NI NI A 304 A 359 ARG A 13 ARG.? 21.03 NI NI A 304 coo 14.41 12.40 16.42 12.92 13.74 15.71 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 12.25 13.04 23.85 11.56 15.02 23.93 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 10.89 14.95 28.28 12.39 12.53 29.31 -9.30 18.06 -38.38 -9.20 20.86 -37.11 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU B 89 GLU~? 11.52 CA CA B 303 A 319 ASP B 90 ASP~? 18.88 CA CA B 303 A 359 ARG B 13 ARG.? 21.21 NI NI B 305 coo 14.41 12.40 16.42 12.92 13.74 15.71 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 12.25 13.04 23.85 11.56 15.02 23.93 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 10.89 14.95 28.28 12.39 12.53 29.31 -4.25 -19.48 -42.40 -4.50 -22.44 -43.20 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 2 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 89 GLU~? 25.01 NI NI A 304 B 319 ASP A 90 ASP~? 20.31 NI NI A 304 B 359 ARG A 13 ARG.? 21.03 NI NI A 304 coo 10.77 13.13 40.94 11.03 14.73 39.51 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 3.77 12.64 38.21 3.35 14.53 37.39 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -9.30 18.06 -38.38 -9.20 20.86 -37.11 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU B 32 GLU~? 21.76 NI NI B 305 B 319 ASP B 197 ASP.? 18.81 NI NI B 305 B 359 ARG B 198 ARG^? 13.15 NI NI B 305 coo 10.77 13.13 40.94 11.03 14.73 39.51 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 3.77 12.64 38.21 3.35 14.53 37.39 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU B 89 GLU~? 11.52 CA CA B 303 B 319 ASP B 90 ASP~? 18.88 CA CA B 303 B 359 ARG B 13 ARG.? 21.21 NI NI B 305 coo 10.77 13.13 40.94 11.03 14.73 39.51 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 3.77 12.64 38.21 3.35 14.53 37.39 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -4.25 -19.48 -42.40 -4.50 -22.44 -43.20 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 3 hits 1fr8_c01 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 198 ARG^? 13.22 CA CA A 306 A 201 HIS A 119 HIS^? -3.69 NI NI A 304s A 204 HIS A 187 HIS^? -3.59 NI NI A 304s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG B 198 ARG^? 13.15 NI NI B 305 A 201 HIS B 119 HIS^? -3.53 NI NI B 305s A 204 HIS B 187 HIS^? -3.54 NI NI B 305s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG B 198 ARG^? 13.15 NI NI B 305 A 201 HIS B 187 HIS^? -3.54 NI NI B 305s A 204 HIS B 119 HIS^? -3.53 NI NI B 305s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 3 hits 1g8f_c00 naa= 3 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 1 3 # 1 A 314 TRP A 181 TRP^? 6.14 NI NI A 304 A 317 GLU A 182 GLU^? 15.51 NI NI A 304 A 365 ARG A 186 ARG^? 12.05 NI NI A 304 coo 79.91 26.87 38.77 78.95 23.18 37.81 -10.21 8.07 -30.50 -11.08 9.23 -26.84 coo 85.55 26.30 41.25 85.59 24.97 39.65 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 83.47 25.30 27.10 83.44 27.82 25.29 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 2 3 # 2 A 314 TRP A 184 TRP.? 13.51 NI NI A 304 A 317 GLU A 182 GLU^? 15.51 NI NI A 304 A 365 ARG A 147 ARG~? 21.93 NI NI A 304 coo 79.91 26.87 38.77 78.95 23.18 37.81 -9.68 5.23 -37.98 -6.80 7.88 -37.55 coo 85.55 26.30 41.25 85.59 24.97 39.65 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 83.47 25.30 27.10 83.44 27.82 25.29 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 3 3 # 3 A 314 TRP A 184 TRP.? 13.51 NI NI A 304 A 317 GLU A 182 GLU^? 15.51 NI NI A 304 A 365 ARG A 186 ARG^? 12.05 NI NI A 304 coo 79.91 26.87 38.77 78.95 23.18 37.81 -9.68 5.23 -37.98 -6.80 7.88 -37.55 coo 85.55 26.30 41.25 85.59 24.97 39.65 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 83.47 25.30 27.10 83.44 27.82 25.29 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 4 3 # 4 A 314 TRP A 184 TRP.? 13.51 NI NI A 304 A 317 GLU A 182 GLU^? 15.51 NI NI A 304 A 365 ARG A 206 ARG^? 17.65 CA CA B 303 coo 79.91 26.87 38.77 78.95 23.18 37.81 -9.68 5.23 -37.98 -6.80 7.88 -37.55 coo 85.55 26.30 41.25 85.59 24.97 39.65 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 83.47 25.30 27.10 83.44 27.82 25.29 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 5 3 # 5 A 314 TRP B 181 TRP^? 6.22 NI NI B 305 A 317 GLU B 182 GLU^? 15.43 NI NI B 305 A 365 ARG B 186 ARG^? 11.32 NI NI B 305 coo 79.91 26.87 38.77 78.95 23.18 37.81 -8.35 -10.18 -50.01 -8.71 -11.53 -53.69 coo 85.55 26.30 41.25 85.59 24.97 39.65 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 83.47 25.30 27.10 83.44 27.82 25.29 -0.49 -2.47 -50.17 -2.28 -0.14 -49.29 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 6 3 # 6 A 314 TRP B 184 TRP.? 13.50 NI NI B 305 A 317 GLU B 182 GLU^? 15.43 NI NI B 305 A 365 ARG B 147 ARG.? 21.34 NI NI B 305 coo 79.91 26.87 38.77 78.95 23.18 37.81 -8.16 -7.40 -42.41 -4.62 -9.04 -42.90 coo 85.55 26.30 41.25 85.59 24.97 39.65 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 83.47 25.30 27.10 83.44 27.82 25.29 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1g8o_c01 N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALuser 7 3 # 7 A 314 TRP B 184 TRP.? 13.50 NI NI B 305 A 317 GLU B 182 GLU^? 15.43 NI NI B 305 A 365 ARG B 186 ARG^? 11.32 NI NI B 305 coo 79.91 26.87 38.77 78.95 23.18 37.81 -8.16 -7.40 -42.41 -4.62 -9.04 -42.90 coo 85.55 26.30 41.25 85.59 24.97 39.65 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 83.47 25.30 27.10 83.44 27.82 25.29 -0.49 -2.47 -50.17 -2.28 -0.14 -49.29 1g8o_c01 source 1g8o N-ACETYLLACTOSAMINIDE ALPHA-1,3- GALACTOSYLTRA: 7 hits 1g8o_c01 naa= 3 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 B 1 CYH A 49 CYH~? 14.80 NI NI A 304 B 98 ASN A 52 ASN~? 15.92 NI NI A 304 B 99 GLY A 53 GLY~? 18.18 NI NI A 304 coo 60.40 53.51 86.58 58.33 55.30 85.83 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 61.33 49.28 88.22 61.64 50.04 86.28 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo 60.75 49.64 92.68 61.49 50.04 92.62 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1gdo_c00 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 B 1 CYH B 49 CYH~? 14.83 NI NI B 305 B 98 ASN B 52 ASN~? 15.59 NI NI B 305 B 99 GLY B 53 GLY~? 17.62 NI NI B 305 coo 60.40 53.51 86.58 58.33 55.30 85.83 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 61.33 49.28 88.22 61.64 50.04 86.28 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 60.75 49.64 92.68 61.49 50.04 92.62 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1gdo_c00 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c00 naa= 3 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 D 1 CYH A 49 CYH~? 14.80 NI NI A 304 D 98 ASN A 52 ASN~? 15.92 NI NI A 304 D 99 GLY A 53 GLY~? 18.18 NI NI A 304 coo 45.17 35.76 43.57 47.17 33.90 42.78 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 44.24 40.01 45.19 43.94 39.25 43.24 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo 44.81 39.60 49.65 44.07 39.23 49.57 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1gdo_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 D 1 CYH B 49 CYH~? 14.83 NI NI B 305 D 98 ASN B 52 ASN~? 15.59 NI NI B 305 D 99 GLY B 53 GLY~? 17.62 NI NI B 305 coo 45.17 35.76 43.57 47.17 33.90 42.78 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 44.24 40.01 45.19 43.94 39.25 43.24 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 44.81 39.60 49.65 44.07 39.23 49.57 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1gdo_c01 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c01 naa= 3 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 49 CYH~? 14.80 NI NI A 304 A 98 ASN A 52 ASN~? 15.92 NI NI A 304 A 99 GLY A 53 GLY~? 18.18 NI NI A 304 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1gdo_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH B 49 CYH~? 14.83 NI NI B 305 A 98 ASN B 52 ASN~? 15.59 NI NI B 305 A 99 GLY B 53 GLY~? 17.62 NI NI B 305 coo 9.96 -7.64 43.39 12.01 -9.40 42.74 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 9.26 -3.27 45.14 8.86 -4.02 43.23 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 9.85 -3.74 49.57 9.12 -4.11 49.52 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1gdo_c02 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c02 naa= 3 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 49 CYH~? 14.80 NI NI A 304 C 98 ASN A 52 ASN~? 15.92 NI NI A 304 C 99 GLY A 53 GLY~? 18.18 NI NI A 304 coo 25.27 14.39 86.45 23.28 16.25 85.80 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 25.97 10.04 88.17 26.35 10.81 86.26 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo 25.32 10.47 92.61 26.06 10.86 92.54 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1gdo_c03 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH B 49 CYH~? 14.83 NI NI B 305 C 98 ASN B 52 ASN~? 15.59 NI NI B 305 C 99 GLY B 53 GLY~? 17.62 NI NI B 305 coo 25.27 14.39 86.45 23.28 16.25 85.80 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 25.97 10.04 88.17 26.35 10.81 86.26 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 25.32 10.47 92.61 26.06 10.86 92.54 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1gdo_c03 source 1gdo GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1gdo_c03 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 40 GLU~? 12.94 CA CA A 306 A 47 ASP A 197 ASP.? 9.27 CA CA A 306 A 161 TYR A 57 TYR^? 15.36 NI NI A 304 coo 37.12 18.35 73.76 37.09 16.69 72.44 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 29.81 8.06 73.13 30.21 10.11 72.95 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 37.29 15.56 67.90 37.37 13.79 70.08 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU B 40 GLU~? 23.91 NI NI B 305 A 47 ASP B 197 ASP.? 18.81 NI NI B 305 A 161 TYR B 57 TYR^? 15.35 NI NI B 305 coo 37.12 18.35 73.76 37.09 16.69 72.44 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 29.81 8.06 73.13 30.21 10.11 72.95 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 37.29 15.56 67.90 37.37 13.79 70.08 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 40 GLU~? 12.94 CA CA A 306 B 47 ASP A 197 ASP.? 9.27 CA CA A 306 B 161 TYR A 57 TYR^? 15.36 NI NI A 304 coo 53.87 35.49 53.22 55.44 35.72 54.61 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 63.47 43.65 53.95 61.45 43.07 54.06 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 56.38 35.81 59.19 58.25 35.77 57.10 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU B 40 GLU~? 23.91 NI NI B 305 B 47 ASP B 197 ASP.? 18.81 NI NI B 305 B 161 TYR B 57 TYR^? 15.35 NI NI B 305 coo 53.87 35.49 53.22 55.44 35.72 54.61 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 63.47 43.65 53.95 61.45 43.07 54.06 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 56.38 35.81 59.19 58.25 35.77 57.10 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 2 hits 1geq_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 139 SER.? 15.61 NI NI A 304 A 164 TYR A 170 TYR^? 15.79 NI NI A 304 A 168 LYS A 142 LYS^? 14.03 NI NI A 304 coo 32.37 52.40 49.35 31.32 53.88 47.74 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 29.69 55.04 42.83 31.98 53.56 43.49 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 26.96 50.99 47.03 31.03 48.83 44.33 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER B 139 SER.? 15.78 NI NI B 305 A 164 TYR B 170 TYR^? 15.66 NI NI B 305 A 168 LYS B 142 LYS^? 13.37 NI NI B 305 coo 32.37 52.40 49.35 31.32 53.88 47.74 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 29.69 55.04 42.83 31.98 53.56 43.49 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 26.96 50.99 47.03 31.03 48.83 44.33 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 139 SER.? 15.61 NI NI A 304 B 164 TYR A 170 TYR^? 15.79 NI NI A 304 B 168 LYS A 142 LYS^? 14.03 NI NI A 304 coo 13.08 50.93 56.67 13.12 48.99 55.27 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 11.52 46.03 51.32 10.06 47.90 52.76 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 15.72 50.86 51.22 10.77 52.35 51.39 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER B 139 SER.? 15.78 NI NI B 305 B 164 TYR B 170 TYR^? 15.66 NI NI B 305 B 168 LYS B 142 LYS^? 13.37 NI NI B 305 coo 13.08 50.93 56.67 13.12 48.99 55.27 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 11.52 46.03 51.32 10.06 47.90 52.76 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 15.72 50.86 51.22 10.77 52.35 51.39 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 139 SER.? 15.61 NI NI A 304 C 164 TYR A 170 TYR^? 15.79 NI NI A 304 C 168 LYS A 142 LYS^? 14.03 NI NI A 304 coo 11.22 34.38 82.32 11.07 36.29 83.78 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 8.83 39.27 87.38 7.60 37.43 85.69 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 12.98 34.46 88.14 8.11 32.96 87.14 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER B 139 SER.? 15.78 NI NI B 305 C 164 TYR B 170 TYR^? 15.66 NI NI B 305 C 168 LYS B 142 LYS^? 13.37 NI NI B 305 coo 11.22 34.38 82.32 11.07 36.29 83.78 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 8.83 39.27 87.38 7.60 37.43 85.69 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 12.98 34.46 88.14 8.11 32.96 87.14 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 139 SER.? 15.61 NI NI A 304 D 164 TYR A 170 TYR^? 15.79 NI NI A 304 D 168 LYS A 142 LYS^? 14.03 NI NI A 304 coo 29.15 32.90 92.57 27.86 31.44 94.02 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 25.49 30.28 98.59 27.88 31.73 98.26 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 23.46 34.31 94.02 27.08 36.46 97.29 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER B 139 SER.? 15.78 NI NI B 305 D 164 TYR B 170 TYR^? 15.66 NI NI B 305 D 168 LYS B 142 LYS^? 13.37 NI NI B 305 coo 29.15 32.90 92.57 27.86 31.44 94.02 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 25.49 30.28 98.59 27.88 31.73 98.26 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 23.46 34.31 94.02 27.08 36.46 97.29 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 2 hits 1gz6_c03 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 46 GLN~? 19.44 CA CA A 306 A 296 GLU A 50 GLU~? 22.49 CA CA A 302 A 383 TYR A 54 TYR.? 11.09 NI NI A 304 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -18.86 -2.85 -7.06 -20.18 -2.72 -5.38 coo 40.93 4.45 2.36 38.91 3.75 2.26 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 30.54 7.22 6.23 31.38 5.79 3.97 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN A 167 GLN.? 22.04 NI NI A 304 A 296 GLU A 144 GLU^? 14.15 NI NI A 304 A 383 TYR A 170 TYR^? 15.79 NI NI A 304 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 6.83 9.65 -32.76 8.52 10.95 -32.65 coo 40.93 4.45 2.36 38.91 3.75 2.26 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 30.54 7.22 6.23 31.38 5.79 3.97 1.42 13.38 -22.88 3.34 11.36 -22.90 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 3 3 # 3 A 271 GLN B 167 GLN.? 21.49 NI NI B 305 A 296 GLU B 144 GLU^? 13.93 NI NI B 305 A 383 TYR B 170 TYR^? 15.66 NI NI B 305 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 8.59 -8.80 -47.03 9.88 -7.15 -46.70 coo 40.93 4.45 2.36 38.91 3.75 2.26 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 30.54 7.22 6.23 31.38 5.79 3.97 4.23 -12.71 -57.64 5.48 -10.20 -57.84 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 3 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 196 ASP.? 6.39 CA CA A 306 A 327 GLU B 101 GLU^? 17.23 CA CA B 303 A 339 ARG B 206 ARG^? 17.11 NI NI B 305 coo 85.81 57.99 116.01 86.03 55.86 115.89 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 75.11 41.01 160.30 76.65 40.06 161.41 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP B 196 ASP.? 23.47 NI NI B 305 A 327 GLU A 101 GLU^? 20.45 NI NI A 304 A 339 ARG A 206 ARG^? 17.65 CA CA B 303 coo 85.81 57.99 116.01 86.03 55.86 115.89 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 75.11 41.01 160.30 76.65 40.06 161.41 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 82.23 40.35 159.87 85.09 40.67 161.01 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 2 hits 1hto_c00 naa= 3 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 A 47 LYS A 142 LYS^? 14.03 NI NI A 304 A 107 HIS A 187 HIS^? -3.59 NI NI A 304s A 137 SER A 139 SER.? 15.61 NI NI A 304 coo 5.11 -0.55 31.43 1.36 1.90 33.24 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 1.06 -1.40 35.67 2.72 0.28 35.10 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 1hy3_c00 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 A 47 LYS B 142 LYS^? 13.37 NI NI B 305 A 107 HIS B 187 HIS^? -3.54 NI NI B 305s A 137 SER B 139 SER.? 15.78 NI NI B 305 coo 5.11 -0.55 31.43 1.36 1.90 33.24 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 6.14 -0.73 24.01 6.05 0.83 25.40 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 1.06 -1.40 35.67 2.72 0.28 35.10 0.49 -14.15 -62.10 2.68 -14.18 -61.04 1hy3_c00 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c00 naa= 3 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 1 3 # 1 B 47 LYS A 142 LYS^? 14.03 NI NI A 304 B 107 HIS A 187 HIS^? -3.59 NI NI A 304s B 137 SER A 139 SER.? 15.61 NI NI A 304 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 1hy3_c01 ESTROGEN SULFOTRANSFERASE user 2 3 # 2 B 47 LYS B 142 LYS^? 13.37 NI NI B 305 B 107 HIS B 187 HIS^? -3.54 NI NI B 305s B 137 SER B 139 SER.? 15.78 NI NI B 305 coo -20.15 -16.49 60.11 -21.92 -14.52 56.18 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo -23.43 -14.78 66.71 -24.10 -15.65 64.93 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -17.90 -14.30 55.11 -19.49 -15.96 55.90 0.49 -14.15 -62.10 2.68 -14.18 -61.04 1hy3_c01 source 1hy3 ESTROGEN SULFOTRANSFERASE : 2 hits 1hy3_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 11 VAL.? 20.82 NI NI A 304 A 200 ASP A 145 ASP.? 18.22 NI NI A 304 A 226 LYS A 159 LYS.? 27.24 CA CA A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.26 14.94 -40.59 -4.42 17.10 -40.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 11 VAL.? 20.82 NI NI A 304 A 200 ASP A 163 ASP~? 21.63 NI NI A 304 A 226 LYS A 159 LYS.? 27.24 CA CA A 302 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -4.26 14.94 -40.59 -4.42 17.10 -40.24 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 84 VAL~? 14.96 NI NI A 304 A 200 ASP A 177 ASP^? 15.76 CA CA A 306 A 226 LYS A 142 LYS^? 14.03 NI NI A 304 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -20.16 13.92 -32.56 -20.09 11.74 -32.19 coo 24.51 43.28 11.18 25.17 44.50 9.58 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 34.47 51.09 7.19 28.58 51.18 7.53 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 11 VAL.? 20.83 NI NI B 305 A 200 ASP B 145 ASP.? 18.27 NI NI B 305 A 226 LYS B 159 LYS.? 30.31 NI NI B 305 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -0.83 -15.33 -39.74 -0.44 -17.47 -40.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.99 -14.57 -52.82 19.67 -12.66 -51.79 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 11 VAL.? 20.83 NI NI B 305 A 200 ASP B 163 ASP.? 22.00 NI NI B 305 A 226 LYS B 159 LYS.? 30.31 NI NI B 305 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -0.83 -15.33 -39.74 -0.44 -17.47 -40.13 coo 24.51 43.28 11.18 25.17 44.50 9.58 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.99 -14.57 -52.82 19.67 -12.66 -51.79 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 84 VAL~? 15.26 NI NI B 305 A 200 ASP B 177 ASP^? 17.56 NI NI B 305 A 226 LYS B 142 LYS^? 13.37 NI NI B 305 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -16.76 -18.01 -47.75 -17.29 -15.88 -48.09 coo 24.51 43.28 11.18 25.17 44.50 9.58 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 34.47 51.09 7.19 28.58 51.18 7.53 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1i29_c03 source 1i29 CSDB : 6 hits 1i29_c03 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 42 ASP~? 18.65 NI NI A 304 158 THR A 58 THR^? 10.17 NI NI A 304 317 ASP A 197 ASP.? 9.27 CA CA A 306 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -16.09 0.01 -15.13 -15.43 -0.83 -17.03 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -12.14 8.73 -7.75 -12.16 7.25 -6.26 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 145 ASP.? 18.22 NI NI A 304 158 THR A 12 THR.? 15.04 NI NI A 304 317 ASP A 163 ASP~? 21.63 NI NI A 304 coo -2.63 8.40 35.07 -3.66 9.81 36.17 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -5.53 13.22 -37.46 -4.86 11.53 -36.29 coo -12.63 17.64 33.66 -10.65 17.90 34.40 1.30 20.20 -30.86 1.78 20.99 -28.95 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP B 42 ASP~? 18.39 NI NI B 305 158 THR B 58 THR^? 10.34 NI NI B 305 317 ASP B 197 ASP.? 18.81 NI NI B 305 coo -2.63 8.40 35.07 -3.66 9.81 36.17 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -15.72 -3.35 -65.18 -15.34 -2.24 -63.34 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 3 hits 1inp_c02 naa= 3 ULMN 3 1iph_c00 CATALASE HPII user 1 3 # 1 A 128 HIS A 116 HIS^? 7.23 NI NI A 304 A 167 SER A 115 SER.? 13.22 NI NI A 304 A 201 ASN A 108 ASN^? 7.27 NI NI A 304 coo 12.95 4.49 19.05 14.87 4.39 19.77 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 10.44 7.96 22.51 12.16 7.57 20.82 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo 19.43 6.74 22.83 19.09 5.15 21.60 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1iph_c00 CATALASE HPII user 2 3 # 2 A 128 HIS B 116 HIS^? 6.69 NI NI B 305 A 167 SER B 115 SER.? 13.16 NI NI B 305 A 201 ASN B 108 ASN^? 7.81 NI NI B 305 coo 12.95 4.49 19.05 14.87 4.39 19.77 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 10.44 7.96 22.51 12.16 7.57 20.82 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 19.43 6.74 22.83 19.09 5.15 21.60 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 1iph_c00 source 1iph CATALASE HPII : 2 hits 1iph_c00 naa= 3 ULMN 3 1iph_c01 CATALASE HPII user 1 3 # 1 B 128 HIS A 116 HIS^? 7.23 NI NI A 304 B 167 SER A 115 SER.? 13.22 NI NI A 304 B 201 ASN A 108 ASN^? 7.27 NI NI A 304 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1iph_c01 CATALASE HPII user 2 3 # 2 B 128 HIS B 116 HIS^? 6.69 NI NI B 305 B 167 SER B 115 SER.? 13.16 NI NI B 305 B 201 ASN B 108 ASN^? 7.81 NI NI B 305 coo -12.95 -4.49 19.05 -14.87 -4.39 19.77 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo -10.44 -7.96 22.51 -12.16 -7.57 20.82 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo -19.43 -6.74 22.83 -19.09 -5.15 21.60 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 1iph_c01 source 1iph CATALASE HPII : 2 hits 1iph_c01 naa= 3 ULMN 3 1iph_c02 CATALASE HPII user 1 3 # 1 C 128 HIS A 116 HIS^? 7.23 NI NI A 304 C 167 SER A 115 SER.? 13.22 NI NI A 304 C 201 ASN A 108 ASN^? 7.27 NI NI A 304 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1iph_c02 CATALASE HPII user 2 3 # 2 C 128 HIS B 116 HIS^? 6.69 NI NI B 305 C 167 SER B 115 SER.? 13.16 NI NI B 305 C 201 ASN B 108 ASN^? 7.81 NI NI B 305 coo -12.95 4.49 -19.05 -14.87 4.39 -19.77 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo -10.44 7.96 -22.51 -12.16 7.57 -20.82 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo -19.43 6.74 -22.83 -19.09 5.15 -21.60 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 1iph_c02 source 1iph CATALASE HPII : 2 hits 1iph_c02 naa= 3 ULMN 3 1iph_c03 CATALASE HPII user 1 3 # 1 D 128 HIS A 116 HIS^? 7.23 NI NI A 304 D 167 SER A 115 SER.? 13.22 NI NI A 304 D 201 ASN A 108 ASN^? 7.27 NI NI A 304 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1iph_c03 CATALASE HPII user 2 3 # 2 D 128 HIS B 116 HIS^? 6.69 NI NI B 305 D 167 SER B 115 SER.? 13.16 NI NI B 305 D 201 ASN B 108 ASN^? 7.81 NI NI B 305 coo 12.95 -4.49 -19.05 14.87 -4.39 -19.77 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 10.44 -7.96 -22.51 12.16 -7.57 -20.82 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 19.43 -6.74 -22.83 19.09 -5.15 -21.60 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 1iph_c03 source 1iph CATALASE HPII : 2 hits 1iph_c03 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 41 ASP.? 21.30 CA CA A 306 A 204 GLU A 43 GLU~? 22.12 CA CA A 306 A 279 TYR A 57 TYR^? 15.36 NI NI A 304 coo 5.85 5.60 30.32 5.00 7.49 29.88 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 7.79 1.83 27.81 9.08 3.25 26.92 -24.31 -5.26 -5.52 -23.36 -4.37 -3.82 coo 8.22 7.77 18.64 7.58 8.47 21.28 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 145 ASP.? 18.22 NI NI A 304 A 204 GLU A 144 GLU^? 14.15 NI NI A 304 A 279 TYR A 170 TYR^? 15.79 NI NI A 304 coo 5.85 5.60 30.32 5.00 7.49 29.88 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 7.79 1.83 27.81 9.08 3.25 26.92 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 8.22 7.77 18.64 7.58 8.47 21.28 1.42 13.38 -22.88 3.34 11.36 -22.90 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 41 ASP.? 25.32 NI NI B 305 A 204 GLU B 43 GLU~? 26.30 NI NI B 305 A 279 TYR B 57 TYR^? 15.35 NI NI B 305 coo 5.85 5.60 30.32 5.00 7.49 29.88 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 7.79 1.83 27.81 9.08 3.25 26.92 -26.02 0.23 -73.88 -25.38 -0.28 -75.86 coo 8.22 7.77 18.64 7.58 8.47 21.28 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP B 145 ASP.? 18.27 NI NI B 305 A 204 GLU B 144 GLU^? 13.93 NI NI B 305 A 279 TYR B 170 TYR^? 15.66 NI NI B 305 coo 5.85 5.60 30.32 5.00 7.49 29.88 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 7.79 1.83 27.81 9.08 3.25 26.92 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 8.22 7.77 18.64 7.58 8.47 21.28 4.23 -12.71 -57.64 5.48 -10.20 -57.84 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 4 hits 1itx_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 198 ARG^? 13.22 CA CA A 306 A 201 HIS A 119 HIS^? -3.69 NI NI A 304s A 204 HIS A 187 HIS^? -3.59 NI NI A 304s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG B 198 ARG^? 13.15 NI NI B 305 A 201 HIS B 119 HIS^? -3.53 NI NI B 305s A 204 HIS B 187 HIS^? -3.54 NI NI B 305s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG B 198 ARG^? 13.15 NI NI B 305 A 201 HIS B 187 HIS^? -3.54 NI NI B 305s A 204 HIS B 119 HIS^? -3.53 NI NI B 305s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 1j70_c00 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 198 ARG^? 13.22 CA CA A 306 B 201 HIS A 119 HIS^? -3.69 NI NI A 304s B 204 HIS A 187 HIS^? -3.59 NI NI A 304s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG B 198 ARG^? 13.15 NI NI B 305 B 201 HIS B 119 HIS^? -3.53 NI NI B 305s B 204 HIS B 187 HIS^? -3.54 NI NI B 305s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG B 198 ARG^? 13.15 NI NI B 305 B 201 HIS B 187 HIS^? -3.54 NI NI B 305s B 204 HIS B 119 HIS^? -3.53 NI NI B 305s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 1j70_c01 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 198 ARG^? 13.22 CA CA A 306 C 201 HIS A 119 HIS^? -3.69 NI NI A 304s C 204 HIS A 187 HIS^? -3.59 NI NI A 304s coo 30.92 14.23 15.70 28.82 13.90 13.48 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo 20.16 5.55 18.86 20.00 7.59 19.34 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 24.92 3.29 16.90 24.41 4.92 15.69 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG B 198 ARG^? 13.15 NI NI B 305 C 201 HIS B 119 HIS^? -3.53 NI NI B 305s C 204 HIS B 187 HIS^? -3.54 NI NI B 305s coo 30.92 14.23 15.70 28.82 13.90 13.48 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 20.16 5.55 18.86 20.00 7.59 19.34 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 24.92 3.29 16.90 24.41 4.92 15.69 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG B 198 ARG^? 13.15 NI NI B 305 C 201 HIS B 187 HIS^? -3.54 NI NI B 305s C 204 HIS B 119 HIS^? -3.53 NI NI B 305s coo 30.92 14.23 15.70 28.82 13.90 13.48 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 20.16 5.55 18.86 20.00 7.59 19.34 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 24.92 3.29 16.90 24.41 4.92 15.69 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 1j70_c02 source 1j70 ATP SULPHURYLASE : 3 hits 1j70_c02 naa= 3 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 1 3 # 1 A 202 SER A 79 SER~? 16.97 CA CA A 301 A 308 ASP A 21 ASP~? 19.27 CA CA A 301 A 338 HIS A 22 HIS~? 21.70 NI NI A 304 coo 37.44 15.05 21.90 37.18 17.02 20.71 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 45.75 18.77 19.41 43.72 18.70 19.99 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 41.13 18.39 17.83 39.67 17.70 19.17 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 2 3 # 2 A 202 SER A 79 SER~? 16.97 CA CA A 301 A 308 ASP A 21 ASP~? 19.27 CA CA A 301 A 338 HIS A 83 HIS~? 17.38 NI NI A 304 coo 37.44 15.05 21.90 37.18 17.02 20.71 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 45.75 18.77 19.41 43.72 18.70 19.99 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 41.13 18.39 17.83 39.67 17.70 19.17 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 3 3 # 3 A 202 SER B 79 SER~? 19.41 NI NI B 305 A 308 ASP B 21 ASP~? 22.52 NI NI B 305 A 338 HIS B 22 HIS~? 22.02 NI NI B 305 coo 37.44 15.05 21.90 37.18 17.02 20.71 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 45.75 18.77 19.41 43.72 18.70 19.99 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 41.13 18.39 17.83 39.67 17.70 19.17 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1jkm_c00 BREFELDIN A ESTERASE user 4 3 # 4 A 202 SER B 79 SER~? 19.41 NI NI B 305 A 308 ASP B 21 ASP~? 22.52 NI NI B 305 A 338 HIS B 83 HIS~? 17.68 NI NI B 305 coo 37.44 15.05 21.90 37.18 17.02 20.71 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 45.75 18.77 19.41 43.72 18.70 19.99 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 41.13 18.39 17.83 39.67 17.70 19.17 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1jkm_c00 source 1jkm BREFELDIN A ESTERASE : 4 hits 1jkm_c00 naa= 3 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 1 3 # 1 B 202 SER A 79 SER~? 16.97 CA CA A 301 B 308 ASP A 21 ASP~? 19.27 CA CA A 301 B 338 HIS A 22 HIS~? 21.70 NI NI A 304 coo 67.81 2.11 21.29 69.09 3.00 23.04 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 64.20 9.21 26.15 65.67 7.96 25.24 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 66.92 5.20 26.82 67.69 4.22 25.14 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 2 3 # 2 B 202 SER A 79 SER~? 16.97 CA CA A 301 B 308 ASP A 21 ASP~? 19.27 CA CA A 301 B 338 HIS A 83 HIS~? 17.38 NI NI A 304 coo 67.81 2.11 21.29 69.09 3.00 23.04 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 64.20 9.21 26.15 65.67 7.96 25.24 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 66.92 5.20 26.82 67.69 4.22 25.14 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 3 3 # 3 B 202 SER B 79 SER~? 19.41 NI NI B 305 B 308 ASP B 21 ASP~? 22.52 NI NI B 305 B 338 HIS B 22 HIS~? 22.02 NI NI B 305 coo 67.81 2.11 21.29 69.09 3.00 23.04 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 64.20 9.21 26.15 65.67 7.96 25.24 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 66.92 5.20 26.82 67.69 4.22 25.14 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1jkm_c01 BREFELDIN A ESTERASE user 4 3 # 4 B 202 SER B 79 SER~? 19.41 NI NI B 305 B 308 ASP B 21 ASP~? 22.52 NI NI B 305 B 338 HIS B 83 HIS~? 17.68 NI NI B 305 coo 67.81 2.11 21.29 69.09 3.00 23.04 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 64.20 9.21 26.15 65.67 7.96 25.24 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 66.92 5.20 26.82 67.69 4.22 25.14 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1jkm_c01 source 1jkm BREFELDIN A ESTERASE : 4 hits 1jkm_c01 naa= 3 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 157 ARG.? 25.34 NI NI A 304 A 581 ARG A 158 ARG.? 32.75 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 157 ARG.? 25.34 NI NI A 304 A 581 ARG A 162 ARG~? 28.37 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 158 ARG.? 32.75 NI NI A 304 A 581 ARG A 157 ARG.? 25.34 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 158 ARG.? 32.75 NI NI A 304 A 581 ARG A 162 ARG~? 28.37 NI NI A 304 A 713 ARG A 157 ARG.? 25.34 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 9.58 14.02 -35.46 8.24 13.80 -38.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 158 ARG.? 32.75 NI NI A 304 A 581 ARG A 162 ARG~? 28.37 NI NI A 304 A 713 ARG A 166 ARG~? 23.27 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 5.93 17.15 -30.01 7.54 17.94 -27.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 158 ARG.? 32.75 NI NI A 304 A 581 ARG A 166 ARG~? 23.27 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG A 162 ARG~? 28.37 NI NI A 304 A 581 ARG A 157 ARG.? 25.34 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG A 162 ARG~? 28.37 NI NI A 304 A 581 ARG A 158 ARG.? 32.75 NI NI A 304 A 713 ARG A 157 ARG.? 25.34 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 9.58 14.02 -35.46 8.24 13.80 -38.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG A 162 ARG~? 28.37 NI NI A 304 A 581 ARG A 158 ARG.? 32.75 NI NI A 304 A 713 ARG A 166 ARG~? 23.27 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 5.93 17.15 -30.01 7.54 17.94 -27.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG A 162 ARG~? 28.37 NI NI A 304 A 581 ARG A 166 ARG~? 23.27 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG A 166 ARG~? 23.27 NI NI A 304 A 581 ARG A 158 ARG.? 32.75 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG A 166 ARG~? 23.27 NI NI A 304 A 581 ARG A 162 ARG~? 28.37 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG B 157 ARG.? 25.43 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG B 157 ARG.? 25.43 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 157 ARG.? 25.43 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 157 ARG.? 25.43 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 12.04 -10.72 -45.32 11.38 -11.87 -42.55 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 166 ARG.? 22.37 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 10.21 -14.86 -50.61 10.48 -15.55 -53.59 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 166 ARG.? 22.37 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 157 ARG.? 25.43 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 157 ARG.? 25.43 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 12.04 -10.72 -45.32 11.38 -11.87 -42.55 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 166 ARG.? 22.37 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 10.21 -14.86 -50.61 10.48 -15.55 -53.59 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 166 ARG.? 22.37 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG B 166 ARG.? 22.37 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1jqn_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 24 3 # 24 A 396 ARG B 166 ARG.? 22.37 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.87 26.44 -10.48 23.95 28.93 -12.26 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 27.15 35.19 -13.19 28.74 37.24 -14.84 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 23.13 28.56 -19.97 22.88 27.45 -17.11 19.54 -16.27 -48.10 20.08 -17.20 -45.23 1jqn_c01 source 1jqn PHOSPHOENOLPYRUVATE CARBOXYLASE : 24 hits 1jqn_c01 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 196 ASP.? 6.39 CA CA A 306 A 58 ASP A 197 ASP.? 9.27 CA CA A 306 A 424 GLU A 32 GLU~? -3.00 CA CA A 306s coo 58.42 47.76 20.67 58.01 49.10 19.12 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 58.59 41.80 18.81 58.94 43.89 18.94 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 52.85 46.34 13.34 54.09 44.97 14.42 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 196 ASP.? 6.39 CA CA A 306 A 58 ASP A 197 ASP.? 9.27 CA CA A 306 A 424 GLU A 112 GLU.? -2.98 CA CA A 302s coo 58.42 47.76 20.67 58.01 49.10 19.12 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 58.59 41.80 18.81 58.94 43.89 18.94 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 52.85 46.34 13.34 54.09 44.97 14.42 -2.93 7.09 -5.49 -2.54 7.70 -3.48 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP A 197 ASP.? 9.27 CA CA A 306 A 58 ASP A 196 ASP.? 6.39 CA CA A 306 A 424 GLU A 32 GLU~? -3.00 CA CA A 306s coo 58.42 47.76 20.67 58.01 49.10 19.12 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 58.59 41.80 18.81 58.94 43.89 18.94 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 52.85 46.34 13.34 54.09 44.97 14.42 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP A 197 ASP.? 9.27 CA CA A 306 A 58 ASP A 196 ASP.? 6.39 CA CA A 306 A 424 GLU A 112 GLU.? -2.98 CA CA A 302s coo 58.42 47.76 20.67 58.01 49.10 19.12 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 58.59 41.80 18.81 58.94 43.89 18.94 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 52.85 46.34 13.34 54.09 44.97 14.42 -2.93 7.09 -5.49 -2.54 7.70 -3.48 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 42 ASP~? 18.39 NI NI B 305 A 58 ASP B 41 ASP.? 25.32 NI NI B 305 A 424 GLU B 40 GLU~? 23.91 NI NI B 305 coo 58.42 47.76 20.67 58.01 49.10 19.12 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 58.59 41.80 18.81 58.94 43.89 18.94 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 52.85 46.34 13.34 54.09 44.97 14.42 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 196 ASP.? 23.47 NI NI B 305 A 58 ASP B 197 ASP.? 18.81 NI NI B 305 A 424 GLU B 32 GLU~? 21.76 NI NI B 305 coo 58.42 47.76 20.67 58.01 49.10 19.12 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 58.59 41.80 18.81 58.94 43.89 18.94 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP B 196 ASP.? 23.47 NI NI B 305 A 58 ASP B 197 ASP.? 18.81 NI NI B 305 A 424 GLU B 112 GLU.? -22.76 NI NI B 305s coo 58.42 47.76 20.67 58.01 49.10 19.12 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 58.59 41.80 18.81 58.94 43.89 18.94 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 52.85 46.34 13.34 54.09 44.97 14.42 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 8 3 # 8 A 55 ASP B 197 ASP.? 18.81 NI NI B 305 A 58 ASP B 196 ASP.? 23.47 NI NI B 305 A 424 GLU B 32 GLU~? 21.76 NI NI B 305 coo 58.42 47.76 20.67 58.01 49.10 19.12 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 58.59 41.80 18.81 58.94 43.89 18.94 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 9 3 # 9 A 55 ASP B 197 ASP.? 18.81 NI NI B 305 A 58 ASP B 196 ASP.? 23.47 NI NI B 305 A 424 GLU B 112 GLU.? -22.76 NI NI B 305s coo 58.42 47.76 20.67 58.01 49.10 19.12 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 58.59 41.80 18.81 58.94 43.89 18.94 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 52.85 46.34 13.34 54.09 44.97 14.42 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 9 hits 1js4_c00 naa= 3 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 1 3 # 1 B 55 ASP A 41 ASP.? 21.30 CA CA A 306 B 58 ASP A 42 ASP~? 18.65 NI NI A 304 B 424 GLU A 40 GLU~? 12.94 CA CA A 306 coo 112.10 61.46 19.99 111.82 60.65 18.07 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 117.85 63.62 21.08 115.96 63.25 20.18 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 118.47 57.23 15.57 119.32 58.77 16.73 -20.35 2.54 -4.22 -20.15 4.43 -3.28 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 2 3 # 2 B 55 ASP A 42 ASP~? 18.65 NI NI A 304 B 58 ASP A 41 ASP.? 21.30 CA CA A 306 B 424 GLU A 40 GLU~? 12.94 CA CA A 306 coo 112.10 61.46 19.99 111.82 60.65 18.07 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 117.85 63.62 21.08 115.96 63.25 20.18 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 118.47 57.23 15.57 119.32 58.77 16.73 -20.35 2.54 -4.22 -20.15 4.43 -3.28 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 3 3 # 3 B 55 ASP A 196 ASP.? 6.39 CA CA A 306 B 58 ASP A 197 ASP.? 9.27 CA CA A 306 B 424 GLU A 32 GLU~? -3.00 CA CA A 306s coo 112.10 61.46 19.99 111.82 60.65 18.07 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 117.85 63.62 21.08 115.96 63.25 20.18 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 118.47 57.23 15.57 119.32 58.77 16.73 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 4 3 # 4 B 55 ASP A 196 ASP.? 6.39 CA CA A 306 B 58 ASP A 197 ASP.? 9.27 CA CA A 306 B 424 GLU A 112 GLU.? -2.98 CA CA A 302s coo 112.10 61.46 19.99 111.82 60.65 18.07 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 117.85 63.62 21.08 115.96 63.25 20.18 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 118.47 57.23 15.57 119.32 58.77 16.73 -2.93 7.09 -5.49 -2.54 7.70 -3.48 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 5 3 # 5 B 55 ASP A 197 ASP.? 9.27 CA CA A 306 B 58 ASP A 196 ASP.? 6.39 CA CA A 306 B 424 GLU A 32 GLU~? -3.00 CA CA A 306s coo 112.10 61.46 19.99 111.82 60.65 18.07 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 117.85 63.62 21.08 115.96 63.25 20.18 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 118.47 57.23 15.57 119.32 58.77 16.73 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 6 3 # 6 B 55 ASP A 197 ASP.? 9.27 CA CA A 306 B 58 ASP A 196 ASP.? 6.39 CA CA A 306 B 424 GLU A 112 GLU.? -2.98 CA CA A 302s coo 112.10 61.46 19.99 111.82 60.65 18.07 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 117.85 63.62 21.08 115.96 63.25 20.18 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 118.47 57.23 15.57 119.32 58.77 16.73 -2.93 7.09 -5.49 -2.54 7.70 -3.48 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 7 3 # 7 B 55 ASP A 197 ASP.? 9.27 CA CA A 306 B 58 ASP A 196 ASP.? 6.39 CA CA A 306 B 424 GLU A 195 GLU.? -3.34 CA CA A 302s coo 112.10 61.46 19.99 111.82 60.65 18.07 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 117.85 63.62 21.08 115.96 63.25 20.18 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 118.47 57.23 15.57 119.32 58.77 16.73 -3.71 10.89 -2.05 -2.53 10.06 -0.48 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 8 3 # 8 B 55 ASP B 41 ASP.? 25.32 NI NI B 305 B 58 ASP B 42 ASP~? 18.39 NI NI B 305 B 424 GLU B 40 GLU~? 23.91 NI NI B 305 coo 112.10 61.46 19.99 111.82 60.65 18.07 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 117.85 63.62 21.08 115.96 63.25 20.18 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 118.47 57.23 15.57 119.32 58.77 16.73 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 9 3 # 9 B 55 ASP B 42 ASP~? 18.39 NI NI B 305 B 58 ASP B 41 ASP.? 25.32 NI NI B 305 B 424 GLU B 40 GLU~? 23.91 NI NI B 305 coo 112.10 61.46 19.99 111.82 60.65 18.07 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 117.85 63.62 21.08 115.96 63.25 20.18 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 118.47 57.23 15.57 119.32 58.77 16.73 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 10 3 # 10 B 55 ASP B 196 ASP.? 23.47 NI NI B 305 B 58 ASP B 197 ASP.? 18.81 NI NI B 305 B 424 GLU B 32 GLU~? 21.76 NI NI B 305 coo 112.10 61.46 19.99 111.82 60.65 18.07 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 117.85 63.62 21.08 115.96 63.25 20.18 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 118.47 57.23 15.57 119.32 58.77 16.73 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 11 3 # 11 B 55 ASP B 196 ASP.? 23.47 NI NI B 305 B 58 ASP B 197 ASP.? 18.81 NI NI B 305 B 424 GLU B 112 GLU.? -22.76 NI NI B 305s coo 112.10 61.46 19.99 111.82 60.65 18.07 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 117.85 63.62 21.08 115.96 63.25 20.18 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 118.47 57.23 15.57 119.32 58.77 16.73 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 12 3 # 12 B 55 ASP B 197 ASP.? 18.81 NI NI B 305 B 58 ASP B 196 ASP.? 23.47 NI NI B 305 B 424 GLU B 32 GLU~? 21.76 NI NI B 305 coo 112.10 61.46 19.99 111.82 60.65 18.07 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 117.85 63.62 21.08 115.96 63.25 20.18 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 118.47 57.23 15.57 119.32 58.77 16.73 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 13 3 # 13 B 55 ASP B 197 ASP.? 18.81 NI NI B 305 B 58 ASP B 196 ASP.? 23.47 NI NI B 305 B 424 GLU B 112 GLU.? -22.76 NI NI B 305s coo 112.10 61.46 19.99 111.82 60.65 18.07 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 117.85 63.62 21.08 115.96 63.25 20.18 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 118.47 57.23 15.57 119.32 58.77 16.73 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 ULMN 3 1js4_c01 ENDO-EXOCELLULASE E4 user 14 3 # 14 B 55 ASP B 197 ASP.? 18.81 NI NI B 305 B 58 ASP B 196 ASP.? 23.47 NI NI B 305 B 424 GLU B 195 GLU.? -26.54 NI NI B 305s coo 112.10 61.46 19.99 111.82 60.65 18.07 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 117.85 63.62 21.08 115.96 63.25 20.18 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 118.47 57.23 15.57 119.32 58.77 16.73 -0.96 -11.31 -77.84 -0.63 -11.36 -79.94 1js4_c01 source 1js4 ENDO-EXOCELLULASE E4 : 14 hits 1js4_c01 naa= 3 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 A 1 CYH A 49 CYH~? 14.80 NI NI A 304 A 98 ASN A 52 ASN~? 15.92 NI NI A 304 A 99 GLY A 53 GLY~? 18.18 NI NI A 304 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1jxa_c02 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 A 1 CYH B 49 CYH~? 14.83 NI NI B 305 A 98 ASN B 52 ASN~? 15.59 NI NI B 305 A 99 GLY B 53 GLY~? 17.62 NI NI B 305 coo -28.39 5.74 -1.35 -27.45 6.62 -3.77 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo -31.76 2.35 -3.84 -31.22 3.45 -2.16 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo -29.05 1.23 -7.23 -29.18 1.88 -7.63 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1jxa_c02 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c02 naa= 3 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 3 # 1 C 1 CYH A 49 CYH~? 14.80 NI NI A 304 C 98 ASN A 52 ASN~? 15.92 NI NI A 304 C 99 GLY A 53 GLY~? 18.18 NI NI A 304 coo 4.88 17.74 73.58 7.14 19.23 72.93 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 8.21 16.91 78.64 7.09 18.75 78.67 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo 11.04 18.39 74.90 10.95 17.56 74.65 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 ULMN 3 1jxa_c04 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 3 # 2 C 1 CYH B 49 CYH~? 14.83 NI NI B 305 C 98 ASN B 52 ASN~? 15.59 NI NI B 305 C 99 GLY B 53 GLY~? 17.62 NI NI B 305 coo 4.88 17.74 73.58 7.14 19.23 72.93 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 8.21 16.91 78.64 7.09 18.75 78.67 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 11.04 18.39 74.90 10.95 17.56 74.65 -9.40 5.82 -68.64 -9.89 5.39 -68.12 1jxa_c04 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c04 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 144 GLU^? 14.15 NI NI A 304 A 56 LYS A 142 LYS^? 14.03 NI NI A 304 A 258 ARG A 147 ARG~? 21.93 NI NI A 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 144 GLU^? 14.15 NI NI A 304 A 56 LYS A 142 LYS^? 14.03 NI NI A 304 A 258 ARG A 157 ARG.? 25.34 NI NI A 304 coo 42.33 1.56 26.99 42.38 2.91 28.66 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 9.58 14.02 -35.46 8.24 13.80 -38.23 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 144 GLU^? 13.93 NI NI B 305 A 56 LYS B 142 LYS^? 13.37 NI NI B 305 A 258 ARG B 147 ARG.? 21.34 NI NI B 305 coo 42.33 1.56 26.99 42.38 2.91 28.66 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 A 2 GLU B 144 GLU^? 13.93 NI NI B 305 A 56 LYS B 142 LYS^? 13.37 NI NI B 305 A 258 ARG B 157 ARG.? 25.43 NI NI B 305 coo 42.33 1.56 26.99 42.38 2.91 28.66 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 38.45 -0.44 19.89 37.36 0.90 25.90 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 12.04 -10.72 -45.32 11.38 -11.87 -42.55 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 144 GLU^? 14.15 NI NI A 304 B 56 LYS A 142 LYS^? 14.03 NI NI A 304 B 258 ARG A 147 ARG~? 21.93 NI NI A 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 2.64 1.83 34.81 1.56 1.13 32.02 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 144 GLU^? 14.15 NI NI A 304 B 56 LYS A 142 LYS^? 14.03 NI NI A 304 B 258 ARG A 157 ARG.? 25.34 NI NI A 304 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 2.64 1.83 34.81 1.56 1.13 32.02 9.58 14.02 -35.46 8.24 13.80 -38.23 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 144 GLU^? 13.93 NI NI B 305 B 56 LYS B 142 LYS^? 13.37 NI NI B 305 B 258 ARG B 147 ARG.? 21.34 NI NI B 305 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 2.64 1.83 34.81 1.56 1.13 32.02 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 144 GLU^? 13.93 NI NI B 305 B 56 LYS B 142 LYS^? 13.37 NI NI B 305 B 258 ARG B 157 ARG.? 25.43 NI NI B 305 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 2.64 1.83 34.81 1.56 1.13 32.02 12.04 -10.72 -45.32 11.38 -11.87 -42.55 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 144 GLU^? 14.15 NI NI A 304 C 56 LYS A 142 LYS^? 14.03 NI NI A 304 C 258 ARG A 147 ARG~? 21.93 NI NI A 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 144 GLU^? 14.15 NI NI A 304 C 56 LYS A 142 LYS^? 14.03 NI NI A 304 C 258 ARG A 157 ARG.? 25.34 NI NI A 304 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 9.58 14.02 -35.46 8.24 13.80 -38.23 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 144 GLU^? 13.93 NI NI B 305 C 56 LYS B 142 LYS^? 13.37 NI NI B 305 C 258 ARG B 147 ARG.? 21.34 NI NI B 305 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 C 2 GLU B 144 GLU^? 13.93 NI NI B 305 C 56 LYS B 142 LYS^? 13.37 NI NI B 305 C 258 ARG B 157 ARG.? 25.43 NI NI B 305 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 12.04 -10.72 -45.32 11.38 -11.87 -42.55 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 144 GLU^? 14.15 NI NI A 304 D 56 LYS A 142 LYS^? 14.03 NI NI A 304 D 258 ARG A 147 ARG~? 21.93 NI NI A 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 144 GLU^? 14.15 NI NI A 304 D 56 LYS A 142 LYS^? 14.03 NI NI A 304 D 258 ARG A 157 ARG.? 25.34 NI NI A 304 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 9.58 14.02 -35.46 8.24 13.80 -38.23 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 144 GLU^? 13.93 NI NI B 305 D 56 LYS B 142 LYS^? 13.37 NI NI B 305 D 258 ARG B 147 ARG.? 21.34 NI NI B 305 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 3.78 -8.72 -40.00 5.97 -10.16 -41.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 D 2 GLU B 144 GLU^? 13.93 NI NI B 305 D 56 LYS B 142 LYS^? 13.37 NI NI B 305 D 258 ARG B 157 ARG.? 25.43 NI NI B 305 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 12.04 -10.72 -45.32 11.38 -11.87 -42.55 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c03 naa= 3 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 54 TYR.? 11.09 NI NI A 304 A 689 HIS A 116 HIS^? 7.23 NI NI A 304 A 732 ASN A 108 ASN^? 7.27 NI NI A 304 coo 22.52 29.89 18.33 23.85 28.06 20.03 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 24.46 23.36 17.42 25.88 24.61 18.33 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 27.06 24.40 21.98 27.51 26.43 21.46 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1kdg_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR B 54 TYR.? 11.06 NI NI B 305 A 689 HIS B 116 HIS^? 6.69 NI NI B 305 A 732 ASN B 108 ASN^? 7.81 NI NI B 305 coo 22.52 29.89 18.33 23.85 28.06 20.03 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 coo 24.46 23.36 17.42 25.88 24.61 18.33 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 27.06 24.40 21.98 27.51 26.43 21.46 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 1kdg_c02 source 1kdg CELLOBIOSE DEHYDROGENASE : 2 hits 1kdg_c02 naa= 3 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 54 TYR.? 11.09 NI NI A 304 B 689 HIS A 116 HIS^? 7.23 NI NI A 304 B 732 ASN A 108 ASN^? 7.27 NI NI A 304 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1kdg_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR B 54 TYR.? 11.06 NI NI B 305 B 689 HIS B 116 HIS^? 6.69 NI NI B 305 B 732 ASN B 108 ASN^? 7.81 NI NI B 305 coo 25.77 15.27 -24.02 28.47 14.70 -24.59 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 coo 31.55 17.32 -20.91 31.51 15.29 -21.43 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 33.56 13.69 -24.17 31.95 12.28 -24.00 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 1kdg_c03 source 1kdg CELLOBIOSE DEHYDROGENASE : 2 hits 1kdg_c03 naa= 3 ULMN 3 1kim_c00 THYMIDINE KINASE user 1 3 # 1 A 83 GLU A 164 GLU~? 25.12 NI NI A 304 A 163 ARG A 162 ARG~? 28.37 NI NI A 304 A 222 ARG A 166 ARG~? 23.27 NI NI A 304 coo 51.27 81.34 48.31 51.67 80.79 50.28 2.03 20.18 -36.55 1.23 21.62 -37.90 coo 48.06 78.22 50.94 48.51 78.27 53.98 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 54.85 84.16 52.60 54.26 81.23 53.34 5.93 17.15 -30.01 7.54 17.94 -27.52 ULMN 3 1kim_c00 THYMIDINE KINASE user 2 3 # 2 A 83 GLU B 101 GLU^? 17.23 CA CA B 303 A 163 ARG B 206 ARG^? 17.11 NI NI B 305 A 222 ARG B 98 ARG.? 11.28 CA CA B 303 coo 51.27 81.34 48.31 51.67 80.79 50.28 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 48.06 78.22 50.94 48.51 78.27 53.98 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 54.85 84.16 52.60 54.26 81.23 53.34 -24.48 -9.95 -37.71 -23.29 -7.54 -36.21 1kim_c00 source 1kim THYMIDINE KINASE : 2 hits 1kim_c00 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 186 ARG^? 12.05 NI NI A 304 A 351 HIS A 119 HIS^? -3.69 NI NI A 304s A 386 LEU A 185 LEU.? 10.10 NI NI A 304 coo 57.36 53.34 128.83 58.45 50.56 128.34 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 coo 60.60 50.64 133.59 60.63 48.82 132.56 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 63.28 54.23 126.45 63.53 52.07 126.70 -6.85 7.54 -32.64 -5.32 9.08 -32.41 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 1 hits 1knp_c00 naa= 3 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 1 3 # 1 198 CYH A 35 CYH~? 11.73 CA CA A 306 229 ASN A 108 ASN^? 7.27 NI NI A 304 232 SER A 202 SER^? 4.82 NI NI A 304 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -21.62 7.57 -11.19 -20.62 8.88 -13.43 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -13.61 4.93 -16.45 -13.33 3.48 -17.96 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 -16.35 6.85 -22.26 -13.93 6.63 -22.28 ULMN 3 1lcb_c00 THYMIDYLATE SYNTHASE user 2 3 # 2 198 CYH B 35 CYH~? 15.94 NI NI B 305 229 ASN B 108 ASN^? 7.81 NI NI B 305 232 SER B 202 SER^? 5.31 NI NI B 305 coo 9.92 49.50 -53.84 12.48 47.89 -53.69 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 coo 9.79 43.22 -47.74 11.15 44.81 -48.24 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 coo 7.03 45.16 -41.61 9.10 46.34 -42.68 -14.59 -10.21 -57.96 -12.31 -9.58 -58.46 1lcb_c00 source 1lcb THYMIDYLATE SYNTHASE : 2 hits 1lcb_c00 naa= 3 ULMN 3 1lci_c00 LUCIFERASE user 1 3 # 1 218 ARG A 198 ARG^? 13.22 CA CA A 306 245 HIS A 187 HIS^? -3.59 NI NI A 304s 343 THR A 129 THR^? 6.33 NI NI A 304 coo 18.11 85.25 41.19 18.04 83.33 43.59 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo 5.34 86.23 43.48 6.16 87.26 45.12 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 9.06 92.76 42.80 7.04 92.63 42.14 -14.59 10.44 -23.35 -13.12 9.26 -22.29 ULMN 3 1lci_c00 LUCIFERASE user 2 3 # 2 218 ARG B 198 ARG^? 13.15 NI NI B 305 245 HIS B 187 HIS^? -3.54 NI NI B 305s 343 THR B 129 THR^? 6.57 NI NI B 305 coo 18.11 85.25 41.19 18.04 83.33 43.59 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 5.34 86.23 43.48 6.16 87.26 45.12 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 9.06 92.76 42.80 7.04 92.63 42.14 -12.09 -13.33 -57.01 -10.85 -11.92 -58.13 1lci_c00 source 1lci LUCIFERASE : 2 hits 1lci_c00 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 145 ASP.? 18.22 NI NI A 304 169 ARG A 147 ARG~? 21.93 NI NI A 304 193 HIS A 148 HIS~? 18.59 NI NI A 304 coo 20.88 15.91 3.60 20.25 17.72 4.50 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 17.70 17.91 -0.80 15.74 19.74 0.84 1.99 9.46 -40.00 3.54 12.00 -39.24 coo 18.81 19.85 7.63 17.55 19.89 5.97 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP B 145 ASP.? 18.27 NI NI B 305 169 ARG B 147 ARG.? 21.34 NI NI B 305 193 HIS B 148 HIS.? 18.38 NI NI B 305 coo 20.88 15.91 3.60 20.25 17.72 4.50 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 17.70 17.91 -0.80 15.74 19.74 0.84 3.78 -8.72 -40.00 5.97 -10.16 -41.63 coo 18.81 19.85 7.63 17.55 19.89 5.97 6.24 -3.74 -47.54 7.83 -3.67 -48.90 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 2 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 44 ALA~? 19.89 CA CA B 303 A 317 GLY A 45 GLY~? 17.79 NI NI A 304 A 318 ASP A 42 ASP~? 18.65 NI NI A 304 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 44 ALA~? 21.16 NI NI B 305 A 317 GLY B 45 GLY~? 17.79 NI NI B 305 A 318 ASP B 42 ASP~? 18.39 NI NI B 305 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -23.24 2.66 -69.27 -24.25 2.76 -68.14 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -20.30 0.43 -68.29 -20.38 0.81 -69.02 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 44 ALA~? 19.89 CA CA B 303 A 317 GLY A 45 GLY~? 17.79 NI NI A 304 A 318 ASP A 42 ASP~? 18.65 NI NI A 304 coo 27.04 23.54 41.85 25.72 24.19 42.18 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 27.87 23.16 38.17 28.43 22.97 38.87 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 coo 32.11 22.71 40.58 33.42 24.22 39.78 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 44 ALA~? 21.16 NI NI B 305 A 317 GLY B 45 GLY~? 17.79 NI NI B 305 A 318 ASP B 42 ASP~? 18.39 NI NI B 305 coo 27.04 23.54 41.85 25.72 24.19 42.18 -23.24 2.66 -69.27 -24.25 2.76 -68.14 coo 27.87 23.16 38.17 28.43 22.97 38.87 -20.30 0.43 -68.29 -20.38 0.81 -69.02 coo 32.11 22.71 40.58 33.42 24.22 39.78 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 1lio_c01 source 1lio ADENOSINE KINASE : 2 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 116 HIS^? 7.23 NI NI A 304 A 45 HIS A 119 HIS^? -3.69 NI NI A 304s A 261 PHE A 203 PHE^? 9.70 NI NI A 304 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -18.96 8.51 -25.60 -17.97 11.08 -26.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 119 HIS^? -3.69 NI NI A 304s A 45 HIS A 187 HIS^? -3.59 NI NI A 304s A 261 PHE A 168 PHE^? 16.43 NI NI A 304 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 4.20 9.10 -27.54 5.46 6.65 -28.03 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS A 119 HIS^? -3.69 NI NI A 304s A 45 HIS A 187 HIS^? -3.59 NI NI A 304s A 261 PHE A 203 PHE^? 9.70 NI NI A 304 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -18.96 8.51 -25.60 -17.97 11.08 -26.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS A 187 HIS^? -3.59 NI NI A 304s A 45 HIS A 119 HIS^? -3.69 NI NI A 304s A 261 PHE A 203 PHE^? 9.70 NI NI A 304 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -18.96 8.51 -25.60 -17.97 11.08 -26.07 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS B 116 HIS^? 6.69 NI NI B 305 A 45 HIS B 119 HIS^? -3.53 NI NI B 305s A 261 PHE B 203 PHE^? 9.81 NI NI B 305 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -16.76 -12.27 -54.75 -15.23 -14.58 -54.58 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS B 119 HIS^? -3.53 NI NI B 305s A 45 HIS B 187 HIS^? -3.54 NI NI B 305s A 261 PHE B 168 PHE^? 16.16 NI NI B 305 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 5.97 -7.92 -52.72 6.39 -5.22 -52.12 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS B 119 HIS^? -3.53 NI NI B 305s A 45 HIS B 187 HIS^? -3.54 NI NI B 305s A 261 PHE B 203 PHE^? 9.81 NI NI B 305 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -16.76 -12.27 -54.75 -15.23 -14.58 -54.58 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS B 187 HIS^? -3.54 NI NI B 305s A 45 HIS B 119 HIS^? -3.53 NI NI B 305s A 261 PHE B 203 PHE^? 9.81 NI NI B 305 coo 49.89 1.93 30.83 50.54 1.43 32.81 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -16.76 -12.27 -54.75 -15.23 -14.58 -54.58 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 8 hits 1luc_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 27 ASP~? -2.92 CA CA A 301s A 295 GLU A 30 GLU~? 7.55 CA CA A 301 A 369 ASP A 75 ASP~? 14.34 CA CA A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 16.11 33.72 80.99 14.10 33.54 81.63 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 104 ASP^? 11.20 NI NI A 304 A 295 GLU A 103 GLU^? 14.47 CA CA B 303 A 369 ASP A 65 ASP~? 19.57 CA CA B 303 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 16.11 33.72 80.99 14.10 33.54 81.63 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 21 ASP~? 19.27 CA CA A 301 A 265 GLU A 30 GLU~? 7.55 CA CA A 301 A 369 ASP A 177 ASP^? 15.76 CA CA A 306 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 21 ASP~? 19.27 CA CA A 301 A 265 GLU A 182 GLU^? 15.51 NI NI A 304 A 369 ASP A 177 ASP^? 15.76 CA CA A 306 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 17.36 23.57 72.04 18.68 21.92 71.98 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 177 ASP^? 15.76 CA CA A 306 A 265 GLU A 30 GLU~? 7.55 CA CA A 301 A 369 ASP A 21 ASP~? 19.27 CA CA A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 12.19 31.08 87.29 11.13 32.66 86.38 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 177 ASP^? 15.76 CA CA A 306 A 265 GLU A 182 GLU^? 15.51 NI NI A 304 A 369 ASP A 21 ASP~? 19.27 CA CA A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 17.36 23.57 72.04 18.68 21.92 71.98 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 12.19 31.08 87.29 11.13 32.66 86.38 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 21 ASP~? 22.52 NI NI B 305 A 265 GLU B 182 GLU^? 15.43 NI NI B 305 A 369 ASP B 177 ASP^? 17.56 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 17.36 23.57 72.04 18.68 21.92 71.98 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 177 ASP^? 17.56 NI NI B 305 A 265 GLU B 30 GLU~? 25.54 NI NI B 305 A 369 ASP B 21 ASP~? 22.52 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 -23.64 -21.41 -69.78 -24.93 -22.08 -68.23 coo 12.19 31.08 87.29 11.13 32.66 86.38 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 177 ASP^? 17.56 NI NI B 305 A 265 GLU B 182 GLU^? 15.43 NI NI B 305 A 369 ASP B 21 ASP~? 22.52 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 17.36 23.57 72.04 18.68 21.92 71.98 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 12.19 31.08 87.29 11.13 32.66 86.38 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 7 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 75 ASP~? 14.34 CA CA A 301 A 279 GLU A 103 GLU^? 14.47 CA CA B 303 A 369 ASP A 27 ASP~? -2.92 CA CA A 301s coo 11.74 38.14 80.19 10.63 36.40 80.65 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 16.54 46.37 63.94 14.77 45.79 62.95 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.76 19.66 -12.70 -25.06 20.72 -11.00 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 81 ASP~? 18.70 NI NI A 304 A 279 GLU A 92 GLU~? 26.61 NI NI A 304 A 369 ASP A 75 ASP~? 14.34 CA CA A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 16.54 46.37 63.94 14.77 45.79 62.95 -15.71 18.15 -44.39 -15.11 19.36 -46.01 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 104 ASP^? 11.20 NI NI A 304 A 279 GLU A 188 GLU^? 11.68 NI NI A 304 A 369 ASP A 65 ASP~? 19.57 CA CA B 303 coo 11.74 38.14 80.19 10.63 36.40 80.65 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 16.54 46.37 63.94 14.77 45.79 62.95 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 12.19 31.08 87.29 11.13 32.66 86.38 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 177 ASP^? 15.76 CA CA A 306 A 279 GLU A 188 GLU^? 11.68 NI NI A 304 A 369 ASP A 21 ASP~? 19.27 CA CA A 301 coo 11.74 38.14 80.19 10.63 36.40 80.65 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 16.54 46.37 63.94 14.77 45.79 62.95 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 12.19 31.08 87.29 11.13 32.66 86.38 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 75 ASP~? 24.42 NI NI B 305 A 279 GLU B 101 GLU^? 17.23 CA CA B 303 A 369 ASP B 27 ASP~? 26.12 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 16.54 46.37 63.94 14.77 45.79 62.95 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 75 ASP~? 24.42 NI NI B 305 A 279 GLU B 103 GLU^? 12.89 NI NI B 305 A 369 ASP B 27 ASP~? 26.12 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 16.54 46.37 63.94 14.77 45.79 62.95 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 12.19 31.08 87.29 11.13 32.66 86.38 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 81 ASP~? 18.56 NI NI B 305 A 279 GLU B 92 GLU.? 12.87 CA CA B 303 A 369 ASP B 75 ASP~? 24.42 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 16.54 46.37 63.94 14.77 45.79 62.95 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 104 ASP^? 11.37 NI NI B 305 A 279 GLU B 188 GLU^? 11.04 NI NI B 305 A 369 ASP B 65 ASP~? 20.64 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 16.54 46.37 63.94 14.77 45.79 62.95 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP B 177 ASP^? 17.56 NI NI B 305 A 279 GLU B 188 GLU^? 11.04 NI NI B 305 A 369 ASP B 21 ASP~? 22.52 NI NI B 305 coo 11.74 38.14 80.19 10.63 36.40 80.65 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 16.54 46.37 63.94 14.77 45.79 62.95 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 12.19 31.08 87.29 11.13 32.66 86.38 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 9 hits 1m53_c06 naa= 3 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 A 10 ASP A 197 ASP.? 9.27 CA CA A 306 A 168 ASN A 192 ASN.? 10.14 CA CA A 302 A 241 HIS A 116 HIS^? 7.23 NI NI A 304 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -4.75 8.04 -11.36 -5.74 9.45 -10.12 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1mas_c00 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 A 10 ASP B 197 ASP.? 18.81 NI NI B 305 A 168 ASN B 192 ASN.? 16.32 NI NI B 305 A 241 HIS B 116 HIS^? 6.69 NI NI B 305 coo 2.16 -17.86 7.84 1.13 -18.57 9.58 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo -3.08 -15.85 14.13 -2.55 -17.63 13.08 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 coo -5.32 -25.12 14.92 -4.53 -26.21 16.52 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 1mas_c00 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c00 naa= 3 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 1 3 # 1 B 10 ASP A 197 ASP.? 9.27 CA CA A 306 B 168 ASN A 192 ASN.? 10.14 CA CA A 302 B 241 HIS A 116 HIS^? 7.23 NI NI A 304 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -4.75 8.04 -11.36 -5.74 9.45 -10.12 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1mas_c01 INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDuser 2 3 # 2 B 10 ASP B 197 ASP.? 18.81 NI NI B 305 B 168 ASN B 192 ASN.? 16.32 NI NI B 305 B 241 HIS B 116 HIS^? 6.69 NI NI B 305 coo -17.05 -4.58 51.44 -17.53 -6.08 49.99 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo -13.80 -8.69 44.98 -15.38 -8.70 46.39 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 coo -21.48 -14.16 44.54 -22.74 -13.73 42.93 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 1mas_c01 source 1mas INOSINE-URIDINE NUCLEOSIDE N-RIBOHYDROLASE : 2 hits 1mas_c01 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG B 206 ARG^? 17.11 NI NI B 305 229 SER B 124 SER.? 10.06 NI NI B 305 325 GLU B 103 GLU^? 12.89 NI NI B 305 coo 2.54 15.84 18.57 3.24 17.85 16.30 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 10.17 13.48 15.92 9.61 15.76 15.27 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo 5.42 13.04 19.75 5.74 13.81 17.79 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 1 hits 1mbb_c00 naa= 3 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 A 199 HIS A 83 HIS~? 17.38 NI NI A 304 A 246 HIS A 16 HIS^? 15.61 NI NI A 304 A 255 TYR A 131 TYR^? 10.29 NI NI A 304 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 A 199 HIS A 121 HIS.? -3.63 NI NI A 304s A 246 HIS A 116 HIS^? 7.23 NI NI A 304 A 255 TYR A 54 TYR.? 11.09 NI NI A 304 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 A 199 HIS A 123 HIS.? 13.29 CA CA B 303 A 246 HIS A 121 HIS.? -3.63 NI NI A 304s A 255 TYR A 60 TYR.? 8.44 NI NI A 304 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 A 199 HIS B 83 HIS~? 17.68 NI NI B 305 A 246 HIS B 16 HIS^? 15.81 NI NI B 305 A 255 TYR B 131 TYR^? 10.67 NI NI B 305 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 A 199 HIS B 121 HIS.? -3.60 NI NI B 305s A 246 HIS B 116 HIS^? 6.69 NI NI B 305 A 255 TYR B 54 TYR.? 11.06 NI NI B 305 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 A 199 HIS B 123 HIS.? 14.82 NI NI B 305 A 246 HIS B 121 HIS.? -3.60 NI NI B 305s A 255 TYR B 60 TYR.? 9.06 NI NI B 305 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 1mpy_c00 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS A 83 HIS~? 17.38 NI NI A 304 B 246 HIS A 16 HIS^? 15.61 NI NI A 304 B 255 TYR A 131 TYR^? 10.29 NI NI A 304 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS A 121 HIS.? -3.63 NI NI A 304s B 246 HIS A 116 HIS^? 7.23 NI NI A 304 B 255 TYR A 54 TYR.? 11.09 NI NI A 304 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 B 199 HIS A 123 HIS.? 13.29 CA CA B 303 B 246 HIS A 121 HIS.? -3.63 NI NI A 304s B 255 TYR A 60 TYR.? 8.44 NI NI A 304 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 B 199 HIS B 83 HIS~? 17.68 NI NI B 305 B 246 HIS B 16 HIS^? 15.81 NI NI B 305 B 255 TYR B 131 TYR^? 10.67 NI NI B 305 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 B 199 HIS B 121 HIS.? -3.60 NI NI B 305s B 246 HIS B 116 HIS^? 6.69 NI NI B 305 B 255 TYR B 54 TYR.? 11.06 NI NI B 305 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 B 199 HIS B 123 HIS.? 14.82 NI NI B 305 B 246 HIS B 121 HIS.? -3.60 NI NI B 305s B 255 TYR B 60 TYR.? 9.06 NI NI B 305 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 83 HIS~? 17.38 NI NI A 304 C 246 HIS A 16 HIS^? 15.61 NI NI A 304 C 255 TYR A 131 TYR^? 10.29 NI NI A 304 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS A 121 HIS.? -3.63 NI NI A 304s C 246 HIS A 116 HIS^? 7.23 NI NI A 304 C 255 TYR A 54 TYR.? 11.09 NI NI A 304 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 C 199 HIS A 123 HIS.? 13.29 CA CA B 303 C 246 HIS A 121 HIS.? -3.63 NI NI A 304s C 255 TYR A 60 TYR.? 8.44 NI NI A 304 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 C 199 HIS B 83 HIS~? 17.68 NI NI B 305 C 246 HIS B 16 HIS^? 15.81 NI NI B 305 C 255 TYR B 131 TYR^? 10.67 NI NI B 305 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 C 199 HIS B 121 HIS.? -3.60 NI NI B 305s C 246 HIS B 116 HIS^? 6.69 NI NI B 305 C 255 TYR B 54 TYR.? 11.06 NI NI B 305 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 C 199 HIS B 123 HIS.? 14.82 NI NI B 305 C 246 HIS B 121 HIS.? -3.60 NI NI B 305s C 255 TYR B 60 TYR.? 9.06 NI NI B 305 coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS A 83 HIS~? 17.38 NI NI A 304 D 246 HIS A 16 HIS^? 15.61 NI NI A 304 D 255 TYR A 131 TYR^? 10.29 NI NI A 304 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS A 121 HIS.? -3.63 NI NI A 304s D 246 HIS A 116 HIS^? 7.23 NI NI A 304 D 255 TYR A 54 TYR.? 11.09 NI NI A 304 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS A 123 HIS.? 13.29 CA CA B 303 D 246 HIS A 121 HIS.? -3.63 NI NI A 304s D 255 TYR A 60 TYR.? 8.44 NI NI A 304 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS B 83 HIS~? 17.68 NI NI B 305 D 246 HIS B 16 HIS^? 15.81 NI NI B 305 D 255 TYR B 131 TYR^? 10.67 NI NI B 305 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 D 199 HIS B 121 HIS.? -3.60 NI NI B 305s D 246 HIS B 116 HIS^? 6.69 NI NI B 305 D 255 TYR B 54 TYR.? 11.06 NI NI B 305 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 D 199 HIS B 123 HIS.? 14.82 NI NI B 305 D 246 HIS B 121 HIS.? -3.60 NI NI B 305s D 255 TYR B 60 TYR.? 9.06 NI NI B 305 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 97 GLY.? 26.69 NI NI B 305 A 501 ASP B 65 ASP~? 20.64 NI NI B 305 B 367 TYR A 60 TYR.? 8.44 NI NI A 304 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -28.92 9.22 -45.08 -28.19 9.03 -44.77 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 23 GLY.? 23.03 NI NI B 305 A 501 ASP B 96 ASP.? 4.50 CA CA B 303 B 367 TYR B 57 TYR^? 15.35 NI NI B 305 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY B 53 GLY~? 17.62 NI NI B 305 A 501 ASP A 94 ASP.? 21.52 NI NI B 305 B 367 TYR B 170 TYR^? 15.66 NI NI B 305 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -9.40 5.82 -68.64 -9.89 5.39 -68.12 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 4.23 -12.71 -57.64 5.48 -10.20 -57.84 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 97 GLY.? 8.10 CA CA B 303 A 501 ASP A 65 ASP~? 19.57 CA CA B 303 B 367 TYR B 60 TYR.? 9.06 NI NI B 305 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -26.11 -15.86 -35.36 -25.49 -15.39 -35.65 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 53 GLY~? 18.18 NI NI A 304 D 501 ASP B 94 ASP.? -2.87 CA CA B 303s E 367 TYR A 170 TYR^? 15.79 NI NI A 304 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -8.34 -7.80 -11.09 -8.80 -7.49 -11.73 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 1.42 13.38 -22.88 3.34 11.36 -22.90 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 23 GLY.? 23.03 NI NI B 305 D 501 ASP B 96 ASP.? 4.50 CA CA B 303 E 367 TYR B 57 TYR^? 15.35 NI NI B 305 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -22.34 -25.18 -54.28 -21.98 -25.83 -54.55 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 53 GLY~? 17.62 NI NI B 305 D 501 ASP A 94 ASP.? 21.52 NI NI B 305 E 367 TYR B 170 TYR^? 15.66 NI NI B 305 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -9.40 5.82 -68.64 -9.89 5.39 -68.12 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 4.23 -12.71 -57.64 5.48 -10.20 -57.84 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 97 GLY.? 8.10 CA CA B 303 D 501 ASP A 65 ASP~? 19.57 CA CA B 303 E 367 TYR B 60 TYR.? 9.06 NI NI B 305 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -26.11 -15.86 -35.36 -25.49 -15.39 -35.65 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 22 HIS~? 21.70 NI NI A 304 A 197 ASP A 81 ASP~? 18.70 NI NI A 304 A 223 ALA A 25 ALA.? 10.05 CA CA A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -27.53 21.43 -19.09 -28.16 22.48 -18.18 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 22 HIS~? 21.70 NI NI A 304 A 197 ASP A 81 ASP~? 18.70 NI NI A 304 A 223 ALA A 88 ALA~? 18.79 NI NI A 304 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -18.23 14.39 -38.25 -19.54 13.62 -38.30 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 83 HIS~? 17.38 NI NI A 304 A 197 ASP A 21 ASP~? 19.27 CA CA A 301 A 223 ALA A 28 ALA~? 7.72 CA CA A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -21.16 18.40 -13.00 -19.95 19.32 -13.09 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 83 HIS~? 17.38 NI NI A 304 A 197 ASP A 21 ASP~? 19.27 CA CA A 301 A 223 ALA A 174 ALA.? 13.13 CA CA A 306 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -10.72 19.94 -17.13 -10.98 21.44 -17.19 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 83 HIS~? 17.38 NI NI A 304 A 197 ASP A 81 ASP~? 18.70 NI NI A 304 A 223 ALA A 25 ALA.? 10.05 CA CA A 301 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -27.53 21.43 -19.09 -28.16 22.48 -18.18 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 22 HIS~? 22.02 NI NI B 305 A 197 ASP B 81 ASP~? 18.56 NI NI B 305 A 223 ALA B 88 ALA~? 13.21 CA CA B 303 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 83 HIS~? 17.68 NI NI B 305 A 197 ASP B 21 ASP~? 22.52 NI NI B 305 A 223 ALA B 28 ALA~? 21.68 NI NI B 305 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -16.96 -22.63 -67.34 -15.58 -23.27 -67.25 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 83 HIS~? 17.68 NI NI B 305 A 197 ASP B 21 ASP~? 22.52 NI NI B 305 A 223 ALA B 174 ALA.? 19.22 NI NI B 305 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -6.23 -21.90 -62.97 -6.14 -23.42 -62.87 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 A 114 HIS B 83 HIS~? 17.68 NI NI B 305 A 197 ASP B 81 ASP~? 18.56 NI NI B 305 A 223 ALA B 25 ALA.? 26.17 NI NI B 305 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -22.22 -26.73 -60.90 -22.43 -27.99 -61.69 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 9 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 22 HIS~? 21.70 NI NI A 304 B 197 ASP A 81 ASP~? 18.70 NI NI A 304 B 223 ALA A 25 ALA.? 10.05 CA CA A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -27.53 21.43 -19.09 -28.16 22.48 -18.18 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 22 HIS~? 21.70 NI NI A 304 B 197 ASP A 81 ASP~? 18.70 NI NI A 304 B 223 ALA A 88 ALA~? 18.79 NI NI A 304 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -18.23 14.39 -38.25 -19.54 13.62 -38.30 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 83 HIS~? 17.38 NI NI A 304 B 197 ASP A 21 ASP~? 19.27 CA CA A 301 B 223 ALA A 28 ALA~? 7.72 CA CA A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -21.16 18.40 -13.00 -19.95 19.32 -13.09 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 83 HIS~? 17.38 NI NI A 304 B 197 ASP A 21 ASP~? 19.27 CA CA A 301 B 223 ALA A 174 ALA.? 13.13 CA CA A 306 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -10.72 19.94 -17.13 -10.98 21.44 -17.19 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 83 HIS~? 17.38 NI NI A 304 B 197 ASP A 81 ASP~? 18.70 NI NI A 304 B 223 ALA A 25 ALA.? 10.05 CA CA A 301 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -27.53 21.43 -19.09 -28.16 22.48 -18.18 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 22 HIS~? 22.02 NI NI B 305 B 197 ASP B 81 ASP~? 18.56 NI NI B 305 B 223 ALA B 88 ALA~? 13.21 CA CA B 303 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 83 HIS~? 17.68 NI NI B 305 B 197 ASP B 21 ASP~? 22.52 NI NI B 305 B 223 ALA B 28 ALA~? 21.68 NI NI B 305 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -16.96 -22.63 -67.34 -15.58 -23.27 -67.25 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 83 HIS~? 17.68 NI NI B 305 B 197 ASP B 21 ASP~? 22.52 NI NI B 305 B 223 ALA B 174 ALA.? 19.22 NI NI B 305 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -6.23 -21.90 -62.97 -6.14 -23.42 -62.87 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 9 3 # 9 B 114 HIS B 83 HIS~? 17.68 NI NI B 305 B 197 ASP B 81 ASP~? 18.56 NI NI B 305 B 223 ALA B 25 ALA.? 26.17 NI NI B 305 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -22.22 -26.73 -60.90 -22.43 -27.99 -61.69 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 9 hits 1n2t_c03 naa= 3 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 A 609 TYR A 54 TYR.? 11.09 NI NI A 304 A 689 HIS A 116 HIS^? 7.23 NI NI A 304 A 732 ASN A 108 ASN^? 7.27 NI NI A 304 coo 23.89 30.33 18.51 26.53 29.83 17.65 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 24.69 23.24 17.44 26.23 24.43 18.22 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 27.47 24.40 22.13 27.89 26.42 21.78 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 A 609 TYR B 54 TYR.? 11.06 NI NI B 305 A 689 HIS B 116 HIS^? 6.69 NI NI B 305 A 732 ASN B 108 ASN^? 7.81 NI NI B 305 coo 23.89 30.33 18.51 26.53 29.83 17.65 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 coo 24.69 23.24 17.44 26.23 24.43 18.22 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 27.47 24.40 22.13 27.89 26.42 21.78 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 ULMN 3 1naa_c02 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 A 609 TYR B 60 TYR.? 9.06 NI NI B 305 A 689 HIS B 121 HIS.? -3.60 NI NI B 305s A 732 ASN B 204 ASN^? 6.73 NI NI B 305 coo 23.89 30.33 18.51 26.53 29.83 17.65 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 coo 24.69 23.24 17.44 26.23 24.43 18.22 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 27.47 24.40 22.13 27.89 26.42 21.78 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 1naa_c02 source 1naa CELLOBIOSE DEHYDROGENASE : 3 hits 1naa_c02 naa= 3 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 1 3 # 1 B 609 TYR A 54 TYR.? 11.09 NI NI A 304 B 689 HIS A 116 HIS^? 7.23 NI NI A 304 B 732 ASN A 108 ASN^? 7.27 NI NI A 304 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 2 3 # 2 B 609 TYR A 60 TYR.? 8.44 NI NI A 304 B 689 HIS A 121 HIS.? -3.63 NI NI A 304s B 732 ASN A 204 ASN^? 6.50 NI NI A 304 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -18.02 3.14 -29.01 -15.99 2.73 -28.54 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 3 3 # 3 B 609 TYR B 54 TYR.? 11.06 NI NI B 305 B 689 HIS B 116 HIS^? 6.69 NI NI B 305 B 732 ASN B 108 ASN^? 7.81 NI NI B 305 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 ULMN 3 1naa_c03 CELLOBIOSE DEHYDROGENASE user 4 3 # 4 B 609 TYR B 60 TYR.? 9.06 NI NI B 305 B 689 HIS B 121 HIS.? -3.60 NI NI B 305s B 732 ASN B 204 ASN^? 6.73 NI NI B 305 coo 26.13 14.71 -23.89 27.40 13.01 -22.05 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 coo 31.95 18.02 -21.08 31.88 15.94 -21.37 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 33.92 13.94 -24.42 32.27 12.62 -24.35 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 1naa_c03 source 1naa CELLOBIOSE DEHYDROGENASE : 4 hits 1naa_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP A 21 ASP~? 19.27 CA CA A 301 A 208 HIS A 22 HIS~? 21.70 NI NI A 304 C 104 HIS A 83 HIS~? 17.38 NI NI A 304 coo 20.72 31.33 73.27 20.15 33.36 73.56 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 17.00 33.82 71.84 16.59 31.98 70.88 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 20.06 38.06 74.21 21.19 36.81 72.96 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP B 21 ASP~? 22.52 NI NI B 305 A 208 HIS B 22 HIS~? 22.02 NI NI B 305 C 104 HIS B 83 HIS~? 17.68 NI NI B 305 coo 20.72 31.33 73.27 20.15 33.36 73.56 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 17.00 33.82 71.84 16.59 31.98 70.88 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 20.06 38.06 74.21 21.19 36.81 72.96 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS A 83 HIS~? 17.38 NI NI A 304 E 205 ASP A 21 ASP~? 19.27 CA CA A 301 E 208 HIS A 22 HIS~? 21.70 NI NI A 304 coo 36.32 11.24 30.83 37.00 13.22 30.81 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 38.79 15.70 26.44 37.66 14.35 27.62 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 34.24 14.63 26.81 34.14 16.25 25.49 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS B 83 HIS~? 17.68 NI NI B 305 E 205 ASP B 21 ASP~? 22.52 NI NI B 305 E 208 HIS B 22 HIS~? 22.02 NI NI B 305 coo 36.32 11.24 30.83 37.00 13.22 30.81 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 38.79 15.70 26.44 37.66 14.35 27.62 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 34.24 14.63 26.81 34.14 16.25 25.49 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP A 21 ASP~? 19.27 CA CA A 301 C 208 HIS A 22 HIS~? 21.70 NI NI A 304 E 104 HIS A 83 HIS~? 17.38 NI NI A 304 coo 36.50 67.03 37.59 36.77 66.38 35.61 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 33.45 66.12 34.16 32.13 66.40 35.76 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 38.29 64.94 31.33 38.08 64.16 33.27 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP B 21 ASP~? 22.52 NI NI B 305 C 208 HIS B 22 HIS~? 22.02 NI NI B 305 E 104 HIS B 83 HIS~? 17.68 NI NI B 305 coo 36.50 67.03 37.59 36.77 66.38 35.61 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 33.45 66.12 34.16 32.13 66.40 35.76 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 38.29 64.94 31.33 38.08 64.16 33.27 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c02 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 119 HIS^? -3.69 NI NI A 304s A 290 LYS A 142 LYS^? 14.03 NI NI A 304 A 405 ARG A 198 ARG^? 13.22 CA CA A 306 coo 41.33 25.99 28.05 41.95 26.95 29.80 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 37.11 33.75 31.82 38.72 27.95 29.90 -1.82 9.73 -24.13 2.97 5.99 -23.26 coo 42.28 27.98 41.30 43.16 28.14 38.35 -7.58 10.63 -14.31 -5.28 12.67 -14.13 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 119 HIS^? -3.53 NI NI B 305s A 290 LYS B 142 LYS^? 13.37 NI NI B 305 A 405 ARG B 198 ARG^? 13.15 NI NI B 305 coo 41.33 25.99 28.05 41.95 26.95 29.80 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 37.11 33.75 31.82 38.72 27.95 29.90 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 42.28 27.98 41.30 43.16 28.14 38.35 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 182 GLU^? 15.51 NI NI A 304 B 128 HIS A 187 HIS^? -3.59 NI NI A 304s C 263 HIS A 16 HIS^? 15.61 NI NI A 304 coo 6.12 5.94 82.00 7.16 6.32 83.81 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 12.51 16.35 80.99 13.16 14.90 82.37 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 11.58 14.94 93.26 12.25 14.03 91.50 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU A 182 GLU^? 15.51 NI NI A 304 B 128 HIS B 123 HIS.? 14.82 NI NI B 305 C 263 HIS A 123 HIS.? 13.29 CA CA B 303 coo 6.12 5.94 82.00 7.16 6.32 83.81 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 12.51 16.35 80.99 13.16 14.90 82.37 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 11.58 14.94 93.26 12.25 14.03 91.50 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU B 182 GLU^? 15.43 NI NI B 305 B 128 HIS B 16 HIS^? 15.81 NI NI B 305 C 263 HIS B 83 HIS~? 17.68 NI NI B 305 coo 6.12 5.94 82.00 7.16 6.32 83.81 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 12.51 16.35 80.99 13.16 14.90 82.37 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 11.58 14.94 93.26 12.25 14.03 91.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 B 59 GLU B 182 GLU^? 15.43 NI NI B 305 B 128 HIS B 187 HIS^? -3.54 NI NI B 305s C 263 HIS B 16 HIS^? 15.81 NI NI B 305 coo 6.12 5.94 82.00 7.16 6.32 83.81 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 12.51 16.35 80.99 13.16 14.90 82.37 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 11.58 14.94 93.26 12.25 14.03 91.50 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 B 59 GLU B 182 GLU^? 15.43 NI NI B 305 B 128 HIS B 187 HIS^? -3.54 NI NI B 305s C 263 HIS B 148 HIS.? 18.38 NI NI B 305 coo 6.12 5.94 82.00 7.16 6.32 83.81 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 12.51 16.35 80.99 13.16 14.90 82.37 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 11.58 14.94 93.26 12.25 14.03 91.50 6.24 -3.74 -47.54 7.83 -3.67 -48.90 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 5 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 16 HIS^? 15.61 NI NI A 304 D 59 GLU A 182 GLU^? 15.51 NI NI A 304 D 128 HIS A 187 HIS^? -3.59 NI NI A 304s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 123 HIS.? 13.29 CA CA B 303 D 59 GLU A 182 GLU^? 15.51 NI NI A 304 D 128 HIS B 123 HIS.? 14.82 NI NI B 305 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -17.13 0.41 -45.08 -16.63 2.43 -44.85 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS B 16 HIS^? 15.81 NI NI B 305 D 59 GLU B 182 GLU^? 15.43 NI NI B 305 D 128 HIS B 187 HIS^? -3.54 NI NI B 305s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS B 83 HIS~? 17.68 NI NI B 305 D 59 GLU B 182 GLU^? 15.43 NI NI B 305 D 128 HIS B 16 HIS^? 15.81 NI NI B 305 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 4 hits 1ni4_c01 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 98 ARG.? 20.57 NI NI B 305 A 101 ASP A 96 ASP.? 21.09 NI NI B 305 A 132 ASP A 94 ASP.? 21.52 NI NI B 305 coo 11.61 22.83 17.30 14.06 21.71 15.78 -25.95 5.08 -43.97 -24.52 2.34 -44.05 coo 11.37 24.94 11.48 12.48 24.45 13.28 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 16.14 18.17 13.37 15.92 19.81 14.71 -19.72 10.83 -48.01 -21.47 10.84 -49.25 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 1 hits 1nu3_c00 naa= 3 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 1 3 # 1 A 62 SER A 118 SER^? 9.86 NI NI A 304 A 154 ASP A 145 ASP.? 18.22 NI NI A 304 A 261 ARG A 186 ARG^? 12.05 NI NI A 304 coo 16.10 74.10 3.11 17.18 73.52 5.20 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo 16.07 84.71 8.14 15.20 82.81 8.14 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 10.59 77.85 4.81 13.09 76.36 5.76 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 2 3 # 2 A 62 SER A 200 SER^? 8.62 NI NI A 304 A 154 ASP A 196 ASP.? 6.39 CA CA A 306 A 261 ARG A 198 ARG^? 13.22 CA CA A 306 coo 16.10 74.10 3.11 17.18 73.52 5.20 -14.80 9.62 -16.70 -13.06 8.20 -17.63 coo 16.07 84.71 8.14 15.20 82.81 8.14 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 10.59 77.85 4.81 13.09 76.36 5.76 -7.58 10.63 -14.31 -5.28 12.67 -14.13 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 3 3 # 3 A 62 SER B 115 SER.? 13.16 NI NI B 305 A 154 ASP B 197 ASP.? 18.81 NI NI B 305 A 261 ARG B 198 ARG^? 13.15 NI NI B 305 coo 16.10 74.10 3.11 17.18 73.52 5.20 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 16.07 84.71 8.14 15.20 82.81 8.14 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 10.59 77.85 4.81 13.09 76.36 5.76 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 4 3 # 4 A 62 SER B 118 SER^? 9.81 NI NI B 305 A 154 ASP B 145 ASP.? 18.27 NI NI B 305 A 261 ARG B 186 ARG^? 11.32 NI NI B 305 coo 16.10 74.10 3.11 17.18 73.52 5.20 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo 16.07 84.71 8.14 15.20 82.81 8.14 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 10.59 77.85 4.81 13.09 76.36 5.76 -0.49 -2.47 -50.17 -2.28 -0.14 -49.29 ULMN 3 1o98_c00 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT user 5 3 # 5 A 62 SER B 200 SER^? 8.90 NI NI B 305 A 154 ASP B 196 ASP.? 23.47 NI NI B 305 A 261 ARG B 198 ARG^? 13.15 NI NI B 305 coo 16.10 74.10 3.11 17.18 73.52 5.20 -12.57 -12.65 -63.59 -11.16 -10.79 -62.91 coo 16.07 84.71 8.14 15.20 82.81 8.14 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 10.59 77.85 4.81 13.09 76.36 5.76 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 1o98_c00 source 1o98 2,3-BISPHOSPHOGLYCERATE-INDEPENDENT PHOSPHOGLY: 5 hits 1o98_c00 naa= 3 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 A 1 CYH A 49 CYH~? 14.80 NI NI A 304 A 903 GLU A 101 GLU^? 20.45 NI NI A 304 A 972 LYS A 78 LYS~? 23.27 CA CA A 301 coo 88.42 112.53 24.94 87.72 110.88 27.11 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 61.58 117.15 13.99 62.31 115.51 15.12 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 60.18 107.64 21.53 58.13 110.55 17.14 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1ofd_c02 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 A 1 CYH B 49 CYH~? 14.83 NI NI B 305 A 903 GLU B 101 GLU^? 17.23 CA CA B 303 A 972 LYS B 78 LYS~? 25.94 CA CA B 303 coo 88.42 112.53 24.94 87.72 110.88 27.11 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 61.58 117.15 13.99 62.31 115.51 15.12 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 60.18 107.64 21.53 58.13 110.55 17.14 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1ofd_c02 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 2 hits 1ofd_c02 naa= 3 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 1 3 # 1 B 1 CYH A 49 CYH~? 14.80 NI NI A 304 B 903 GLU A 101 GLU^? 20.45 NI NI A 304 B 972 LYS A 78 LYS~? 23.27 CA CA A 301 coo 31.47 38.87 24.90 30.94 36.98 26.93 -13.59 -5.88 -11.58 -14.45 -3.37 -12.41 coo 4.13 40.53 14.21 5.06 38.89 15.19 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 4.08 30.40 21.12 1.62 33.28 16.83 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1ofd_c03 FERREDOXIN-DEPENDENT GLUTAMATE SYNTHuser 2 3 # 2 B 1 CYH B 49 CYH~? 14.83 NI NI B 305 B 903 GLU B 101 GLU^? 17.23 CA CA B 303 B 972 LYS B 78 LYS~? 25.94 CA CA B 303 coo 31.47 38.87 24.90 30.94 36.98 26.93 -14.53 2.94 -68.74 -14.94 0.30 -67.91 coo 4.13 40.53 14.21 5.06 38.89 15.19 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 4.08 30.40 21.12 1.62 33.28 16.83 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1ofd_c03 source 1ofd FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE 2 : 2 hits 1ofd_c03 naa= 3 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 1 3 # 1 A 170 SER A 127 SER^? 6.45 NI NI A 304 A 239 VAL A 125 VAL.? 13.94 NI NI A 304 A 413 ASN A 204 ASN^? 6.50 NI NI A 304 coo 80.14 40.76 52.28 77.73 40.59 51.94 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 75.67 35.37 52.30 76.00 35.96 50.23 -16.35 5.50 -36.29 -17.63 6.19 -37.94 coo 81.75 35.21 52.13 80.92 37.12 51.69 -18.02 3.14 -29.01 -15.99 2.73 -28.54 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 2 3 # 2 A 170 SER B 127 SER^? 6.61 NI NI B 305 A 239 VAL B 125 VAL.? 13.95 NI NI B 305 A 413 ASN B 204 ASN^? 6.73 NI NI B 305 coo 80.14 40.76 52.28 77.73 40.59 51.94 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 75.67 35.37 52.30 76.00 35.96 50.23 -14.70 -8.86 -44.06 -15.81 -9.76 -42.41 coo 81.75 35.21 52.13 80.92 37.12 51.69 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 ULMN 3 1oqz_c00 GLUTARYL ACYLASE user 3 3 # 3 A 170 SER B 183 SER.? 9.15 NI NI B 305 A 239 VAL B 125 VAL.? 13.95 NI NI B 305 A 413 ASN B 204 ASN^? 6.73 NI NI B 305 coo 80.14 40.76 52.28 77.73 40.59 51.94 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 75.67 35.37 52.30 76.00 35.96 50.23 -14.70 -8.86 -44.06 -15.81 -9.76 -42.41 coo 81.75 35.21 52.13 80.92 37.12 51.69 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 1oqz_c00 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c00 naa= 3 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 1 3 # 1 B 170 SER A 127 SER^? 6.45 NI NI A 304 B 239 VAL A 125 VAL.? 13.94 NI NI A 304 B 413 ASN A 204 ASN^? 6.50 NI NI A 304 coo 25.22 6.41 2.90 27.67 6.33 3.11 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 29.71 1.00 2.66 29.43 1.57 4.74 -16.35 5.50 -36.29 -17.63 6.19 -37.94 coo 23.72 0.88 2.95 24.56 2.79 3.34 -18.02 3.14 -29.01 -15.99 2.73 -28.54 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 2 3 # 2 B 170 SER B 127 SER^? 6.61 NI NI B 305 B 239 VAL B 125 VAL.? 13.95 NI NI B 305 B 413 ASN B 204 ASN^? 6.73 NI NI B 305 coo 25.22 6.41 2.90 27.67 6.33 3.11 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 29.71 1.00 2.66 29.43 1.57 4.74 -14.70 -8.86 -44.06 -15.81 -9.76 -42.41 coo 23.72 0.88 2.95 24.56 2.79 3.34 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 ULMN 3 1oqz_c01 GLUTARYL ACYLASE user 3 3 # 3 B 170 SER B 183 SER.? 9.15 NI NI B 305 B 239 VAL B 125 VAL.? 13.95 NI NI B 305 B 413 ASN B 204 ASN^? 6.73 NI NI B 305 coo 25.22 6.41 2.90 27.67 6.33 3.11 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 29.71 1.00 2.66 29.43 1.57 4.74 -14.70 -8.86 -44.06 -15.81 -9.76 -42.41 coo 23.72 0.88 2.95 24.56 2.79 3.34 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 1oqz_c01 source 1oqz GLUTARYL ACYLASE : 3 hits 1oqz_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 65 ASP~? 19.57 CA CA B 303 A 247 ASP A 104 ASP^? 11.20 NI NI A 304 A 342 GLU A 103 GLU^? 14.47 CA CA B 303 coo 44.36 35.68 9.71 43.29 36.20 11.51 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 41.40 28.81 12.91 40.82 30.90 12.97 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 40.37 33.11 18.06 39.99 34.93 17.06 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP A 75 ASP~? 14.34 CA CA A 301 A 247 ASP A 27 ASP~? -2.92 CA CA A 301s A 342 GLU A 30 GLU~? 7.55 CA CA A 301 coo 44.36 35.68 9.71 43.29 36.20 11.51 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 41.40 28.81 12.91 40.82 30.90 12.97 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 40.37 33.11 18.06 39.99 34.93 17.06 -27.55 15.68 -10.70 -29.15 16.50 -11.85 1oyg_c00 source 1oyg LEVANSUCRASE : 2 hits 1oyg_c00 naa= 3 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 79 SER~? 16.97 CA CA A 301 A 708 ASP A 21 ASP~? 19.27 CA CA A 301 A 740 HIS A 22 HIS~? 21.70 NI NI A 304 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 79 SER~? 16.97 CA CA A 301 A 708 ASP A 21 ASP~? 19.27 CA CA A 301 A 740 HIS A 83 HIS~? 17.38 NI NI A 304 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER B 79 SER~? 19.41 NI NI B 305 A 708 ASP B 21 ASP~? 22.52 NI NI B 305 A 740 HIS B 22 HIS~? 22.02 NI NI B 305 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1pfq_c00 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER B 79 SER~? 19.41 NI NI B 305 A 708 ASP B 21 ASP~? 22.52 NI NI B 305 A 740 HIS B 83 HIS~? 17.68 NI NI B 305 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -5.35 2.36 14.19 -6.28 2.60 12.26 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1pfq_c00 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 4 hits 1pfq_c00 naa= 3 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 79 SER~? 16.97 CA CA A 301 B 708 ASP A 21 ASP~? 19.27 CA CA A 301 B 740 HIS A 22 HIS~? 21.70 NI NI A 304 coo 4.44 13.29 37.64 6.01 11.66 38.49 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 6.39 7.18 30.33 6.92 8.20 32.17 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 8.57 10.09 34.47 7.10 10.73 35.82 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 79 SER~? 16.97 CA CA A 301 B 708 ASP A 21 ASP~? 19.27 CA CA A 301 B 740 HIS A 83 HIS~? 17.38 NI NI A 304 coo 4.44 13.29 37.64 6.01 11.66 38.49 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 6.39 7.18 30.33 6.92 8.20 32.17 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 8.57 10.09 34.47 7.10 10.73 35.82 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER B 79 SER~? 19.41 NI NI B 305 B 708 ASP B 21 ASP~? 22.52 NI NI B 305 B 740 HIS B 22 HIS~? 22.02 NI NI B 305 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 6.39 7.18 30.33 6.92 8.20 32.17 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 8.57 10.09 34.47 7.10 10.73 35.82 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1pfq_c01 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER B 79 SER~? 19.41 NI NI B 305 B 708 ASP B 21 ASP~? 22.52 NI NI B 305 B 740 HIS B 83 HIS~? 17.68 NI NI B 305 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 6.39 7.18 30.33 6.92 8.20 32.17 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 8.57 10.09 34.47 7.10 10.73 35.82 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1pfq_c01 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 4 hits 1pfq_c01 naa= 3 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 A 630 SER A 20 SER~? 13.98 CA CA A 301 A 709 ASP A 81 ASP~? 18.70 NI NI A 304 A 740 HIS A 22 HIS~? 21.70 NI NI A 304 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 A 630 SER A 20 SER~? 13.98 CA CA A 301 A 709 ASP A 81 ASP~? 18.70 NI NI A 304 A 740 HIS A 83 HIS~? 17.38 NI NI A 304 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 A 630 SER A 183 SER.? 9.24 NI NI A 304 A 709 ASP A 104 ASP^? 11.20 NI NI A 304 A 740 HIS A 121 HIS.? -3.63 NI NI A 304s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -12.61 2.09 -28.60 -12.23 2.44 -26.56 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 A 630 SER B 20 SER~? 23.19 NI NI B 305 A 709 ASP B 81 ASP~? 18.56 NI NI B 305 A 740 HIS B 22 HIS~? 22.02 NI NI B 305 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 A 630 SER B 20 SER~? 23.19 NI NI B 305 A 709 ASP B 81 ASP~? 18.56 NI NI B 305 A 740 HIS B 83 HIS~? 17.68 NI NI B 305 coo -7.09 7.44 6.22 -7.53 5.14 5.59 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1pfq_c02 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 A 630 SER B 183 SER.? 9.15 NI NI B 305 A 709 ASP B 104 ASP^? 11.37 NI NI B 305 A 740 HIS B 121 HIS.? -3.60 NI NI B 305s coo -7.09 7.44 6.22 -7.53 5.14 5.59 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo -6.04 -3.54 13.59 -7.99 -3.21 12.73 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -8.70 2.86 9.96 -8.03 3.92 8.29 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 1pfq_c02 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 6 hits 1pfq_c02 naa= 3 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 1 3 # 1 B 630 SER A 20 SER~? 13.98 CA CA A 301 B 709 ASP A 81 ASP~? 18.70 NI NI A 304 B 740 HIS A 22 HIS~? 21.70 NI NI A 304 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo 10.26 2.81 31.69 11.64 4.30 32.43 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 8.57 10.09 34.47 7.10 10.73 35.82 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 2 3 # 2 B 630 SER A 20 SER~? 13.98 CA CA A 301 B 709 ASP A 81 ASP~? 18.70 NI NI A 304 B 740 HIS A 83 HIS~? 17.38 NI NI A 304 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo 10.26 2.81 31.69 11.64 4.30 32.43 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 8.57 10.09 34.47 7.10 10.73 35.82 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 3 3 # 3 B 630 SER A 79 SER~? 16.97 CA CA A 301 B 709 ASP A 177 ASP^? 15.76 CA CA A 306 B 740 HIS A 83 HIS~? 17.38 NI NI A 304 coo 4.44 13.29 37.64 6.01 11.66 38.49 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 10.26 2.81 31.69 11.64 4.30 32.43 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 8.57 10.09 34.47 7.10 10.73 35.82 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 4 3 # 4 B 630 SER A 183 SER.? 9.24 NI NI A 304 B 709 ASP A 104 ASP^? 11.20 NI NI A 304 B 740 HIS A 121 HIS.? -3.63 NI NI A 304s coo 4.44 13.29 37.64 6.01 11.66 38.49 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 10.26 2.81 31.69 11.64 4.30 32.43 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 8.57 10.09 34.47 7.10 10.73 35.82 -12.61 2.09 -28.60 -12.23 2.44 -26.56 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 5 3 # 5 B 630 SER B 20 SER~? 23.19 NI NI B 305 B 709 ASP B 81 ASP~? 18.56 NI NI B 305 B 740 HIS B 22 HIS~? 22.02 NI NI B 305 coo 4.44 13.29 37.64 6.01 11.66 38.49 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo 10.26 2.81 31.69 11.64 4.30 32.43 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 8.57 10.09 34.47 7.10 10.73 35.82 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 6 3 # 6 B 630 SER B 20 SER~? 23.19 NI NI B 305 B 709 ASP B 81 ASP~? 18.56 NI NI B 305 B 740 HIS B 83 HIS~? 17.68 NI NI B 305 coo 4.44 13.29 37.64 6.01 11.66 38.49 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo 10.26 2.81 31.69 11.64 4.30 32.43 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 8.57 10.09 34.47 7.10 10.73 35.82 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 7 3 # 7 B 630 SER B 79 SER~? 19.41 NI NI B 305 B 709 ASP B 177 ASP^? 17.56 NI NI B 305 B 740 HIS B 83 HIS~? 17.68 NI NI B 305 coo 4.44 13.29 37.64 6.01 11.66 38.49 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 10.26 2.81 31.69 11.64 4.30 32.43 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 8.57 10.09 34.47 7.10 10.73 35.82 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1pfq_c03 DIPEPTIDYL PEPTIDASE IV SOLUBLE FORMuser 8 3 # 8 B 630 SER B 183 SER.? 9.15 NI NI B 305 B 709 ASP B 104 ASP^? 11.37 NI NI B 305 B 740 HIS B 121 HIS.? -3.60 NI NI B 305s coo 4.44 13.29 37.64 6.01 11.66 38.49 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 10.26 2.81 31.69 11.64 4.30 32.43 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 8.57 10.09 34.47 7.10 10.73 35.82 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 1pfq_c03 source 1pfq DIPEPTIDYL PEPTIDASE IV SOLUBLE FORM : 8 hits 1pfq_c03 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 16 HIS^? 15.61 NI NI A 304 A 259 TYR A 131 TYR^? 10.29 NI NI A 304 A 552 ASP B 104 ASP^? 11.37 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 14.91 97.39 18.63 13.39 95.60 20.20 -12.31 13.71 -19.00 -10.79 12.16 -20.76 coo 46.37 82.54 38.83 45.97 84.66 38.77 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS A 22 HIS~? 21.70 NI NI A 304 A 259 TYR A 15 TYR^? 16.16 NI NI A 304 A 552 ASP B 65 ASP~? 20.64 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 14.91 97.39 18.63 13.39 95.60 20.20 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 46.37 82.54 38.83 45.97 84.66 38.77 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 3 3 # 3 A 225 HIS A 83 HIS~? 17.38 NI NI A 304 A 259 TYR A 15 TYR^? 16.16 NI NI A 304 A 552 ASP B 65 ASP~? 20.64 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 14.91 97.39 18.63 13.39 95.60 20.20 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 46.37 82.54 38.83 45.97 84.66 38.77 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 4 3 # 4 A 225 HIS A 116 HIS^? 7.23 NI NI A 304 A 259 TYR A 54 TYR.? 11.09 NI NI A 304 A 552 ASP B 81 ASP~? 18.56 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 5 3 # 5 A 225 HIS A 116 HIS^? 7.23 NI NI A 304 A 259 TYR A 54 TYR.? 11.09 NI NI A 304 A 552 ASP B 104 ASP^? 11.37 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 6 3 # 6 A 225 HIS A 116 HIS^? 7.23 NI NI A 304 A 259 TYR A 54 TYR.? 11.09 NI NI A 304 A 552 ASP B 163 ASP.? 22.00 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.69 -3.33 -14.71 -11.00 -1.05 -16.30 coo 46.37 82.54 38.83 45.97 84.66 38.77 5.53 -18.94 -49.54 6.46 -20.22 -50.93 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 7 3 # 7 A 225 HIS A 121 HIS.? -3.63 NI NI A 304s A 259 TYR A 60 TYR.? 8.44 NI NI A 304 A 552 ASP B 21 ASP~? 22.52 NI NI B 305 coo 11.34 95.90 25.54 12.13 96.42 23.67 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 14.91 97.39 18.63 13.39 95.60 20.20 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 coo 46.37 82.54 38.83 45.97 84.66 38.77 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 8 3 # 8 A 225 HIS B 16 HIS^? 15.81 NI NI B 305 A 259 TYR B 131 TYR^? 10.67 NI NI B 305 A 552 ASP A 104 ASP^? 11.20 NI NI A 304 coo 11.34 95.90 25.54 12.13 96.42 23.67 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 14.91 97.39 18.63 13.39 95.60 20.20 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 coo 46.37 82.54 38.83 45.97 84.66 38.77 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 9 3 # 9 A 225 HIS B 22 HIS~? 22.02 NI NI B 305 A 259 TYR B 15 TYR^? 16.36 NI NI B 305 A 552 ASP A 65 ASP~? 19.57 CA CA B 303 coo 11.34 95.90 25.54 12.13 96.42 23.67 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 46.37 82.54 38.83 45.97 84.66 38.77 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 10 3 # 10 A 225 HIS B 83 HIS~? 17.68 NI NI B 305 A 259 TYR B 15 TYR^? 16.36 NI NI B 305 A 552 ASP A 65 ASP~? 19.57 CA CA B 303 coo 11.34 95.90 25.54 12.13 96.42 23.67 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 14.91 97.39 18.63 13.39 95.60 20.20 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 46.37 82.54 38.83 45.97 84.66 38.77 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 11 3 # 11 A 225 HIS B 116 HIS^? 6.69 NI NI B 305 A 259 TYR B 54 TYR.? 11.06 NI NI B 305 A 552 ASP A 81 ASP~? 18.70 NI NI A 304 coo 11.34 95.90 25.54 12.13 96.42 23.67 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 14.91 97.39 18.63 13.39 95.60 20.20 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 coo 46.37 82.54 38.83 45.97 84.66 38.77 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 12 3 # 12 A 225 HIS B 116 HIS^? 6.69 NI NI B 305 A 259 TYR B 54 TYR.? 11.06 NI NI B 305 A 552 ASP A 163 ASP~? 21.63 NI NI A 304 coo 11.34 95.90 25.54 12.13 96.42 23.67 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 14.91 97.39 18.63 13.39 95.60 20.20 -11.45 0.75 -65.78 -11.53 -1.42 -64.02 coo 46.37 82.54 38.83 45.97 84.66 38.77 1.30 20.20 -30.86 1.78 20.99 -28.95 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 13 3 # 13 A 225 HIS B 121 HIS.? -3.60 NI NI B 305s A 259 TYR B 60 TYR.? 9.06 NI NI B 305 A 552 ASP A 21 ASP~? 19.27 CA CA A 301 coo 11.34 95.90 25.54 12.13 96.42 23.67 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 14.91 97.39 18.63 13.39 95.60 20.20 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 coo 46.37 82.54 38.83 45.97 84.66 38.77 -20.19 23.48 -26.91 -18.56 24.69 -26.31 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 13 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 85 ALA~? 20.35 NI NI A 304 A 126 LEU A 100 LEU^? 16.85 NI NI A 304 A 158 GLU A 101 GLU^? 20.45 NI NI A 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -22.48 9.10 -36.15 -20.64 8.88 -37.30 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 88 ALA~? 18.79 NI NI A 304 A 126 LEU A 91 LEU~? 17.48 NI NI A 304 A 158 GLU A 92 GLU~? 26.61 NI NI A 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.23 14.39 -38.25 -19.54 13.62 -38.30 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -14.04 13.99 -39.85 -12.72 13.34 -38.24 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -15.71 18.15 -44.39 -15.11 19.36 -46.01 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 88 ALA~? 18.79 NI NI A 304 A 126 LEU A 91 LEU~? 17.48 NI NI A 304 A 158 GLU A 182 GLU^? 15.51 NI NI A 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.23 14.39 -38.25 -19.54 13.62 -38.30 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -14.04 13.99 -39.85 -12.72 13.34 -38.24 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -11.04 10.12 -36.92 -10.45 10.15 -38.96 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 161 ALA.? 25.95 NI NI A 304 A 126 LEU A 165 LEU~? 24.90 NI NI A 304 A 158 GLU A 164 GLU~? 25.12 NI NI A 304 coo -2.29 37.66 144.73 -1.46 37.12 145.87 9.05 20.07 -31.59 9.16 18.69 -32.23 coo -4.62 32.83 147.14 -5.50 32.85 149.12 5.99 17.28 -35.79 6.38 17.80 -37.86 coo -0.83 29.57 149.77 -0.39 31.47 148.95 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 85 ALA~? 16.03 CA CA B 303 A 126 LEU B 100 LEU.? 14.54 CA CA B 303 A 158 GLU B 101 GLU^? 17.23 CA CA B 303 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -19.77 -13.71 -44.23 -18.03 -13.06 -43.10 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 88 ALA~? 13.21 CA CA B 303 A 126 LEU B 91 LEU~? 15.74 CA CA B 303 A 158 GLU B 92 GLU.? 12.87 CA CA B 303 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -10.83 -16.72 -40.57 -9.53 -15.86 -42.08 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 88 ALA~? 13.21 CA CA B 303 A 126 LEU B 91 LEU~? 15.74 CA CA B 303 A 158 GLU B 182 GLU^? 15.43 NI NI B 305 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -10.83 -16.72 -40.57 -9.53 -15.86 -42.08 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 7 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 85 ALA~? 20.35 NI NI A 304 B 126 LEU A 100 LEU^? 16.85 NI NI A 304 B 158 GLU A 101 GLU^? 20.45 NI NI A 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -22.48 9.10 -36.15 -20.64 8.88 -37.30 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 88 ALA~? 18.79 NI NI A 304 B 126 LEU A 91 LEU~? 17.48 NI NI A 304 B 158 GLU A 182 GLU^? 15.51 NI NI A 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.23 14.39 -38.25 -19.54 13.62 -38.30 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -14.04 13.99 -39.85 -12.72 13.34 -38.24 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -11.04 10.12 -36.92 -10.45 10.15 -38.96 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 161 ALA.? 25.95 NI NI A 304 B 126 LEU A 165 LEU~? 24.90 NI NI A 304 B 158 GLU A 164 GLU~? 25.12 NI NI A 304 coo -39.79 4.61 147.27 -39.61 5.56 148.47 9.05 20.07 -31.59 9.16 18.69 -32.23 coo -34.22 5.06 149.25 -33.65 4.24 151.15 5.99 17.28 -35.79 6.38 17.80 -37.86 coo -33.03 9.93 151.71 -34.98 9.38 151.11 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA B 85 ALA~? 16.03 CA CA B 303 B 126 LEU B 100 LEU.? 14.54 CA CA B 303 B 158 GLU B 101 GLU^? 17.23 CA CA B 303 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -19.77 -13.71 -44.23 -18.03 -13.06 -43.10 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 88 ALA~? 13.21 CA CA B 303 B 126 LEU B 91 LEU~? 15.74 CA CA B 303 B 158 GLU B 92 GLU.? 12.87 CA CA B 303 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -10.83 -16.72 -40.57 -9.53 -15.86 -42.08 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 88 ALA~? 13.21 CA CA B 303 B 126 LEU B 91 LEU~? 15.74 CA CA B 303 B 158 GLU B 182 GLU^? 15.43 NI NI B 305 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -10.83 -16.72 -40.57 -9.53 -15.86 -42.08 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 6 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 85 ALA~? 20.35 NI NI A 304 C 126 LEU A 100 LEU^? 16.85 NI NI A 304 C 158 GLU A 101 GLU^? 20.45 NI NI A 304 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -22.48 9.10 -36.15 -20.64 8.88 -37.30 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 88 ALA~? 18.79 NI NI A 304 C 126 LEU A 91 LEU~? 17.48 NI NI A 304 C 158 GLU A 92 GLU~? 26.61 NI NI A 304 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.23 14.39 -38.25 -19.54 13.62 -38.30 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -14.04 13.99 -39.85 -12.72 13.34 -38.24 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -15.71 18.15 -44.39 -15.11 19.36 -46.01 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 88 ALA~? 18.79 NI NI A 304 C 126 LEU A 91 LEU~? 17.48 NI NI A 304 C 158 GLU A 182 GLU^? 15.51 NI NI A 304 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.23 14.39 -38.25 -19.54 13.62 -38.30 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -14.04 13.99 -39.85 -12.72 13.34 -38.24 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -11.04 10.12 -36.92 -10.45 10.15 -38.96 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 161 ALA.? 25.95 NI NI A 304 C 126 LEU A 165 LEU~? 24.90 NI NI A 304 C 158 GLU A 164 GLU~? 25.12 NI NI A 304 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 9.05 20.07 -31.59 9.16 18.69 -32.23 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 5.99 17.28 -35.79 6.38 17.80 -37.86 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 85 ALA~? 16.03 CA CA B 303 C 126 LEU B 100 LEU.? 14.54 CA CA B 303 C 158 GLU B 101 GLU^? 17.23 CA CA B 303 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -19.77 -13.71 -44.23 -18.03 -13.06 -43.10 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 88 ALA~? 13.21 CA CA B 303 C 126 LEU B 91 LEU~? 15.74 CA CA B 303 C 158 GLU B 92 GLU.? 12.87 CA CA B 303 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -10.83 -16.72 -40.57 -9.53 -15.86 -42.08 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 88 ALA~? 13.21 CA CA B 303 C 126 LEU B 91 LEU~? 15.74 CA CA B 303 C 158 GLU B 182 GLU^? 15.43 NI NI B 305 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -14.80 -18.10 -41.94 -16.25 -17.67 -41.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -10.83 -16.72 -40.57 -9.53 -15.86 -42.08 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 7 hits 1pjh_c02 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 188 GLU^? 11.68 NI NI A 304 A 67 ARG A 186 ARG^? 12.05 NI NI A 304 A 86 HIS A 119 HIS^? -3.69 NI NI A 304s coo 18.15 3.28 18.56 20.10 2.92 19.20 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 21.52 6.83 26.64 21.22 5.53 23.85 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -7.63 0.70 -25.42 -8.53 2.19 -24.26 1pyl_c00 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 188 GLU^? 11.68 NI NI A 304 B 67 ARG A 186 ARG^? 12.05 NI NI A 304 B 86 HIS A 119 HIS^? -3.69 NI NI A 304s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -0.98 2.39 -29.96 -1.75 -0.06 -31.65 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -7.63 0.70 -25.42 -8.53 2.19 -24.26 1pyl_c01 source 1pyl RIBONUCLEASE : 1 hits 1pyl_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 21 ASP~? 19.27 CA CA A 301 A 68 ALA A 17 ALA^? 18.31 NI NI A 304 A 72 LEU A 19 LEU.? 15.07 CA CA A 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 48.88 4.35 16.59 48.73 5.09 15.20 -14.68 21.22 -26.29 -15.64 21.37 -27.47 coo 53.89 6.25 15.09 52.88 7.92 14.14 -19.95 18.49 -21.95 -20.99 16.60 -21.94 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP A 177 ASP^? 15.76 CA CA A 306 A 68 ALA A 17 ALA^? 18.31 NI NI A 304 A 72 LEU A 19 LEU.? 15.07 CA CA A 301 coo 46.76 7.59 18.65 45.27 6.01 18.52 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 48.88 4.35 16.59 48.73 5.09 15.20 -14.68 21.22 -26.29 -15.64 21.37 -27.47 coo 53.89 6.25 15.09 52.88 7.92 14.14 -19.95 18.49 -21.95 -20.99 16.60 -21.94 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 3 # 3 A 67 ASP B 21 ASP~? 22.52 NI NI B 305 A 68 ALA B 17 ALA^? 18.38 NI NI B 305 A 72 LEU B 19 LEU.? 17.32 NI NI B 305 coo 46.76 7.59 18.65 45.27 6.01 18.52 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 48.88 4.35 16.59 48.73 5.09 15.20 -9.66 -23.82 -53.96 -10.57 -24.14 -52.79 coo 53.89 6.25 15.09 52.88 7.92 14.14 -15.61 -22.59 -58.39 -16.97 -20.91 -58.28 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 4 3 # 4 A 67 ASP B 177 ASP^? 17.56 NI NI B 305 A 68 ALA B 17 ALA^? 18.38 NI NI B 305 A 72 LEU B 19 LEU.? 17.32 NI NI B 305 coo 46.76 7.59 18.65 45.27 6.01 18.52 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 48.88 4.35 16.59 48.73 5.09 15.20 -9.66 -23.82 -53.96 -10.57 -24.14 -52.79 coo 53.89 6.25 15.09 52.88 7.92 14.14 -15.61 -22.59 -58.39 -16.97 -20.91 -58.28 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 4 hits 1q6l_c05 naa= 3 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 1 3 # 1 A 396 ARG A 157 ARG.? 25.34 NI NI A 304 A 581 ARG A 158 ARG.? 32.75 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 2 3 # 2 A 396 ARG A 157 ARG.? 25.34 NI NI A 304 A 581 ARG A 162 ARG~? 28.37 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 3 3 # 3 A 396 ARG A 157 ARG.? 25.34 NI NI A 304 A 581 ARG A 166 ARG~? 23.27 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 4 3 # 4 A 396 ARG A 158 ARG.? 32.75 NI NI A 304 A 581 ARG A 157 ARG.? 25.34 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 5 3 # 5 A 396 ARG A 162 ARG~? 28.37 NI NI A 304 A 581 ARG A 157 ARG.? 25.34 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 6 3 # 6 A 396 ARG A 162 ARG~? 28.37 NI NI A 304 A 581 ARG A 166 ARG~? 23.27 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 7 3 # 7 A 396 ARG A 166 ARG~? 23.27 NI NI A 304 A 581 ARG A 157 ARG.? 25.34 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 8 3 # 8 A 396 ARG A 166 ARG~? 23.27 NI NI A 304 A 581 ARG A 157 ARG.? 25.34 NI NI A 304 A 713 ARG A 162 ARG~? 28.37 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 6.53 22.97 -35.99 6.11 21.84 -38.80 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 9 3 # 9 A 396 ARG A 166 ARG~? 23.27 NI NI A 304 A 581 ARG A 162 ARG~? 28.37 NI NI A 304 A 713 ARG A 158 ARG.? 32.75 NI NI A 304 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 16.04 19.72 -32.20 15.13 21.26 -34.70 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 10 3 # 10 A 396 ARG B 157 ARG.? 25.43 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 11 3 # 11 A 396 ARG B 157 ARG.? 25.43 NI NI B 305 A 581 ARG B 166 ARG.? 22.37 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 12 3 # 12 A 396 ARG B 157 ARG.? 25.43 NI NI B 305 A 581 ARG B 166 ARG.? 22.37 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 13 3 # 13 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 157 ARG.? 25.43 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 14 3 # 14 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 157 ARG.? 25.43 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 12.04 -10.72 -45.32 11.38 -11.87 -42.55 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 15 3 # 15 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 166 ARG.? 22.37 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 10.21 -14.86 -50.61 10.48 -15.55 -53.59 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 16 3 # 16 A 396 ARG B 158 ARG.? 33.41 NI NI B 305 A 581 ARG B 166 ARG.? 22.37 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 17 3 # 17 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 157 ARG.? 25.43 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 12.04 -10.72 -45.32 11.38 -11.87 -42.55 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 18 3 # 18 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 166 ARG.? 22.37 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 10.21 -14.86 -50.61 10.48 -15.55 -53.59 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 19 3 # 19 A 396 ARG B 162 ARG.? 29.21 NI NI B 305 A 581 ARG B 166 ARG.? 22.37 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 20 3 # 20 A 396 ARG B 166 ARG.? 22.37 NI NI B 305 A 581 ARG B 157 ARG.? 25.43 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 21 3 # 21 A 396 ARG B 166 ARG.? 22.37 NI NI B 305 A 581 ARG B 157 ARG.? 25.43 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 22 3 # 22 A 396 ARG B 166 ARG.? 22.37 NI NI B 305 A 581 ARG B 158 ARG.? 33.41 NI NI B 305 A 713 ARG B 162 ARG.? 29.21 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 11.46 -20.60 -44.52 11.73 -20.08 -41.52 ULMN 3 1qb4_c01 PHOSPHOENOLPYRUVATE CARBOXYLASE user 23 3 # 23 A 396 ARG B 166 ARG.? 22.37 NI NI B 305 A 581 ARG B 162 ARG.? 29.21 NI NI B 305 A 713 ARG B 158 ARG.? 33.41 NI NI B 305 coo 23.94 27.00 -9.66 23.90 28.89 -12.21 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 24.10 34.79 -11.24 24.18 32.99 -13.65 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 24.26 28.71 -19.68 23.74 27.73 -16.81 19.54 -16.27 -48.10 20.08 -17.20 -45.23 1qb4_c01 source 1qb4 PHOSPHOENOLPYRUVATE CARBOXYLASE : 23 hits 1qb4_c01 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER B 115 SER.? 13.16 NI NI B 305 A 310 GLU B 188 GLU^? 11.04 NI NI B 305 A 399 HIS B 116 HIS^? 6.69 NI NI B 305 coo 2.67 37.96 55.23 1.78 40.01 56.16 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 6.61 38.44 63.61 6.69 38.31 61.50 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 4.95 41.82 59.53 3.85 40.70 58.14 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 1 hits 1qe3_c00 naa= 3 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 1 3 # 1 A 554 SER A 79 SER~? 16.97 CA CA A 301 A 641 ASP A 21 ASP~? 19.27 CA CA A 301 A 680 HIS A 22 HIS~? 21.70 NI NI A 304 coo 34.48 40.33 79.08 36.40 39.98 80.55 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 40.64 47.22 77.43 39.90 45.49 78.43 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 38.53 44.50 81.45 37.60 42.73 80.84 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 2 3 # 2 A 554 SER A 79 SER~? 16.97 CA CA A 301 A 641 ASP A 21 ASP~? 19.27 CA CA A 301 A 680 HIS A 83 HIS~? 17.38 NI NI A 304 coo 34.48 40.33 79.08 36.40 39.98 80.55 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 40.64 47.22 77.43 39.90 45.49 78.43 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 38.53 44.50 81.45 37.60 42.73 80.84 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 3 3 # 3 A 554 SER B 79 SER~? 19.41 NI NI B 305 A 641 ASP B 21 ASP~? 22.52 NI NI B 305 A 680 HIS B 22 HIS~? 22.02 NI NI B 305 coo 34.48 40.33 79.08 36.40 39.98 80.55 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 40.64 47.22 77.43 39.90 45.49 78.43 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 38.53 44.50 81.45 37.60 42.73 80.84 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1qfm_c00 PROLYL OLIGOPEPTIDASE user 4 3 # 4 A 554 SER B 79 SER~? 19.41 NI NI B 305 A 641 ASP B 21 ASP~? 22.52 NI NI B 305 A 680 HIS B 83 HIS~? 17.68 NI NI B 305 coo 34.48 40.33 79.08 36.40 39.98 80.55 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 40.64 47.22 77.43 39.90 45.49 78.43 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 38.53 44.50 81.45 37.60 42.73 80.84 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1qfm_c00 source 1qfm PROLYL OLIGOPEPTIDASE : 4 hits 1qfm_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 148 HIS~? 18.59 NI NI A 304 B 236 ASP B 145 ASP.? 18.27 NI NI B 305 B 261 LYS B 142 LYS^? 13.37 NI NI B 305 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 148 HIS~? 18.59 NI NI A 304 C 236 ASP B 145 ASP.? 18.27 NI NI B 305 C 261 LYS B 142 LYS^? 13.37 NI NI B 305 coo 55.11 47.10 12.61 53.44 47.85 11.58 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 45.78 31.11 9.51 44.25 30.06 10.53 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 37.54 22.37 12.10 37.83 27.55 13.24 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 148 HIS~? 18.59 NI NI A 304 F 236 ASP B 145 ASP.? 18.27 NI NI B 305 F 261 LYS B 142 LYS^? 13.37 NI NI B 305 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 148 HIS~? 18.59 NI NI A 304 G 236 ASP B 145 ASP.? 18.27 NI NI B 305 G 261 LYS B 142 LYS^? 13.37 NI NI B 305 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 206 ARG^? 17.65 CA CA B 303 C 163 TYR A 205 TYR^? 13.62 NI NI A 304 C 236 ASP A 81 ASP~? 18.70 NI NI A 304 coo 39.01 29.77 22.02 37.48 31.30 19.84 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 39.51 34.34 13.63 37.63 32.61 14.79 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 45.78 31.11 9.51 44.25 30.06 10.53 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 206 ARG^? 17.11 NI NI B 305 C 163 TYR B 205 TYR^? 13.71 NI NI B 305 C 236 ASP B 81 ASP~? 18.56 NI NI B 305 coo 39.01 29.77 22.02 37.48 31.30 19.84 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 39.51 34.34 13.63 37.63 32.61 14.79 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 45.78 31.11 9.51 44.25 30.06 10.53 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 206 ARG^? 17.65 CA CA B 303 D 163 TYR A 205 TYR^? 13.62 NI NI A 304 D 236 ASP A 81 ASP~? 18.70 NI NI A 304 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 206 ARG^? 17.11 NI NI B 305 D 163 TYR B 205 TYR^? 13.71 NI NI B 305 D 236 ASP B 81 ASP~? 18.56 NI NI B 305 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 205 TYR^? 13.62 NI NI A 304 A 236 ASP A 81 ASP~? 18.70 NI NI A 304 C 110 ARG A 206 ARG^? 17.65 CA CA B 303 coo 55.48 26.51 40.65 55.39 23.99 39.43 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 48.87 29.19 44.63 49.10 27.34 43.63 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 52.39 23.42 32.10 54.51 23.27 34.29 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 205 TYR^? 13.71 NI NI B 305 A 236 ASP B 81 ASP~? 18.56 NI NI B 305 C 110 ARG B 206 ARG^? 17.11 NI NI B 305 coo 55.48 26.51 40.65 55.39 23.99 39.43 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 48.87 29.19 44.63 49.10 27.34 43.63 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 52.39 23.42 32.10 54.51 23.27 34.29 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 205 TYR^? 13.62 NI NI A 304 B 236 ASP A 81 ASP~? 18.70 NI NI A 304 D 110 ARG A 206 ARG^? 17.65 CA CA B 303 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 205 TYR^? 13.71 NI NI B 305 B 236 ASP B 81 ASP~? 18.56 NI NI B 305 D 110 ARG B 206 ARG^? 17.11 NI NI B 305 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 206 ARG^? 17.65 CA CA B 303 G 163 TYR A 205 TYR^? 13.62 NI NI A 304 G 236 ASP A 81 ASP~? 18.70 NI NI A 304 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 206 ARG^? 17.11 NI NI B 305 G 163 TYR B 205 TYR^? 13.71 NI NI B 305 G 236 ASP B 81 ASP~? 18.56 NI NI B 305 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 206 ARG^? 17.65 CA CA B 303 H 163 TYR A 205 TYR^? 13.62 NI NI A 304 H 236 ASP A 81 ASP~? 18.70 NI NI A 304 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 206 ARG^? 17.11 NI NI B 305 H 163 TYR B 205 TYR^? 13.71 NI NI B 305 H 236 ASP B 81 ASP~? 18.56 NI NI B 305 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 205 TYR^? 13.62 NI NI A 304 E 236 ASP A 81 ASP~? 18.70 NI NI A 304 G 110 ARG A 206 ARG^? 17.65 CA CA B 303 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 205 TYR^? 13.71 NI NI B 305 E 236 ASP B 81 ASP~? 18.56 NI NI B 305 G 110 ARG B 206 ARG^? 17.11 NI NI B 305 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 205 TYR^? 13.62 NI NI A 304 F 236 ASP A 81 ASP~? 18.70 NI NI A 304 H 110 ARG A 206 ARG^? 17.65 CA CA B 303 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -21.20 8.17 -31.41 -22.93 9.66 -29.80 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 205 TYR^? 13.71 NI NI B 305 F 236 ASP B 81 ASP~? 18.56 NI NI B 305 H 110 ARG B 206 ARG^? 17.11 NI NI B 305 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 42 ASP~? 18.65 NI NI A 304 A 147 THR A 58 THR^? 10.17 NI NI A 304 A 294 ASP A 197 ASP.? 9.27 CA CA A 306 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -16.09 0.01 -15.13 -15.43 -0.83 -17.03 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -12.14 8.73 -7.75 -12.16 7.25 -6.26 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP B 42 ASP~? 18.39 NI NI B 305 A 147 THR B 58 THR^? 10.34 NI NI B 305 A 294 ASP B 197 ASP.? 18.81 NI NI B 305 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -15.72 -3.35 -65.18 -15.34 -2.24 -63.34 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 2 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 65 ASP~? 19.57 CA CA B 303 A 261 ASP B 96 ASP.? 4.50 CA CA B 303 A 329 ASP A 104 ASP^? 11.20 NI NI A 304 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 34.02 79.89 42.60 34.73 78.01 41.86 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 75 ASP~? 14.34 CA CA A 301 A 261 ASP A 104 ASP^? 11.20 NI NI A 304 A 329 ASP A 81 ASP~? 18.70 NI NI A 304 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 34.02 79.89 42.60 34.73 78.01 41.86 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 81 ASP~? 18.70 NI NI A 304 A 261 ASP A 27 ASP~? -2.92 CA CA A 301s A 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 104 ASP^? 11.20 NI NI A 304 A 261 ASP A 41 ASP.? 21.30 CA CA A 306 A 329 ASP A 65 ASP~? 19.57 CA CA B 303 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 34.02 79.89 42.60 34.73 78.01 41.86 -26.48 0.30 -6.99 -28.31 -0.66 -6.48 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 104 ASP^? 11.20 NI NI A 304 A 261 ASP A 75 ASP~? 14.34 CA CA A 301 A 329 ASP A 65 ASP~? 19.57 CA CA B 303 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 34.02 79.89 42.60 34.73 78.01 41.86 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 65 ASP~? 20.64 NI NI B 305 A 261 ASP A 96 ASP.? 21.09 NI NI B 305 A 329 ASP B 104 ASP^? 11.37 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 75 ASP~? 24.42 NI NI B 305 A 261 ASP B 104 ASP^? 11.37 NI NI B 305 A 329 ASP B 81 ASP~? 18.56 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 34.02 79.89 42.60 34.73 78.01 41.86 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 37.87 70.12 31.80 36.61 69.74 30.15 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 104 ASP^? 11.37 NI NI B 305 A 261 ASP B 41 ASP.? 25.32 NI NI B 305 A 329 ASP B 65 ASP~? 20.64 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 1qho_c05 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP B 104 ASP^? 11.37 NI NI B 305 A 261 ASP B 75 ASP~? 24.42 NI NI B 305 A 329 ASP B 65 ASP~? 20.64 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 34.02 79.89 42.60 34.73 78.01 41.86 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 1qho_c05 source 1qho ALPHA-AMYLASE : 9 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 21 ASP~? 19.27 CA CA A 301 A 260 ASP A 27 ASP~? -2.92 CA CA A 301s A 329 ASP A 177 ASP^? 15.76 CA CA A 306 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 30.73 81.29 37.61 31.23 82.07 35.69 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 27 ASP~? -2.92 CA CA A 301s A 260 ASP A 21 ASP~? 19.27 CA CA A 301 A 329 ASP A 75 ASP~? 14.34 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 30.73 81.29 37.61 31.23 82.07 35.69 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 65 ASP~? 19.57 CA CA B 303 A 260 ASP A 81 ASP~? 18.70 NI NI A 304 A 329 ASP A 104 ASP^? 11.20 NI NI A 304 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 30.73 81.29 37.61 31.23 82.07 35.69 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 75 ASP~? 14.34 CA CA A 301 A 260 ASP A 21 ASP~? 19.27 CA CA A 301 A 329 ASP A 27 ASP~? -2.92 CA CA A 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 30.73 81.29 37.61 31.23 82.07 35.69 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.76 19.66 -12.70 -25.06 20.72 -11.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP A 75 ASP~? 14.34 CA CA A 301 A 260 ASP A 21 ASP~? 19.27 CA CA A 301 A 329 ASP A 81 ASP~? 18.70 NI NI A 304 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 30.73 81.29 37.61 31.23 82.07 35.69 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP A 75 ASP~? 14.34 CA CA A 301 A 260 ASP A 65 ASP~? 19.57 CA CA B 303 A 329 ASP A 81 ASP~? 18.70 NI NI A 304 coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 30.73 81.29 37.61 31.23 82.07 35.69 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qho_c07 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP A 75 ASP~? 14.34 CA CA A 301 A 260 ASP A 177 ASP^? 15.76 CA CA A 306 A 329 ASP A 27 ASP~? -2.92 CA CA A 301s coo 28.46 69.88 26.74 30.40 70.70 26.53 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 30.73 81.29 37.61 31.23 82.07 35.69 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.76 19.66 -12.70 -25.06 20.72 -11.00 ULMN 3 1qho_c07 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP A 81 ASP~? 18.70 NI NI A 304 A 260 ASP A 65 ASP~? 19.57 CA CA B 303 A 329 ASP A 75 ASP~? 14.34 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1qho_c07 ALPHA-AMYLASE user 9 3 # 9 A 228 ASP A 81 ASP~? 18.70 NI NI A 304 A 260 ASP A 90 ASP~? 20.31 NI NI A 304 A 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 10 3 # 10 A 228 ASP A 104 ASP^? 11.20 NI NI A 304 A 260 ASP A 42 ASP~? 18.65 NI NI A 304 A 329 ASP A 65 ASP~? 19.57 CA CA B 303 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 30.73 81.29 37.61 31.23 82.07 35.69 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1qho_c07 ALPHA-AMYLASE user 11 3 # 11 A 228 ASP A 104 ASP^? 11.20 NI NI A 304 A 260 ASP A 81 ASP~? 18.70 NI NI A 304 A 329 ASP A 65 ASP~? 19.57 CA CA B 303 coo 28.46 69.88 26.74 30.40 70.70 26.53 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 30.73 81.29 37.61 31.23 82.07 35.69 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1qho_c07 ALPHA-AMYLASE user 12 3 # 12 A 228 ASP A 177 ASP^? 15.76 CA CA A 306 A 260 ASP A 27 ASP~? -2.92 CA CA A 301s A 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 30.73 81.29 37.61 31.23 82.07 35.69 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 13 3 # 13 A 228 ASP A 177 ASP^? 15.76 CA CA A 306 A 260 ASP A 75 ASP~? 14.34 CA CA A 301 A 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 30.73 81.29 37.61 31.23 82.07 35.69 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 14 3 # 14 A 228 ASP A 177 ASP^? 15.76 CA CA A 306 A 260 ASP A 81 ASP~? 18.70 NI NI A 304 A 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 30.73 81.29 37.61 31.23 82.07 35.69 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 15 3 # 15 A 228 ASP A 177 ASP^? 15.76 CA CA A 306 A 260 ASP A 90 ASP~? 20.31 NI NI A 304 A 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 37.87 70.12 31.80 36.61 69.74 30.15 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qho_c07 ALPHA-AMYLASE user 16 3 # 16 A 228 ASP B 21 ASP~? 22.52 NI NI B 305 A 260 ASP B 27 ASP~? 26.12 NI NI B 305 A 329 ASP B 177 ASP^? 17.56 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 30.73 81.29 37.61 31.23 82.07 35.69 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 ULMN 3 1qho_c07 ALPHA-AMYLASE user 17 3 # 17 A 228 ASP B 27 ASP~? 26.12 NI NI B 305 A 260 ASP B 21 ASP~? 22.52 NI NI B 305 A 329 ASP B 75 ASP~? 24.42 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 ULMN 3 1qho_c07 ALPHA-AMYLASE user 18 3 # 18 A 228 ASP B 65 ASP~? 20.64 NI NI B 305 A 260 ASP B 81 ASP~? 18.56 NI NI B 305 A 329 ASP B 104 ASP^? 11.37 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 30.73 81.29 37.61 31.23 82.07 35.69 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1qho_c07 ALPHA-AMYLASE user 19 3 # 19 A 228 ASP B 75 ASP~? 24.42 NI NI B 305 A 260 ASP B 21 ASP~? 22.52 NI NI B 305 A 329 ASP B 27 ASP~? 26.12 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 ULMN 3 1qho_c07 ALPHA-AMYLASE user 20 3 # 20 A 228 ASP B 75 ASP~? 24.42 NI NI B 305 A 260 ASP B 21 ASP~? 22.52 NI NI B 305 A 329 ASP B 81 ASP~? 18.56 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 30.73 81.29 37.61 31.23 82.07 35.69 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 37.87 70.12 31.80 36.61 69.74 30.15 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qho_c07 ALPHA-AMYLASE user 21 3 # 21 A 228 ASP B 75 ASP~? 24.42 NI NI B 305 A 260 ASP B 65 ASP~? 20.64 NI NI B 305 A 329 ASP B 81 ASP~? 18.56 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qho_c07 ALPHA-AMYLASE user 22 3 # 22 A 228 ASP B 75 ASP~? 24.42 NI NI B 305 A 260 ASP B 177 ASP^? 17.56 NI NI B 305 A 329 ASP B 27 ASP~? 26.12 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 30.73 81.29 37.61 31.23 82.07 35.69 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 37.87 70.12 31.80 36.61 69.74 30.15 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 ULMN 3 1qho_c07 ALPHA-AMYLASE user 23 3 # 23 A 228 ASP B 81 ASP~? 18.56 NI NI B 305 A 260 ASP B 65 ASP~? 20.64 NI NI B 305 A 329 ASP B 75 ASP~? 24.42 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 30.73 81.29 37.61 31.23 82.07 35.69 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 37.87 70.12 31.80 36.61 69.74 30.15 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 ULMN 3 1qho_c07 ALPHA-AMYLASE user 24 3 # 24 A 228 ASP B 104 ASP^? 11.37 NI NI B 305 A 260 ASP B 42 ASP~? 18.39 NI NI B 305 A 329 ASP B 65 ASP~? 20.64 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 30.73 81.29 37.61 31.23 82.07 35.69 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 25 3 # 25 A 228 ASP B 104 ASP^? 11.37 NI NI B 305 A 260 ASP B 81 ASP~? 18.56 NI NI B 305 A 329 ASP B 65 ASP~? 20.64 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 30.73 81.29 37.61 31.23 82.07 35.69 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 1qho_c07 ALPHA-AMYLASE user 26 3 # 26 A 228 ASP B 177 ASP^? 17.56 NI NI B 305 A 260 ASP B 27 ASP~? 26.12 NI NI B 305 A 329 ASP B 21 ASP~? 22.52 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 30.73 81.29 37.61 31.23 82.07 35.69 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 27 3 # 27 A 228 ASP B 177 ASP^? 17.56 NI NI B 305 A 260 ASP B 75 ASP~? 24.42 NI NI B 305 A 329 ASP B 21 ASP~? 22.52 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 30.73 81.29 37.61 31.23 82.07 35.69 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 37.87 70.12 31.80 36.61 69.74 30.15 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 28 3 # 28 A 228 ASP B 177 ASP^? 17.56 NI NI B 305 A 260 ASP B 81 ASP~? 18.56 NI NI B 305 A 329 ASP B 21 ASP~? 22.52 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 30.73 81.29 37.61 31.23 82.07 35.69 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 37.87 70.12 31.80 36.61 69.74 30.15 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qho_c07 ALPHA-AMYLASE user 29 3 # 29 A 228 ASP B 177 ASP^? 17.56 NI NI B 305 A 260 ASP B 90 ASP~? 18.88 CA CA B 303 A 329 ASP B 21 ASP~? 22.52 NI NI B 305 coo 28.46 69.88 26.74 30.40 70.70 26.53 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 30.73 81.29 37.61 31.23 82.07 35.69 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 37.87 70.12 31.80 36.61 69.74 30.15 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1qho_c07 source 1qho ALPHA-AMYLASE : 29 hits 1qho_c07 naa= 3 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 1 3 # 1 A 80 SER A 79 SER~? 16.97 CA CA A 301 A 207 ASP A 21 ASP~? 19.27 CA CA A 301 A 235 HIS A 22 HIS~? 21.70 NI NI A 304 coo 15.54 46.73 17.13 17.06 48.44 16.17 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 23.60 50.31 20.82 21.66 50.51 20.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 20.17 51.16 17.08 18.31 50.28 17.44 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 2 3 # 2 A 80 SER A 79 SER~? 16.97 CA CA A 301 A 207 ASP A 21 ASP~? 19.27 CA CA A 301 A 235 HIS A 83 HIS~? 17.38 NI NI A 304 coo 15.54 46.73 17.13 17.06 48.44 16.17 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 23.60 50.31 20.82 21.66 50.51 20.06 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 20.17 51.16 17.08 18.31 50.28 17.44 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 3 3 # 3 A 80 SER B 79 SER~? 19.41 NI NI B 305 A 207 ASP B 21 ASP~? 22.52 NI NI B 305 A 235 HIS B 22 HIS~? 22.02 NI NI B 305 coo 15.54 46.73 17.13 17.06 48.44 16.17 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 23.60 50.31 20.82 21.66 50.51 20.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 20.17 51.16 17.08 18.31 50.28 17.44 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1qj4_c00 HYDROXYNITRILE LYASE user 4 3 # 4 A 80 SER B 79 SER~? 19.41 NI NI B 305 A 207 ASP B 21 ASP~? 22.52 NI NI B 305 A 235 HIS B 83 HIS~? 17.68 NI NI B 305 coo 15.54 46.73 17.13 17.06 48.44 16.17 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 23.60 50.31 20.82 21.66 50.51 20.06 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 20.17 51.16 17.08 18.31 50.28 17.44 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1qj4_c00 source 1qj4 HYDROXYNITRILE LYASE : 4 hits 1qj4_c00 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 82 ALA~? 21.17 NI NI A 304 A 148 HIS A 83 HIS~? 17.38 NI NI A 304 A 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo 1.42 19.18 21.84 1.11 19.57 23.28 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 0.71 19.67 27.92 2.43 19.16 26.83 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 7.15 16.22 27.50 6.15 18.00 27.94 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 86 ALA~? 20.62 NI NI A 304 A 148 HIS A 22 HIS~? 21.70 NI NI A 304 A 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo 1.42 19.18 21.84 1.11 19.57 23.28 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 0.71 19.67 27.92 2.43 19.16 26.83 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 7.15 16.22 27.50 6.15 18.00 27.94 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA A 86 ALA~? 20.62 NI NI A 304 A 148 HIS A 83 HIS~? 17.38 NI NI A 304 A 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo 1.42 19.18 21.84 1.11 19.57 23.28 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 0.71 19.67 27.92 2.43 19.16 26.83 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 7.15 16.22 27.50 6.15 18.00 27.94 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA A 86 ALA~? 20.62 NI NI A 304 A 148 HIS A 83 HIS~? 17.38 NI NI A 304 A 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo 1.42 19.18 21.84 1.11 19.57 23.28 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 0.71 19.67 27.92 2.43 19.16 26.83 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 7.15 16.22 27.50 6.15 18.00 27.94 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 A 51 ALA B 82 ALA~? 21.25 NI NI B 305 A 148 HIS B 83 HIS~? 17.68 NI NI B 305 A 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo 1.42 19.18 21.84 1.11 19.57 23.28 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 0.71 19.67 27.92 2.43 19.16 26.83 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 7.15 16.22 27.50 6.15 18.00 27.94 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 A 51 ALA B 86 ALA~? 18.65 CA CA B 303 A 148 HIS B 22 HIS~? 22.02 NI NI B 305 A 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo 1.42 19.18 21.84 1.11 19.57 23.28 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 0.71 19.67 27.92 2.43 19.16 26.83 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 7.15 16.22 27.50 6.15 18.00 27.94 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 A 51 ALA B 86 ALA~? 18.65 CA CA B 303 A 148 HIS B 83 HIS~? 17.68 NI NI B 305 A 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo 1.42 19.18 21.84 1.11 19.57 23.28 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 0.71 19.67 27.92 2.43 19.16 26.83 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 7.15 16.22 27.50 6.15 18.00 27.94 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 A 51 ALA B 86 ALA~? 18.65 CA CA B 303 A 148 HIS B 83 HIS~? 17.68 NI NI B 305 A 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo 1.42 19.18 21.84 1.11 19.57 23.28 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 0.71 19.67 27.92 2.43 19.16 26.83 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 7.15 16.22 27.50 6.15 18.00 27.94 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 82 ALA~? 21.17 NI NI A 304 B 148 HIS A 83 HIS~? 17.38 NI NI A 304 B 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 86 ALA~? 20.62 NI NI A 304 B 148 HIS A 22 HIS~? 21.70 NI NI A 304 B 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA A 86 ALA~? 20.62 NI NI A 304 B 148 HIS A 83 HIS~? 17.38 NI NI A 304 B 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA A 86 ALA~? 20.62 NI NI A 304 B 148 HIS A 83 HIS~? 17.38 NI NI A 304 B 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA B 82 ALA~? 21.25 NI NI B 305 B 148 HIS B 83 HIS~? 17.68 NI NI B 305 B 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 B 51 ALA B 86 ALA~? 18.65 CA CA B 303 B 148 HIS B 22 HIS~? 22.02 NI NI B 305 B 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 B 51 ALA B 86 ALA~? 18.65 CA CA B 303 B 148 HIS B 83 HIS~? 17.68 NI NI B 305 B 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 B 51 ALA B 86 ALA~? 18.65 CA CA B 303 B 148 HIS B 83 HIS~? 17.68 NI NI B 305 B 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 82 ALA~? 21.17 NI NI A 304 C 148 HIS A 83 HIS~? 17.38 NI NI A 304 C 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 86 ALA~? 20.62 NI NI A 304 C 148 HIS A 22 HIS~? 21.70 NI NI A 304 C 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA A 86 ALA~? 20.62 NI NI A 304 C 148 HIS A 83 HIS~? 17.38 NI NI A 304 C 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA A 86 ALA~? 20.62 NI NI A 304 C 148 HIS A 83 HIS~? 17.38 NI NI A 304 C 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 C 51 ALA B 82 ALA~? 21.25 NI NI B 305 C 148 HIS B 83 HIS~? 17.68 NI NI B 305 C 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 C 51 ALA B 86 ALA~? 18.65 CA CA B 303 C 148 HIS B 22 HIS~? 22.02 NI NI B 305 C 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 C 51 ALA B 86 ALA~? 18.65 CA CA B 303 C 148 HIS B 83 HIS~? 17.68 NI NI B 305 C 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 C 51 ALA B 86 ALA~? 18.65 CA CA B 303 C 148 HIS B 83 HIS~? 17.68 NI NI B 305 C 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 82 ALA~? 21.17 NI NI A 304 D 148 HIS A 83 HIS~? 17.38 NI NI A 304 D 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 86 ALA~? 20.62 NI NI A 304 D 148 HIS A 22 HIS~? 21.70 NI NI A 304 D 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA A 86 ALA~? 20.62 NI NI A 304 D 148 HIS A 83 HIS~? 17.38 NI NI A 304 D 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA A 86 ALA~? 20.62 NI NI A 304 D 148 HIS A 83 HIS~? 17.38 NI NI A 304 D 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA B 82 ALA~? 21.25 NI NI B 305 D 148 HIS B 83 HIS~? 17.68 NI NI B 305 D 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 D 51 ALA B 86 ALA~? 18.65 CA CA B 303 D 148 HIS B 22 HIS~? 22.02 NI NI B 305 D 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 D 51 ALA B 86 ALA~? 18.65 CA CA B 303 D 148 HIS B 83 HIS~? 17.68 NI NI B 305 D 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 D 51 ALA B 86 ALA~? 18.65 CA CA B 303 D 148 HIS B 83 HIS~? 17.68 NI NI B 305 D 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 82 ALA~? 21.17 NI NI A 304 E 148 HIS A 83 HIS~? 17.38 NI NI A 304 E 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA A 86 ALA~? 20.62 NI NI A 304 E 148 HIS A 22 HIS~? 21.70 NI NI A 304 E 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA A 86 ALA~? 20.62 NI NI A 304 E 148 HIS A 83 HIS~? 17.38 NI NI A 304 E 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA A 86 ALA~? 20.62 NI NI A 304 E 148 HIS A 83 HIS~? 17.38 NI NI A 304 E 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 E 51 ALA A 149 ALA~? 19.73 NI NI A 304 E 148 HIS A 148 HIS~? 18.59 NI NI A 304 E 163 ASP A 145 ASP.? 18.22 NI NI A 304 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 5.60 1.53 -36.46 4.63 0.36 -36.50 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 E 51 ALA B 82 ALA~? 21.25 NI NI B 305 E 148 HIS B 83 HIS~? 17.68 NI NI B 305 E 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 E 51 ALA B 86 ALA~? 18.65 CA CA B 303 E 148 HIS B 22 HIS~? 22.02 NI NI B 305 E 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 E 51 ALA B 86 ALA~? 18.65 CA CA B 303 E 148 HIS B 83 HIS~? 17.68 NI NI B 305 E 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 E 51 ALA B 86 ALA~? 18.65 CA CA B 303 E 148 HIS B 83 HIS~? 17.68 NI NI B 305 E 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 9 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 82 ALA~? 21.17 NI NI A 304 F 148 HIS A 83 HIS~? 17.38 NI NI A 304 F 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 86 ALA~? 20.62 NI NI A 304 F 148 HIS A 22 HIS~? 21.70 NI NI A 304 F 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA A 86 ALA~? 20.62 NI NI A 304 F 148 HIS A 83 HIS~? 17.38 NI NI A 304 F 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA A 86 ALA~? 20.62 NI NI A 304 F 148 HIS A 83 HIS~? 17.38 NI NI A 304 F 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 F 51 ALA B 82 ALA~? 21.25 NI NI B 305 F 148 HIS B 83 HIS~? 17.68 NI NI B 305 F 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 F 51 ALA B 86 ALA~? 18.65 CA CA B 303 F 148 HIS B 22 HIS~? 22.02 NI NI B 305 F 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 F 51 ALA B 86 ALA~? 18.65 CA CA B 303 F 148 HIS B 83 HIS~? 17.68 NI NI B 305 F 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 F 51 ALA B 86 ALA~? 18.65 CA CA B 303 F 148 HIS B 83 HIS~? 17.68 NI NI B 305 F 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 82 ALA~? 21.17 NI NI A 304 G 148 HIS A 83 HIS~? 17.38 NI NI A 304 G 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 85 ALA~? 20.35 NI NI A 304 G 148 HIS A 83 HIS~? 17.38 NI NI A 304 G 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -22.28 15.15 -35.49 -23.77 15.40 -35.47 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA A 86 ALA~? 20.62 NI NI A 304 G 148 HIS A 22 HIS~? 21.70 NI NI A 304 G 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA A 86 ALA~? 20.62 NI NI A 304 G 148 HIS A 83 HIS~? 17.38 NI NI A 304 G 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA A 86 ALA~? 20.62 NI NI A 304 G 148 HIS A 83 HIS~? 17.38 NI NI A 304 G 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 G 51 ALA A 149 ALA~? 19.73 NI NI A 304 G 148 HIS A 148 HIS~? 18.59 NI NI A 304 G 163 ASP A 145 ASP.? 18.22 NI NI A 304 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 5.60 1.53 -36.46 4.63 0.36 -36.50 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 G 51 ALA B 82 ALA~? 21.25 NI NI B 305 G 148 HIS B 83 HIS~? 17.68 NI NI B 305 G 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 G 51 ALA B 85 ALA~? 16.03 CA CA B 303 G 148 HIS B 83 HIS~? 17.68 NI NI B 305 G 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 G 51 ALA B 86 ALA~? 18.65 CA CA B 303 G 148 HIS B 22 HIS~? 22.02 NI NI B 305 G 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 G 51 ALA B 86 ALA~? 18.65 CA CA B 303 G 148 HIS B 83 HIS~? 17.68 NI NI B 305 G 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 11 3 # 11 G 51 ALA B 86 ALA~? 18.65 CA CA B 303 G 148 HIS B 83 HIS~? 17.68 NI NI B 305 G 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 11 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 82 ALA~? 21.17 NI NI A 304 H 148 HIS A 83 HIS~? 17.38 NI NI A 304 H 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 86 ALA~? 20.62 NI NI A 304 H 148 HIS A 22 HIS~? 21.70 NI NI A 304 H 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA A 86 ALA~? 20.62 NI NI A 304 H 148 HIS A 83 HIS~? 17.38 NI NI A 304 H 163 ASP A 21 ASP~? 19.27 CA CA A 301 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA A 86 ALA~? 20.62 NI NI A 304 H 148 HIS A 83 HIS~? 17.38 NI NI A 304 H 163 ASP A 81 ASP~? 18.70 NI NI A 304 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 H 51 ALA B 82 ALA~? 21.25 NI NI B 305 H 148 HIS B 83 HIS~? 17.68 NI NI B 305 H 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 H 51 ALA B 86 ALA~? 18.65 CA CA B 303 H 148 HIS B 22 HIS~? 22.02 NI NI B 305 H 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 H 51 ALA B 86 ALA~? 18.65 CA CA B 303 H 148 HIS B 83 HIS~? 17.68 NI NI B 305 H 163 ASP B 21 ASP~? 22.52 NI NI B 305 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 H 51 ALA B 86 ALA~? 18.65 CA CA B 303 H 148 HIS B 83 HIS~? 17.68 NI NI B 305 H 163 ASP B 81 ASP~? 18.56 NI NI B 305 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 83 HIS~? 17.38 NI NI A 304 A 646 ASP A 177 ASP^? 15.76 CA CA A 306 A 741 SER A 20 SER~? 13.98 CA CA A 301 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -21.98 22.65 -22.42 -20.53 24.32 -21.40 ULMN 3 1qrz_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 121 HIS.? -3.63 NI NI A 304s A 646 ASP A 104 ASP^? 11.20 NI NI A 304 A 741 SER A 183 SER.? 9.24 NI NI A 304 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 1qrz_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS B 83 HIS~? 17.68 NI NI B 305 A 646 ASP B 177 ASP^? 17.56 NI NI B 305 A 741 SER B 20 SER~? 23.19 NI NI B 305 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 ULMN 3 1qrz_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 121 HIS.? -3.60 NI NI B 305s A 646 ASP B 104 ASP^? 11.37 NI NI B 305 A 741 SER B 127 SER^? 6.61 NI NI B 305 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 ULMN 3 1qrz_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 121 HIS.? -3.60 NI NI B 305s A 646 ASP B 104 ASP^? 11.37 NI NI B 305 A 741 SER B 183 SER.? 9.15 NI NI B 305 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -16.10 -1.48 32.49 -17.38 0.37 33.40 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 1qrz_c12 source 1qrz PLASMINOGEN : 5 hits 1qrz_c12 naa= 3 ULMN 3 1qrz_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 83 HIS~? 17.38 NI NI A 304 B 646 ASP A 177 ASP^? 15.76 CA CA A 306 B 741 SER A 20 SER~? 13.98 CA CA A 301 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -21.98 22.65 -22.42 -20.53 24.32 -21.40 ULMN 3 1qrz_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 121 HIS.? -3.63 NI NI A 304s B 646 ASP A 104 ASP^? 11.20 NI NI A 304 B 741 SER A 124 SER.? 9.62 NI NI A 304 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -16.69 2.20 -34.43 -16.43 1.36 -32.16 ULMN 3 1qrz_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS A 121 HIS.? -3.63 NI NI A 304s B 646 ASP A 104 ASP^? 11.20 NI NI A 304 B 741 SER A 127 SER^? 6.45 NI NI A 304 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -14.78 7.24 -29.97 -14.14 4.91 -30.21 ULMN 3 1qrz_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS A 121 HIS.? -3.63 NI NI A 304s B 646 ASP A 104 ASP^? 11.20 NI NI A 304 B 741 SER A 183 SER.? 9.24 NI NI A 304 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 1qrz_c13 PLASMINOGEN user 5 3 # 5 B 603 HIS A 123 HIS.? 13.29 CA CA B 303 B 646 ASP A 104 ASP^? 11.20 NI NI A 304 B 741 SER A 124 SER.? 9.62 NI NI A 304 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -16.69 2.20 -34.43 -16.43 1.36 -32.16 ULMN 3 1qrz_c13 PLASMINOGEN user 6 3 # 6 B 603 HIS B 83 HIS~? 17.68 NI NI B 305 B 646 ASP B 177 ASP^? 17.56 NI NI B 305 B 741 SER B 20 SER~? 23.19 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 ULMN 3 1qrz_c13 PLASMINOGEN user 7 3 # 7 B 603 HIS B 121 HIS.? -3.60 NI NI B 305s B 646 ASP B 104 ASP^? 11.37 NI NI B 305 B 741 SER B 124 SER.? 10.06 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 ULMN 3 1qrz_c13 PLASMINOGEN user 8 3 # 8 B 603 HIS B 121 HIS.? -3.60 NI NI B 305s B 646 ASP B 104 ASP^? 11.37 NI NI B 305 B 741 SER B 127 SER^? 6.61 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 ULMN 3 1qrz_c13 PLASMINOGEN user 9 3 # 9 B 603 HIS B 121 HIS.? -3.60 NI NI B 305s B 646 ASP B 104 ASP^? 11.37 NI NI B 305 B 741 SER B 183 SER.? 9.15 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 1qrz_c13 PLASMINOGEN user 10 3 # 10 B 603 HIS B 123 HIS.? 14.82 NI NI B 305 B 646 ASP B 104 ASP^? 11.37 NI NI B 305 B 741 SER B 124 SER.? 10.06 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -43.75 -1.60 -6.12 -44.85 0.33 -5.15 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 1qrz_c13 source 1qrz PLASMINOGEN : 10 hits 1qrz_c13 naa= 3 ULMN 3 1qrz_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 83 HIS~? 17.38 NI NI A 304 C 646 ASP A 177 ASP^? 15.76 CA CA A 306 C 741 SER A 20 SER~? 13.98 CA CA A 301 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -21.98 22.65 -22.42 -20.53 24.32 -21.40 ULMN 3 1qrz_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 121 HIS.? -3.63 NI NI A 304s C 646 ASP A 104 ASP^? 11.20 NI NI A 304 C 741 SER A 127 SER^? 6.45 NI NI A 304 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -14.78 7.24 -29.97 -14.14 4.91 -30.21 ULMN 3 1qrz_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 121 HIS.? -3.63 NI NI A 304s C 646 ASP A 104 ASP^? 11.20 NI NI A 304 C 741 SER A 183 SER.? 9.24 NI NI A 304 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 1qrz_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 83 HIS~? 17.68 NI NI B 305 C 646 ASP B 177 ASP^? 17.56 NI NI B 305 C 741 SER B 20 SER~? 23.19 NI NI B 305 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 ULMN 3 1qrz_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 121 HIS.? -3.60 NI NI B 305s C 646 ASP B 104 ASP^? 11.37 NI NI B 305 C 741 SER B 127 SER^? 6.61 NI NI B 305 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 ULMN 3 1qrz_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 121 HIS.? -3.60 NI NI B 305s C 646 ASP B 104 ASP^? 11.37 NI NI B 305 C 741 SER B 183 SER.? 9.15 NI NI B 305 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 4.71 -4.57 4.71 3.58 -6.49 5.69 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 1qrz_c14 source 1qrz PLASMINOGEN : 6 hits 1qrz_c14 naa= 3 ULMN 3 1qrz_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 83 HIS~? 17.38 NI NI A 304 D 646 ASP A 177 ASP^? 15.76 CA CA A 306 D 741 SER A 20 SER~? 13.98 CA CA A 301 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -21.98 22.65 -22.42 -20.53 24.32 -21.40 ULMN 3 1qrz_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 121 HIS.? -3.63 NI NI A 304s D 646 ASP A 104 ASP^? 11.20 NI NI A 304 D 741 SER A 127 SER^? 6.45 NI NI A 304 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -14.78 7.24 -29.97 -14.14 4.91 -30.21 ULMN 3 1qrz_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS A 121 HIS.? -3.63 NI NI A 304s D 646 ASP A 104 ASP^? 11.20 NI NI A 304 D 741 SER A 183 SER.? 9.24 NI NI A 304 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 1qrz_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 83 HIS~? 17.68 NI NI B 305 D 646 ASP B 177 ASP^? 17.56 NI NI B 305 D 741 SER B 20 SER~? 23.19 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 ULMN 3 1qrz_c15 PLASMINOGEN user 5 3 # 5 D 603 HIS B 121 HIS.? -3.60 NI NI B 305s D 646 ASP B 104 ASP^? 11.37 NI NI B 305 D 741 SER B 124 SER.? 10.06 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 ULMN 3 1qrz_c15 PLASMINOGEN user 6 3 # 6 D 603 HIS B 121 HIS.? -3.60 NI NI B 305s D 646 ASP B 104 ASP^? 11.37 NI NI B 305 D 741 SER B 127 SER^? 6.61 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 ULMN 3 1qrz_c15 PLASMINOGEN user 7 3 # 7 D 603 HIS B 121 HIS.? -3.60 NI NI B 305s D 646 ASP B 104 ASP^? 11.37 NI NI B 305 D 741 SER B 183 SER.? 9.15 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 1qrz_c15 PLASMINOGEN user 8 3 # 8 D 603 HIS B 123 HIS.? 14.82 NI NI B 305 D 646 ASP B 104 ASP^? 11.37 NI NI B 305 D 741 SER B 124 SER.? 10.06 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -49.16 -4.56 43.16 -50.44 -6.45 43.96 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 1qrz_c15 source 1qrz PLASMINOGEN : 8 hits 1qrz_c15 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 22 HIS~? 21.70 NI NI A 304 A 646 ASP A 81 ASP~? 18.70 NI NI A 304 A 739 GLY A 176 GLY.? 12.58 CA CA A 306 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -16.93 18.91 -18.06 -16.18 18.74 -18.33 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS B 22 HIS~? 22.02 NI NI B 305 A 646 ASP B 81 ASP~? 18.56 NI NI B 305 A 739 GLY B 176 GLY.? 17.70 NI NI B 305 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 1qrz_c20 source 1qrz PLASMINOGEN : 2 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 22 HIS~? 21.70 NI NI A 304 B 646 ASP A 81 ASP~? 18.70 NI NI A 304 B 739 GLY A 176 GLY.? 12.58 CA CA A 306 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -16.93 18.91 -18.06 -16.18 18.74 -18.33 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS B 22 HIS~? 22.02 NI NI B 305 B 646 ASP B 81 ASP~? 18.56 NI NI B 305 B 739 GLY B 176 GLY.? 17.70 NI NI B 305 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 1qrz_c21 source 1qrz PLASMINOGEN : 2 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 22 HIS~? 21.70 NI NI A 304 C 646 ASP A 81 ASP~? 18.70 NI NI A 304 C 739 GLY A 176 GLY.? 12.58 CA CA A 306 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 7.82 1.25 3.03 7.30 1.31 3.65 -16.93 18.91 -18.06 -16.18 18.74 -18.33 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS B 22 HIS~? 22.02 NI NI B 305 C 646 ASP B 81 ASP~? 18.56 NI NI B 305 C 739 GLY B 176 GLY.? 17.70 NI NI B 305 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo 7.82 1.25 3.03 7.30 1.31 3.65 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 1qrz_c22 source 1qrz PLASMINOGEN : 2 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 22 HIS~? 21.70 NI NI A 304 D 646 ASP A 81 ASP~? 18.70 NI NI A 304 D 739 GLY A 176 GLY.? 12.58 CA CA A 306 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -16.93 18.91 -18.06 -16.18 18.74 -18.33 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS B 22 HIS~? 22.02 NI NI B 305 D 646 ASP B 81 ASP~? 18.56 NI NI B 305 D 739 GLY B 176 GLY.? 17.70 NI NI B 305 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 1qrz_c23 source 1qrz PLASMINOGEN : 2 hits 1qrz_c23 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 73 PHE~? 16.31 CA CA A 301 A 201 ASP A 65 ASP~? 19.57 CA CA B 303 A 227 LYS A 78 LYS~? 23.27 CA CA A 301 coo 23.39 49.81 32.16 21.33 51.68 32.26 -25.83 8.44 -17.90 -23.57 8.20 -16.27 coo 25.52 45.12 37.98 23.98 46.65 37.85 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 12.68 46.83 36.69 18.26 48.67 34.51 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 168 PHE^? 16.43 NI NI A 304 A 201 ASP A 145 ASP.? 18.22 NI NI A 304 A 227 LYS A 159 LYS.? 27.24 CA CA A 302 coo 23.39 49.81 32.16 21.33 51.68 32.26 4.20 9.10 -27.54 5.46 6.65 -28.03 coo 25.52 45.12 37.98 23.98 46.65 37.85 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 12.68 46.83 36.69 18.26 48.67 34.51 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE B 73 PHE~? 16.83 NI NI B 305 A 201 ASP B 65 ASP~? 20.64 NI NI B 305 A 227 LYS B 78 LYS~? 25.94 CA CA B 303 coo 23.39 49.81 32.16 21.33 51.68 32.26 -23.58 -13.67 -62.51 -21.58 -13.05 -64.36 coo 25.52 45.12 37.98 23.98 46.65 37.85 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 12.68 46.83 36.69 18.26 48.67 34.51 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 168 PHE^? 16.16 NI NI B 305 A 201 ASP B 145 ASP.? 18.27 NI NI B 305 A 227 LYS B 159 LYS.? 30.31 NI NI B 305 coo 23.39 49.81 32.16 21.33 51.68 32.26 5.97 -7.92 -52.72 6.39 -5.22 -52.12 coo 25.52 45.12 37.98 23.98 46.65 37.85 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 12.68 46.83 36.69 18.26 48.67 34.51 15.99 -14.57 -52.82 19.67 -12.66 -51.79 1qz9_c02 source 1qz9 KYNURENINASE : 4 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 196 ASP.? 6.39 CA CA A 306 A 186 ASN A 192 ASN.? 10.14 CA CA A 302 A 260 ALA A 140 ALA.? 11.16 NI NI A 304 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 11.43 26.53 7.41 13.01 27.56 8.43 -4.75 8.04 -11.36 -5.74 9.45 -10.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 -5.86 11.67 -18.64 -7.20 12.33 -18.40 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 197 ASP.? 9.27 CA CA A 306 A 186 ASN A 108 ASN^? 7.27 NI NI A 304 A 260 ALA A 39 ALA~? 14.49 CA CA A 306 coo 11.81 33.10 11.71 13.07 31.45 11.40 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 11.43 26.53 7.41 13.01 27.56 8.43 -13.61 4.93 -16.45 -13.33 3.48 -17.96 coo 21.53 26.33 6.96 20.26 25.69 7.52 -20.98 1.90 -9.17 -19.68 2.67 -9.17 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP A 197 ASP.? 9.27 CA CA A 306 A 186 ASN A 108 ASN^? 7.27 NI NI A 304 A 260 ALA A 140 ALA.? 11.16 NI NI A 304 coo 11.81 33.10 11.71 13.07 31.45 11.40 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 11.43 26.53 7.41 13.01 27.56 8.43 -13.61 4.93 -16.45 -13.33 3.48 -17.96 coo 21.53 26.33 6.96 20.26 25.69 7.52 -5.86 11.67 -18.64 -7.20 12.33 -18.40 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP A 197 ASP.? 9.27 CA CA A 306 A 186 ASN A 192 ASN.? 10.14 CA CA A 302 A 260 ALA A 140 ALA.? 11.16 NI NI A 304 coo 11.81 33.10 11.71 13.07 31.45 11.40 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 11.43 26.53 7.41 13.01 27.56 8.43 -4.75 8.04 -11.36 -5.74 9.45 -10.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 -5.86 11.67 -18.64 -7.20 12.33 -18.40 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 5 3 # 5 A 10 ASP B 196 ASP.? 23.47 NI NI B 305 A 186 ASN B 192 ASN.? 16.32 NI NI B 305 A 260 ALA B 140 ALA.? 11.62 NI NI B 305 coo 11.81 33.10 11.71 13.07 31.45 11.40 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 11.43 26.53 7.41 13.01 27.56 8.43 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 coo 21.53 26.33 6.96 20.26 25.69 7.52 -3.13 -13.00 -61.85 -4.31 -13.89 -62.21 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 6 3 # 6 A 10 ASP B 197 ASP.? 18.81 NI NI B 305 A 186 ASN B 108 ASN^? 7.81 NI NI B 305 A 260 ALA B 39 ALA~? 18.17 NI NI B 305 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 11.43 26.53 7.41 13.01 27.56 8.43 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 coo 21.53 26.33 6.96 20.26 25.69 7.52 -20.16 -6.34 -71.14 -18.74 -6.88 -71.28 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 7 3 # 7 A 10 ASP B 197 ASP.? 18.81 NI NI B 305 A 186 ASN B 108 ASN^? 7.81 NI NI B 305 A 260 ALA B 140 ALA.? 11.62 NI NI B 305 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 11.43 26.53 7.41 13.01 27.56 8.43 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 coo 21.53 26.33 6.96 20.26 25.69 7.52 -3.13 -13.00 -61.85 -4.31 -13.89 -62.21 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 8 3 # 8 A 10 ASP B 197 ASP.? 18.81 NI NI B 305 A 186 ASN B 192 ASN.? 16.32 NI NI B 305 A 260 ALA B 140 ALA.? 11.62 NI NI B 305 coo 11.81 33.10 11.71 13.07 31.45 11.40 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 11.43 26.53 7.41 13.01 27.56 8.43 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 coo 21.53 26.33 6.96 20.26 25.69 7.52 -3.13 -13.00 -61.85 -4.31 -13.89 -62.21 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 8 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS B 116 HIS^? 6.69 NI NI B 305 A 41 LYS B 142 LYS^? 13.37 NI NI B 305 A 119 HIS B 121 HIS.? -3.60 NI NI B 305s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 1 hits 1rbn_c01 naa= 3 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 1 3 # 1 A 608 ASP A 21 ASP~? 19.27 CA CA A 301 A 610 HIS A 22 HIS~? 21.70 NI NI A 304 A 661 HIS A 16 HIS^? 15.61 NI NI A 304 coo 75.99 81.56 1.86 73.91 81.34 2.28 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 71.04 78.84 0.46 71.54 76.90 1.02 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 75.40 81.38 12.06 74.88 79.42 12.63 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 2 3 # 2 A 608 ASP A 21 ASP~? 19.27 CA CA A 301 A 610 HIS A 83 HIS~? 17.38 NI NI A 304 A 661 HIS A 16 HIS^? 15.61 NI NI A 304 coo 75.99 81.56 1.86 73.91 81.34 2.28 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 71.04 78.84 0.46 71.54 76.90 1.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 75.40 81.38 12.06 74.88 79.42 12.63 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 3 3 # 3 A 608 ASP A 177 ASP^? 15.76 CA CA A 306 A 610 HIS A 16 HIS^? 15.61 NI NI A 304 A 661 HIS A 83 HIS~? 17.38 NI NI A 304 coo 75.99 81.56 1.86 73.91 81.34 2.28 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 71.04 78.84 0.46 71.54 76.90 1.02 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 75.40 81.38 12.06 74.88 79.42 12.63 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 4 3 # 4 A 608 ASP B 21 ASP~? 22.52 NI NI B 305 A 610 HIS B 22 HIS~? 22.02 NI NI B 305 A 661 HIS B 16 HIS^? 15.81 NI NI B 305 coo 75.99 81.56 1.86 73.91 81.34 2.28 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 71.04 78.84 0.46 71.54 76.90 1.02 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 75.40 81.38 12.06 74.88 79.42 12.63 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 5 3 # 5 A 608 ASP B 21 ASP~? 22.52 NI NI B 305 A 610 HIS B 83 HIS~? 17.68 NI NI B 305 A 661 HIS B 16 HIS^? 15.81 NI NI B 305 coo 75.99 81.56 1.86 73.91 81.34 2.28 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 71.04 78.84 0.46 71.54 76.90 1.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 75.40 81.38 12.06 74.88 79.42 12.63 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1req_c10 METHYLMALONYL-COA MUTASE user 6 3 # 6 A 608 ASP B 177 ASP^? 17.56 NI NI B 305 A 610 HIS B 16 HIS^? 15.81 NI NI B 305 A 661 HIS B 83 HIS~? 17.68 NI NI B 305 coo 75.99 81.56 1.86 73.91 81.34 2.28 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 71.04 78.84 0.46 71.54 76.90 1.02 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 75.40 81.38 12.06 74.88 79.42 12.63 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1req_c10 source 1req METHYLMALONYL-COA MUTASE : 6 hits 1req_c10 naa= 3 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 1 3 # 1 C 608 ASP A 21 ASP~? 19.27 CA CA A 301 C 610 HIS A 22 HIS~? 21.70 NI NI A 304 C 661 HIS A 16 HIS^? 15.61 NI NI A 304 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 2 3 # 2 C 608 ASP A 21 ASP~? 19.27 CA CA A 301 C 610 HIS A 83 HIS~? 17.38 NI NI A 304 C 661 HIS A 16 HIS^? 15.61 NI NI A 304 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -10.06 19.38 -25.76 -9.54 19.61 -23.74 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 3 3 # 3 C 608 ASP A 177 ASP^? 15.76 CA CA A 306 C 610 HIS A 16 HIS^? 15.61 NI NI A 304 C 661 HIS A 83 HIS~? 17.38 NI NI A 304 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 4 3 # 4 C 608 ASP B 21 ASP~? 22.52 NI NI B 305 C 610 HIS B 22 HIS~? 22.02 NI NI B 305 C 661 HIS B 16 HIS^? 15.81 NI NI B 305 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 5 3 # 5 C 608 ASP B 21 ASP~? 22.52 NI NI B 305 C 610 HIS B 83 HIS~? 17.68 NI NI B 305 C 661 HIS B 16 HIS^? 15.81 NI NI B 305 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 ULMN 3 1req_c11 METHYLMALONYL-COA MUTASE user 6 3 # 6 C 608 ASP B 177 ASP^? 17.56 NI NI B 305 C 610 HIS B 16 HIS^? 15.81 NI NI B 305 C 661 HIS B 83 HIS~? 17.68 NI NI B 305 coo -17.65 80.52 58.00 -16.23 80.79 56.41 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -8.38 80.78 62.24 -7.53 82.67 62.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1req_c11 source 1req METHYLMALONYL-COA MUTASE : 6 hits 1req_c11 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 83 HIS~? 17.38 NI NI A 304 B 84 ASP A 21 ASP~? 19.27 CA CA A 301 B 140 GLY A 128 GLY^? 7.35 NI NI A 304 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS A 83 HIS~? 17.38 NI NI A 304 B 84 ASP A 81 ASP~? 18.70 NI NI A 304 B 140 GLY A 176 GLY.? 12.58 CA CA A 306 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -16.93 18.91 -18.06 -16.18 18.74 -18.33 ULMN 3 1rgq_c01 NS4A PEPTIDE user 3 3 # 3 B 60 HIS B 83 HIS~? 17.68 NI NI B 305 B 84 ASP B 21 ASP~? 22.52 NI NI B 305 B 140 GLY B 128 GLY^? 7.45 NI NI B 305 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1rgq_c01 source 1rgq NS4A PEPTIDE : 3 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 196 ASP.? 6.39 CA CA A 306 35 SER A 194 SER.? 9.10 CA CA A 302 215 ASP A 197 ASP.? 9.27 CA CA A 306 coo 11.85 17.24 72.81 11.09 15.37 72.36 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 12.20 12.71 75.45 13.69 13.84 74.03 -3.34 11.88 -6.70 -5.38 12.98 -7.40 coo 5.22 15.03 71.43 7.19 14.88 70.83 -12.14 8.73 -7.75 -12.16 7.25 -6.26 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 197 ASP.? 9.27 CA CA A 306 35 SER A 133 SER.? 4.86 CA CA A 306 215 ASP A 196 ASP.? 6.39 CA CA A 306 coo 11.85 17.24 72.81 11.09 15.37 72.36 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 12.20 12.71 75.45 13.69 13.84 74.03 -13.59 14.24 -12.04 -13.08 13.73 -9.72 coo 5.22 15.03 71.43 7.19 14.88 70.83 -9.18 12.61 -5.36 -9.90 13.29 -3.47 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP B 196 ASP.? 23.47 NI NI B 305 35 SER B 194 SER.? 19.35 NI NI B 305 215 ASP B 197 ASP.? 18.81 NI NI B 305 coo 11.85 17.24 72.81 11.09 15.37 72.36 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 12.20 12.71 75.45 13.69 13.84 74.03 -0.75 -12.31 -73.01 -2.71 -13.39 -72.05 coo 5.22 15.03 71.43 7.19 14.88 70.83 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 3 hits 1rne_c04 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 50 GLU~? 22.49 CA CA A 302 A 288 HIS A 119 HIS^? -3.69 NI NI A 304s A 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 29.27 18.78 14.99 27.16 18.62 14.76 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 57.80 12.92 13.83 53.77 8.42 12.15 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 51 GLU~? 19.07 CA CA B 303 A 288 HIS A 119 HIS^? -3.69 NI NI A 304s A 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 29.27 18.78 14.99 27.16 18.62 14.76 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 57.80 12.92 13.83 53.77 8.42 12.15 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 101 GLU^? 20.45 NI NI A 304 A 288 HIS A 119 HIS^? -3.69 NI NI A 304s A 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 29.27 18.78 14.99 27.16 18.62 14.76 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 57.80 12.92 13.83 53.77 8.42 12.15 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 182 GLU^? 15.51 NI NI A 304 A 288 HIS B 119 HIS^? -3.53 NI NI B 305s A 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 29.27 18.78 14.99 27.16 18.62 14.76 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU A 188 GLU^? 11.68 NI NI A 304 A 288 HIS A 83 HIS~? 17.38 NI NI A 304 A 329 LYS A 78 LYS~? 23.27 CA CA A 301 coo 29.27 18.78 14.99 27.16 18.62 14.76 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 49.52 10.06 10.36 50.99 9.65 8.92 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 57.80 12.92 13.83 53.77 8.42 12.15 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU B 50 GLU~? 24.18 NI NI B 305 A 288 HIS B 119 HIS^? -3.53 NI NI B 305s A 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 29.27 18.78 14.99 27.16 18.62 14.76 -13.23 5.78 -74.13 -14.26 6.16 -75.95 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU B 51 GLU~? 22.61 NI NI B 305 A 288 HIS B 119 HIS^? -3.53 NI NI B 305s A 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 29.27 18.78 14.99 27.16 18.62 14.76 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 101 GLU^? 17.23 CA CA B 303 A 288 HIS B 119 HIS^? -3.53 NI NI B 305s A 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 29.27 18.78 14.99 27.16 18.62 14.76 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 182 GLU^? 15.43 NI NI B 305 A 288 HIS A 119 HIS^? -3.69 NI NI A 304s A 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 29.27 18.78 14.99 27.16 18.62 14.76 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 49.52 10.06 10.36 50.99 9.65 8.92 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 57.80 12.92 13.83 53.77 8.42 12.15 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 188 GLU^? 11.04 NI NI B 305 A 288 HIS B 83 HIS~? 17.68 NI NI B 305 A 329 LYS B 78 LYS~? 25.94 CA CA B 303 coo 29.27 18.78 14.99 27.16 18.62 14.76 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 49.52 10.06 10.36 50.99 9.65 8.92 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 57.80 12.92 13.83 53.77 8.42 12.15 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 10 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 29 GLU~? -4.66 CA CA A 301s B 288 HIS A 116 HIS^? 7.23 NI NI A 304 B 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -21.95 18.47 -6.84 -23.04 19.65 -5.43 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 40 GLU~? 12.94 CA CA A 306 B 288 HIS A 119 HIS^? -3.69 NI NI A 304s B 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 50 GLU~? 22.49 CA CA A 302 B 288 HIS A 119 HIS^? -3.69 NI NI A 304s B 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 51 GLU~? 19.07 CA CA B 303 B 288 HIS A 119 HIS^? -3.69 NI NI A 304s B 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -14.85 -12.69 -10.25 -16.74 -13.26 -11.02 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU A 101 GLU^? 20.45 NI NI A 304 B 288 HIS A 119 HIS^? -3.69 NI NI A 304s B 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU A 182 GLU^? 15.51 NI NI A 304 B 288 HIS B 119 HIS^? -3.53 NI NI B 305s B 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -11.04 10.12 -36.92 -10.45 10.15 -38.96 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU A 188 GLU^? 11.68 NI NI A 304 B 288 HIS A 83 HIS~? 17.38 NI NI A 304 B 329 LYS A 78 LYS~? 23.27 CA CA A 301 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 29 GLU~? 27.87 NI NI B 305 B 288 HIS B 116 HIS^? 6.69 NI NI B 305 B 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -17.38 -22.83 -73.54 -18.54 -23.97 -74.92 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU B 40 GLU~? 23.91 NI NI B 305 B 288 HIS B 119 HIS^? -3.53 NI NI B 305s B 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU B 51 GLU~? 22.61 NI NI B 305 B 288 HIS B 119 HIS^? -3.53 NI NI B 305s B 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -16.78 9.18 -70.22 -18.83 9.09 -69.69 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU B 101 GLU^? 17.23 CA CA B 303 B 288 HIS B 119 HIS^? -3.53 NI NI B 305s B 329 LYS B 142 LYS^? 13.37 NI NI B 305 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 0.13 -9.81 -56.44 3.59 -4.88 -57.01 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU B 182 GLU^? 15.43 NI NI B 305 B 288 HIS A 119 HIS^? -3.69 NI NI A 304s B 329 LYS A 142 LYS^? 14.03 NI NI A 304 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU B 188 GLU^? 11.04 NI NI B 305 B 288 HIS B 83 HIS~? 17.68 NI NI B 305 B 329 LYS B 78 LYS~? 25.94 CA CA B 303 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 13 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 22 HIS~? 21.70 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 195 SER A 79 SER~? 16.97 CA CA A 301 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 3 # 3 B 57 HIS B 22 HIS~? 22.02 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 1rtf_c03 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 3 # 4 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 195 SER B 79 SER~? 19.41 NI NI B 305 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 1rtf_c03 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 83 HIS~? 17.38 NI NI A 304 B 102 ASP A 21 ASP~? 19.27 CA CA A 301 B 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 83 HIS~? 17.68 NI NI B 305 B 102 ASP B 21 ASP~? 22.52 NI NI B 305 B 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c06 naa= 3 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 21 ASP~? 19.27 CA CA A 301 64 HIS A 22 HIS~? 21.70 NI NI A 304 221 SER A 79 SER~? 16.97 CA CA A 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 78.27 67.69 61.83 79.58 67.76 60.19 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 83.63 66.07 58.16 81.31 66.75 57.98 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 21 ASP~? 19.27 CA CA A 301 64 HIS A 83 HIS~? 17.38 NI NI A 304 221 SER A 79 SER~? 16.97 CA CA A 301 coo 80.16 73.25 62.48 80.01 71.25 61.82 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 78.27 67.69 61.83 79.58 67.76 60.19 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 83.63 66.07 58.16 81.31 66.75 57.98 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 21 ASP~? 22.52 NI NI B 305 64 HIS B 22 HIS~? 22.02 NI NI B 305 221 SER B 79 SER~? 19.41 NI NI B 305 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 78.27 67.69 61.83 79.58 67.76 60.19 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 83.63 66.07 58.16 81.31 66.75 57.98 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 1sca_c00 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 21 ASP~? 22.52 NI NI B 305 64 HIS B 83 HIS~? 17.68 NI NI B 305 221 SER B 79 SER~? 19.41 NI NI B 305 coo 80.16 73.25 62.48 80.01 71.25 61.82 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 78.27 67.69 61.83 79.58 67.76 60.19 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 83.63 66.07 58.16 81.31 66.75 57.98 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 1sca_c00 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c00 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 104 ASP^? 11.20 NI NI A 304 595 GLU A 101 GLU^? 20.45 NI NI A 304 713 TYR A 205 TYR^? 13.62 NI NI A 304 coo 5.64 2.82 38.49 4.59 4.19 37.25 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 4.35 13.73 37.63 3.39 12.18 36.55 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 3.76 10.25 31.38 3.16 9.87 34.10 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP A 196 ASP.? 6.39 CA CA A 306 595 GLU A 32 GLU~? -3.00 CA CA A 306s 713 TYR A 36 TYR~? 7.82 CA CA A 306 coo 5.64 2.82 38.49 4.59 4.19 37.25 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 4.35 13.73 37.63 3.39 12.18 36.55 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 3.76 10.25 31.38 3.16 9.87 34.10 -19.14 8.29 -6.46 -16.48 9.15 -6.41 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP A 197 ASP.? 9.27 CA CA A 306 595 GLU A 40 GLU~? 12.94 CA CA A 306 713 TYR A 57 TYR^? 15.36 NI NI A 304 coo 5.64 2.82 38.49 4.59 4.19 37.25 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 4.35 13.73 37.63 3.39 12.18 36.55 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 3.76 10.25 31.38 3.16 9.87 34.10 -16.92 0.76 -11.33 -19.53 0.25 -12.18 ULMN 3 1sll_c00 SIALIDASE L user 4 3 # 4 318 ASP B 104 ASP^? 11.37 NI NI B 305 595 GLU B 101 GLU^? 17.23 CA CA B 303 713 TYR B 205 TYR^? 13.71 NI NI B 305 coo 5.64 2.82 38.49 4.59 4.19 37.25 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 4.35 13.73 37.63 3.39 12.18 36.55 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 3.76 10.25 31.38 3.16 9.87 34.10 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 ULMN 3 1sll_c00 SIALIDASE L user 5 3 # 5 318 ASP B 196 ASP.? 23.47 NI NI B 305 595 GLU B 32 GLU~? 21.76 NI NI B 305 713 TYR B 36 TYR~? 20.19 NI NI B 305 coo 5.64 2.82 38.49 4.59 4.19 37.25 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 4.35 13.73 37.63 3.39 12.18 36.55 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 3.76 10.25 31.38 3.16 9.87 34.10 -17.07 -12.06 -73.78 -14.28 -12.36 -73.84 ULMN 3 1sll_c00 SIALIDASE L user 6 3 # 6 318 ASP B 197 ASP.? 18.81 NI NI B 305 595 GLU B 40 GLU~? 23.91 NI NI B 305 713 TYR B 57 TYR^? 15.35 NI NI B 305 coo 5.64 2.82 38.49 4.59 4.19 37.25 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 4.35 13.73 37.63 3.39 12.18 36.55 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 3.76 10.25 31.38 3.16 9.87 34.10 -16.19 -4.30 -69.06 -18.86 -4.46 -68.25 1sll_c00 source 1sll SIALIDASE L : 6 hits 1sll_c00 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 83 HIS~? 17.38 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 15.02 29.17 19.44 15.63 29.96 17.60 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 19.67 30.58 22.61 18.30 29.87 21.17 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 14.52 29.10 10.01 15.08 29.66 10.19 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 83 HIS~? 17.68 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 15.02 29.17 19.44 15.63 29.96 17.60 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 19.67 30.58 22.61 18.30 29.87 21.17 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 14.52 29.10 10.01 15.08 29.66 10.19 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 2 hits 1ssx_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 148 HIS~? 18.59 NI NI A 304 B 80 GLU A 144 GLU^? 14.15 NI NI A 304 B 223 ARG A 98 ARG.? 20.57 NI NI B 305 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 1.81 5.70 -30.20 2.38 3.69 -29.88 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -25.95 5.08 -43.97 -24.52 2.34 -44.05 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 148 HIS~? 18.59 NI NI A 304 B 80 GLU A 144 GLU^? 14.15 NI NI A 304 B 223 ARG B 158 ARG.? 33.41 NI NI B 305 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 1.81 5.70 -30.20 2.38 3.69 -29.88 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 19.54 -16.27 -48.10 20.08 -17.20 -45.23 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS A 148 HIS~? 18.59 NI NI A 304 B 80 GLU A 144 GLU^? 14.15 NI NI A 304 B 223 ARG B 206 ARG^? 17.11 NI NI B 305 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 1.81 5.70 -30.20 2.38 3.69 -29.88 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS A 187 HIS^? -3.59 NI NI A 304s B 80 GLU A 188 GLU^? 11.68 NI NI A 304 B 223 ARG B 13 ARG.? 21.21 NI NI B 305 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -4.25 -19.48 -42.40 -4.50 -22.44 -43.20 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 5 3 # 5 B 8 HIS B 116 HIS^? 6.69 NI NI B 305 B 80 GLU B 188 GLU^? 11.04 NI NI B 305 B 223 ARG A 206 ARG^? 17.65 CA CA B 303 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 6 3 # 6 B 8 HIS B 148 HIS.? 18.38 NI NI B 305 B 80 GLU B 144 GLU^? 13.93 NI NI B 305 B 223 ARG A 98 ARG.? 20.57 NI NI B 305 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -25.95 5.08 -43.97 -24.52 2.34 -44.05 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 6 hits 1t0u_c01 naa= 3 ULMN 3 1tah_c00 LIPASE user 1 3 # 1 B 87 SER A 79 SER~? 16.97 CA CA A 301 B 263 ASP A 21 ASP~? 19.27 CA CA A 301 B 285 HIS A 22 HIS~? 21.70 NI NI A 304 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1tah_c00 LIPASE user 2 3 # 2 B 87 SER A 79 SER~? 16.97 CA CA A 301 B 263 ASP A 21 ASP~? 19.27 CA CA A 301 B 285 HIS A 83 HIS~? 17.38 NI NI A 304 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1tah_c00 LIPASE user 3 3 # 3 B 87 SER B 79 SER~? 19.41 NI NI B 305 B 263 ASP B 21 ASP~? 22.52 NI NI B 305 B 285 HIS B 22 HIS~? 22.02 NI NI B 305 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1tah_c00 LIPASE user 4 3 # 4 B 87 SER B 79 SER~? 19.41 NI NI B 305 B 263 ASP B 21 ASP~? 22.52 NI NI B 305 B 285 HIS B 83 HIS~? 17.68 NI NI B 305 coo 22.42 -97.03 -8.07 21.76 -97.41 -5.67 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 16.89 -89.90 -4.68 18.61 -91.11 -4.79 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 17.98 -94.63 -4.37 19.67 -95.43 -5.31 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1tah_c00 source 1tah LIPASE : 4 hits 1tah_c00 naa= 3 ULMN 3 1tah_c01 LIPASE user 1 3 # 1 A 87 SER A 79 SER~? 16.97 CA CA A 301 A 263 ASP A 21 ASP~? 19.27 CA CA A 301 A 285 HIS A 22 HIS~? 21.70 NI NI A 304 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1tah_c01 LIPASE user 2 3 # 2 A 87 SER A 79 SER~? 16.97 CA CA A 301 A 263 ASP A 21 ASP~? 19.27 CA CA A 301 A 285 HIS A 83 HIS~? 17.38 NI NI A 304 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1tah_c01 LIPASE user 3 3 # 3 A 87 SER B 79 SER~? 19.41 NI NI B 305 A 263 ASP B 21 ASP~? 22.52 NI NI B 305 A 285 HIS B 22 HIS~? 22.02 NI NI B 305 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1tah_c01 LIPASE user 4 3 # 4 A 87 SER B 79 SER~? 19.41 NI NI B 305 A 263 ASP B 21 ASP~? 22.52 NI NI B 305 A 285 HIS B 83 HIS~? 17.68 NI NI B 305 coo 22.12 -58.48 -5.22 21.49 -58.54 -7.64 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 14.10 -63.60 -6.78 16.16 -63.15 -6.92 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 16.85 -59.90 -8.29 18.78 -59.58 -7.55 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1tah_c01 source 1tah LIPASE : 4 hits 1tah_c01 naa= 3 ULMN 3 1tah_c02 LIPASE user 1 3 # 1 C 87 SER A 79 SER~? 16.97 CA CA A 301 C 263 ASP A 21 ASP~? 19.27 CA CA A 301 C 285 HIS A 22 HIS~? 21.70 NI NI A 304 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1tah_c02 LIPASE user 2 3 # 2 C 87 SER A 79 SER~? 16.97 CA CA A 301 C 263 ASP A 21 ASP~? 19.27 CA CA A 301 C 285 HIS A 83 HIS~? 17.38 NI NI A 304 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1tah_c02 LIPASE user 3 3 # 3 C 87 SER B 79 SER~? 19.41 NI NI B 305 C 263 ASP B 21 ASP~? 22.52 NI NI B 305 C 285 HIS B 22 HIS~? 22.02 NI NI B 305 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1tah_c02 LIPASE user 4 3 # 4 C 87 SER B 79 SER~? 19.41 NI NI B 305 C 263 ASP B 21 ASP~? 22.52 NI NI B 305 C 285 HIS B 83 HIS~? 17.68 NI NI B 305 coo -11.81 -66.75 15.59 -10.14 -64.90 16.04 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -12.58 -63.22 24.54 -12.69 -63.15 22.41 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -9.60 -64.04 20.79 -10.32 -64.61 18.90 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1tah_c02 source 1tah LIPASE : 4 hits 1tah_c02 naa= 3 ULMN 3 1tah_c03 LIPASE user 1 3 # 1 D 87 SER A 79 SER~? 16.97 CA CA A 301 D 263 ASP A 21 ASP~? 19.27 CA CA A 301 D 285 HIS A 22 HIS~? 21.70 NI NI A 304 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1tah_c03 LIPASE user 2 3 # 2 D 87 SER A 79 SER~? 16.97 CA CA A 301 D 263 ASP A 21 ASP~? 19.27 CA CA A 301 D 285 HIS A 83 HIS~? 17.38 NI NI A 304 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1tah_c03 LIPASE user 3 3 # 3 D 87 SER B 79 SER~? 19.41 NI NI B 305 D 263 ASP B 21 ASP~? 22.52 NI NI B 305 D 285 HIS B 22 HIS~? 22.02 NI NI B 305 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1tah_c03 LIPASE user 4 3 # 4 D 87 SER B 79 SER~? 19.41 NI NI B 305 D 263 ASP B 21 ASP~? 22.52 NI NI B 305 D 285 HIS B 83 HIS~? 17.68 NI NI B 305 coo -33.67 -57.82 -16.64 -34.00 -55.36 -17.02 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -32.45 -52.67 -8.57 -33.54 -53.48 -10.22 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -32.12 -52.68 -13.42 -32.95 -54.21 -14.59 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1tah_c03 source 1tah LIPASE : 4 hits 1tah_c03 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 115 SER.? 13.22 NI NI A 304 354 GLU A 188 GLU^? 11.68 NI NI A 304 463 HIS A 116 HIS^? 7.23 NI NI A 304 coo 48.87 13.74 2.81 48.49 11.54 3.93 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo 39.95 14.43 3.01 41.55 14.10 1.63 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 43.90 10.50 2.81 45.63 11.48 3.27 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 115 SER.? 13.16 NI NI B 305 354 GLU B 188 GLU^? 11.04 NI NI B 305 463 HIS B 116 HIS^? 6.69 NI NI B 305 coo 48.87 13.74 2.81 48.49 11.54 3.93 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 39.95 14.43 3.01 41.55 14.10 1.63 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 43.90 10.50 2.81 45.63 11.48 3.27 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 2 hits 1thg_c00 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 16 HIS^? 15.61 NI NI A 304 A 174 ASP A 21 ASP~? 19.27 CA CA A 301 A 404 TYR A 131 TYR^? 10.29 NI NI A 304 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 83 HIS~? 17.38 NI NI A 304 A 174 ASP A 177 ASP^? 15.76 CA CA A 306 A 404 TYR A 205 TYR^? 13.62 NI NI A 304 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS B 16 HIS^? 15.81 NI NI B 305 A 174 ASP B 21 ASP~? 22.52 NI NI B 305 A 404 TYR B 131 TYR^? 10.67 NI NI B 305 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS B 83 HIS~? 17.68 NI NI B 305 A 174 ASP B 177 ASP^? 17.56 NI NI B 305 A 404 TYR B 205 TYR^? 13.71 NI NI B 305 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 16 HIS^? 15.61 NI NI A 304 C 174 ASP A 21 ASP~? 19.27 CA CA A 301 C 404 TYR A 131 TYR^? 10.29 NI NI A 304 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 83 HIS~? 17.38 NI NI A 304 C 174 ASP A 177 ASP^? 15.76 CA CA A 306 C 404 TYR A 205 TYR^? 13.62 NI NI A 304 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS B 16 HIS^? 15.81 NI NI B 305 C 174 ASP B 21 ASP~? 22.52 NI NI B 305 C 404 TYR B 131 TYR^? 10.67 NI NI B 305 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS B 83 HIS~? 17.68 NI NI B 305 C 174 ASP B 177 ASP^? 17.56 NI NI B 305 C 404 TYR B 205 TYR^? 13.71 NI NI B 305 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 16 HIS^? 15.61 NI NI A 304 E 174 ASP A 21 ASP~? 19.27 CA CA A 301 E 404 TYR A 131 TYR^? 10.29 NI NI A 304 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 83 HIS~? 17.38 NI NI A 304 E 174 ASP A 177 ASP^? 15.76 CA CA A 306 E 404 TYR A 205 TYR^? 13.62 NI NI A 304 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS B 16 HIS^? 15.81 NI NI B 305 E 174 ASP B 21 ASP~? 22.52 NI NI B 305 E 404 TYR B 131 TYR^? 10.67 NI NI B 305 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS B 83 HIS~? 17.68 NI NI B 305 E 174 ASP B 177 ASP^? 17.56 NI NI B 305 E 404 TYR B 205 TYR^? 13.71 NI NI B 305 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 16 HIS^? 15.61 NI NI A 304 G 174 ASP A 21 ASP~? 19.27 CA CA A 301 G 404 TYR A 131 TYR^? 10.29 NI NI A 304 coo 60.48-101.16 45.95 60.56-101.20 43.85 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 58.10-108.15 40.62 59.57-106.86 41.51 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 83 HIS~? 17.38 NI NI A 304 G 174 ASP A 177 ASP^? 15.76 CA CA A 306 G 404 TYR A 205 TYR^? 13.62 NI NI A 304 coo 60.48-101.16 45.95 60.56-101.20 43.85 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 58.10-108.15 40.62 59.57-106.86 41.51 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS B 16 HIS^? 15.81 NI NI B 305 G 174 ASP B 21 ASP~? 22.52 NI NI B 305 G 404 TYR B 131 TYR^? 10.67 NI NI B 305 coo 60.48-101.16 45.95 60.56-101.20 43.85 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 58.10-108.15 40.62 59.57-106.86 41.51 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS B 83 HIS~? 17.68 NI NI B 305 G 174 ASP B 177 ASP^? 17.56 NI NI B 305 G 404 TYR B 205 TYR^? 13.71 NI NI B 305 coo 60.48-101.16 45.95 60.56-101.20 43.85 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 16 HIS^? 15.61 NI NI A 304 I 174 ASP A 21 ASP~? 19.27 CA CA A 301 I 404 TYR A 131 TYR^? 10.29 NI NI A 304 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 83 HIS~? 17.38 NI NI A 304 I 174 ASP A 177 ASP^? 15.76 CA CA A 306 I 404 TYR A 205 TYR^? 13.62 NI NI A 304 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS B 16 HIS^? 15.81 NI NI B 305 I 174 ASP B 21 ASP~? 22.52 NI NI B 305 I 404 TYR B 131 TYR^? 10.67 NI NI B 305 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS B 83 HIS~? 17.68 NI NI B 305 I 174 ASP B 177 ASP^? 17.56 NI NI B 305 I 404 TYR B 205 TYR^? 13.71 NI NI B 305 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 16 HIS^? 15.61 NI NI A 304 K 174 ASP A 21 ASP~? 19.27 CA CA A 301 K 404 TYR A 131 TYR^? 10.29 NI NI A 304 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 102.36 30.86 6.31 102.45 29.08 5.12 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 83 HIS~? 17.38 NI NI A 304 K 174 ASP A 177 ASP^? 15.76 CA CA A 306 K 404 TYR A 205 TYR^? 13.62 NI NI A 304 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 102.36 30.86 6.31 102.45 29.08 5.12 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS B 16 HIS^? 15.81 NI NI B 305 K 174 ASP B 21 ASP~? 22.52 NI NI B 305 K 404 TYR B 131 TYR^? 10.67 NI NI B 305 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 102.36 30.86 6.31 102.45 29.08 5.12 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS B 83 HIS~? 17.68 NI NI B 305 K 174 ASP B 177 ASP^? 17.56 NI NI B 305 K 404 TYR B 205 TYR^? 13.71 NI NI B 305 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 4 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 44 ALA~? 19.89 CA CA B 303 A 251 GLY A 45 GLY~? 17.79 NI NI A 304 A 252 ASP A 42 ASP~? 18.65 NI NI A 304 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 44 ALA~? 21.16 NI NI B 305 A 251 GLY B 45 GLY~? 17.79 NI NI B 305 A 252 ASP B 42 ASP~? 18.39 NI NI B 305 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -23.24 2.66 -69.27 -24.25 2.76 -68.14 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -20.30 0.43 -68.29 -20.38 0.81 -69.02 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 44 ALA~? 19.89 CA CA B 303 B 251 GLY A 45 GLY~? 17.79 NI NI A 304 B 252 ASP A 42 ASP~? 18.65 NI NI A 304 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -21.97 -7.39 -10.64 -23.06 -7.73 -11.64 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 44 ALA~? 21.16 NI NI B 305 B 251 GLY B 45 GLY~? 17.79 NI NI B 305 B 252 ASP B 42 ASP~? 18.39 NI NI B 305 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -23.24 2.66 -69.27 -24.25 2.76 -68.14 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -20.30 0.43 -68.29 -20.38 0.81 -69.02 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c03 naa= 3 ULMN 3 1uaq_c00 CYTOSINE DEAMINASE user 1 3 # 1 A 64 GLU B 40 GLU~? 23.91 NI NI B 305 A 89 SER B 33 SER~? 24.13 NI NI B 305 A 91 CYH B 35 CYH~? 15.94 NI NI B 305 coo -18.27 -3.12 10.92 -16.30 -3.26 10.07 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo -16.83 -3.83 3.62 -17.28 -5.61 2.05 -19.79 -15.84 -72.82 -21.16 -17.82 -73.17 coo -13.84 -8.33 7.58 -13.00 -8.13 10.24 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 1uaq_c00 source 1uaq CYTOSINE DEAMINASE : 1 hits 1uaq_c00 naa= 3 ULMN 3 1uaq_c01 CYTOSINE DEAMINASE user 1 3 # 1 B 64 GLU B 40 GLU~? 23.91 NI NI B 305 B 89 SER B 33 SER~? 24.13 NI NI B 305 B 91 CYH B 35 CYH~? 15.94 NI NI B 305 coo -13.67 -17.67 21.70 -15.74 -17.78 22.24 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo -17.71 -23.81 20.93 -18.57 -24.92 18.94 -19.79 -15.84 -72.82 -21.16 -17.82 -73.17 coo -20.38 -18.31 18.13 -20.06 -15.64 18.96 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 1uaq_c01 source 1uaq CYTOSINE DEAMINASE : 1 hits 1uaq_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 82 ALA~? 21.17 NI NI A 304 A 224 ASP A 21 ASP~? 19.27 CA CA A 301 A 252 HIS A 22 HIS~? 21.70 NI NI A 304 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 82 ALA~? 21.17 NI NI A 304 A 224 ASP A 21 ASP~? 19.27 CA CA A 301 A 252 HIS A 83 HIS~? 17.38 NI NI A 304 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA A 86 ALA~? 20.62 NI NI A 304 A 224 ASP A 21 ASP~? 19.27 CA CA A 301 A 252 HIS A 22 HIS~? 21.70 NI NI A 304 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA A 86 ALA~? 20.62 NI NI A 304 A 224 ASP A 21 ASP~? 19.27 CA CA A 301 A 252 HIS A 83 HIS~? 17.38 NI NI A 304 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1uk7_c00 3.07.01.0009 user 5 3 # 5 A 103 ALA A 149 ALA~? 19.73 NI NI A 304 A 224 ASP A 145 ASP.? 18.22 NI NI A 304 A 252 HIS A 148 HIS~? 18.59 NI NI A 304 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 5.60 1.53 -36.46 4.63 0.36 -36.50 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1uk7_c00 3.07.01.0009 user 6 3 # 6 A 103 ALA B 82 ALA~? 21.25 NI NI B 305 A 224 ASP B 21 ASP~? 22.52 NI NI B 305 A 252 HIS B 22 HIS~? 22.02 NI NI B 305 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1uk7_c00 3.07.01.0009 user 7 3 # 7 A 103 ALA B 82 ALA~? 21.25 NI NI B 305 A 224 ASP B 21 ASP~? 22.52 NI NI B 305 A 252 HIS B 83 HIS~? 17.68 NI NI B 305 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1uk7_c00 3.07.01.0009 user 8 3 # 8 A 103 ALA B 86 ALA~? 18.65 CA CA B 303 A 224 ASP B 21 ASP~? 22.52 NI NI B 305 A 252 HIS B 22 HIS~? 22.02 NI NI B 305 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1uk7_c00 3.07.01.0009 user 9 3 # 9 A 103 ALA B 86 ALA~? 18.65 CA CA B 303 A 224 ASP B 21 ASP~? 22.52 NI NI B 305 A 252 HIS B 83 HIS~? 17.68 NI NI B 305 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1uk7_c00 3.07.01.0009 user 10 3 # 10 A 103 ALA B 149 ALA.? 19.34 NI NI B 305 A 224 ASP B 145 ASP.? 18.27 NI NI B 305 A 252 HIS B 148 HIS.? 18.38 NI NI B 305 coo 10.74 41.88 -3.62 10.55 41.61 -5.11 5.50 -0.36 -43.85 4.23 0.46 -43.75 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 6.24 -3.74 -47.54 7.83 -3.67 -48.90 1uk7_c00 source 1uk7 3.07.01.0009 : 10 hits 1uk7_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU B 89 GLU~? 11.52 CA CA B 303 A 87 ASP B 90 ASP~? 18.88 CA CA B 303 A 89 GLU B 92 GLU.? 12.87 CA CA B 303 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU B 92 GLU.? 12.87 CA CA B 303 A 87 ASP B 90 ASP~? 18.88 CA CA B 303 A 89 GLU B 89 GLU~? 11.52 CA CA B 303 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 2 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU B 92 GLU.? 12.87 CA CA B 303 B 87 ASP B 90 ASP~? 18.88 CA CA B 303 B 89 GLU B 89 GLU~? 11.52 CA CA B 303 coo 19.32 178.30 3.72 20.56 176.87 2.77 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 coo 22.91 179.81 6.56 22.10 178.65 5.00 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 26.74 177.55 7.48 27.16 177.47 5.41 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 1 hits 1un1_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 27 ASP~? -2.92 CA CA A 301s 255 GLU A 30 GLU~? 7.55 CA CA A 301 329 ASP A 75 ASP~? 14.34 CA CA A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 52.57 37.12 10.17 53.37 35.95 11.75 -27.55 15.68 -10.70 -29.15 16.50 -11.85 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 104 ASP^? 11.20 NI NI A 304 255 GLU A 103 GLU^? 14.47 CA CA B 303 329 ASP A 65 ASP~? 19.57 CA CA B 303 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 52.57 37.12 10.17 53.37 35.95 11.75 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 27 ASP~? -2.92 CA CA A 301s 218 GLU A 92 GLU~? 26.61 NI NI A 304 329 ASP A 75 ASP~? 14.34 CA CA A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.71 18.15 -44.39 -15.11 19.36 -46.01 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 27 ASP~? -2.92 CA CA A 301s 218 GLU A 188 GLU^? 11.68 NI NI A 304 329 ASP A 75 ASP~? 14.34 CA CA A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.63 15.16 -19.97 -31.70 15.36 -19.47 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 65 ASP~? 19.57 CA CA B 303 218 GLU A 112 GLU.? -2.98 CA CA A 302s 329 ASP A 104 ASP^? 11.20 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.93 7.09 -5.49 -2.54 7.70 -3.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 65 ASP~? 19.57 CA CA B 303 218 GLU B 89 GLU~? 11.52 CA CA B 303 329 ASP A 104 ASP^? 11.20 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 75 ASP~? 14.34 CA CA A 301 218 GLU A 112 GLU.? -2.98 CA CA A 302s 329 ASP A 27 ASP~? -2.92 CA CA A 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.93 7.09 -5.49 -2.54 7.70 -3.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.76 19.66 -12.70 -25.06 20.72 -11.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP A 75 ASP~? 14.34 CA CA A 301 218 GLU A 188 GLU^? 11.68 NI NI A 304 329 ASP A 27 ASP~? -2.92 CA CA A 301s coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.76 19.66 -12.70 -25.06 20.72 -11.00 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP A 75 ASP~? 14.34 CA CA A 301 218 GLU A 188 GLU^? 11.68 NI NI A 304 329 ASP A 81 ASP~? 18.70 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 70.09 11.71 8.46 70.56 12.89 6.77 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP A 145 ASP.? 18.22 NI NI A 304 218 GLU A 32 GLU~? -3.00 CA CA A 306s 329 ASP A 163 ASP~? 21.63 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.30 20.20 -30.86 1.78 20.99 -28.95 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP A 145 ASP.? 18.22 NI NI A 304 218 GLU A 195 GLU.? -3.34 CA CA A 302s 329 ASP A 163 ASP~? 21.63 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 70.09 11.71 8.46 70.56 12.89 6.77 -3.71 10.89 -2.05 -2.53 10.06 -0.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.30 20.20 -30.86 1.78 20.99 -28.95 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 10 3 # 10 199 ASP A 163 ASP~? 21.63 NI NI A 304 218 GLU A 101 GLU^? 20.45 NI NI A 304 329 ASP A 145 ASP.? 18.22 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 -27.78 6.23 -34.62 -28.76 7.90 -33.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 11 3 # 11 199 ASP A 163 ASP~? 21.63 NI NI A 304 218 GLU A 103 GLU^? 14.47 CA CA B 303 329 ASP A 145 ASP.? 18.22 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 70.09 11.71 8.46 70.56 12.89 6.77 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 12 3 # 12 199 ASP B 27 ASP~? 26.12 NI NI B 305 218 GLU B 92 GLU.? 12.87 CA CA B 303 329 ASP B 75 ASP~? 24.42 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 70.09 11.71 8.46 70.56 12.89 6.77 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 13 3 # 13 199 ASP B 27 ASP~? 26.12 NI NI B 305 218 GLU B 188 GLU^? 11.04 NI NI B 305 329 ASP B 75 ASP~? 24.42 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 70.09 11.71 8.46 70.56 12.89 6.77 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 59.16 37.82 13.95 57.63 37.03 15.12 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 14 3 # 14 199 ASP B 65 ASP~? 20.64 NI NI B 305 218 GLU A 89 GLU~? 25.01 NI NI A 304 329 ASP B 104 ASP^? 11.37 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -21.16 18.26 -40.17 -21.59 18.20 -42.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 15 3 # 15 199 ASP B 65 ASP~? 20.64 NI NI B 305 218 GLU B 112 GLU.? -22.76 NI NI B 305s 329 ASP B 104 ASP^? 11.37 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 70.09 11.71 8.46 70.56 12.89 6.77 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 16 3 # 16 199 ASP B 75 ASP~? 24.42 NI NI B 305 218 GLU B 112 GLU.? -22.76 NI NI B 305s 329 ASP B 27 ASP~? 26.12 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 70.09 11.71 8.46 70.56 12.89 6.77 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 17 3 # 17 199 ASP B 75 ASP~? 24.42 NI NI B 305 218 GLU B 144 GLU^? 13.93 NI NI B 305 329 ASP B 81 ASP~? 18.56 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 70.09 11.71 8.46 70.56 12.89 6.77 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 18 3 # 18 199 ASP B 145 ASP.? 18.27 NI NI B 305 218 GLU B 32 GLU~? 21.76 NI NI B 305 329 ASP B 163 ASP.? 22.00 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.53 -18.94 -49.54 6.46 -20.22 -50.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 19 3 # 19 199 ASP B 145 ASP.? 18.27 NI NI B 305 218 GLU B 195 GLU.? -26.54 NI NI B 305s 329 ASP B 163 ASP.? 22.00 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 70.09 11.71 8.46 70.56 12.89 6.77 -0.96 -11.31 -77.84 -0.63 -11.36 -79.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.53 -18.94 -49.54 6.46 -20.22 -50.93 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 20 3 # 20 199 ASP B 163 ASP.? 22.00 NI NI B 305 218 GLU B 101 GLU^? 17.23 CA CA B 303 329 ASP B 145 ASP.? 18.27 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 70.09 11.71 8.46 70.56 12.89 6.77 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 4.18 -8.01 -46.36 4.59 -9.01 -44.53 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 20 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 75 ASP~? 14.34 CA CA A 301 242 GLU A 40 GLU~? 12.94 CA CA A 306 329 ASP A 81 ASP~? 18.70 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo 30.42 34.74 5.00 29.09 35.09 3.38 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 59.16 37.82 13.95 57.63 37.03 15.12 -26.56 13.16 -30.46 -27.24 11.22 -29.94 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 104 ASP^? 11.20 NI NI A 304 242 GLU A 144 GLU^? 14.15 NI NI A 304 329 ASP A 65 ASP~? 19.57 CA CA B 303 coo 49.16 35.16 15.19 51.08 34.43 15.65 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 145 ASP.? 18.22 NI NI A 304 242 GLU B 144 GLU^? 13.93 NI NI B 305 329 ASP A 163 ASP~? 21.63 NI NI A 304 coo 49.16 35.16 15.19 51.08 34.43 15.65 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 30.42 34.74 5.00 29.09 35.09 3.38 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.30 20.20 -30.86 1.78 20.99 -28.95 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 177 ASP^? 15.76 CA CA A 306 242 GLU A 112 GLU.? -2.98 CA CA A 302s 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 -2.93 7.09 -5.49 -2.54 7.70 -3.48 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP A 177 ASP^? 15.76 CA CA A 306 242 GLU A 144 GLU^? 14.15 NI NI A 304 329 ASP A 21 ASP~? 19.27 CA CA A 301 coo 49.16 35.16 15.19 51.08 34.43 15.65 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 75 ASP~? 24.42 NI NI B 305 242 GLU B 40 GLU~? 23.91 NI NI B 305 329 ASP B 81 ASP~? 18.56 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 145 ASP.? 18.27 NI NI B 305 242 GLU A 144 GLU^? 14.15 NI NI A 304 329 ASP B 163 ASP.? 22.00 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 30.42 34.74 5.00 29.09 35.09 3.38 1.81 5.70 -30.20 2.38 3.69 -29.88 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.53 -18.94 -49.54 6.46 -20.22 -50.93 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 177 ASP^? 17.56 NI NI B 305 242 GLU B 112 GLU.? -22.76 NI NI B 305s 329 ASP B 21 ASP~? 22.52 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 9 3 # 9 199 ASP B 177 ASP^? 17.56 NI NI B 305 242 GLU B 144 GLU^? 13.93 NI NI B 305 329 ASP B 21 ASP~? 22.52 NI NI B 305 coo 49.16 35.16 15.19 51.08 34.43 15.65 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 30.42 34.74 5.00 29.09 35.09 3.38 2.78 -5.24 -49.99 3.13 -3.29 -50.74 coo 59.16 37.82 13.95 57.63 37.03 15.12 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 9 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 164 GLU~? 25.12 NI NI A 304 A 596 ARG A 162 ARG~? 28.37 NI NI A 304 A 647 ARG A 157 ARG.? 25.34 NI NI A 304 coo 69.13 32.20 28.58 68.39 32.96 30.44 2.03 20.18 -36.55 1.23 21.62 -37.90 coo 70.89 37.31 29.70 69.54 36.29 32.39 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 66.09 40.54 34.70 66.92 37.69 35.49 9.58 14.02 -35.46 8.24 13.80 -38.23 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 164 GLU~? 25.12 NI NI A 304 B 596 ARG A 162 ARG~? 28.37 NI NI A 304 B 647 ARG A 157 ARG.? 25.34 NI NI A 304 coo 38.22 57.83 70.36 36.82 56.74 69.18 2.03 20.18 -36.55 1.23 21.62 -37.90 coo 34.24 60.89 68.08 33.31 57.93 67.63 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 31.43 57.38 61.97 31.90 55.58 64.41 9.58 14.02 -35.46 8.24 13.80 -38.23 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 164 GLU~? 25.12 NI NI A 304 C 596 ARG A 162 ARG~? 28.37 NI NI A 304 C 647 ARG A 157 ARG.? 25.34 NI NI A 304 coo 11.31 31.26 27.00 13.31 30.71 26.58 2.03 20.18 -36.55 1.23 21.62 -37.90 coo 13.44 32.78 22.07 15.56 30.91 23.37 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 21.00 33.35 22.82 19.83 30.82 24.09 9.58 14.02 -35.46 8.24 13.80 -38.23 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 164 GLU~? 25.12 NI NI A 304 D 596 ARG A 162 ARG~? 28.37 NI NI A 304 D 647 ARG A 157 ARG.? 25.34 NI NI A 304 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 2.03 20.18 -36.55 1.23 21.62 -37.90 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 6.53 22.97 -35.99 6.11 21.84 -38.80 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 9.58 14.02 -35.46 8.24 13.80 -38.23 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 164 GLU~? 25.12 NI NI A 304 E 596 ARG A 162 ARG~? 28.37 NI NI A 304 E 647 ARG A 157 ARG.? 25.34 NI NI A 304 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 2.03 20.18 -36.55 1.23 21.62 -37.90 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 9.58 14.02 -35.46 8.24 13.80 -38.23 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 164 GLU~? 25.12 NI NI A 304 F 596 ARG A 162 ARG~? 28.37 NI NI A 304 F 647 ARG A 157 ARG.? 25.34 NI NI A 304 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 2.03 20.18 -36.55 1.23 21.62 -37.90 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 6.53 22.97 -35.99 6.11 21.84 -38.80 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 9.58 14.02 -35.46 8.24 13.80 -38.23 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 1 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 52 ASN~? 15.92 NI NI A 304 457 GLY A 47 GLY~? 21.14 NI NI A 304 459 GLU A 50 GLU~? 22.49 CA CA A 302 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN B 52 ASN~? 15.59 NI NI B 305 457 GLY B 47 GLY~? 21.31 NI NI B 305 459 GLU B 50 GLU~? 24.18 NI NI B 305 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -12.94 6.22 -65.59 -12.73 7.00 -63.62 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.23 5.78 -74.13 -14.26 6.16 -75.95 1vom_c00 source 1vom MYOSIN : 2 hits 1vom_c00 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 15 TYR^? 16.16 NI NI A 304 A 40 ASP A 177 ASP^? 15.76 CA CA A 306 A 103 LEU A 179 LEU^? 10.75 NI NI A 304 coo 12.09 16.13 10.57 11.28 18.80 10.73 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 7.55 25.51 14.34 9.65 25.73 14.24 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 11.83 18.73 16.99 10.99 19.71 15.26 -11.43 14.14 -25.66 -9.59 15.13 -25.11 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 170 TYR^? 15.79 NI NI A 304 A 40 ASP A 145 ASP.? 18.22 NI NI A 304 A 103 LEU A 143 LEU^? 10.47 NI NI A 304 coo 12.09 16.13 10.57 11.28 18.80 10.73 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 7.55 25.51 14.34 9.65 25.73 14.24 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 11.83 18.73 16.99 10.99 19.71 15.26 -3.01 10.64 -28.74 -4.82 11.31 -27.73 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 15 TYR^? 16.36 NI NI B 305 A 40 ASP B 177 ASP^? 17.56 NI NI B 305 A 103 LEU B 179 LEU^? 10.95 NI NI B 305 coo 12.09 16.13 10.57 11.28 18.80 10.73 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 11.83 18.73 16.99 10.99 19.71 15.26 -8.09 -16.27 -54.87 -6.09 -16.98 -55.28 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 170 TYR^? 15.66 NI NI B 305 A 40 ASP B 145 ASP.? 18.27 NI NI B 305 A 103 LEU B 143 LEU^? 10.73 NI NI B 305 coo 12.09 16.13 10.57 11.28 18.80 10.73 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 11.83 18.73 16.99 10.99 19.71 15.26 -0.80 -11.24 -52.39 -2.14 -12.40 -51.23 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 5 3 # 5 A 16 TYR B 170 TYR^? 15.66 NI NI B 305 A 40 ASP B 163 ASP.? 22.00 NI NI B 305 A 103 LEU B 143 LEU^? 10.73 NI NI B 305 coo 12.09 16.13 10.57 11.28 18.80 10.73 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 7.55 25.51 14.34 9.65 25.73 14.24 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 11.83 18.73 16.99 10.99 19.71 15.26 -0.80 -11.24 -52.39 -2.14 -12.40 -51.23 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 5 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 15 TYR^? 16.16 NI NI A 304 B 40 ASP A 177 ASP^? 15.76 CA CA A 306 B 103 LEU A 179 LEU^? 10.75 NI NI A 304 coo 14.25 20.09 37.35 13.48 17.40 37.38 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 9.39 10.77 34.53 11.50 10.63 34.41 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 12.89 17.60 31.13 12.34 16.51 32.90 -11.43 14.14 -25.66 -9.59 15.13 -25.11 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 170 TYR^? 15.79 NI NI A 304 B 40 ASP A 145 ASP.? 18.22 NI NI A 304 B 103 LEU A 143 LEU^? 10.47 NI NI A 304 coo 14.25 20.09 37.35 13.48 17.40 37.38 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 9.39 10.77 34.53 11.50 10.63 34.41 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 12.89 17.60 31.13 12.34 16.51 32.90 -3.01 10.64 -28.74 -4.82 11.31 -27.73 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 15 TYR^? 16.36 NI NI B 305 B 40 ASP B 177 ASP^? 17.56 NI NI B 305 B 103 LEU B 179 LEU^? 10.95 NI NI B 305 coo 14.25 20.09 37.35 13.48 17.40 37.38 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 12.89 17.60 31.13 12.34 16.51 32.90 -8.09 -16.27 -54.87 -6.09 -16.98 -55.28 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 170 TYR^? 15.66 NI NI B 305 B 40 ASP B 145 ASP.? 18.27 NI NI B 305 B 103 LEU B 143 LEU^? 10.73 NI NI B 305 coo 14.25 20.09 37.35 13.48 17.40 37.38 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 12.89 17.60 31.13 12.34 16.51 32.90 -0.80 -11.24 -52.39 -2.14 -12.40 -51.23 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 5 3 # 5 B 16 TYR B 170 TYR^? 15.66 NI NI B 305 B 40 ASP B 163 ASP.? 22.00 NI NI B 305 B 103 LEU B 143 LEU^? 10.73 NI NI B 305 coo 14.25 20.09 37.35 13.48 17.40 37.38 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 9.39 10.77 34.53 11.50 10.63 34.41 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 12.89 17.60 31.13 12.34 16.51 32.90 -0.80 -11.24 -52.39 -2.14 -12.40 -51.23 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 5 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 16 HIS^? 15.61 NI NI A 304 A 169 ASP A 90 ASP~? 20.31 NI NI A 304 A 288 GLU A 89 GLU~? 25.01 NI NI A 304 coo 67.72 35.99 30.87 69.77 36.13 31.33 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 73.17 30.66 22.56 72.87 30.30 20.46 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 74.06 28.51 15.92 73.77 29.56 17.73 -21.16 18.26 -40.17 -21.59 18.20 -42.25 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 16 HIS^? 15.61 NI NI A 304 A 169 ASP A 90 ASP~? 20.31 NI NI A 304 A 288 GLU A 92 GLU~? 26.61 NI NI A 304 coo 67.72 35.99 30.87 69.77 36.13 31.33 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 73.17 30.66 22.56 72.87 30.30 20.46 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 74.06 28.51 15.92 73.77 29.56 17.73 -15.71 18.15 -44.39 -15.11 19.36 -46.01 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS A 16 HIS^? 15.61 NI NI A 304 A 169 ASP A 163 ASP~? 21.63 NI NI A 304 A 288 GLU A 164 GLU~? 25.12 NI NI A 304 coo 67.72 35.99 30.87 69.77 36.13 31.33 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 73.17 30.66 22.56 72.87 30.30 20.46 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 74.06 28.51 15.92 73.77 29.56 17.73 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS A 22 HIS~? 21.70 NI NI A 304 A 169 ASP A 90 ASP~? 20.31 NI NI A 304 A 288 GLU A 92 GLU~? 26.61 NI NI A 304 coo 67.72 35.99 30.87 69.77 36.13 31.33 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 73.17 30.66 22.56 72.87 30.30 20.46 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 74.06 28.51 15.92 73.77 29.56 17.73 -15.71 18.15 -44.39 -15.11 19.36 -46.01 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS A 83 HIS~? 17.38 NI NI A 304 A 169 ASP A 90 ASP~? 20.31 NI NI A 304 A 288 GLU A 92 GLU~? 26.61 NI NI A 304 coo 67.72 35.99 30.87 69.77 36.13 31.33 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 73.17 30.66 22.56 72.87 30.30 20.46 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 74.06 28.51 15.92 73.77 29.56 17.73 -15.71 18.15 -44.39 -15.11 19.36 -46.01 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS A 119 HIS^? -3.69 NI NI A 304s A 169 ASP A 104 ASP^? 11.20 NI NI A 304 A 288 GLU A 103 GLU^? 14.47 CA CA B 303 coo 67.72 35.99 30.87 69.77 36.13 31.33 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 73.17 30.66 22.56 72.87 30.30 20.46 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 74.06 28.51 15.92 73.77 29.56 17.73 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS B 16 HIS^? 15.81 NI NI B 305 A 169 ASP B 90 ASP~? 18.88 CA CA B 303 A 288 GLU B 89 GLU~? 11.52 CA CA B 303 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 73.17 30.66 22.56 72.87 30.30 20.46 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 74.06 28.51 15.92 73.77 29.56 17.73 -15.23 -23.75 -39.37 -16.24 -23.09 -37.63 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 8 3 # 8 A 105 HIS B 16 HIS^? 15.81 NI NI B 305 A 169 ASP B 90 ASP~? 18.88 CA CA B 303 A 288 GLU B 92 GLU.? 12.87 CA CA B 303 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 73.17 30.66 22.56 72.87 30.30 20.46 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 74.06 28.51 15.92 73.77 29.56 17.73 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 9 3 # 9 A 105 HIS B 16 HIS^? 15.81 NI NI B 305 A 169 ASP B 163 ASP.? 22.00 NI NI B 305 A 288 GLU B 164 GLU.? 26.04 NI NI B 305 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 73.17 30.66 22.56 72.87 30.30 20.46 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 74.06 28.51 15.92 73.77 29.56 17.73 7.04 -19.25 -44.07 7.68 -20.18 -42.28 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 10 3 # 10 A 105 HIS B 22 HIS~? 22.02 NI NI B 305 A 169 ASP B 90 ASP~? 18.88 CA CA B 303 A 288 GLU B 92 GLU.? 12.87 CA CA B 303 coo 67.72 35.99 30.87 69.77 36.13 31.33 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 73.17 30.66 22.56 72.87 30.30 20.46 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 74.06 28.51 15.92 73.77 29.56 17.73 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 11 3 # 11 A 105 HIS B 83 HIS~? 17.68 NI NI B 305 A 169 ASP B 90 ASP~? 18.88 CA CA B 303 A 288 GLU B 92 GLU.? 12.87 CA CA B 303 coo 67.72 35.99 30.87 69.77 36.13 31.33 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 73.17 30.66 22.56 72.87 30.30 20.46 -10.23 -21.58 -42.46 -8.09 -21.67 -42.56 coo 74.06 28.51 15.92 73.77 29.56 17.73 -10.18 -20.36 -35.99 -10.44 -22.09 -34.83 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 11 hits 1w1o_c00 naa= 3 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 420 ALA A 39 ALA~? 14.49 CA CA A 306 B 182 GLY A 47 GLY~? 21.14 NI NI A 304 B 183 GLY A 45 GLY~? 17.79 NI NI A 304 coo 38.36-101.47-135.52 39.62-101.29-136.35 -20.98 1.90 -9.17 -19.68 2.67 -9.17 coo 41.93-102.35-126.87 41.52-101.89-126.30 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 38.37-101.99-128.11 38.63-102.24-127.37 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 420 ALA A 61 ALA.? 14.13 NI NI A 304 B 182 GLY A 47 GLY~? 21.14 NI NI A 304 B 183 GLY A 45 GLY~? 17.79 NI NI A 304 coo 38.36-101.47-135.52 39.62-101.29-136.35 -19.24 -5.59 -18.94 -18.07 -6.50 -18.56 coo 41.93-102.35-126.87 41.52-101.89-126.30 -17.64 -8.30 -8.91 -17.42 -7.78 -9.49 coo 38.37-101.99-128.11 38.63-102.24-127.37 -19.73 -4.57 -11.91 -19.66 -4.96 -11.18 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 3 3 # 3 A 420 ALA B 39 ALA~? 18.17 NI NI B 305 B 182 GLY B 47 GLY~? 21.31 NI NI B 305 B 183 GLY B 45 GLY~? 17.79 NI NI B 305 coo 38.36-101.47-135.52 39.62-101.29-136.35 -20.16 -6.34 -71.14 -18.74 -6.88 -71.28 coo 41.93-102.35-126.87 41.52-101.89-126.30 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 38.37-101.99-128.11 38.63-102.24-127.37 -20.30 0.43 -68.29 -20.38 0.81 -69.02 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 4 3 # 4 A 420 ALA B 61 ALA.? 13.75 NI NI B 305 B 182 GLY B 47 GLY~? 21.31 NI NI B 305 B 183 GLY B 45 GLY~? 17.79 NI NI B 305 coo 38.36-101.47-135.52 39.62-101.29-136.35 -19.86 1.34 -61.00 -18.91 2.54 -61.09 coo 41.93-102.35-126.87 41.52-101.89-126.30 -19.22 4.48 -71.48 -18.85 4.02 -70.91 coo 38.37-101.99-128.11 38.63-102.24-127.37 -20.30 0.43 -68.29 -20.38 0.81 -69.02 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 5 3 # 5 A 420 ALA B 140 ALA.? 11.62 NI NI B 305 B 182 GLY B 136 GLY.? 20.18 NI NI B 305 B 183 GLY B 137 GLY.? 20.05 NI NI B 305 coo 38.36-101.47-135.52 39.62-101.29-136.35 -3.13 -13.00 -61.85 -4.31 -13.89 -62.21 coo 41.93-102.35-126.87 41.52-101.89-126.30 -0.60 -16.44 -70.27 -0.80 -17.18 -70.05 coo 38.37-101.99-128.11 38.63-102.24-127.37 0.49 -18.64 -67.37 0.53 -17.81 -67.38 ULMN 3 1xny_c01 PROPIONYL-COA CARBOXYLASE COMPLEX B user 6 3 # 6 A 420 ALA B 174 ALA.? 19.22 NI NI B 305 B 182 GLY B 136 GLY.? 20.18 NI NI B 305 B 183 GLY B 137 GLY.? 20.05 NI NI B 305 coo 38.36-101.47-135.52 39.62-101.29-136.35 -6.23 -21.90 -62.97 -6.14 -23.42 -62.87 coo 41.93-102.35-126.87 41.52-101.89-126.30 -0.60 -16.44 -70.27 -0.80 -17.18 -70.05 coo 38.37-101.99-128.11 38.63-102.24-127.37 0.49 -18.64 -67.37 0.53 -17.81 -67.38 1xny_c01 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 6 hits 1xny_c01 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 82 ALA~? 21.17 NI NI A 304 A 244 ASP A 21 ASP~? 19.27 CA CA A 301 A 271 HIS A 22 HIS~? 21.70 NI NI A 304 coo 15.05 3.71 6.93 14.58 4.88 7.78 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 9.85 8.15 0.76 10.61 7.04 2.39 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 10.61 7.65 6.01 12.39 6.55 6.23 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 82 ALA~? 21.17 NI NI A 304 A 244 ASP A 21 ASP~? 19.27 CA CA A 301 A 271 HIS A 83 HIS~? 17.38 NI NI A 304 coo 15.05 3.71 6.93 14.58 4.88 7.78 -24.62 16.98 -31.39 -25.35 18.12 -30.70 coo 9.85 8.15 0.76 10.61 7.04 2.39 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 10.61 7.65 6.01 12.39 6.55 6.23 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA A 86 ALA~? 20.62 NI NI A 304 A 244 ASP A 21 ASP~? 19.27 CA CA A 301 A 271 HIS A 22 HIS~? 21.70 NI NI A 304 coo 15.05 3.71 6.93 14.58 4.88 7.78 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 9.85 8.15 0.76 10.61 7.04 2.39 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 10.61 7.65 6.01 12.39 6.55 6.23 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA A 86 ALA~? 20.62 NI NI A 304 A 244 ASP A 21 ASP~? 19.27 CA CA A 301 A 271 HIS A 83 HIS~? 17.38 NI NI A 304 coo 15.05 3.71 6.93 14.58 4.88 7.78 -20.35 18.44 -35.44 -20.40 19.47 -34.33 coo 9.85 8.15 0.76 10.61 7.04 2.39 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 10.61 7.65 6.01 12.39 6.55 6.23 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 5 3 # 5 A 105 ALA A 149 ALA~? 19.73 NI NI A 304 A 244 ASP A 145 ASP.? 18.22 NI NI A 304 A 271 HIS A 148 HIS~? 18.59 NI NI A 304 coo 15.05 3.71 6.93 14.58 4.88 7.78 5.60 1.53 -36.46 4.63 0.36 -36.50 coo 9.85 8.15 0.76 10.61 7.04 2.39 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 10.61 7.65 6.01 12.39 6.55 6.23 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 6 3 # 6 A 105 ALA B 82 ALA~? 21.25 NI NI B 305 A 244 ASP B 21 ASP~? 22.52 NI NI B 305 A 271 HIS B 22 HIS~? 22.02 NI NI B 305 coo 15.05 3.71 6.93 14.58 4.88 7.78 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 9.85 8.15 0.76 10.61 7.04 2.39 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 7 3 # 7 A 105 ALA B 82 ALA~? 21.25 NI NI B 305 A 244 ASP B 21 ASP~? 22.52 NI NI B 305 A 271 HIS B 83 HIS~? 17.68 NI NI B 305 coo 15.05 3.71 6.93 14.58 4.88 7.78 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 coo 9.85 8.15 0.76 10.61 7.04 2.39 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 10.61 7.65 6.01 12.39 6.55 6.23 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 8 3 # 8 A 105 ALA B 86 ALA~? 18.65 CA CA B 303 A 244 ASP B 21 ASP~? 22.52 NI NI B 305 A 271 HIS B 22 HIS~? 22.02 NI NI B 305 coo 15.05 3.71 6.93 14.58 4.88 7.78 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 9.85 8.15 0.76 10.61 7.04 2.39 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 10.61 7.65 6.01 12.39 6.55 6.23 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 9 3 # 9 A 105 ALA B 86 ALA~? 18.65 CA CA B 303 A 244 ASP B 21 ASP~? 22.52 NI NI B 305 A 271 HIS B 83 HIS~? 17.68 NI NI B 305 coo 15.05 3.71 6.93 14.58 4.88 7.78 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 coo 9.85 8.15 0.76 10.61 7.04 2.39 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 10.61 7.65 6.01 12.39 6.55 6.23 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 10 3 # 10 A 105 ALA B 149 ALA.? 19.34 NI NI B 305 A 244 ASP B 145 ASP.? 18.27 NI NI B 305 A 271 HIS B 148 HIS.? 18.38 NI NI B 305 coo 15.05 3.71 6.93 14.58 4.88 7.78 5.50 -0.36 -43.85 4.23 0.46 -43.75 coo 9.85 8.15 0.76 10.61 7.04 2.39 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 10.61 7.65 6.01 12.39 6.55 6.23 6.24 -3.74 -47.54 7.83 -3.67 -48.90 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 10 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 161 ALA.? 25.95 NI NI A 304 B 126 ARG A 158 ARG.? 32.75 NI NI A 304 B 138 GLU A 164 GLU~? 25.12 NI NI A 304 coo 2.11 4.00 19.31 3.14 4.86 19.99 9.05 20.07 -31.59 9.16 18.69 -32.23 coo 2.45 5.53 11.28 3.59 7.56 13.29 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 6.10 2.00 25.24 6.12 1.84 23.13 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA B 161 ALA.? 26.26 NI NI B 305 B 126 ARG B 158 ARG.? 33.41 NI NI B 305 B 138 GLU B 164 GLU.? 26.04 NI NI B 305 coo 2.11 4.00 19.31 3.14 4.86 19.99 12.98 -18.16 -48.61 12.88 -16.95 -47.69 coo 2.45 5.53 11.28 3.59 7.56 13.29 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 6.10 2.00 25.24 6.12 1.84 23.13 7.04 -19.25 -44.07 7.68 -20.18 -42.28 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 208 ALA.? 14.58 CA CA B 303 B 126 ARG A 206 ARG^? 17.65 CA CA B 303 B 138 GLU B 101 GLU^? 17.23 CA CA B 303 coo 2.11 4.00 19.31 3.14 4.86 19.99 -23.52 -6.90 -39.82 -23.13 -5.57 -39.16 coo 2.45 5.53 11.28 3.59 7.56 13.29 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 coo 6.10 2.00 25.24 6.12 1.84 23.13 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 3 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 161 ALA.? 25.95 NI NI A 304 C 126 ARG A 158 ARG.? 32.75 NI NI A 304 C 138 GLU A 164 GLU~? 25.12 NI NI A 304 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 9.05 20.07 -31.59 9.16 18.69 -32.23 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 16.04 19.72 -32.20 15.13 21.26 -34.70 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA B 161 ALA.? 26.26 NI NI B 305 C 126 ARG B 158 ARG.? 33.41 NI NI B 305 C 138 GLU B 164 GLU.? 26.04 NI NI B 305 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 12.98 -18.16 -48.61 12.88 -16.95 -47.69 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 7.04 -19.25 -44.07 7.68 -20.18 -42.28 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 161 ALA.? 25.95 NI NI A 304 D 126 ARG A 158 ARG.? 32.75 NI NI A 304 D 138 GLU A 164 GLU~? 25.12 NI NI A 304 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 9.05 20.07 -31.59 9.16 18.69 -32.23 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 16.04 19.72 -32.20 15.13 21.26 -34.70 coo 6.23 0.50 57.10 5.93 0.72 59.19 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA B 161 ALA.? 26.26 NI NI B 305 D 126 ARG B 158 ARG.? 33.41 NI NI B 305 D 138 GLU B 164 GLU.? 26.04 NI NI B 305 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 12.98 -18.16 -48.61 12.88 -16.95 -47.69 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo 6.23 0.50 57.10 5.93 0.72 59.19 7.04 -19.25 -44.07 7.68 -20.18 -42.28 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 161 ALA.? 25.95 NI NI A 304 E 126 ARG A 158 ARG.? 32.75 NI NI A 304 E 138 GLU A 164 GLU~? 25.12 NI NI A 304 coo -4.56 10.03 62.36 -4.38 11.31 61.55 9.05 20.07 -31.59 9.16 18.69 -32.23 coo -3.02 12.00 70.07 -1.94 13.84 67.82 16.04 19.72 -32.20 15.13 21.26 -34.70 coo -8.67 12.22 56.54 -8.68 12.09 58.65 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA B 161 ALA.? 26.26 NI NI B 305 E 126 ARG B 158 ARG.? 33.41 NI NI B 305 E 138 GLU B 164 GLU.? 26.04 NI NI B 305 coo -4.56 10.03 62.36 -4.38 11.31 61.55 12.98 -18.16 -48.61 12.88 -16.95 -47.69 coo -3.02 12.00 70.07 -1.94 13.84 67.82 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo -8.67 12.22 56.54 -8.68 12.09 58.65 7.04 -19.25 -44.07 7.68 -20.18 -42.28 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 161 ALA.? 25.95 NI NI A 304 F 126 ARG A 158 ARG.? 32.75 NI NI A 304 F 138 GLU A 164 GLU~? 25.12 NI NI A 304 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 9.05 20.07 -31.59 9.16 18.69 -32.23 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 16.04 19.72 -32.20 15.13 21.26 -34.70 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 2.03 20.18 -36.55 1.23 21.62 -37.90 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA B 161 ALA.? 26.26 NI NI B 305 F 126 ARG B 158 ARG.? 33.41 NI NI B 305 F 138 GLU B 164 GLU.? 26.04 NI NI B 305 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 12.98 -18.16 -48.61 12.88 -16.95 -47.69 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 19.54 -16.27 -48.10 20.08 -17.20 -45.23 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 7.04 -19.25 -44.07 7.68 -20.18 -42.28 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 2 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 136 GLY.? 11.63 CA CA A 306 B 175 ARG A 198 ARG^? 13.22 CA CA A 306 B 242 TYR A 131 TYR^? 10.29 NI NI A 304 coo 99.45 58.28 3.33 99.57 58.61 4.10 -4.15 16.62 -9.82 -4.70 16.92 -10.32 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo 100.93 69.04 4.38 99.52 68.48 2.09 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 137 GLY.? 14.81 CA CA A 306 B 175 ARG A 198 ARG^? 13.22 CA CA A 306 B 242 TYR A 131 TYR^? 10.29 NI NI A 304 coo 99.45 58.28 3.33 99.57 58.61 4.10 -2.03 18.07 -12.62 -1.94 17.26 -12.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo 100.93 69.04 4.38 99.52 68.48 2.09 -12.31 13.71 -19.00 -10.79 12.16 -20.76 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY B 136 GLY.? 20.18 NI NI B 305 B 175 ARG B 198 ARG^? 13.15 NI NI B 305 B 242 TYR B 131 TYR^? 10.67 NI NI B 305 coo 99.45 58.28 3.33 99.57 58.61 4.10 -0.60 -16.44 -70.27 -0.80 -17.18 -70.05 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 100.93 69.04 4.38 99.52 68.48 2.09 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 137 GLY.? 20.05 NI NI B 305 B 175 ARG B 198 ARG^? 13.15 NI NI B 305 B 242 TYR B 131 TYR^? 10.67 NI NI B 305 coo 99.45 58.28 3.33 99.57 58.61 4.10 0.49 -18.64 -67.37 0.53 -17.81 -67.38 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 100.93 69.04 4.38 99.52 68.48 2.09 -9.20 -16.29 -61.35 -7.98 -14.59 -59.50 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 4 hits 1xva_c03 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER A 139 SER.? 15.61 NI NI A 304 A 178 TYR A 170 TYR^? 15.79 NI NI A 304 A 182 LYS A 142 LYS^? 14.03 NI NI A 304 coo 81.46 10.53 21.66 82.20 10.82 19.39 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 87.67 8.69 17.10 86.62 10.83 18.52 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 85.30 6.17 22.83 87.26 11.02 23.50 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER B 139 SER.? 15.78 NI NI B 305 A 178 TYR B 170 TYR^? 15.66 NI NI B 305 A 182 LYS B 142 LYS^? 13.37 NI NI B 305 coo 81.46 10.53 21.66 82.20 10.82 19.39 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 87.67 8.69 17.10 86.62 10.83 18.52 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 85.30 6.17 22.83 87.26 11.02 23.50 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER A 139 SER.? 15.61 NI NI A 304 B 178 TYR A 170 TYR^? 15.79 NI NI A 304 B 182 LYS A 142 LYS^? 14.03 NI NI A 304 coo 61.22 3.61 34.51 60.46 1.86 35.98 -2.62 13.57 -18.05 -0.50 14.15 -19.08 coo 54.99 -1.20 35.40 56.04 1.15 36.44 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 57.40 2.23 30.19 55.43 5.44 33.87 -1.82 9.73 -24.13 2.97 5.99 -23.26 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER B 139 SER.? 15.78 NI NI B 305 B 178 TYR B 170 TYR^? 15.66 NI NI B 305 B 182 LYS B 142 LYS^? 13.37 NI NI B 305 coo 61.22 3.61 34.51 60.46 1.86 35.98 0.49 -14.15 -62.10 2.68 -14.18 -61.04 coo 54.99 -1.20 35.40 56.04 1.15 36.44 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 57.40 2.23 30.19 55.43 5.44 33.87 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c01 naa= 3 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 1 3 # 1 146 SER A 79 SER~? 16.97 CA CA A 301 338 ASP A 21 ASP~? 19.27 CA CA A 301 397 HIS A 22 HIS~? 21.70 NI NI A 304 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 2 3 # 2 146 SER A 79 SER~? 16.97 CA CA A 301 338 ASP A 21 ASP~? 19.27 CA CA A 301 397 HIS A 83 HIS~? 17.38 NI NI A 304 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 3 3 # 3 146 SER B 79 SER~? 19.41 NI NI B 305 338 ASP B 21 ASP~? 22.52 NI NI B 305 397 HIS B 22 HIS~? 22.02 NI NI B 305 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1ysc_c01 SERINE CARBOXYPEPTIDASE (CPY, CPD-Y,user 4 3 # 4 146 SER B 79 SER~? 19.41 NI NI B 305 338 ASP B 21 ASP~? 22.52 NI NI B 305 397 HIS B 83 HIS~? 17.68 NI NI B 305 coo 45.26 -1.97 35.69 47.76 -2.02 35.82 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 43.14 -11.10 34.55 44.24 -9.84 35.75 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 46.65 -7.57 34.11 46.60 -5.84 35.18 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1ysc_c01 source 1ysc SERINE CARBOXYPEPTIDASE (CPY, CPD-Y, OR PROTEI: 4 hits 1ysc_c01 naa= 3 ULMN 3 1zoi_c00 ESTERASE user 1 3 # 1 A 97 SER A 79 SER~? 16.97 CA CA A 301 A 227 ASP A 21 ASP~? 19.27 CA CA A 301 A 256 HIS A 22 HIS~? 21.70 NI NI A 304 coo 64.84 24.93 59.62 66.28 24.42 57.72 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 73.80 27.56 60.96 72.24 26.45 60.08 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 70.86 23.63 59.28 68.91 24.23 58.80 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1zoi_c00 ESTERASE user 2 3 # 2 A 97 SER A 79 SER~? 16.97 CA CA A 301 A 227 ASP A 21 ASP~? 19.27 CA CA A 301 A 256 HIS A 83 HIS~? 17.38 NI NI A 304 coo 64.84 24.93 59.62 66.28 24.42 57.72 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 73.80 27.56 60.96 72.24 26.45 60.08 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 70.86 23.63 59.28 68.91 24.23 58.80 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1zoi_c00 ESTERASE user 3 3 # 3 A 97 SER B 79 SER~? 19.41 NI NI B 305 A 227 ASP B 21 ASP~? 22.52 NI NI B 305 A 256 HIS B 22 HIS~? 22.02 NI NI B 305 coo 64.84 24.93 59.62 66.28 24.42 57.72 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 73.80 27.56 60.96 72.24 26.45 60.08 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 70.86 23.63 59.28 68.91 24.23 58.80 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1zoi_c00 ESTERASE user 4 3 # 4 A 97 SER B 79 SER~? 19.41 NI NI B 305 A 227 ASP B 21 ASP~? 22.52 NI NI B 305 A 256 HIS B 83 HIS~? 17.68 NI NI B 305 coo 64.84 24.93 59.62 66.28 24.42 57.72 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 73.80 27.56 60.96 72.24 26.45 60.08 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 70.86 23.63 59.28 68.91 24.23 58.80 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1zoi_c00 source 1zoi ESTERASE : 4 hits 1zoi_c00 naa= 3 ULMN 3 1zoi_c01 ESTERASE user 1 3 # 1 B 97 SER A 79 SER~? 16.97 CA CA A 301 B 227 ASP A 21 ASP~? 19.27 CA CA A 301 B 256 HIS A 22 HIS~? 21.70 NI NI A 304 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1zoi_c01 ESTERASE user 2 3 # 2 B 97 SER A 79 SER~? 16.97 CA CA A 301 B 227 ASP A 21 ASP~? 19.27 CA CA A 301 B 256 HIS A 83 HIS~? 17.38 NI NI A 304 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1zoi_c01 ESTERASE user 3 3 # 3 B 97 SER B 79 SER~? 19.41 NI NI B 305 B 227 ASP B 21 ASP~? 22.52 NI NI B 305 B 256 HIS B 22 HIS~? 22.02 NI NI B 305 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1zoi_c01 ESTERASE user 4 3 # 4 B 97 SER B 79 SER~? 19.41 NI NI B 305 B 227 ASP B 21 ASP~? 22.52 NI NI B 305 B 256 HIS B 83 HIS~? 17.68 NI NI B 305 coo 64.71 -1.59 29.78 66.19 -2.95 31.16 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 73.58 -1.50 26.67 72.07 -1.71 28.10 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 70.69 -1.01 30.98 68.78 -1.84 30.74 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1zoi_c01 source 1zoi ESTERASE : 4 hits 1zoi_c01 naa= 3 ULMN 3 1zoi_c02 ESTERASE user 1 3 # 1 C 97 SER A 79 SER~? 16.97 CA CA A 301 C 227 ASP A 21 ASP~? 19.27 CA CA A 301 C 256 HIS A 22 HIS~? 21.70 NI NI A 304 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 1zoi_c02 ESTERASE user 2 3 # 2 C 97 SER A 79 SER~? 16.97 CA CA A 301 C 227 ASP A 21 ASP~? 19.27 CA CA A 301 C 256 HIS A 83 HIS~? 17.38 NI NI A 304 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 1zoi_c02 ESTERASE user 3 3 # 3 C 97 SER B 79 SER~? 19.41 NI NI B 305 C 227 ASP B 21 ASP~? 22.52 NI NI B 305 C 256 HIS B 22 HIS~? 22.02 NI NI B 305 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 1zoi_c02 ESTERASE user 4 3 # 4 C 97 SER B 79 SER~? 19.41 NI NI B 305 C 227 ASP B 21 ASP~? 22.52 NI NI B 305 C 256 HIS B 83 HIS~? 17.68 NI NI B 305 coo 65.79 -14.04 67.57 66.89 -11.91 68.05 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 74.87 -16.69 68.52 73.28 -15.36 68.17 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 71.71 -13.16 66.29 69.81 -13.09 67.19 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 1zoi_c02 source 1zoi ESTERASE : 4 hits 1zoi_c02 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 207 TRP^? 21.27 NI NI A 304 223 ASP A 94 ASP.? 21.52 NI NI B 305 258 ALA A 86 ALA~? 20.62 NI NI A 304 coo 128.40 33.01 26.67 128.12 36.28 28.81 -23.03 6.23 -40.88 -21.50 5.17 -44.34 coo 127.91 41.73 23.55 129.18 40.35 24.44 -19.72 10.83 -48.01 -21.47 10.84 -49.25 coo 141.00 37.49 25.74 139.80 37.53 24.78 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP B 207 TRP.? 10.18 CA CA B 303 223 ASP B 94 ASP.? -2.87 CA CA B 303s 258 ALA B 86 ALA~? 18.65 CA CA B 303 coo 128.40 33.01 26.67 128.12 36.28 28.81 -20.87 -11.01 -39.41 -19.26 -9.54 -36.14 coo 127.91 41.73 23.55 129.18 40.35 24.44 -16.77 -14.78 -32.39 -18.46 -15.06 -31.10 coo 141.00 37.49 25.74 139.80 37.53 24.78 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 2 hits 2aat_c01 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 115 SER.? 13.22 NI NI A 304 327 GLU A 188 GLU^? 11.68 NI NI A 304 440 HIS A 116 HIS^? 7.23 NI NI A 304 coo 6.96 64.04 57.84 6.74 63.69 60.26 -4.09 2.55 -15.69 -1.77 3.10 -15.16 coo 14.82 64.63 62.37 13.47 65.72 61.17 -1.46 3.98 -22.30 0.62 3.68 -22.46 coo 9.52 66.51 63.07 8.75 65.02 61.81 -7.88 2.26 -18.66 -9.47 2.70 -17.37 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 115 SER.? 13.16 NI NI B 305 327 GLU B 188 GLU^? 11.04 NI NI B 305 440 HIS B 116 HIS^? 6.69 NI NI B 305 coo 6.96 64.04 57.84 6.74 63.69 60.26 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 coo 14.82 64.63 62.37 13.47 65.72 61.17 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 9.52 66.51 63.07 8.75 65.02 61.81 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 21 ASP~? 19.27 CA CA A 301 231 ASP A 65 ASP~? 19.57 CA CA B 303 294 ASP A 177 ASP^? 15.76 CA CA A 306 coo 27.89 102.52 14.98 29.35 101.92 13.57 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 65 ASP~? 19.57 CA CA B 303 231 ASP A 27 ASP~? -2.92 CA CA A 301s 294 ASP A 104 ASP^? 11.20 NI NI A 304 coo 27.89 102.52 14.98 29.35 101.92 13.57 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 104 ASP^? 11.20 NI NI A 304 231 ASP A 21 ASP~? 19.27 CA CA A 301 294 ASP A 65 ASP~? 19.57 CA CA B 303 coo 27.89 102.52 14.98 29.35 101.92 13.57 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 104 ASP^? 11.20 NI NI A 304 231 ASP A 96 ASP.? 21.09 NI NI B 305 294 ASP A 65 ASP~? 19.57 CA CA B 303 coo 27.89 102.52 14.98 29.35 101.92 13.57 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -25.65 8.23 -47.38 -24.09 7.78 -48.74 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP A 104 ASP^? 11.20 NI NI A 304 231 ASP A 197 ASP.? 9.27 CA CA A 306 294 ASP A 65 ASP~? 19.57 CA CA B 303 coo 27.89 102.52 14.98 29.35 101.92 13.57 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 33.16 106.80 7.72 33.34 104.87 6.92 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP A 177 ASP^? 15.76 CA CA A 306 231 ASP A 65 ASP~? 19.57 CA CA B 303 294 ASP A 21 ASP~? 19.27 CA CA A 301 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 -20.19 23.48 -26.91 -18.56 24.69 -26.31 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 65 ASP~? 20.64 NI NI B 305 231 ASP B 27 ASP~? 26.12 NI NI B 305 294 ASP B 104 ASP^? 11.37 NI NI B 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -21.16 -24.87 -67.71 -20.16 -25.44 -69.49 coo 33.16 106.80 7.72 33.34 104.87 6.92 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 104 ASP^? 11.37 NI NI B 305 231 ASP B 21 ASP~? 22.52 NI NI B 305 294 ASP B 65 ASP~? 20.64 NI NI B 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 33.16 106.80 7.72 33.34 104.87 6.92 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 3 # 9 193 ASP B 104 ASP^? 11.37 NI NI B 305 231 ASP B 96 ASP.? 4.50 CA CA B 303 294 ASP B 65 ASP~? 20.64 NI NI B 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -23.48 -13.65 -33.09 -22.31 -12.65 -31.66 coo 33.16 106.80 7.72 33.34 104.87 6.92 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 3 # 10 193 ASP B 104 ASP^? 11.37 NI NI B 305 231 ASP B 197 ASP.? 18.81 NI NI B 305 294 ASP B 65 ASP~? 20.64 NI NI B 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 33.16 106.80 7.72 33.34 104.87 6.92 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 3 # 11 193 ASP B 177 ASP^? 17.56 NI NI B 305 231 ASP B 65 ASP~? 20.64 NI NI B 305 294 ASP B 21 ASP~? 22.52 NI NI B 305 coo 27.89 102.52 14.98 29.35 101.92 13.57 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 14.74 93.05 -1.00 14.30 94.22 0.73 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 33.16 106.80 7.72 33.34 104.87 6.92 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 11 hits 2amg_c06 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU A 29 GLU~? -4.66 CA CA A 301s 107 ASP A 27 ASP~? -2.92 CA CA A 301s 109 GLU A 30 GLU~? 7.55 CA CA A 301 coo 15.97 13.58 10.29 15.12 15.36 9.48 -21.95 18.47 -6.84 -23.04 19.65 -5.43 coo 20.07 16.34 11.47 18.03 16.15 11.04 -25.76 19.66 -12.70 -25.06 20.72 -11.00 coo 20.99 19.84 9.56 19.07 20.34 10.22 -27.55 15.68 -10.70 -29.15 16.50 -11.85 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 1 hits 2ayh_c00 naa= 3 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 1 3 # 1 B 46 HIS A 116 HIS^? 7.23 NI NI A 304 B 163 ALA A 117 ALA^? 9.93 NI NI A 304 B 182 SER A 118 SER^? 9.86 NI NI A 304 coo 30.42 1.98 4.36 29.07 0.41 4.68 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -3.31 -0.27 -21.61 -3.23 -1.78 -21.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -2.77 1.07 -25.15 -1.27 2.29 -26.62 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 2 3 # 2 B 46 HIS A 187 HIS^? -3.59 NI NI A 304s B 163 ALA A 117 ALA^? 9.93 NI NI A 304 B 182 SER A 118 SER^? 9.86 NI NI A 304 coo 30.42 1.98 4.36 29.07 0.41 4.68 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -3.31 -0.27 -21.61 -3.23 -1.78 -21.83 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -2.77 1.07 -25.15 -1.27 2.29 -26.62 ULMN 3 2bhg_c02 FOOT-AND-MOUTH DISEASE VIRUS 3C PROTuser 3 3 # 3 B 46 HIS B 187 HIS^? -3.54 NI NI B 305s B 163 ALA B 117 ALA^? 9.69 NI NI B 305 B 182 SER B 118 SER^? 9.81 NI NI B 305 coo 30.42 1.98 4.36 29.07 0.41 4.68 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 25.72 -4.33 3.52 26.60 -3.24 4.12 -3.41 -0.56 -58.89 -3.69 0.94 -58.77 coo 24.00 -0.17 2.07 24.51 1.00 0.04 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 2bhg_c02 source 2bhg FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE : 3 hits 2bhg_c02 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 69 ARG~? 22.34 NI NI A 304 A 161 ASP A 104 ASP^? 11.20 NI NI A 304 A 174 TYR A 60 TYR.? 8.44 NI NI A 304 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -30.00 0.47 -17.16 -30.02 -0.97 -14.43 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG A 98 ARG.? 20.57 NI NI B 305 A 161 ASP A 81 ASP~? 18.70 NI NI A 304 A 174 TYR A 205 TYR^? 13.62 NI NI A 304 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -25.95 5.08 -43.97 -24.52 2.34 -44.05 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 3 3 # 3 A 14 ARG B 69 ARG~? 22.61 NI NI B 305 A 161 ASP B 104 ASP^? 11.37 NI NI B 305 A 174 TYR B 60 TYR.? 9.06 NI NI B 305 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -29.41 -6.49 -63.38 -29.52 -5.70 -66.36 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 69 ARG~? 22.34 NI NI A 304 B 161 ASP A 104 ASP^? 11.20 NI NI A 304 B 174 TYR A 60 TYR.? 8.44 NI NI A 304 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -30.00 0.47 -17.16 -30.02 -0.97 -14.43 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG A 98 ARG.? 20.57 NI NI B 305 B 161 ASP A 81 ASP~? 18.70 NI NI A 304 B 174 TYR A 205 TYR^? 13.62 NI NI A 304 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -25.95 5.08 -43.97 -24.52 2.34 -44.05 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 3 3 # 3 B 14 ARG B 69 ARG~? 22.61 NI NI B 305 B 161 ASP B 104 ASP^? 11.37 NI NI B 305 B 174 TYR B 60 TYR.? 9.06 NI NI B 305 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -29.41 -6.49 -63.38 -29.52 -5.70 -66.36 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 4 3 # 4 B 14 ARG B 98 ARG.? 11.28 CA CA B 303 B 161 ASP B 81 ASP~? 18.56 NI NI B 305 B 174 TYR B 205 TYR^? 13.71 NI NI B 305 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -24.48 -9.95 -37.71 -23.29 -7.54 -36.21 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 4 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 69 ARG~? 22.34 NI NI A 304 C 161 ASP A 104 ASP^? 11.20 NI NI A 304 C 174 TYR A 60 TYR.? 8.44 NI NI A 304 coo 2.84 19.43 40.34 1.59 20.35 37.65 -30.00 0.47 -17.16 -30.02 -0.97 -14.43 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 5.94 13.28 27.17 3.53 13.05 28.58 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG A 98 ARG.? 20.57 NI NI B 305 C 161 ASP A 81 ASP~? 18.70 NI NI A 304 C 174 TYR A 205 TYR^? 13.62 NI NI A 304 coo 2.84 19.43 40.34 1.59 20.35 37.65 -25.95 5.08 -43.97 -24.52 2.34 -44.05 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 5.94 13.28 27.17 3.53 13.05 28.58 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 3 3 # 3 C 14 ARG B 69 ARG~? 22.61 NI NI B 305 C 161 ASP B 104 ASP^? 11.37 NI NI B 305 C 174 TYR B 60 TYR.? 9.06 NI NI B 305 coo 2.84 19.43 40.34 1.59 20.35 37.65 -29.41 -6.49 -63.38 -29.52 -5.70 -66.36 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 5.94 13.28 27.17 3.53 13.05 28.58 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 69 ARG~? 22.34 NI NI A 304 D 161 ASP A 104 ASP^? 11.20 NI NI A 304 D 174 TYR A 60 TYR.? 8.44 NI NI A 304 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -30.00 0.47 -17.16 -30.02 -0.97 -14.43 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -16.58 -2.04 -21.35 -15.82 -2.45 -24.01 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG A 98 ARG.? 20.57 NI NI B 305 D 161 ASP A 81 ASP~? 18.70 NI NI A 304 D 174 TYR A 205 TYR^? 13.62 NI NI A 304 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -25.95 5.08 -43.97 -24.52 2.34 -44.05 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -21.20 8.17 -31.41 -22.93 9.66 -29.80 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 3 3 # 3 D 14 ARG B 69 ARG~? 22.61 NI NI B 305 D 161 ASP B 104 ASP^? 11.37 NI NI B 305 D 174 TYR B 60 TYR.? 9.06 NI NI B 305 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -29.41 -6.49 -63.38 -29.52 -5.70 -66.36 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -17.13 -1.59 -58.60 -17.07 -0.63 -55.97 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 196 ASP.? 6.39 CA CA A 306 A 233 GLU A 112 GLU.? -2.98 CA CA A 302s A 300 ASN A 192 ASN.? 10.14 CA CA A 302 coo 12.51 17.07 49.46 12.44 16.89 47.35 -9.18 12.61 -5.36 -9.90 13.29 -3.47 coo 6.52 19.14 48.16 7.77 18.42 46.61 -2.93 7.09 -5.49 -2.54 7.70 -3.48 coo 9.30 22.40 41.76 10.10 20.96 40.36 -4.75 8.04 -11.36 -5.74 9.45 -10.12 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 196 ASP.? 23.47 NI NI B 305 A 233 GLU B 195 GLU.? -26.54 NI NI B 305s A 300 ASN B 192 ASN.? 16.32 NI NI B 305 coo 12.51 17.07 49.46 12.44 16.89 47.35 -6.32 -14.10 -75.13 -6.62 -14.73 -77.14 coo 6.52 19.14 48.16 7.77 18.42 46.61 -0.96 -11.31 -77.84 -0.63 -11.36 -79.94 coo 9.30 22.40 41.76 10.10 20.96 40.36 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 2cpu_c01 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 32 GLU~? -3.00 CA CA A 306s A 156 GLU A 40 GLU~? 12.94 CA CA A 306 A 194 ASN A 108 ASN^? 7.27 NI NI A 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 67.47 20.07 1.34 65.99 20.06 2.88 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 40 GLU~? 12.94 CA CA A 306 A 156 GLU A 32 GLU~? -3.00 CA CA A 306s A 194 ASN A 108 ASN^? 7.27 NI NI A 304 coo 74.14 15.91 8.55 72.08 15.36 8.63 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 67.47 20.07 1.34 65.99 20.06 2.88 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 67.44 25.26 13.91 67.54 23.65 15.28 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 32 GLU~? 21.76 NI NI B 305 A 156 GLU B 40 GLU~? 23.91 NI NI B 305 A 194 ASN B 108 ASN^? 7.81 NI NI B 305 coo 74.14 15.91 8.55 72.08 15.36 8.63 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 67.47 20.07 1.34 65.99 20.06 2.88 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 67.44 25.26 13.91 67.54 23.65 15.28 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 40 GLU~? 23.91 NI NI B 305 A 156 GLU B 32 GLU~? 21.76 NI NI B 305 A 194 ASN B 108 ASN^? 7.81 NI NI B 305 coo 74.14 15.91 8.55 72.08 15.36 8.63 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 67.47 20.07 1.34 65.99 20.06 2.88 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 67.44 25.26 13.91 67.54 23.65 15.28 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 2dbt_c00 source 2dbt CHITINASE C : 4 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 32 GLU~? -3.00 CA CA A 306s B 156 GLU A 40 GLU~? 12.94 CA CA A 306 B 194 ASN A 108 ASN^? 7.27 NI NI A 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 54.43 67.89 19.82 55.62 67.90 18.07 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 40 GLU~? 12.94 CA CA A 306 B 156 GLU A 32 GLU~? -3.00 CA CA A 306s B 194 ASN A 108 ASN^? 7.27 NI NI A 304 coo 45.64 63.11 17.20 47.48 62.43 16.45 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 54.43 67.89 19.82 55.62 67.90 18.07 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 49.79 70.75 7.78 50.10 68.90 6.86 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 32 GLU~? 21.76 NI NI B 305 B 156 GLU B 40 GLU~? 23.91 NI NI B 305 B 194 ASN B 108 ASN^? 7.81 NI NI B 305 coo 45.64 63.11 17.20 47.48 62.43 16.45 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 49.79 70.75 7.78 50.10 68.90 6.86 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 40 GLU~? 23.91 NI NI B 305 B 156 GLU B 32 GLU~? 21.76 NI NI B 305 B 194 ASN B 108 ASN^? 7.81 NI NI B 305 coo 45.64 63.11 17.20 47.48 62.43 16.45 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 54.43 67.89 19.82 55.62 67.90 18.07 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 49.79 70.75 7.78 50.10 68.90 6.86 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 2dbt_c01 source 2dbt CHITINASE C : 4 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 32 GLU~? -3.00 CA CA A 306s C 156 GLU A 40 GLU~? 12.94 CA CA A 306 C 194 ASN A 108 ASN^? 7.27 NI NI A 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 44.75 23.09 5.51 46.77 22.91 6.12 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 40 GLU~? 12.94 CA CA A 306 C 156 GLU A 32 GLU~? -3.00 CA CA A 306s C 194 ASN A 108 ASN^? 7.27 NI NI A 304 coo 41.23 29.31 13.28 43.03 29.85 12.29 -20.35 2.54 -4.22 -20.15 4.43 -3.28 coo 44.75 23.09 5.51 46.77 22.91 6.12 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 49.75 21.00 18.12 50.45 23.02 18.26 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 32 GLU~? 21.76 NI NI B 305 C 156 GLU B 40 GLU~? 23.91 NI NI B 305 C 194 ASN B 108 ASN^? 7.81 NI NI B 305 coo 41.23 29.31 13.28 43.03 29.85 12.29 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 49.75 21.00 18.12 50.45 23.02 18.26 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 40 GLU~? 23.91 NI NI B 305 C 156 GLU B 32 GLU~? 21.76 NI NI B 305 C 194 ASN B 108 ASN^? 7.81 NI NI B 305 coo 41.23 29.31 13.28 43.03 29.85 12.29 -19.65 -7.02 -76.00 -19.19 -8.60 -77.34 coo 44.75 23.09 5.51 46.77 22.91 6.12 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 49.75 21.00 18.12 50.45 23.02 18.26 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 1 3 # 1 A 235 GLU A 29 GLU~? -4.66 CA CA A 301s A 340 GLU A 32 GLU~? -3.00 CA CA A 306s A 342 CYH A 35 CYH~? 11.73 CA CA A 306 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 -21.95 18.47 -6.84 -23.04 19.65 -5.43 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 -21.62 7.57 -11.19 -20.62 8.88 -13.43 ULMN 3 2f61_c00 ACID BETA-GLUCOSIDASE user 2 3 # 2 A 235 GLU B 29 GLU~? 27.87 NI NI B 305 A 340 GLU B 32 GLU~? 21.76 NI NI B 305 A 342 CYH B 35 CYH~? 15.94 NI NI B 305 coo 13.45 37.14 -1.68 12.32 37.89 -3.28 -17.38 -22.83 -73.54 -18.54 -23.97 -74.92 coo 14.96 43.86 -2.28 14.91 42.15 -3.51 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 11.37 47.97 -4.08 11.06 45.43 -5.26 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 2f61_c00 source 2f61 ACID BETA-GLUCOSIDASE : 2 hits 2f61_c00 naa= 3 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 1 3 # 1 B 235 GLU A 29 GLU~? -4.66 CA CA A 301s B 340 GLU A 32 GLU~? -3.00 CA CA A 306s B 342 CYH A 35 CYH~? 11.73 CA CA A 306 coo 41.63 98.81 4.74 43.45 99.80 5.19 -21.95 18.47 -6.84 -23.04 19.65 -5.43 coo 40.49 105.59 6.14 40.82 103.64 6.89 -18.33 13.18 -8.58 -17.06 14.63 -7.73 coo 45.58 109.64 7.60 45.90 106.93 8.23 -21.62 7.57 -11.19 -20.62 8.88 -13.43 ULMN 3 2f61_c01 ACID BETA-GLUCOSIDASE user 2 3 # 2 B 235 GLU B 29 GLU~? 27.87 NI NI B 305 B 340 GLU B 32 GLU~? 21.76 NI NI B 305 B 342 CYH B 35 CYH~? 15.94 NI NI B 305 coo 41.63 98.81 4.74 43.45 99.80 5.19 -17.38 -22.83 -73.54 -18.54 -23.97 -74.92 coo 40.49 105.59 6.14 40.82 103.64 6.89 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 coo 45.58 109.64 7.60 45.90 106.93 8.23 -19.51 -12.05 -69.02 -18.15 -13.27 -66.92 2f61_c01 source 2f61 ACID BETA-GLUCOSIDASE : 2 hits 2f61_c01 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 15 TYR^? 16.16 NI NI A 304 A 245 ASP A 21 ASP~? 19.27 CA CA A 301 A 273 LYS A 78 LYS~? 23.27 CA CA A 301 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 170 TYR^? 15.79 NI NI A 304 A 245 ASP A 163 ASP~? 21.63 NI NI A 304 A 273 LYS A 159 LYS.? 27.24 CA CA A 302 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 1.42 13.38 -22.88 3.34 11.36 -22.90 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 1.30 20.20 -30.86 1.78 20.99 -28.95 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 12.17 17.61 -27.47 15.70 15.20 -22.78 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 15 TYR^? 16.36 NI NI B 305 A 245 ASP B 21 ASP~? 22.52 NI NI B 305 A 273 LYS B 78 LYS~? 25.94 CA CA B 303 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -24.78 -19.72 -53.92 -29.05 -23.56 -52.85 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR B 170 TYR^? 15.66 NI NI B 305 A 245 ASP B 163 ASP.? 22.00 NI NI B 305 A 273 LYS B 159 LYS.? 30.31 NI NI B 305 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 4.23 -12.71 -57.64 5.48 -10.20 -57.84 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.99 -14.57 -52.82 19.67 -12.66 -51.79 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c02 naa= 3 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 1 3 # 1 B 137 SER A 127 SER^? 6.45 NI NI A 304 B 158 HIS A 121 HIS.? -3.63 NI NI A 304s B 208 ASN A 204 ASN^? 6.50 NI NI A 304 coo 50.29 50.10 71.46 47.85 50.06 71.46 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 48.67 45.40 71.68 47.67 46.90 70.60 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 48.91 49.12 65.17 47.29 49.14 66.54 -18.02 3.14 -29.01 -15.99 2.73 -28.54 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 2 3 # 2 B 137 SER A 183 SER.? 9.24 NI NI A 304 B 158 HIS A 121 HIS.? -3.63 NI NI A 304s B 208 ASN A 204 ASN^? 6.50 NI NI A 304 coo 50.29 50.10 71.46 47.85 50.06 71.46 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 48.67 45.40 71.68 47.67 46.90 70.60 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo 48.91 49.12 65.17 47.29 49.14 66.54 -18.02 3.14 -29.01 -15.99 2.73 -28.54 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 3 3 # 3 B 137 SER B 124 SER.? 10.06 NI NI B 305 B 158 HIS B 123 HIS.? 14.82 NI NI B 305 B 208 ASN B 204 ASN^? 6.73 NI NI B 305 coo 50.29 50.10 71.46 47.85 50.06 71.46 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo 48.67 45.40 71.68 47.67 46.90 70.60 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 48.91 49.12 65.17 47.29 49.14 66.54 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 4 3 # 4 B 137 SER B 127 SER^? 6.61 NI NI B 305 B 158 HIS B 121 HIS.? -3.60 NI NI B 305s B 208 ASN B 204 ASN^? 6.73 NI NI B 305 coo 50.29 50.10 71.46 47.85 50.06 71.46 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 48.67 45.40 71.68 47.67 46.90 70.60 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 48.91 49.12 65.17 47.29 49.14 66.54 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 ULMN 3 2hdh_c02 L-3-HYDROXYACYL COA DEHYDROGENASE user 5 3 # 5 B 137 SER B 183 SER.? 9.15 NI NI B 305 B 158 HIS B 121 HIS.? -3.60 NI NI B 305s B 208 ASN B 204 ASN^? 6.73 NI NI B 305 coo 50.29 50.10 71.46 47.85 50.06 71.46 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 48.67 45.40 71.68 47.67 46.90 70.60 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo 48.91 49.12 65.17 47.29 49.14 66.54 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 2hdh_c02 source 2hdh L-3-HYDROXYACYL COA DEHYDROGENASE : 5 hits 2hdh_c02 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS B 116 HIS^? 6.69 NI NI B 305 A 341 GLU B 188 GLU^? 11.04 NI NI B 305 A 356 HIS B 121 HIS.? -3.60 NI NI B 305s coo 121.00 36.37 19.26 121.57 38.37 19.56 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 125.72 32.70 19.75 124.44 34.16 18.84 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 124.34 41.73 25.55 123.79 42.60 23.72 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS B 123 HIS.? 14.82 NI NI B 305 A 341 GLU B 103 GLU^? 12.89 NI NI B 305 A 356 HIS B 121 HIS.? -3.60 NI NI B 305s coo 121.00 36.37 19.26 121.57 38.37 19.56 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 125.72 32.70 19.75 124.44 34.16 18.84 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 124.34 41.73 25.55 123.79 42.60 23.72 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS B 116 HIS^? 6.69 NI NI B 305 B 341 GLU B 188 GLU^? 11.04 NI NI B 305 B 356 HIS B 121 HIS.? -3.60 NI NI B 305s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS B 123 HIS.? 14.82 NI NI B 305 B 341 GLU B 103 GLU^? 12.89 NI NI B 305 B 356 HIS B 121 HIS.? -3.60 NI NI B 305s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 2 hits 2isd_c01 naa= 3 ULMN 3 2lip_c00 LIPASE user 1 3 # 1 87 SER A 79 SER~? 16.97 CA CA A 301 264 ASP A 21 ASP~? 19.27 CA CA A 301 286 HIS A 22 HIS~? 21.70 NI NI A 304 coo 10.47 25.91 18.67 10.67 27.13 20.84 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 2.34 22.49 22.56 3.80 23.95 22.00 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.10 24.11 23.40 8.18 25.09 21.87 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 2lip_c00 LIPASE user 2 3 # 2 87 SER A 79 SER~? 16.97 CA CA A 301 264 ASP A 21 ASP~? 19.27 CA CA A 301 286 HIS A 83 HIS~? 17.38 NI NI A 304 coo 10.47 25.91 18.67 10.67 27.13 20.84 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 2.34 22.49 22.56 3.80 23.95 22.00 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.10 24.11 23.40 8.18 25.09 21.87 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 2lip_c00 LIPASE user 3 3 # 3 87 SER B 79 SER~? 19.41 NI NI B 305 264 ASP B 21 ASP~? 22.52 NI NI B 305 286 HIS B 22 HIS~? 22.02 NI NI B 305 coo 10.47 25.91 18.67 10.67 27.13 20.84 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 2.34 22.49 22.56 3.80 23.95 22.00 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.10 24.11 23.40 8.18 25.09 21.87 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 2lip_c00 LIPASE user 4 3 # 4 87 SER B 79 SER~? 19.41 NI NI B 305 264 ASP B 21 ASP~? 22.52 NI NI B 305 286 HIS B 83 HIS~? 17.68 NI NI B 305 coo 10.47 25.91 18.67 10.67 27.13 20.84 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 2.34 22.49 22.56 3.80 23.95 22.00 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.10 24.11 23.40 8.18 25.09 21.87 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 2lip_c00 source 2lip LIPASE : 4 hits 2lip_c00 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 83 HIS~? 17.38 NI NI A 304 A 102 ASP A 21 ASP~? 19.27 CA CA A 301 A 193 GLY A 128 GLY^? 7.35 NI NI A 304 coo 14.96 29.22 19.55 15.62 29.93 17.67 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 19.64 30.69 22.61 18.18 29.94 21.25 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 14.54 28.99 9.76 15.06 29.59 10.02 -14.74 9.68 -27.07 -14.93 8.99 -26.74 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 83 HIS~? 17.68 NI NI B 305 A 102 ASP B 21 ASP~? 22.52 NI NI B 305 A 193 GLY B 128 GLY^? 7.45 NI NI B 305 coo 14.96 29.22 19.55 15.62 29.93 17.67 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 19.64 30.69 22.61 18.18 29.94 21.25 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 14.54 28.99 9.76 15.06 29.59 10.02 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 2 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE B 168 PHE^? 16.16 NI NI B 305 A 263 ASP B 163 ASP.? 22.00 NI NI B 305 A 292 LYS B 159 LYS.? 30.31 NI NI B 305 coo 51.51 50.32 16.39 52.13 49.68 13.75 5.97 -7.92 -52.72 6.39 -5.22 -52.12 coo 54.43 44.82 23.74 55.21 45.06 21.80 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 63.95 45.30 16.71 59.11 49.15 16.05 15.99 -14.57 -52.82 19.67 -12.66 -51.79 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c03 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 70 PHE~? 18.84 CA CA A 301 C 263 ASP A 65 ASP~? 19.57 CA CA B 303 C 292 LYS A 78 LYS~? 23.27 CA CA A 301 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -29.55 5.68 -14.32 -29.26 3.28 -12.93 coo 19.84 12.02 9.33 18.68 11.23 7.75 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 -28.42 14.17 -26.53 -31.51 16.17 -30.16 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE B 168 PHE^? 16.16 NI NI B 305 C 263 ASP B 163 ASP.? 22.00 NI NI B 305 C 292 LYS B 159 LYS.? 30.31 NI NI B 305 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 5.97 -7.92 -52.72 6.39 -5.22 -52.12 coo 19.84 12.02 9.33 18.68 11.23 7.75 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 12.82 3.49 4.98 17.80 5.59 1.90 15.99 -14.57 -52.82 19.67 -12.66 -51.79 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c05 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 68 TRP~? 24.70 CA CA B 303 C 263 ASP A 65 ASP~? 19.57 CA CA B 303 C 292 LYS A 78 LYS~? 23.27 CA CA A 301 coo 20.52 16.65 4.15 17.32 18.91 4.39 -34.66 2.79 -23.28 -36.73 0.83 -20.56 coo 19.84 12.02 9.33 18.68 11.23 7.75 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 -28.42 14.17 -26.53 -31.51 16.17 -30.16 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c08 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS B 116 HIS^? 6.69 NI NI B 305 A 40 LYS B 142 LYS^? 13.37 NI NI B 305 A 116 HIS B 121 HIS.? -3.60 NI NI B 305s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 18.50 3.53 20.10 16.17 2.61 14.41 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 14.70 6.01 5.61 14.27 7.69 6.78 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 1 hits 2rnf_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 42 ASP~? 18.65 NI NI A 304 166 GLY A 114 GLY.? 12.41 CA CA A 302 169 GLU A 188 GLU^? 11.68 NI NI A 304 coo 8.28 6.87 1.62 10.08 5.77 1.34 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.84 2.83 -11.96 -4.27 3.38 -12.10 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -1.46 3.98 -22.30 0.62 3.68 -22.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 65 ASP~? 19.57 CA CA B 303 166 GLY A 128 GLY^? 7.35 NI NI A 304 169 GLU A 182 GLU^? 15.51 NI NI A 304 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.74 9.68 -27.07 -14.93 8.99 -26.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.04 10.12 -36.92 -10.45 10.15 -38.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 75 ASP~? 14.34 CA CA A 301 166 GLY A 128 GLY^? 7.35 NI NI A 304 169 GLU A 182 GLU^? 15.51 NI NI A 304 coo 8.28 6.87 1.62 10.08 5.77 1.34 -29.63 15.16 -19.97 -31.70 15.36 -19.47 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.74 9.68 -27.07 -14.93 8.99 -26.74 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.04 10.12 -36.92 -10.45 10.15 -38.96 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 81 ASP~? 18.70 NI NI A 304 166 GLY A 176 GLY.? 12.58 CA CA A 306 169 GLU A 32 GLU~? -3.00 CA CA A 306s coo 8.28 6.87 1.62 10.08 5.77 1.34 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -16.93 18.91 -18.06 -16.18 18.74 -18.33 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -18.33 13.18 -8.58 -17.06 14.63 -7.73 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 104 ASP^? 11.20 NI NI A 304 166 GLY A 56 GLY.? 14.57 NI NI A 304 169 GLU A 50 GLU~? 22.49 CA CA A 302 coo 8.28 6.87 1.62 10.08 5.77 1.34 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.81 0.60 -10.59 -10.93 -0.17 -10.81 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 104 ASP^? 11.20 NI NI A 304 166 GLY B 97 GLY.? 8.10 CA CA B 303 169 GLU B 101 GLU^? 17.23 CA CA B 303 coo 8.28 6.87 1.62 10.08 5.77 1.34 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -26.11 -15.86 -35.36 -25.49 -15.39 -35.65 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -25.45 -12.05 -45.21 -26.04 -14.03 -45.67 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP B 41 ASP.? 25.32 NI NI B 305 166 GLY B 56 GLY.? 14.39 NI NI B 305 169 GLU B 112 GLU.? -22.76 NI NI B 305s coo 8.28 6.87 1.62 10.08 5.77 1.34 -25.97 -5.97 -72.92 -27.99 -5.32 -73.02 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.26 -2.88 -69.60 -10.59 -2.15 -69.46 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.93 -7.38 -74.21 0.03 -7.35 -76.11 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP B 42 ASP~? 18.39 NI NI B 305 166 GLY B 114 GLY.? 14.04 NI NI B 305 169 GLU B 188 GLU^? 11.04 NI NI B 305 coo 8.28 6.87 1.62 10.08 5.77 1.34 -22.61 -3.06 -69.64 -22.72 -1.93 -67.85 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.30 -3.98 -68.39 -3.58 -4.34 -68.25 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -0.95 -4.07 -57.64 0.90 -3.17 -57.13 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP B 65 ASP~? 20.64 NI NI B 305 166 GLY B 128 GLY^? 7.45 NI NI B 305 169 GLU B 182 GLU^? 15.43 NI NI B 305 coo 8.28 6.87 1.62 10.08 5.77 1.34 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP B 75 ASP~? 24.42 NI NI B 305 166 GLY B 128 GLY^? 7.45 NI NI B 305 169 GLU B 182 GLU^? 15.43 NI NI B 305 coo 8.28 6.87 1.62 10.08 5.77 1.34 -25.75 -20.95 -60.07 -27.69 -21.73 -60.41 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.27 -12.59 -53.30 -12.65 -11.97 -53.60 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.28 -12.45 -43.83 -7.77 -12.67 -41.79 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP B 81 ASP~? 18.56 NI NI B 305 166 GLY B 176 GLY.? 17.70 NI NI B 305 169 GLU B 32 GLU~? 21.76 NI NI B 305 coo 8.28 6.87 1.62 10.08 5.77 1.34 -23.01 -18.44 -49.89 -23.99 -16.67 -50.55 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.48 -22.17 -62.17 -11.78 -21.87 -61.92 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -15.02 -16.95 -71.76 -13.90 -18.05 -73.18 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP B 104 ASP^? 11.37 NI NI B 305 166 GLY A 97 GLY.? 26.69 NI NI B 305 169 GLU A 101 GLU^? 20.45 NI NI A 304 coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -28.92 9.22 -45.08 -28.19 9.03 -44.77 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -27.78 6.23 -34.62 -28.76 7.90 -33.74 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 104 ASP^? 11.37 NI NI B 305 166 GLY B 56 GLY.? 14.39 NI NI B 305 169 GLU B 50 GLU~? 24.18 NI NI B 305 coo 8.28 6.87 1.62 10.08 5.77 1.34 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.26 -2.88 -69.60 -10.59 -2.15 -69.46 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.23 5.78 -74.13 -14.26 6.16 -75.95 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 13 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 15 TYR^? 16.16 NI NI A 304 A 172 HIS A 16 HIS^? 15.61 NI NI A 304 A 267 ASP A 177 ASP^? 15.76 CA CA A 306 coo 26.78 20.44 0.03 28.51 18.26 0.09 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 15 TYR^? 16.36 NI NI B 305 A 172 HIS B 16 HIS^? 15.81 NI NI B 305 A 267 ASP B 177 ASP^? 17.56 NI NI B 305 coo 26.78 20.44 0.03 28.51 18.26 0.09 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 15 TYR^? 16.16 NI NI A 304 B 172 HIS A 16 HIS^? 15.61 NI NI A 304 B 267 ASP A 177 ASP^? 15.76 CA CA A 306 coo 44.86 1.98 33.27 42.75 1.12 31.67 -14.58 17.46 -30.91 -16.88 18.89 -30.21 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -13.19 18.68 -21.15 -12.48 20.64 -20.80 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 15 TYR^? 16.36 NI NI B 305 B 172 HIS B 16 HIS^? 15.81 NI NI B 305 B 267 ASP B 177 ASP^? 17.56 NI NI B 305 coo 44.86 1.98 33.27 42.75 1.12 31.67 -10.51 -20.18 -49.32 -12.54 -22.03 -49.84 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 147 ARG~? 21.93 NI NI A 304 195 HIS A 148 HIS~? 18.59 NI NI A 304 199 ASP A 145 ASP.? 18.22 NI NI A 304 coo 21.96 2.03 15.24 19.33 1.86 13.55 1.99 9.46 -40.00 3.54 12.00 -39.24 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 2.28 8.76 -34.03 2.39 9.78 -35.87 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 147 ARG.? 21.34 NI NI B 305 195 HIS B 148 HIS.? 18.38 NI NI B 305 199 ASP B 145 ASP.? 18.27 NI NI B 305 coo 21.96 2.03 15.24 19.33 1.86 13.55 3.78 -8.72 -40.00 5.97 -10.16 -41.63 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 4.18 -8.01 -46.36 4.59 -9.01 -44.53 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 2 hits 3cla_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 16 HIS^? 15.61 NI NI A 304 A 295 HIS A 22 HIS~? 21.70 NI NI A 304 A 296 HIS A 83 HIS~? 17.38 NI NI A 304 coo 65.34 65.04 50.22 63.95 63.70 51.06 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 63.46 53.34 50.98 63.08 55.39 51.17 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 64.71 54.80 47.28 63.92 56.57 48.06 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS B 16 HIS^? 15.81 NI NI B 305 A 295 HIS B 22 HIS~? 22.02 NI NI B 305 A 296 HIS B 83 HIS~? 17.68 NI NI B 305 coo 65.34 65.04 50.22 63.95 63.70 51.06 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 63.46 53.34 50.98 63.08 55.39 51.17 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 64.71 54.80 47.28 63.92 56.57 48.06 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 16 HIS^? 15.61 NI NI A 304 B 295 HIS A 22 HIS~? 21.70 NI NI A 304 B 296 HIS A 83 HIS~? 17.38 NI NI A 304 coo 20.09 23.80 58.44 19.07 25.34 59.44 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 19.00 35.58 58.05 18.83 33.61 58.74 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 22.88 34.01 57.66 22.04 32.37 58.63 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS B 16 HIS^? 15.81 NI NI B 305 B 295 HIS B 22 HIS~? 22.02 NI NI B 305 B 296 HIS B 83 HIS~? 17.68 NI NI B 305 coo 20.09 23.80 58.44 19.07 25.34 59.44 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 19.00 35.58 58.05 18.83 33.61 58.74 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 22.88 34.01 57.66 22.04 32.37 58.63 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 16 HIS^? 15.61 NI NI A 304 C 295 HIS A 22 HIS~? 21.70 NI NI A 304 C 296 HIS A 83 HIS~? 17.38 NI NI A 304 coo 56.07 24.38 61.64 57.15 25.46 60.21 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 57.19 35.56 57.82 57.34 33.47 57.88 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 53.24 34.19 58.78 54.08 32.31 58.44 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS B 16 HIS^? 15.81 NI NI B 305 C 295 HIS B 22 HIS~? 22.02 NI NI B 305 C 296 HIS B 83 HIS~? 17.68 NI NI B 305 coo 56.07 24.38 61.64 57.15 25.46 60.21 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 57.19 35.56 57.82 57.34 33.47 57.88 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 53.24 34.19 58.78 54.08 32.31 58.44 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 16 HIS^? 15.61 NI NI A 304 D 295 HIS A 22 HIS~? 21.70 NI NI A 304 D 296 HIS A 83 HIS~? 17.38 NI NI A 304 coo 61.78 113.98 49.61 62.80 115.33 50.85 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo 63.27 125.61 50.94 63.59 123.54 51.16 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 63.24 124.12 46.99 63.79 122.40 48.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS B 16 HIS^? 15.81 NI NI B 305 D 295 HIS B 22 HIS~? 22.02 NI NI B 305 D 296 HIS B 83 HIS~? 17.68 NI NI B 305 coo 61.78 113.98 49.61 62.80 115.33 50.85 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 63.27 125.61 50.94 63.59 123.54 51.16 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 63.24 124.12 46.99 63.79 122.40 48.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 2 hits 4kbp_c03 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 145 ASP.? 18.22 NI NI A 304 A 161 ARG A 147 ARG~? 21.93 NI NI A 304 A 186 HIS A 148 HIS~? 18.59 NI NI A 304 coo 18.62 26.83 58.17 18.48 28.64 57.08 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 23.76 27.69 57.88 24.05 29.81 55.69 1.99 9.46 -40.00 3.54 12.00 -39.24 coo 16.67 31.22 54.64 18.74 31.15 54.14 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 145 ASP.? 18.27 NI NI B 305 A 161 ARG B 147 ARG.? 21.34 NI NI B 305 A 186 HIS B 148 HIS.? 18.38 NI NI B 305 coo 18.62 26.83 58.17 18.48 28.64 57.08 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 23.76 27.69 57.88 24.05 29.81 55.69 3.78 -8.72 -40.00 5.97 -10.16 -41.63 coo 16.67 31.22 54.64 18.74 31.15 54.14 6.24 -3.74 -47.54 7.83 -3.67 -48.90 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 145 ASP.? 18.22 NI NI A 304 B 161 ARG A 147 ARG~? 21.93 NI NI A 304 B 186 HIS A 148 HIS~? 18.59 NI NI A 304 coo 44.53 16.44 28.54 44.89 18.45 28.77 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 39.64 19.27 28.15 40.19 21.74 29.94 1.99 9.46 -40.00 3.54 12.00 -39.24 coo 48.32 20.00 31.44 46.45 20.91 31.50 5.38 4.99 -32.76 7.02 5.39 -31.51 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP B 145 ASP.? 18.27 NI NI B 305 B 161 ARG B 147 ARG.? 21.34 NI NI B 305 B 186 HIS B 148 HIS.? 18.38 NI NI B 305 coo 44.53 16.44 28.54 44.89 18.45 28.77 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 39.64 19.27 28.15 40.19 21.74 29.94 3.78 -8.72 -40.00 5.97 -10.16 -41.63 coo 48.32 20.00 31.44 46.45 20.91 31.50 6.24 -3.74 -47.54 7.83 -3.67 -48.90 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 157 ARG.? 25.34 NI NI A 304 127 ARG A 166 ARG~? 23.27 NI NI A 304 270 GLU A 144 GLU^? 14.15 NI NI A 304 coo -1.14 25.72 1.64 0.76 28.10 1.50 9.58 14.02 -35.46 8.24 13.80 -38.23 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 5.93 17.15 -30.01 7.54 17.94 -27.52 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 166 ARG~? 23.27 NI NI A 304 127 ARG A 157 ARG.? 25.34 NI NI A 304 270 GLU A 144 GLU^? 14.15 NI NI A 304 coo -1.14 25.72 1.64 0.76 28.10 1.50 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 9.58 14.02 -35.46 8.24 13.80 -38.23 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 1.81 5.70 -30.20 2.38 3.69 -29.88 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG B 157 ARG.? 25.43 NI NI B 305 127 ARG B 166 ARG.? 22.37 NI NI B 305 270 GLU B 144 GLU^? 13.93 NI NI B 305 coo -1.14 25.72 1.64 0.76 28.10 1.50 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 2.78 -5.24 -49.99 3.13 -3.29 -50.74 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG B 166 ARG.? 22.37 NI NI B 305 127 ARG B 157 ARG.? 25.43 NI NI B 305 270 GLU B 144 GLU^? 13.93 NI NI B 305 coo -1.14 25.72 1.64 0.76 28.10 1.50 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 12.04 -10.72 -45.32 11.38 -11.87 -42.55 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 2.78 -5.24 -49.99 3.13 -3.29 -50.74 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 4 hits 5cpa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 52 ASN~? 15.92 NI NI A 304 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.27 -8.81 -14.53 -11.19 -9.68 -16.47 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 108 ASN^? 7.27 NI NI A 304 coo 5.80 63.03 55.85 5.52 65.03 56.45 -13.61 4.93 -16.45 -13.33 3.48 -17.96 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 192 ASN.? 10.14 CA CA A 302 coo 5.80 63.03 55.85 5.52 65.03 56.45 -4.75 8.04 -11.36 -5.74 9.45 -10.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 204 ASN^? 6.50 NI NI A 304 coo 5.80 63.03 55.85 5.52 65.03 56.45 -18.02 3.14 -29.01 -15.99 2.73 -28.54 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN B 52 ASN~? 15.59 NI NI B 305 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.94 6.22 -65.59 -12.73 7.00 -63.62 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN B 108 ASN^? 7.81 NI NI B 305 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 192 ASN.? 16.32 NI NI B 305 coo 5.80 63.03 55.85 5.52 65.03 56.45 -3.09 -8.84 -69.12 -3.80 -10.60 -70.09 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 204 ASN^? 6.73 NI NI B 305 coo 5.80 63.03 55.85 5.52 65.03 56.45 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 8 hits 1kbk_p00 naa= 1 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 1 3 # 1 A 26 HIS A 123 HIS.? 13.29 CA CA B 303 A 76 ASN A 204 ASN^? 6.50 NI NI A 304 A 81 ASP A 104 ASP^? 11.20 NI NI A 304 coo 4.09 43.69 67.89 2.45 42.40 68.10 -16.87 -4.00 -35.22 -16.06 -5.92 -35.48 coo 4.75 48.17 75.81 4.99 47.30 77.74 -18.02 3.14 -29.01 -15.99 2.73 -28.54 coo 0.57 50.41 73.18 0.46 48.28 73.56 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 ULMN 3 2c3x_p00 ALPHA-AMYLASE G-6 user 2 3 # 2 A 26 HIS B 123 HIS.? 14.82 NI NI B 305 A 76 ASN B 204 ASN^? 6.73 NI NI B 305 A 81 ASP B 104 ASP^? 11.37 NI NI B 305 coo 4.09 43.69 67.89 2.45 42.40 68.10 -17.13 0.41 -45.08 -16.63 2.43 -44.85 coo 4.75 48.17 75.81 4.99 47.30 77.74 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 coo 0.57 50.41 73.18 0.46 48.28 73.56 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 2c3x_p00 source 2c3x ALPHA-AMYLASE G-6 : 2 hits 2c3x_p00 naa= 3 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG B 206 ARG^? 17.11 NI NI B 305 A 188 TYR B 205 TYR^? 13.71 NI NI B 305 A 190 SER B 124 SER.? 10.06 NI NI B 305 coo 37.69 7.64 13.51 38.82 8.84 16.11 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 coo 47.14 12.10 13.73 48.75 12.33 16.01 -18.96 -12.49 -48.86 -20.25 -14.29 -50.57 coo 43.77 6.93 15.46 45.49 7.21 17.11 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 204 ASN^? 6.50 NI NI A 304 A 384 ASN B 204 ASN^? 6.73 NI NI B 305 A 385 GLU B 103 GLU^? 12.89 NI NI B 305 coo 22.28 63.17 110.61 22.47 65.06 111.53 -18.02 3.14 -29.01 -15.99 2.73 -28.54 coo 7.06 50.07 96.17 8.50 48.54 96.31 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 coo 11.59 49.83 99.41 10.92 47.97 100.16 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 1 hits 2v3r_p00 naa= 3 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 1 3 # 1 A 82 HIS A 22 HIS~? 21.70 NI NI A 304 A 166 SER A 79 SER~? 16.97 CA CA A 301 A 168 HIS A 83 HIS~? 17.38 NI NI A 304 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 2 3 # 2 A 82 HIS A 83 HIS~? 17.38 NI NI A 304 A 166 SER A 20 SER~? 13.98 CA CA A 301 A 168 HIS A 22 HIS~? 21.70 NI NI A 304 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 3 3 # 3 A 82 HIS A 83 HIS~? 17.38 NI NI A 304 A 166 SER A 79 SER~? 16.97 CA CA A 301 A 168 HIS A 22 HIS~? 21.70 NI NI A 304 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 4 3 # 4 A 82 HIS A 116 HIS^? 7.23 NI NI A 304 A 166 SER A 118 SER^? 9.86 NI NI A 304 A 168 HIS A 119 HIS^? -3.69 NI NI A 304s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -7.63 0.70 -25.42 -8.53 2.19 -24.26 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 5 3 # 5 A 82 HIS A 119 HIS^? -3.69 NI NI A 304s A 166 SER A 118 SER^? 9.86 NI NI A 304 A 168 HIS A 187 HIS^? -3.59 NI NI A 304s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -7.23 5.85 -26.66 -9.01 4.75 -26.69 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 6 3 # 6 A 82 HIS A 187 HIS^? -3.59 NI NI A 304s A 166 SER A 118 SER^? 9.86 NI NI A 304 A 168 HIS A 119 HIS^? -3.69 NI NI A 304s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -7.63 0.70 -25.42 -8.53 2.19 -24.26 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 7 3 # 7 A 82 HIS A 187 HIS^? -3.59 NI NI A 304s A 166 SER A 127 SER^? 6.45 NI NI A 304 A 168 HIS A 121 HIS.? -3.63 NI NI A 304s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -12.61 2.09 -28.60 -12.23 2.44 -26.56 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 8 3 # 8 A 82 HIS A 187 HIS^? -3.59 NI NI A 304s A 166 SER A 183 SER.? 9.24 NI NI A 304 A 168 HIS A 121 HIS.? -3.63 NI NI A 304s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -12.61 2.09 -28.60 -12.23 2.44 -26.56 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 9 3 # 9 A 82 HIS B 22 HIS~? 22.02 NI NI B 305 A 166 SER B 79 SER~? 19.41 NI NI B 305 A 168 HIS B 83 HIS~? 17.68 NI NI B 305 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 10 3 # 10 A 82 HIS B 83 HIS~? 17.68 NI NI B 305 A 166 SER B 79 SER~? 19.41 NI NI B 305 A 168 HIS B 22 HIS~? 22.02 NI NI B 305 coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 11 3 # 11 A 82 HIS B 116 HIS^? 6.69 NI NI B 305 A 166 SER B 118 SER^? 9.81 NI NI B 305 A 168 HIS B 119 HIS^? -3.53 NI NI B 305s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 12 3 # 12 A 82 HIS B 119 HIS^? -3.53 NI NI B 305s A 166 SER B 118 SER^? 9.81 NI NI B 305 A 168 HIS B 187 HIS^? -3.54 NI NI B 305s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 13 3 # 13 A 82 HIS B 187 HIS^? -3.54 NI NI B 305s A 166 SER B 118 SER^? 9.81 NI NI B 305 A 168 HIS B 119 HIS^? -3.53 NI NI B 305s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 14 3 # 14 A 82 HIS B 187 HIS^? -3.54 NI NI B 305s A 166 SER B 127 SER^? 6.61 NI NI B 305 A 168 HIS B 121 HIS.? -3.60 NI NI B 305s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 ULMN 3 2vmg_p00 FIBRONECTIN TYPE III DOMAIN PROTEIN user 15 3 # 15 A 82 HIS B 187 HIS^? -3.54 NI NI B 305s A 166 SER B 183 SER.? 9.15 NI NI B 305 A 168 HIS B 121 HIS.? -3.60 NI NI B 305s coo -0.13 -10.57 9.17 -1.77 -11.50 8.23 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -3.43 -11.92 3.54 -4.49 -13.13 1.70 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo 1.64 -11.03 4.40 1.43 -13.11 4.63 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 2vmg_p00 source 2vmg FIBRONECTIN TYPE III DOMAIN PROTEIN : 15 hits 2vmg_p00 naa= 3 ULMN 3 1emh_d00 HYDROLASE/DNA user 1 3 # 1 A 271 PRO A 67 PRO~? 18.20 NI NI A 304 A 272 LEU A 102 LEU^? 13.98 NI NI A 304 A 276 ARG A 206 ARG^? 17.65 CA CA B 303 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -28.40 5.79 -22.92 -28.95 5.93 -20.76 coo 10.97 0.43 16.73 11.31 2.11 18.06 -24.47 6.48 -28.80 -24.05 6.29 -26.69 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -22.64 0.50 -34.53 -24.99 -0.48 -36.25 ULMN 3 1emh_d00 HYDROLASE/DNA user 2 3 # 2 A 271 PRO B 67 PRO~? 18.29 NI NI B 305 A 272 LEU B 102 LEU^? 14.37 NI NI B 305 A 276 ARG B 206 ARG^? 17.11 NI NI B 305 coo 16.45 -2.42 17.59 14.58 -2.74 16.47 -26.66 -11.52 -57.18 -26.98 -11.91 -59.36 coo 10.97 0.43 16.73 11.31 2.11 18.06 -22.82 -11.61 -51.52 -22.39 -11.31 -53.62 coo 5.13 -4.12 13.47 2.16 -3.72 14.17 -22.75 -5.44 -45.58 -21.53 -3.48 -43.51 1emh_d00 source 1emh HYDROLASE/DNA : 2 hits 1emh_d00 naa= 3 ULMN 4 1mnm_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 19 ARG B 166 ARG.? 22.37 NI NI B 305 A 30 THR B 138 THR.? 18.53 NI NI B 305 A 34 VAL B 171 VAL^? 13.27 NI NI B 305 A 38 LYS B 142 LYS^? 13.37 NI NI B 305 coo 30.09 31.19 5.41 30.53 28.24 4.72 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 19.67 42.24 -1.18 20.37 41.83 -3.18 1.67 -15.56 -65.45 2.40 -14.20 -66.99 coo 18.16 36.88 2.14 19.60 35.97 0.73 -0.57 -16.29 -57.29 -2.08 -16.28 -55.70 coo 16.75 32.35 6.21 21.42 30.93 2.22 0.13 -9.81 -56.44 3.59 -4.88 -57.01 1mnm_d00 source 1mnm TRANSCRIPTION/DNA : 1 hits 1mnm_d00 naa= 4 ULMN 4 1v15_d00 HYDROLASE user 1 4 # 1 D 5 ARG A 162 ARG~? 28.37 NI NI A 304 D 51 ASP A 163 ASP~? 21.63 NI NI A 304 D 54 ARG A 166 ARG~? 23.27 NI NI A 304 D 96 ARG A 147 ARG~? 21.93 NI NI A 304 coo 26.68 123.37 35.42 27.02 123.02 38.47 6.53 22.97 -35.99 6.11 21.84 -38.80 coo 28.85 117.12 30.52 26.97 118.21 30.78 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 27.03 113.91 36.12 26.66 115.85 33.77 5.93 17.15 -30.01 7.54 17.94 -27.52 coo 15.69 117.00 39.50 16.92 119.48 40.82 1.99 9.46 -40.00 3.54 12.00 -39.24 ULMN 4 1v15_d00 HYDROLASE user 2 4 # 2 D 5 ARG B 162 ARG.? 29.21 NI NI B 305 D 51 ASP B 163 ASP.? 22.00 NI NI B 305 D 54 ARG B 166 ARG.? 22.37 NI NI B 305 D 96 ARG B 147 ARG.? 21.34 NI NI B 305 coo 26.68 123.37 35.42 27.02 123.02 38.47 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 28.85 117.12 30.52 26.97 118.21 30.78 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 27.03 113.91 36.12 26.66 115.85 33.77 10.21 -14.86 -50.61 10.48 -15.55 -53.59 coo 15.69 117.00 39.50 16.92 119.48 40.82 3.78 -8.72 -40.00 5.97 -10.16 -41.63 1v15_d00 source 1v15 HYDROLASE : 2 hits 1v15_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 8 SER.? 27.03 NI NI A 304 E 5 VAL A 11 VAL.? 20.82 NI NI A 304 E 7 ARG A 13 ARG.? 21.03 NI NI A 304 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 0.31 19.42 -44.19 0.84 20.85 -42.30 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -4.26 14.94 -40.59 -4.42 17.10 -40.24 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -9.30 18.06 -38.38 -9.20 20.86 -37.11 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER B 8 SER.? 27.12 NI NI B 305 E 5 VAL B 11 VAL.? 20.83 NI NI B 305 E 7 ARG B 13 ARG.? 21.21 NI NI B 305 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 4.51 -18.88 -36.03 5.40 -20.07 -37.94 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -0.83 -15.33 -39.74 -0.44 -17.47 -40.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -4.25 -19.48 -42.40 -4.50 -22.44 -43.20 2bsq_d00 source 2bsq TRANSCRIPTION : 2 hits 2bsq_d00 naa= 3 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 B 34 SER A 124 SER.? 9.62 NI NI A 304 B 37 ASN A 204 ASN^? 6.50 NI NI A 304 B 45 THR A 130 THR^? 12.91 NI NI A 304 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -18.02 3.14 -29.01 -15.99 2.73 -28.54 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.25 13.13 -21.25 -18.28 13.57 -20.56 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 B 34 SER A 127 SER^? 6.45 NI NI A 304 B 37 ASN A 204 ASN^? 6.50 NI NI A 304 B 45 THR A 58 THR^? 10.17 NI NI A 304 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -18.02 3.14 -29.01 -15.99 2.73 -28.54 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -16.09 0.01 -15.13 -15.43 -0.83 -17.03 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 B 34 SER A 200 SER^? 8.62 NI NI A 304 B 37 ASN A 108 ASN^? 7.27 NI NI A 304 B 45 THR A 64 THR.? 16.06 CA CA B 303 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -14.80 9.62 -16.70 -13.06 8.20 -17.63 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -13.61 4.93 -16.45 -13.33 3.48 -17.96 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -25.62 -1.76 -21.36 -26.72 -3.59 -21.63 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 B 34 SER B 124 SER.? 10.06 NI NI B 305 B 37 ASN B 204 ASN^? 6.73 NI NI B 305 B 45 THR B 130 THR^? 13.17 NI NI B 305 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -13.11 -16.31 -59.13 -14.98 -17.32 -59.67 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 B 34 SER B 127 SER^? 6.61 NI NI B 305 B 37 ASN B 204 ASN^? 6.73 NI NI B 305 B 45 THR B 58 THR^? 10.34 NI NI B 305 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -16.94 -6.91 -51.06 -15.11 -5.98 -51.62 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -15.72 -3.35 -65.18 -15.34 -2.24 -63.34 ULMN 3 2z3x_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 B 34 SER B 200 SER^? 8.90 NI NI B 305 B 37 ASN B 108 ASN^? 7.81 NI NI B 305 B 45 THR B 64 THR.? 17.22 NI NI B 305 coo -19.49 41.97 71.08 -17.37 40.80 71.17 -12.57 -12.65 -63.59 -11.16 -10.79 -62.91 coo -23.05 39.62 69.74 -22.86 39.59 67.61 -12.53 -7.57 -63.84 -12.70 -5.76 -62.76 coo -30.87 34.84 80.57 -28.94 34.51 81.49 -25.12 -3.86 -59.08 -26.20 -2.11 -58.37 2z3x_d00 source 2z3x DNA BINDING PROTEIN/DNA : 6 hits 2z3x_d00 naa= 3 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 18 SER A 20 SER~? 13.98 CA CA A 301 A 20 HIS A 83 HIS~? 17.38 NI NI A 304 A 22 LEU A 179 LEU^? 10.75 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -11.43 14.14 -25.66 -9.59 15.13 -25.11 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 18 SER A 20 SER~? 13.98 CA CA A 301 A 20 HIS A 83 HIS~? 17.38 NI NI A 304 A 22 LEU A 180 LEU^? 11.88 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -21.98 22.65 -22.42 -20.53 24.32 -21.40 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -14.60 13.44 -30.34 -16.70 13.27 -29.89 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 A 18 SER A 79 SER~? 16.97 CA CA A 301 A 20 HIS A 83 HIS~? 17.38 NI NI A 304 A 22 LEU A 179 LEU^? 10.75 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -11.43 14.14 -25.66 -9.59 15.13 -25.11 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 A 18 SER A 118 SER^? 9.86 NI NI A 304 A 20 HIS A 116 HIS^? 7.23 NI NI A 304 A 22 LEU A 110 LEU^? 11.66 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -9.23 5.57 -12.93 -7.54 4.65 -13.94 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 5 3 # 5 A 18 SER A 118 SER^? 9.86 NI NI A 304 A 20 HIS A 187 HIS^? -3.59 NI NI A 304s A 22 LEU A 179 LEU^? 10.75 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.77 1.07 -25.15 -1.27 2.29 -26.62 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -11.43 14.14 -25.66 -9.59 15.13 -25.11 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 6 3 # 6 A 18 SER A 127 SER^? 6.45 NI NI A 304 A 20 HIS A 187 HIS^? -3.59 NI NI A 304s A 22 LEU A 143 LEU^? 10.47 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -3.01 10.64 -28.74 -4.82 11.31 -27.73 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 7 3 # 7 A 18 SER A 183 SER.? 9.24 NI NI A 304 A 20 HIS A 187 HIS^? -3.59 NI NI A 304s A 22 LEU A 141 LEU^? 7.83 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -6.04 11.17 -23.18 -7.25 9.74 -24.30 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 8 3 # 8 A 18 SER A 202 SER^? 4.82 NI NI A 304 A 20 HIS A 121 HIS.? -3.63 NI NI A 304s A 22 LEU A 185 LEU.? 10.10 NI NI A 304 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -16.35 6.85 -22.26 -13.93 6.63 -22.28 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -12.61 2.09 -28.60 -12.23 2.44 -26.56 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -6.85 7.54 -32.64 -5.32 9.08 -32.41 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 9 3 # 9 A 18 SER B 20 SER~? 23.19 NI NI B 305 A 20 HIS B 83 HIS~? 17.68 NI NI B 305 A 22 LEU B 180 LEU^? 12.00 NI NI B 305 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -11.44 -16.26 -50.10 -13.47 -16.66 -50.69 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 10 3 # 10 A 18 SER B 118 SER^? 9.81 NI NI B 305 A 20 HIS B 116 HIS^? 6.69 NI NI B 305 A 22 LEU B 110 LEU^? 11.53 NI NI B 305 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -7.77 -7.70 -67.37 -6.37 -6.61 -66.12 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 11 3 # 11 A 18 SER B 118 SER^? 9.81 NI NI B 305 A 20 HIS B 187 HIS^? -3.54 NI NI B 305s A 22 LEU B 179 LEU^? 10.95 NI NI B 305 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -8.09 -16.27 -54.87 -6.09 -16.98 -55.28 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 12 3 # 12 A 18 SER B 127 SER^? 6.61 NI NI B 305 A 20 HIS B 187 HIS^? -3.54 NI NI B 305s A 22 LEU B 143 LEU^? 10.73 NI NI B 305 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -0.80 -11.24 -52.39 -2.14 -12.40 -51.23 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 13 3 # 13 A 18 SER B 183 SER.? 9.15 NI NI B 305 A 20 HIS B 187 HIS^? -3.54 NI NI B 305s A 22 LEU B 141 LEU^? 8.26 NI NI B 305 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -3.54 -12.50 -57.35 -4.65 -11.53 -55.74 ULMN 3 3gxq_d00 DNA BINDING PROTEIN/DNA user 14 3 # 14 A 18 SER B 202 SER^? 5.31 NI NI B 305 A 20 HIS B 121 HIS.? -3.60 NI NI B 305s A 22 LEU B 185 LEU.? 10.00 NI NI B 305 coo -2.78 -5.11 11.04 -4.18 -3.84 9.51 -14.59 -10.21 -57.96 -12.31 -9.58 -58.46 coo -8.47 -0.77 9.86 -9.21 0.76 8.62 -11.85 -4.68 -51.78 -11.37 -4.89 -53.81 coo -14.55 2.62 13.63 -14.94 2.66 11.50 -5.18 -8.78 -47.78 -3.39 -10.02 -47.93 3gxq_d00 source 3gxq DNA BINDING PROTEIN/DNA : 14 hits 3gxq_d00 naa= 3 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG B 162 ARG.? 29.21 NI NI B 305 B 148 LYS B 142 LYS^? 13.37 NI NI B 305 B 151 LEU B 143 LEU^? 10.73 NI NI B 305 B 154 ILE B 169 ILE^? 15.39 NI NI B 305 coo 13.00 32.05 60.31 16.02 31.73 59.80 11.46 -20.60 -44.52 11.73 -20.08 -41.52 coo 11.05 44.13 44.68 12.77 44.45 49.56 0.13 -9.81 -56.44 3.59 -4.88 -57.01 coo 11.72 38.91 44.77 13.11 39.67 46.23 -0.80 -11.24 -52.39 -2.14 -12.40 -51.23 coo 7.03 36.97 46.99 7.83 37.90 47.52 2.20 -13.90 -51.75 2.90 -15.11 -51.52 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 1 hits 3odc_d00 naa= 4 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 G 386 ARG A 198 ARG^? 13.22 CA CA A 306 G 387 HIS A 116 HIS^? 7.23 NI NI A 304 G 390 SER A 115 SER.? 13.22 NI NI A 304 coo 93.17 52.97 31.81 95.66 54.71 32.14 -7.58 10.63 -14.31 -5.28 12.67 -14.13 coo 95.60 53.07 40.31 97.10 52.52 41.67 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 93.25 46.91 38.79 94.12 47.43 36.62 -4.09 2.55 -15.69 -1.77 3.10 -15.16 ULMN 3 3qrf_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 G 386 ARG B 198 ARG^? 13.15 NI NI B 305 G 387 HIS B 116 HIS^? 6.69 NI NI B 305 G 390 SER B 115 SER.? 13.16 NI NI B 305 coo 93.17 52.97 31.81 95.66 54.71 32.14 -6.07 -11.42 -65.42 -3.04 -11.97 -65.24 coo 95.60 53.07 40.31 97.10 52.52 41.67 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 93.25 46.91 38.79 94.12 47.43 36.62 -3.54 -3.63 -64.68 -1.18 -3.44 -65.30 3qrf_d00 source 3qrf DNA BINDING PROTEIN/DNA : 2 hits 3qrf_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 22 HIS~? 21.70 NI NI A 304 A 208 ASP A 90 ASP~? 20.31 NI NI A 304 A 296 SER A 139 SER.? 15.61 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 18.47 29.19 29.68 19.30 29.17 27.75 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo 6.89 17.22 46.63 5.08 16.21 47.91 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 116 HIS^? 7.23 NI NI A 304 A 208 ASP A 197 ASP.? 9.27 CA CA A 306 A 296 SER A 79 SER~? 16.97 CA CA A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo 18.47 29.19 29.68 19.30 29.17 27.75 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo 6.89 17.22 46.63 5.08 16.21 47.91 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS A 119 HIS^? -3.69 NI NI A 304s A 208 ASP A 104 ASP^? 11.20 NI NI A 304 A 296 SER B 183 SER.? 9.15 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 18.47 29.19 29.68 19.30 29.17 27.75 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 6.89 17.22 46.63 5.08 16.21 47.91 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o00 PORIN D user 4 3 # 4 A 156 HIS A 119 HIS^? -3.69 NI NI A 304s A 208 ASP A 145 ASP.? 18.22 NI NI A 304 A 296 SER B 183 SER.? 9.15 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo 18.47 29.19 29.68 19.30 29.17 27.75 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 6.89 17.22 46.63 5.08 16.21 47.91 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o00 PORIN D user 5 3 # 5 A 156 HIS A 148 HIS~? 18.59 NI NI A 304 A 208 ASP A 163 ASP~? 21.63 NI NI A 304 A 296 SER A 124 SER.? 9.62 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 6.89 17.22 46.63 5.08 16.21 47.91 -16.69 2.20 -34.43 -16.43 1.36 -32.16 ULMN 3 2odj_o00 PORIN D user 6 3 # 6 A 156 HIS A 148 HIS~? 18.59 NI NI A 304 A 208 ASP A 163 ASP~? 21.63 NI NI A 304 A 296 SER A 202 SER^? 4.82 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 5.38 4.99 -32.76 7.02 5.39 -31.51 coo 18.47 29.19 29.68 19.30 29.17 27.75 1.30 20.20 -30.86 1.78 20.99 -28.95 coo 6.89 17.22 46.63 5.08 16.21 47.91 -16.35 6.85 -22.26 -13.93 6.63 -22.28 ULMN 3 2odj_o00 PORIN D user 7 3 # 7 A 156 HIS A 187 HIS^? -3.59 NI NI A 304s A 208 ASP A 104 ASP^? 11.20 NI NI A 304 A 296 SER A 20 SER~? 13.98 CA CA A 301 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 18.47 29.19 29.68 19.30 29.17 27.75 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 6.89 17.22 46.63 5.08 16.21 47.91 -21.98 22.65 -22.42 -20.53 24.32 -21.40 ULMN 3 2odj_o00 PORIN D user 8 3 # 8 A 156 HIS A 187 HIS^? -3.59 NI NI A 304s A 208 ASP A 104 ASP^? 11.20 NI NI A 304 A 296 SER B 183 SER.? 9.15 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 18.47 29.19 29.68 19.30 29.17 27.75 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo 6.89 17.22 46.63 5.08 16.21 47.91 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o00 PORIN D user 9 3 # 9 A 156 HIS A 187 HIS^? -3.59 NI NI A 304s A 208 ASP A 145 ASP.? 18.22 NI NI A 304 A 296 SER B 183 SER.? 9.15 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo 18.47 29.19 29.68 19.30 29.17 27.75 2.28 8.76 -34.03 2.39 9.78 -35.87 coo 6.89 17.22 46.63 5.08 16.21 47.91 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o00 PORIN D user 10 3 # 10 A 156 HIS B 16 HIS^? 15.81 NI NI B 305 A 208 ASP B 163 ASP.? 22.00 NI NI B 305 A 296 SER B 194 SER.? 19.35 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo 18.47 29.19 29.68 19.30 29.17 27.75 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 6.89 17.22 46.63 5.08 16.21 47.91 -0.75 -12.31 -73.01 -2.71 -13.39 -72.05 ULMN 3 2odj_o00 PORIN D user 11 3 # 11 A 156 HIS B 116 HIS^? 6.69 NI NI B 305 A 208 ASP B 197 ASP.? 18.81 NI NI B 305 A 296 SER B 79 SER~? 19.41 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo 18.47 29.19 29.68 19.30 29.17 27.75 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo 6.89 17.22 46.63 5.08 16.21 47.91 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 2odj_o00 PORIN D user 12 3 # 12 A 156 HIS B 119 HIS^? -3.53 NI NI B 305s A 208 ASP B 104 ASP^? 11.37 NI NI B 305 A 296 SER A 183 SER.? 9.24 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 18.47 29.19 29.68 19.30 29.17 27.75 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 6.89 17.22 46.63 5.08 16.21 47.91 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o00 PORIN D user 13 3 # 13 A 156 HIS B 119 HIS^? -3.53 NI NI B 305s A 208 ASP B 145 ASP.? 18.27 NI NI B 305 A 296 SER A 183 SER.? 9.24 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo 18.47 29.19 29.68 19.30 29.17 27.75 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 6.89 17.22 46.63 5.08 16.21 47.91 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o00 PORIN D user 14 3 # 14 A 156 HIS B 148 HIS.? 18.38 NI NI B 305 A 208 ASP B 163 ASP.? 22.00 NI NI B 305 A 296 SER B 124 SER.? 10.06 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 18.47 29.19 29.68 19.30 29.17 27.75 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 6.89 17.22 46.63 5.08 16.21 47.91 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 ULMN 3 2odj_o00 PORIN D user 15 3 # 15 A 156 HIS B 148 HIS.? 18.38 NI NI B 305 A 208 ASP B 163 ASP.? 22.00 NI NI B 305 A 296 SER B 202 SER^? 5.31 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo 18.47 29.19 29.68 19.30 29.17 27.75 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo 6.89 17.22 46.63 5.08 16.21 47.91 -14.59 -10.21 -57.96 -12.31 -9.58 -58.46 ULMN 3 2odj_o00 PORIN D user 16 3 # 16 A 156 HIS B 187 HIS^? -3.54 NI NI B 305s A 208 ASP B 104 ASP^? 11.37 NI NI B 305 A 296 SER A 183 SER.? 9.24 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 6.89 17.22 46.63 5.08 16.21 47.91 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o00 PORIN D user 17 3 # 17 A 156 HIS B 187 HIS^? -3.54 NI NI B 305s A 208 ASP B 104 ASP^? 11.37 NI NI B 305 A 296 SER B 20 SER~? 23.19 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo 6.89 17.22 46.63 5.08 16.21 47.91 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 ULMN 3 2odj_o00 PORIN D user 18 3 # 18 A 156 HIS B 187 HIS^? -3.54 NI NI B 305s A 208 ASP B 145 ASP.? 18.27 NI NI B 305 A 296 SER A 183 SER.? 9.24 NI NI A 304 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo 6.89 17.22 46.63 5.08 16.21 47.91 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o00 PORIN D user 19 3 # 19 A 156 HIS B 187 HIS^? -3.54 NI NI B 305s A 208 ASP B 177 ASP^? 17.56 NI NI B 305 A 296 SER B 62 SER.? 17.58 NI NI B 305 coo 12.72 17.48 24.71 12.80 19.37 23.81 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo 18.47 29.19 29.68 19.30 29.17 27.75 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo 6.89 17.22 46.63 5.08 16.21 47.91 -22.39 0.18 -63.59 -22.61 -0.21 -65.96 2odj_o00 source 2ODJ PORIN D : 19 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 22 HIS~? 21.70 NI NI A 304 B 208 ASP A 90 ASP~? 20.31 NI NI A 304 B 296 SER A 139 SER.? 15.61 NI NI A 304 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -14.57 18.81 -37.83 -12.52 19.38 -37.82 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 116 HIS^? 7.23 NI NI A 304 B 208 ASP A 197 ASP.? 9.27 CA CA A 306 B 296 SER A 79 SER~? 16.97 CA CA A 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.88 2.26 -18.66 -9.47 2.70 -17.37 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -12.14 8.73 -7.75 -12.16 7.25 -6.26 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -25.42 16.48 -26.01 -23.81 17.85 -24.82 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS A 119 HIS^? -3.69 NI NI A 304s B 208 ASP A 104 ASP^? 11.20 NI NI A 304 B 296 SER B 183 SER.? 9.15 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS A 119 HIS^? -3.69 NI NI A 304s B 208 ASP A 145 ASP.? 18.22 NI NI A 304 B 296 SER B 183 SER.? 9.15 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.63 0.70 -25.42 -8.53 2.19 -24.26 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o01 PORIN D user 5 3 # 5 B 156 HIS A 148 HIS~? 18.59 NI NI A 304 B 208 ASP A 163 ASP~? 21.63 NI NI A 304 B 296 SER A 202 SER^? 4.82 NI NI A 304 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 1.30 20.20 -30.86 1.78 20.99 -28.95 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -16.35 6.85 -22.26 -13.93 6.63 -22.28 ULMN 3 2odj_o01 PORIN D user 6 3 # 6 B 156 HIS A 187 HIS^? -3.59 NI NI A 304s B 208 ASP A 104 ASP^? 11.20 NI NI A 304 B 296 SER A 20 SER~? 13.98 CA CA A 301 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -21.98 22.65 -22.42 -20.53 24.32 -21.40 ULMN 3 2odj_o01 PORIN D user 7 3 # 7 B 156 HIS A 187 HIS^? -3.59 NI NI A 304s B 208 ASP A 104 ASP^? 11.20 NI NI A 304 B 296 SER B 183 SER.? 9.15 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -20.27 0.99 -26.46 -20.60 -0.84 -27.46 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o01 PORIN D user 8 3 # 8 B 156 HIS A 187 HIS^? -3.59 NI NI A 304s B 208 ASP A 145 ASP.? 18.22 NI NI A 304 B 296 SER B 183 SER.? 9.15 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.23 5.85 -26.66 -9.01 4.75 -26.69 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 ULMN 3 2odj_o01 PORIN D user 9 3 # 9 B 156 HIS B 116 HIS^? 6.69 NI NI B 305 B 208 ASP B 197 ASP.? 18.81 NI NI B 305 B 296 SER B 79 SER~? 19.41 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.49 -3.87 -61.28 -9.28 -4.07 -62.35 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -9.89 -11.06 -72.57 -10.14 -9.55 -74.03 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 ULMN 3 2odj_o01 PORIN D user 10 3 # 10 B 156 HIS B 119 HIS^? -3.53 NI NI B 305s B 208 ASP B 104 ASP^? 11.37 NI NI B 305 B 296 SER A 183 SER.? 9.24 NI NI A 304 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o01 PORIN D user 11 3 # 11 B 156 HIS B 119 HIS^? -3.53 NI NI B 305s B 208 ASP B 145 ASP.? 18.27 NI NI B 305 B 296 SER A 183 SER.? 9.24 NI NI A 304 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -7.49 -2.20 -55.02 -8.07 -3.82 -56.22 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o01 PORIN D user 12 3 # 12 B 156 HIS B 148 HIS.? 18.38 NI NI B 305 B 208 ASP B 163 ASP.? 22.00 NI NI B 305 B 296 SER B 202 SER^? 5.31 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 5.53 -18.94 -49.54 6.46 -20.22 -50.93 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -14.59 -10.21 -57.96 -12.31 -9.58 -58.46 ULMN 3 2odj_o01 PORIN D user 13 3 # 13 B 156 HIS B 187 HIS^? -3.54 NI NI B 305s B 208 ASP B 104 ASP^? 11.37 NI NI B 305 B 296 SER A 183 SER.? 9.24 NI NI A 304 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -11.85 5.13 -33.39 -14.24 4.93 -33.29 ULMN 3 2odj_o01 PORIN D user 14 3 # 14 B 156 HIS B 187 HIS^? -3.54 NI NI B 305s B 208 ASP B 104 ASP^? 11.37 NI NI B 305 B 296 SER B 20 SER~? 23.19 NI NI B 305 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -19.74 -5.13 -53.85 -20.36 -3.51 -52.65 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -16.50 -27.06 -57.74 -14.71 -28.41 -58.64 ULMN 3 2odj_o01 PORIN D user 15 3 # 15 B 156 HIS B 187 HIS^? -3.54 NI NI B 305s B 208 ASP B 145 ASP.? 18.27 NI NI B 305 B 296 SER A 183 SER.? 9.24 NI NI A 304 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -5.88 -7.37 -53.55 -7.83 -6.62 -53.76 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -11.85 5.13 -33.39 -14.24 4.93 -33.29 2odj_o01 source 2ODJ PORIN D : 15 hits 2odj_o01 naa= 3 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 A 75 SER A 79 SER~? 16.97 CA CA A 301 A 138 ASP A 21 ASP~? 19.27 CA CA A 301 A 165 HIS A 22 HIS~? 21.70 NI NI A 304 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 A 75 SER A 79 SER~? 16.97 CA CA A 301 A 138 ASP A 21 ASP~? 19.27 CA CA A 301 A 165 HIS A 83 HIS~? 17.38 NI NI A 304 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 3 3 # 3 A 75 SER B 79 SER~? 19.41 NI NI B 305 A 138 ASP B 21 ASP~? 22.52 NI NI B 305 A 165 HIS B 22 HIS~? 22.02 NI NI B 305 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 2qs9_o00 RETINOBLASTOMA-BINDING PROTEIN 9 user 4 3 # 4 A 75 SER B 79 SER~? 19.41 NI NI B 305 A 138 ASP B 21 ASP~? 22.52 NI NI B 305 A 165 HIS B 83 HIS~? 17.68 NI NI B 305 coo -3.36 14.75 15.05 -1.15 14.48 16.07 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -1.70 6.81 20.56 -1.10 8.43 19.35 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 0.22 9.72 16.41 -0.34 11.71 16.80 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 2qs9_o00 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 4 hits 2qs9_o00 naa= 3 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 1 3 # 1 B 75 SER A 79 SER~? 16.97 CA CA A 301 B 138 ASP A 21 ASP~? 19.27 CA CA A 301 B 165 HIS A 22 HIS~? 21.70 NI NI A 304 coo 6.59 48.30 3.28 6.43 48.98 5.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 13.13 55.06 6.15 11.38 53.90 6.43 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.83 53.78 5.96 7.73 51.68 6.00 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 2 3 # 2 B 75 SER A 79 SER~? 16.97 CA CA A 301 B 138 ASP A 21 ASP~? 19.27 CA CA A 301 B 165 HIS A 83 HIS~? 17.38 NI NI A 304 coo 6.59 48.30 3.28 6.43 48.98 5.63 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 13.13 55.06 6.15 11.38 53.90 6.43 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.83 53.78 5.96 7.73 51.68 6.00 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 3 3 # 3 B 75 SER B 79 SER~? 19.41 NI NI B 305 B 138 ASP B 21 ASP~? 22.52 NI NI B 305 B 165 HIS B 22 HIS~? 22.02 NI NI B 305 coo 6.59 48.30 3.28 6.43 48.98 5.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 13.13 55.06 6.15 11.38 53.90 6.43 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.83 53.78 5.96 7.73 51.68 6.00 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 2qs9_o01 RETINOBLASTOMA-BINDING PROTEIN 9 user 4 3 # 4 B 75 SER B 79 SER~? 19.41 NI NI B 305 B 138 ASP B 21 ASP~? 22.52 NI NI B 305 B 165 HIS B 83 HIS~? 17.68 NI NI B 305 coo 6.59 48.30 3.28 6.43 48.98 5.63 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 13.13 55.06 6.15 11.38 53.90 6.43 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.83 53.78 5.96 7.73 51.68 6.00 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 2qs9_o01 source 2QS9 RETINOBLASTOMA-BINDING PROTEIN 9 : 4 hits 2qs9_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 124 SER.? 9.62 NI NI A 304 A 166 PHE A 93 PHE.? 18.21 NI NI A 304 A 182 PHE A 87 PHE~? 14.67 NI NI A 304 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -16.69 10.81 -41.88 -14.54 9.88 -40.35 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -15.23 15.08 -34.28 -12.65 14.01 -34.51 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 127 SER^? 6.45 NI NI A 304 A 166 PHE A 87 PHE~? 14.67 NI NI A 304 A 182 PHE A 93 PHE.? 18.21 NI NI A 304 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.69 10.81 -41.88 -14.54 9.88 -40.35 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 183 SER.? 9.24 NI NI A 304 A 166 PHE A 87 PHE~? 14.67 NI NI A 304 A 182 PHE A 93 PHE.? 18.21 NI NI A 304 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -16.69 10.81 -41.88 -14.54 9.88 -40.35 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER B 124 SER.? 10.06 NI NI B 305 A 166 PHE B 93 PHE.? 12.64 CA CA B 303 A 182 PHE B 87 PHE~? 14.92 NI NI B 305 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 127 SER^? 6.61 NI NI B 305 A 166 PHE B 87 PHE~? 14.92 NI NI B 305 A 182 PHE B 93 PHE.? 12.64 CA CA B 303 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 183 SER.? 9.15 NI NI B 305 A 166 PHE B 87 PHE~? 14.92 NI NI B 305 A 182 PHE B 93 PHE.? 12.64 CA CA B 303 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 124 SER.? 9.62 NI NI A 304 B 166 PHE A 93 PHE.? 18.21 NI NI A 304 B 182 PHE A 87 PHE~? 14.67 NI NI A 304 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -16.69 10.81 -41.88 -14.54 9.88 -40.35 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -15.23 15.08 -34.28 -12.65 14.01 -34.51 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 127 SER^? 6.45 NI NI A 304 B 166 PHE A 87 PHE~? 14.67 NI NI A 304 B 182 PHE A 93 PHE.? 18.21 NI NI A 304 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -16.69 10.81 -41.88 -14.54 9.88 -40.35 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER B 124 SER.? 10.06 NI NI B 305 B 166 PHE B 93 PHE.? 12.64 CA CA B 303 B 182 PHE B 87 PHE~? 14.92 NI NI B 305 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER B 127 SER^? 6.61 NI NI B 305 B 166 PHE B 87 PHE~? 14.92 NI NI B 305 B 182 PHE B 93 PHE.? 12.64 CA CA B 303 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 124 SER.? 9.62 NI NI A 304 C 166 PHE A 93 PHE.? 18.21 NI NI A 304 C 182 PHE A 87 PHE~? 14.67 NI NI A 304 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -16.69 10.81 -41.88 -14.54 9.88 -40.35 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -15.23 15.08 -34.28 -12.65 14.01 -34.51 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 127 SER^? 6.45 NI NI A 304 C 166 PHE A 87 PHE~? 14.67 NI NI A 304 C 182 PHE A 93 PHE.? 18.21 NI NI A 304 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.69 10.81 -41.88 -14.54 9.88 -40.35 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 183 SER.? 9.24 NI NI A 304 C 166 PHE A 87 PHE~? 14.67 NI NI A 304 C 182 PHE A 93 PHE.? 18.21 NI NI A 304 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -11.85 5.13 -33.39 -14.24 4.93 -33.29 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -16.69 10.81 -41.88 -14.54 9.88 -40.35 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER B 124 SER.? 10.06 NI NI B 305 C 166 PHE B 93 PHE.? 12.64 CA CA B 303 C 182 PHE B 87 PHE~? 14.92 NI NI B 305 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER B 127 SER^? 6.61 NI NI B 305 C 166 PHE B 87 PHE~? 14.92 NI NI B 305 C 182 PHE B 93 PHE.? 12.64 CA CA B 303 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER B 183 SER.? 9.15 NI NI B 305 C 166 PHE B 87 PHE~? 14.92 NI NI B 305 C 182 PHE B 93 PHE.? 12.64 CA CA B 303 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -10.52 -7.57 -46.92 -12.88 -7.91 -47.22 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 6 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 124 SER.? 9.62 NI NI A 304 D 166 PHE A 93 PHE.? 18.21 NI NI A 304 D 182 PHE A 87 PHE~? 14.67 NI NI A 304 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -16.69 2.20 -34.43 -16.43 1.36 -32.16 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -16.69 10.81 -41.88 -14.54 9.88 -40.35 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -15.23 15.08 -34.28 -12.65 14.01 -34.51 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 127 SER^? 6.45 NI NI A 304 D 166 PHE A 87 PHE~? 14.67 NI NI A 304 D 182 PHE A 93 PHE.? 18.21 NI NI A 304 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.78 7.24 -29.97 -14.14 4.91 -30.21 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -15.23 15.08 -34.28 -12.65 14.01 -34.51 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -16.69 10.81 -41.88 -14.54 9.88 -40.35 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER B 124 SER.? 10.06 NI NI B 305 D 166 PHE B 93 PHE.? 12.64 CA CA B 303 D 182 PHE B 87 PHE~? 14.92 NI NI B 305 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -15.84 -5.66 -45.77 -16.30 -5.05 -48.07 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER B 127 SER^? 6.61 NI NI B 305 D 166 PHE B 87 PHE~? 14.92 NI NI B 305 D 182 PHE B 93 PHE.? 12.64 CA CA B 303 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -12.93 -10.30 -50.35 -12.81 -7.89 -50.08 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -11.66 -18.10 -46.00 -9.30 -16.59 -45.86 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -13.98 -14.25 -38.58 -12.12 -12.70 -40.01 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 4 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 22 HIS~? 21.70 NI NI A 304 A 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 22 HIS~? 21.70 NI NI A 304 A 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 83 HIS~? 17.38 NI NI A 304 A 250 ALA A 82 ALA~? 21.17 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -24.62 16.98 -31.39 -25.35 18.12 -30.70 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 83 HIS~? 17.38 NI NI A 304 A 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 A 49 ASP A 21 ASP~? 19.27 CA CA A 301 A 86 HIS A 83 HIS~? 17.38 NI NI A 304 A 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 22 HIS~? 22.02 NI NI B 305 A 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 22 HIS~? 22.02 NI NI B 305 A 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 83 HIS~? 17.68 NI NI B 305 A 250 ALA B 82 ALA~? 21.25 NI NI B 305 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 83 HIS~? 17.68 NI NI B 305 A 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 A 49 ASP B 21 ASP~? 22.52 NI NI B 305 A 86 HIS B 83 HIS~? 17.68 NI NI B 305 A 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 10 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 21 ASP~? 19.27 CA CA A 301 B 86 HIS A 22 HIS~? 21.70 NI NI A 304 B 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 21 ASP~? 19.27 CA CA A 301 B 86 HIS A 22 HIS~? 21.70 NI NI A 304 B 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP A 21 ASP~? 19.27 CA CA A 301 B 86 HIS A 83 HIS~? 17.38 NI NI A 304 B 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP A 21 ASP~? 19.27 CA CA A 301 B 86 HIS A 83 HIS~? 17.38 NI NI A 304 B 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 B 49 ASP B 21 ASP~? 22.52 NI NI B 305 B 86 HIS B 22 HIS~? 22.02 NI NI B 305 B 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 B 49 ASP B 21 ASP~? 22.52 NI NI B 305 B 86 HIS B 22 HIS~? 22.02 NI NI B 305 B 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 B 49 ASP B 21 ASP~? 22.52 NI NI B 305 B 86 HIS B 83 HIS~? 17.68 NI NI B 305 B 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 B 49 ASP B 21 ASP~? 22.52 NI NI B 305 B 86 HIS B 83 HIS~? 17.68 NI NI B 305 B 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 21 ASP~? 19.27 CA CA A 301 C 86 HIS A 22 HIS~? 21.70 NI NI A 304 C 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 21 ASP~? 19.27 CA CA A 301 C 86 HIS A 22 HIS~? 21.70 NI NI A 304 C 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP A 21 ASP~? 19.27 CA CA A 301 C 86 HIS A 83 HIS~? 17.38 NI NI A 304 C 250 ALA A 82 ALA~? 21.17 NI NI A 304 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -24.62 16.98 -31.39 -25.35 18.12 -30.70 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP A 21 ASP~? 19.27 CA CA A 301 C 86 HIS A 83 HIS~? 17.38 NI NI A 304 C 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 C 49 ASP A 21 ASP~? 19.27 CA CA A 301 C 86 HIS A 83 HIS~? 17.38 NI NI A 304 C 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 C 49 ASP A 81 ASP~? 18.70 NI NI A 304 C 86 HIS A 83 HIS~? 17.38 NI NI A 304 C 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -26.56 13.16 -30.46 -27.24 11.22 -29.94 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 C 49 ASP B 21 ASP~? 22.52 NI NI B 305 C 86 HIS B 22 HIS~? 22.02 NI NI B 305 C 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 C 49 ASP B 21 ASP~? 22.52 NI NI B 305 C 86 HIS B 22 HIS~? 22.02 NI NI B 305 C 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 C 49 ASP B 21 ASP~? 22.52 NI NI B 305 C 86 HIS B 83 HIS~? 17.68 NI NI B 305 C 250 ALA B 82 ALA~? 21.25 NI NI B 305 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -20.32 -21.85 -49.01 -20.79 -23.12 -49.71 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 10 3 # 10 C 49 ASP B 21 ASP~? 22.52 NI NI B 305 C 86 HIS B 83 HIS~? 17.68 NI NI B 305 C 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 11 3 # 11 C 49 ASP B 21 ASP~? 22.52 NI NI B 305 C 86 HIS B 83 HIS~? 17.68 NI NI B 305 C 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 11 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 21 ASP~? 19.27 CA CA A 301 D 86 HIS A 22 HIS~? 21.70 NI NI A 304 D 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 21 ASP~? 19.27 CA CA A 301 D 86 HIS A 83 HIS~? 17.38 NI NI A 304 D 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP B 21 ASP~? 22.52 NI NI B 305 D 86 HIS B 22 HIS~? 22.02 NI NI B 305 D 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP B 21 ASP~? 22.52 NI NI B 305 D 86 HIS B 83 HIS~? 17.68 NI NI B 305 D 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 21 ASP~? 19.27 CA CA A 301 E 86 HIS A 22 HIS~? 21.70 NI NI A 304 E 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 21 ASP~? 19.27 CA CA A 301 E 86 HIS A 22 HIS~? 21.70 NI NI A 304 E 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP A 21 ASP~? 19.27 CA CA A 301 E 86 HIS A 83 HIS~? 17.38 NI NI A 304 E 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP A 21 ASP~? 19.27 CA CA A 301 E 86 HIS A 83 HIS~? 17.38 NI NI A 304 E 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 E 49 ASP B 21 ASP~? 22.52 NI NI B 305 E 86 HIS B 22 HIS~? 22.02 NI NI B 305 E 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 E 49 ASP B 21 ASP~? 22.52 NI NI B 305 E 86 HIS B 22 HIS~? 22.02 NI NI B 305 E 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 E 49 ASP B 21 ASP~? 22.52 NI NI B 305 E 86 HIS B 83 HIS~? 17.68 NI NI B 305 E 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 E 49 ASP B 21 ASP~? 22.52 NI NI B 305 E 86 HIS B 83 HIS~? 17.68 NI NI B 305 E 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 8 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 21 ASP~? 19.27 CA CA A 301 F 86 HIS A 22 HIS~? 21.70 NI NI A 304 F 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 21 ASP~? 19.27 CA CA A 301 F 86 HIS A 22 HIS~? 21.70 NI NI A 304 F 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -22.98 20.93 -29.25 -22.09 21.84 -30.91 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP A 21 ASP~? 19.27 CA CA A 301 F 86 HIS A 83 HIS~? 17.38 NI NI A 304 F 250 ALA A 85 ALA~? 20.35 NI NI A 304 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -22.28 15.15 -35.49 -23.77 15.40 -35.47 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP A 21 ASP~? 19.27 CA CA A 301 F 86 HIS A 83 HIS~? 17.38 NI NI A 304 F 250 ALA A 86 ALA~? 20.62 NI NI A 304 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -20.38 17.51 -27.93 -20.16 19.07 -26.55 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -20.35 18.44 -35.44 -20.40 19.47 -34.33 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 5 3 # 5 F 49 ASP A 145 ASP.? 18.22 NI NI A 304 F 86 HIS A 148 HIS~? 18.59 NI NI A 304 F 250 ALA A 156 ALA.? 26.30 NI NI A 304 coo -82.12 8.55 35.60 -81.93 9.84 37.19 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -84.21 11.81 39.90 -82.43 12.70 39.26 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -78.49 17.13 41.31 -79.25 15.85 41.61 13.23 10.94 -33.22 13.62 10.60 -31.79 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 6 3 # 6 F 49 ASP B 21 ASP~? 22.52 NI NI B 305 F 86 HIS B 22 HIS~? 22.02 NI NI B 305 F 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 7 3 # 7 F 49 ASP B 21 ASP~? 22.52 NI NI B 305 F 86 HIS B 22 HIS~? 22.02 NI NI B 305 F 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 8 3 # 8 F 49 ASP B 21 ASP~? 22.52 NI NI B 305 F 86 HIS B 83 HIS~? 17.68 NI NI B 305 F 250 ALA B 85 ALA~? 16.03 CA CA B 303 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -18.58 -19.74 -44.85 -19.95 -20.40 -44.93 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 9 3 # 9 F 49 ASP B 21 ASP~? 22.52 NI NI B 305 F 86 HIS B 83 HIS~? 17.68 NI NI B 305 F 250 ALA B 86 ALA~? 18.65 CA CA B 303 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -15.95 -22.50 -44.83 -15.76 -23.52 -45.94 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 9 hits 2wwt_o05 naa= 3 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 1 3 # 1 A 89 SER A 79 SER~? 16.97 CA CA A 301 A 216 ASP A 21 ASP~? 19.27 CA CA A 301 A 243 HIS A 22 HIS~? 21.70 NI NI A 304 coo 11.52 10.39 18.97 12.10 9.11 20.95 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 20.60 4.89 19.19 18.56 4.62 19.55 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 16.75 7.77 21.42 14.85 7.46 20.58 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 2 3 # 2 A 89 SER A 79 SER~? 16.97 CA CA A 301 A 216 ASP A 21 ASP~? 19.27 CA CA A 301 A 243 HIS A 83 HIS~? 17.38 NI NI A 304 coo 11.52 10.39 18.97 12.10 9.11 20.95 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 20.60 4.89 19.19 18.56 4.62 19.55 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 16.75 7.77 21.42 14.85 7.46 20.58 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 3 3 # 3 A 89 SER B 79 SER~? 19.41 NI NI B 305 A 216 ASP B 21 ASP~? 22.52 NI NI B 305 A 243 HIS B 22 HIS~? 22.02 NI NI B 305 coo 11.52 10.39 18.97 12.10 9.11 20.95 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 20.60 4.89 19.19 18.56 4.62 19.55 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 16.75 7.77 21.42 14.85 7.46 20.58 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 2xmz_o00 HYDROLASE, ALPHA/BETA HYDROLASE FOLDuser 4 3 # 4 A 89 SER B 79 SER~? 19.41 NI NI B 305 A 216 ASP B 21 ASP~? 22.52 NI NI B 305 A 243 HIS B 83 HIS~? 17.68 NI NI B 305 coo 11.52 10.39 18.97 12.10 9.11 20.95 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 20.60 4.89 19.19 18.56 4.62 19.55 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 16.75 7.77 21.42 14.85 7.46 20.58 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 2xmz_o00 source 2XMZ HYDROLASE, ALPHA/BETA HYDROLASE FOLD FAMILY : 4 hits 2xmz_o00 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 103 GLU^? 14.47 CA CA B 303 A 44 ASP A 65 ASP~? 19.57 CA CA B 303 A 50 THR A 64 THR.? 16.06 CA CA B 303 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -23.83 -0.23 -30.74 -22.64 -1.94 -31.08 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -29.28 0.86 -22.94 -30.35 -0.84 -22.27 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -25.62 -1.76 -21.36 -26.72 -3.59 -21.63 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU B 103 GLU^? 12.89 NI NI B 305 A 44 ASP B 65 ASP~? 20.64 NI NI B 305 A 50 THR B 64 THR.? 17.22 NI NI B 305 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 -25.12 -3.86 -59.08 -26.20 -2.11 -58.37 3hde_o00 source 3HDE LYSOZYME : 2 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU B 103 GLU^? 12.89 NI NI B 305 B 44 ASP B 65 ASP~? 20.64 NI NI B 305 B 50 THR B 64 THR.? 17.22 NI NI B 305 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 -25.12 -3.86 -59.08 -26.20 -2.11 -58.37 3hde_o01 source 3HDE LYSOZYME : 1 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 50 GLU~? 22.49 CA CA A 302 C 44 ASP A 42 ASP~? 18.65 NI NI A 304 C 50 THR A 58 THR^? 10.17 NI NI A 304 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -12.94 -8.82 -6.13 -14.30 -9.14 -4.53 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -23.16 -1.83 -10.79 -22.81 -3.20 -12.38 coo 25.48 4.87 1.60 23.90 4.95 0.15 -16.09 0.01 -15.13 -15.43 -0.83 -17.03 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU B 103 GLU^? 12.89 NI NI B 305 C 44 ASP B 65 ASP~? 20.64 NI NI B 305 C 50 THR B 64 THR.? 17.22 NI NI B 305 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 -21.42 -4.91 -49.10 -19.88 -3.95 -47.98 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 -28.81 -6.82 -57.89 -30.04 -5.31 -58.71 coo 25.48 4.87 1.60 23.90 4.95 0.15 -25.12 -3.86 -59.08 -26.20 -2.11 -58.37 3hde_o02 source 3HDE LYSOZYME : 2 hits 3hde_o02 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 16 HIS^? 15.61 NI NI A 304 A 250 ASP A 177 ASP^? 15.76 CA CA A 306 A 328 SER A 139 SER.? 15.61 NI NI A 304 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS A 148 HIS~? 18.59 NI NI A 304 A 250 ASP A 145 ASP.? 18.22 NI NI A 304 A 328 SER A 118 SER^? 9.86 NI NI A 304 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -2.77 1.07 -25.15 -1.27 2.29 -26.62 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 3 3 # 3 A 220 HIS B 16 HIS^? 15.81 NI NI B 305 A 250 ASP B 177 ASP^? 17.56 NI NI B 305 A 328 SER B 139 SER.? 15.78 NI NI B 305 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 0.49 -14.15 -62.10 2.68 -14.18 -61.04 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 4 3 # 4 A 220 HIS B 148 HIS.? 18.38 NI NI B 305 A 250 ASP B 145 ASP.? 18.27 NI NI B 305 A 328 SER B 118 SER^? 9.81 NI NI B 305 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 4 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 16 HIS^? 15.61 NI NI A 304 B 250 ASP A 177 ASP^? 15.76 CA CA A 306 B 328 SER A 139 SER.? 15.61 NI NI A 304 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS A 148 HIS~? 18.59 NI NI A 304 B 250 ASP A 145 ASP.? 18.22 NI NI A 304 B 328 SER A 118 SER^? 9.86 NI NI A 304 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -2.77 1.07 -25.15 -1.27 2.29 -26.62 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 3 3 # 3 B 220 HIS B 16 HIS^? 15.81 NI NI B 305 B 250 ASP B 177 ASP^? 17.56 NI NI B 305 B 328 SER B 139 SER.? 15.78 NI NI B 305 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 0.49 -14.15 -62.10 2.68 -14.18 -61.04 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 4 3 # 4 B 220 HIS B 148 HIS.? 18.38 NI NI B 305 B 250 ASP B 145 ASP.? 18.27 NI NI B 305 B 328 SER B 118 SER^? 9.81 NI NI B 305 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 4 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 16 HIS^? 15.61 NI NI A 304 C 250 ASP A 177 ASP^? 15.76 CA CA A 306 C 328 SER A 139 SER.? 15.61 NI NI A 304 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -10.06 19.38 -25.76 -9.54 19.61 -23.74 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -13.19 18.68 -21.15 -12.48 20.64 -20.80 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -2.62 13.57 -18.05 -0.50 14.15 -19.08 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS A 148 HIS~? 18.59 NI NI A 304 C 250 ASP A 145 ASP.? 18.22 NI NI A 304 C 328 SER A 118 SER^? 9.86 NI NI A 304 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 5.38 4.99 -32.76 7.02 5.39 -31.51 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 2.28 8.76 -34.03 2.39 9.78 -35.87 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -2.77 1.07 -25.15 -1.27 2.29 -26.62 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 3 3 # 3 C 220 HIS B 16 HIS^? 15.81 NI NI B 305 C 250 ASP B 177 ASP^? 17.56 NI NI B 305 C 328 SER B 139 SER.? 15.78 NI NI B 305 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -5.67 -21.14 -54.74 -5.34 -21.35 -56.80 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -8.82 -21.23 -59.09 -7.75 -23.02 -59.40 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 0.49 -14.15 -62.10 2.68 -14.18 -61.04 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 4 3 # 4 C 220 HIS B 148 HIS.? 18.38 NI NI B 305 C 250 ASP B 145 ASP.? 18.27 NI NI B 305 C 328 SER B 118 SER^? 9.81 NI NI B 305 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 6.24 -3.74 -47.54 7.83 -3.67 -48.90 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 4.18 -8.01 -46.36 4.59 -9.01 -44.53 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -2.58 -1.42 -55.26 -1.16 -1.65 -53.30 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 4 hits 3nwu_o02 naa= 3 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 A 445 SER A 79 SER~? 16.97 CA CA A 301 A 524 ASP A 21 ASP~? 19.27 CA CA A 301 A 556 HIS A 22 HIS~? 21.70 NI NI A 304 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 A 445 SER A 79 SER~? 16.97 CA CA A 301 A 524 ASP A 21 ASP~? 19.27 CA CA A 301 A 556 HIS A 83 HIS~? 17.38 NI NI A 304 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 A 445 SER B 79 SER~? 19.41 NI NI B 305 A 524 ASP B 21 ASP~? 22.52 NI NI B 305 A 556 HIS B 22 HIS~? 22.02 NI NI B 305 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 3o4g_o00 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 A 445 SER B 79 SER~? 19.41 NI NI B 305 A 524 ASP B 21 ASP~? 22.52 NI NI B 305 A 556 HIS B 83 HIS~? 17.68 NI NI B 305 coo 12.47 10.19 -6.98 12.48 12.40 -7.89 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo 3.92 10.81 -9.94 5.89 11.57 -9.70 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo 7.59 13.76 -7.91 9.53 12.97 -7.82 -16.05 -21.62 -52.39 -15.59 -23.14 -53.77 3o4g_o00 source 3O4G ACYLAMINO-ACID-RELEASING ENZYME : 4 hits 3o4g_o00 naa= 3 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 1 3 # 1 C 445 SER A 79 SER~? 16.97 CA CA A 301 C 524 ASP A 21 ASP~? 19.27 CA CA A 301 C 556 HIS A 22 HIS~? 21.70 NI NI A 304 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -22.98 20.93 -29.25 -22.09 21.84 -30.91 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 2 3 # 2 C 445 SER A 79 SER~? 16.97 CA CA A 301 C 524 ASP A 21 ASP~? 19.27 CA CA A 301 C 556 HIS A 83 HIS~? 17.38 NI NI A 304 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -25.42 16.48 -26.01 -23.81 17.85 -24.82 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -20.19 23.48 -26.91 -18.56 24.69 -26.31 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -20.38 17.51 -27.93 -20.16 19.07 -26.55 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 3 3 # 3 C 445 SER B 79 SER~? 19.41 NI NI B 305 C 524 ASP B 21 ASP~? 22.52 NI NI B 305 C 556 HIS B 22 HIS~? 22.02 NI NI B 305 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59 coo -39.65 7.59 52.45 -39.69 5.70 53.46 -14.50 -27.44 -53.30 -12.66 -28.25 -53.95 coo -39.51 2.45 52.87 -38.69 1.68 54.64 -17.86 -25.50 -50.84 -16.94 -26.15 -49.07 ULMN 3 3o4g_o02 ACYLAMINO-ACID-RELEASING ENZYME user 4 3 # 4 C 445 SER B 79 SER~? 19.41 NI NI B 305 C 524 ASP B 21 ASP~? 22.52 NI NI B 305 C 556 HIS B 83 HIS~? 17.68 NI NI B 305 coo -35.83 1.21 57.61 -37.94 0.15 57.18 -21.44 -21.50 -54.43 -19.64 -22.64 -55.59